PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI,label
36043521,CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review),"Huang J, Zheng L, Sun Z, Li J.",Int J Mol Med. 2022 Oct;50(4):128. doi: 10.3892/ijmm.2022.5184. Epub 2022 Aug 31.,Huang J,Int J Mol Med,2022,31/8/2022,PMC9448295,,10.3892/ijmm.2022.5184,CDK
35552450,Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data,"Martin JM, Handorf EA, Montero AJ, Goldstein LJ.",Oncologist. 2022 Jun 8;27(6):441-446. doi: 10.1093/oncolo/oyac075.,Martin JM,Oncologist,2022,13/5/2022,PMC9177121,,10.1093/oncolo/oyac075,CDK
35982377,Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors,"Cai Z, Wang J, Li Y, Shi Q, Jin L, Li S, Zhu M, Wang Q, Wong LL, Yang W, Lai H, Gong C, Yao Y, Liu Y, Zhang J, Yao H, Liu Q.",Sci China Life Sci. 2023 Jan;66(1):94-109. doi: 10.1007/s11427-021-2140-8. Epub 2022 Aug 11.,Cai Z,Sci China Life Sci,2023,18/8/2022,,,10.1007/s11427-021-2140-8,CDK
36530984,CDK4/6 inhibitor resistance: A bibliometric analysis,"Pang J, Li H, Sheng Y.",Front Oncol. 2022 Dec 1;12:917707. doi: 10.3389/fonc.2022.917707. eCollection 2022.,Pang J,Front Oncol,2022,19/12/2022,PMC9752919,,10.3389/fonc.2022.917707,CDK
36346366,Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer,"Goodwin CM, Waters AM, Klomp JE, Javaid S, Bryant KL, Stalnecker CA, Drizyte-Miller K, Papke B, Yang R, Amparo AM, Ozkan-Dagliyan I, Baldelli E, Calvert V, Pierobon M, Sorrentino JA, Beelen AP, Bublitz N, Lüthen M, Wood KC, Petricoin EF, Sers C, McRee AJ, Cox AD, Der CJ.",Cancer Res. 2023 Jan 4;83(1):141-157. doi: 10.1158/0008-5472.CAN-22-0391.,Goodwin CM,Cancer Res,2023,8/11/2022,PMC9812941,NIHMS1849841,10.1158/0008-5472.CAN-22-0391,CDK
36176758,Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer,"Main SC, Cescon DW, Bratman SV.",Cancer Drug Resist. 2022 Jun 22;5(3):727-748. doi: 10.20517/cdr.2022.37. eCollection 2022.,Main SC,Cancer Drug Resist,2022,30/9/2022,PMC9511796,,10.20517/cdr.2022.37,CDK
37035239,"CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective","Zhou FH, Downton T, Freelander A, Hurwitz J, Caldon CE, Lim E.",Front Cell Dev Biol. 2023 Mar 22;11:1148792. doi: 10.3389/fcell.2023.1148792. eCollection 2023.,Zhou FH,Front Cell Dev Biol,2023,10/4/2023,PMC10073728,,10.3389/fcell.2023.1148792,CDK
35792620,CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma,"Xiao J, Liang J, Fan J, Hou P, Li X, Zhang H, Li K, Bu L, Li P, He M, Zhong Y, Guo L, Jia P, Xiao Q, Wu J, Peng H, Li C, Xing F, Guo D.",Cancer Res. 2022 Sep 16;82(18):3359-3374. doi: 10.1158/0008-5472.CAN-21-3656.,Xiao J,Cancer Res,2022,6/7/2022,,,10.1158/0008-5472.CAN-21-3656,CDK
36070391,The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER(+) breast cancer with mitotic aberrations,"Soria-Bretones I, Thu KL, Silvester J, Cruickshank J, El Ghamrasni S, Ba-Alawi W, Fletcher GC, Kiarash R, Elliott MJ, Chalmers JJ, Elia AC, Cheng A, Rose AAN, Bray MR, Haibe-Kains B, Mak TW, Cescon DW.",Sci Adv. 2022 Sep 9;8(36):eabq4293. doi: 10.1126/sciadv.abq4293. Epub 2022 Sep 7.,Soria-Bretones I,Sci Adv,2022,7/9/2022,PMC9451148,,10.1126/sciadv.abq4293,CDK
36071033,High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer,"Palafox M, Monserrat L, Bellet M, Villacampa G, Gonzalez-Perez A, Oliveira M, Brasó-Maristany F, Ibrahimi N, Kannan S, Mina L, Herrera-Abreu MT, Òdena A, Sánchez-Guixé M, Capelán M, Azaro A, Bruna A, Rodríguez O, Guzmán M, Grueso J, Viaplana C, Hernández J, Su F, Lin K, Clarke RB, Caldas C, Arribas J, Michiels S, García-Sanz A, Turner NC, Prat A, Nuciforo P, Dienstmann R, Verma CS, Lopez-Bigas N, Scaltriti M, Arnedos M, Saura C, Serra V.",Nat Commun. 2022 Sep 7;13(1):5258. doi: 10.1038/s41467-022-32828-6.,Palafox M,Nat Commun,2022,7/9/2022,PMC9452562,,10.1038/s41467-022-32828-6,CDK
35913398,Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6,"Sorokin AV, Kanikarla Marie P, Bitner L, Syed M, Woods M, Manyam G, Kwong LN, Johnson B, Morris VK, Jones P, Menter DG, Lee MS, Kopetz S.",Cancer Res. 2022 Sep 16;82(18):3335-3344. doi: 10.1158/0008-5472.CAN-22-0198.,Sorokin AV,Cancer Res,2022,1/8/2022,PMC9478530,,10.1158/0008-5472.CAN-22-0198,CDK
36185294,Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy - non-mitotic mechanisms of paclitaxel,"Smith ER, Huang M, Schlumbrecht MP, George SHL, Xu XX.",Front Oncol. 2022 Sep 15;12:907520. doi: 10.3389/fonc.2022.907520. eCollection 2022.,Smith ER,Front Oncol,2022,3/10/2022,PMC9520484,,10.3389/fonc.2022.907520,CDK
36074908,Breast cancer: an up-to-date review and future perspectives,"Hong R, Xu B.",Cancer Commun (Lond). 2022 Oct;42(10):913-936. doi: 10.1002/cac2.12358. Epub 2022 Sep 8.,Hong R,Cancer Commun (Lond),2022,8/9/2022,PMC9558690,,10.1002/cac2.12358,CDK
36042494,S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer,"Mo H, Liu X, Xue Y, Chen H, Guo S, Li Z, Wang S, Li C, Han J, Fu M, Song Y, Li D, Ma F.",Mol Cancer. 2022 Aug 30;21(1):171. doi: 10.1186/s12943-022-01642-5.,Mo H,Mol Cancer,2022,30/8/2022,PMC9426012,,10.1186/s12943-022-01642-5,CDK
35730565,Blocking cell cycle progression through CDK4/6 protects against chronic kidney disease,"Osaki Y, Manolopoulou M, Ivanova AV, Vartanian N, Mignemi MP, Kern J, Chen J, Yang H, Fogo AB, Zhang M, Robinson-Cohen C, Gewin LS.",JCI Insight. 2022 Jun 22;7(12):e158754. doi: 10.1172/jci.insight.158754.,Osaki Y,JCI Insight,2022,22/6/2022,PMC9309053,,10.1172/jci.insight.158754,CDK
36584672,Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma,"Liu Z, Zhao Y, Kong P, Liu Y, Huang J, Xu E, Wei W, Li G, Cheng X, Xue L, Li Y, Chen H, Wei S, Sun R, Cui H, Meng Y, Liu M, Li Y, Feng R, Yu X, Zhu R, Wu Y, Li L, Yang B, Ma Y, Wang J, Zhu W, Deng D, Xi Y, Wang F, Li H, Guo S, Zhuang X, Wang X, Jiao Y, Cui Y, Zhan Q.",Cancer Cell. 2023 Jan 9;41(1):181-195.e9. doi: 10.1016/j.ccell.2022.12.004. Epub 2022 Dec 29.,Liu Z,Cancer Cell,2023,30/12/2022,,,10.1016/j.ccell.2022.12.004,CDK
36637424,SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors,"Huang Z, Li X, Tang B, Li H, Zhang J, Sun R, Ma J, Pan Y, Yan B, Zhou Y, Ding D, Yan Y, Jimenez R, Orme JJ, Jin X, Yang J, Huang H, Jia Z.",Cancer Res. 2023 Mar 15;83(6):875-889. doi: 10.1158/0008-5472.CAN-22-0264.,Huang Z,Cancer Res,2023,13/1/2023,,,10.1158/0008-5472.CAN-22-0264,CDK
36030016,Resistance to CDK4/6 inhibition: Mechanisms and strategies to overcome a therapeutic problem in the treatment of hormone receptor-positive metastatic breast cancer,"Papadimitriou MC, Pazaiti A, Iliakopoulos K, Markouli M, Michalaki V, Papadimitriou CA.",Biochim Biophys Acta Mol Cell Res. 2022 Dec;1869(12):119346. doi: 10.1016/j.bbamcr.2022.119346. Epub 2022 Aug 24.,Papadimitriou MC,Biochim Biophys Acta Mol Cell Res,2022,27/8/2022,,,10.1016/j.bbamcr.2022.119346,CDK
35583555,"VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results","Lindeman GJ, Fernando TM, Bowen R, Jerzak KJ, Song X, Decker T, Boyle F, McCune S, Armstrong A, Shannon C, Bertelli G, Chang CW, Desai R, Gupta K, Wilson TR, Flechais A, Bardia A.",Clin Cancer Res. 2022 Aug 2;28(15):3256-3267. doi: 10.1158/1078-0432.CCR-21-3811.,Lindeman GJ,Clin Cancer Res,2022,18/5/2022,PMC9662928,,10.1158/1078-0432.CCR-21-3811,CDK
35948546,Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus,"Koch J, Schober SJ, Hindupur SV, Schöning C, Klein FG, Mantwill K, Ehrenfeld M, Schillinger U, Hohnecker T, Qi P, Steiger K, Aichler M, Gschwend JE, Nawroth R, Holm PS.",Nat Commun. 2022 Aug 10;13(1):4689. doi: 10.1038/s41467-022-32087-5.,Koch J,Nat Commun,2022,10/8/2022,PMC9365808,,10.1038/s41467-022-32087-5,CDK
35395071,Functional Genomic Analysis of CDK4 and CDK6 Gene Dependency across Human Cancer Cell Lines,"Zhang Z, Golomb L, Meyerson M.",Cancer Res. 2022 Jun 6;82(11):2171-2184. doi: 10.1158/0008-5472.CAN-21-2428.,Zhang Z,Cancer Res,2022,8/4/2022,PMC9618034,NIHMS1799066,10.1158/0008-5472.CAN-21-2428,CDK
36978197,CDK4/6 inhibitor modulating active and quiescent intestinal stem cells for prevention of chemotherapy-induced diarrhea,"Xiang J, Wang H, Tao Q, Li W, Huang Y, Zhang Y, Yang L, Zhang S.",J Pathol. 2023 Mar 28. doi: 10.1002/path.6078. Online ahead of print.,Xiang J,J Pathol,2023,28/3/2023,,,10.1002/path.6078,CDK
36375386,Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer,"Zhou J, Wu X, Zhang H, Wang X, Yuan Y, Zhang S, Jiang Z, Wang T.",Breast. 2022 Dec;66:255-261. doi: 10.1016/j.breast.2022.10.018. Epub 2022 Nov 2.,Zhou J,Breast,2022,14/11/2022,PMC9661714,,10.1016/j.breast.2022.10.018,CDK
36806814,CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation,"Xiao Y, Yan Y, Chang L, Ji H, Sun H, Song S, Feng K, Nuermaimaiti A, Lu Z, Wang L.",Antiviral Res. 2023 Apr;212:105558. doi: 10.1016/j.antiviral.2023.105558. Epub 2023 Feb 18.,Xiao Y,Antiviral Res,2023,22/2/2023,PMC9938000,,10.1016/j.antiviral.2023.105558,CDK
36399953,Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review,"Di Lauro V, Barchiesi G, Martorana F, Zucchini G, Muratore M, Fontanella C, Arpino G, Del Mastro L, Giuliano M, Puglisi F, De Laurentiis M.",ESMO Open. 2022 Dec;7(6):100629. doi: 10.1016/j.esmoop.2022.100629. Epub 2022 Nov 16.,Di Lauro V,ESMO Open,2022,18/11/2022,PMC9808450,,10.1016/j.esmoop.2022.100629,CDK
36257536,Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach,"Fontanella C, Giorgi CA, Russo S, Angelini S, Nicolardi L, Giarratano T, Frezzini S, Pestrin M, Palleschi D, Bolzonello S, Parolin V, Haspinger ER, De Rossi C, Greco F, Gerratana L.",Crit Rev Oncol Hematol. 2022 Dec;180:103848. doi: 10.1016/j.critrevonc.2022.103848. Epub 2022 Oct 17.,Fontanella C,Crit Rev Oncol Hematol,2022,18/10/2022,,,10.1016/j.critrevonc.2022.103848,CDK
36373891,Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study,"Funasaka C, Naito Y, Kusuhara S, Nakao T, Nakajima H, Kawamoto M, Baba K, Mamishin K, Kondoh C, Harano K, Matsubara N, Hosono A, Sasaki T, Kawasaki T, Mukohara T.",Jpn J Clin Oncol. 2023 Jan 28;53(2):105-114. doi: 10.1093/jjco/hyac168.,Funasaka C,Jpn J Clin Oncol,2023,14/11/2022,,,10.1093/jjco/hyac168,CDK
36548336,Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells,"Choupani E, Madjd Z, Saraygord-Afshari N, Kiani J, Hosseini A.",PLoS One. 2022 Dec 22;17(12):e0279522. doi: 10.1371/journal.pone.0279522. eCollection 2022.,Choupani E,PLoS One,2022,22/12/2022,PMC9779032,,10.1371/journal.pone.0279522,CDK
35405009,A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer,"Rodríguez Y, Unno K, Truica MI, Chalmers ZR, Yoo YA, Vatapalli R, Sagar V, Yu J, Lysy B, Hussain M, Han H, Abdulkadir SA.",Cancer Res. 2022 Jun 6;82(11):2110-2123. doi: 10.1158/0008-5472.CAN-21-3565.,Rodríguez Y,Cancer Res,2022,11/4/2022,PMC9177667,NIHMS1797195,10.1158/0008-5472.CAN-21-3565,CDK
35814226,"Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells","Sun CY, Talukder M, Cao D, Chen CW.",Front Pharmacol. 2022 Jun 23;13:829759. doi: 10.3389/fphar.2022.829759. eCollection 2022.,Sun CY,Front Pharmacol,2022,11/7/2022,PMC9262324,,10.3389/fphar.2022.829759,CDK
36871040,CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy,"Bai X, Guo ZQ, Zhang YP, Fan ZZ, Liu LJ, Liu L, Long LL, Ma SC, Wang J, Fang Y, Tang XR, Zeng YJ, Pan X, Wu DH, Dong ZY.",Nat Commun. 2023 Mar 4;14(1):1247. doi: 10.1038/s41467-023-36892-4.,Bai X,Nat Commun,2023,4/3/2023,PMC9985635,,10.1038/s41467-023-36892-4,CDK
36505864,In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts,"Passeri T, Dahmani A, Masliah-Planchon J, El Botty R, Courtois L, Vacher S, Marangoni E, Nemati F, Roman-Roman S, Adle-Biassette H, Mammar H, Froelich S, Bièche I, Decaudin D.",Front Oncol. 2022 Nov 25;12:960720. doi: 10.3389/fonc.2022.960720. eCollection 2022.,Passeri T,Front Oncol,2022,12/12/2022,PMC9732546,,10.3389/fonc.2022.960720,CDK
36135204,Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study,"D'Angelo A, Giudici F, Chapman R, Darlow J, Kilili H, Sobhani N, Cinelli M, Cappelletti MR, Strina C, Milani M, Generali D.",Curr Issues Mol Biol. 2022 Sep 15;44(9):4255-4267. doi: 10.3390/cimb44090292.,D'Angelo A,Curr Issues Mol Biol,2022,22/9/2022,PMC9497904,,10.3390/cimb44090292,CDK
36222720,Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer,"Duro-Sánchez S, Nadal-Serrano M, Lalinde-Gutiérrez M, Arenas EJ, Bernadó Morales C, Morancho B, Escorihuela M, Pérez-Ramos S, Escrivá-de-Romaní S, Gandullo-Sánchez L, Pandiella A, Esteve-Codina A, Rodilla V, Dijcks FA, Dokter WHA, Cortés J, Saura C, Arribas J.",Cancer Res. 2022 Dec 16;82(24):4670-4679. doi: 10.1158/0008-5472.CAN-22-0787.,Duro-Sánchez S,Cancer Res,2022,12/10/2022,PMC9755966,,10.1158/0008-5472.CAN-22-0787,CDK
35792876,Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset,"Febres-Aldana CA, Chang JC, Ptashkin R, Wang Y, Gedvilaite E, Baine MK, Travis WD, Ventura K, Bodd F, Yu HA, Quintanal-Villalonga A, Lai WV, Egger JV, Offin M, Ladanyi M, Rudin CM, Rekhtman N.",Clin Cancer Res. 2022 Nov 1;28(21):4702-4713. doi: 10.1158/1078-0432.CCR-22-1115.,Febres-Aldana CA,Clin Cancer Res,2022,6/7/2022,PMC9623236,NIHMS1823284,10.1158/1078-0432.CCR-22-1115,CDK
37182667,Immunomodulatory effects of CDK4/6 inhibitors,"Zhang S, Xu Q, Sun W, Zhou J, Zhou J.",Biochim Biophys Acta Rev Cancer. 2023 May 12;1878(4):188912. doi: 10.1016/j.bbcan.2023.188912. Online ahead of print.,Zhang S,Biochim Biophys Acta Rev Cancer,2023,14/5/2023,,,10.1016/j.bbcan.2023.188912,CDK
35784555,"The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D(3) Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer","Vanhevel J, Verlinden L, Loopmans S, Doms S, Janssens I, Bevers S, Stegen S, Wildiers H, Verstuyf A.",Front Endocrinol (Lausanne). 2022 Jun 17;13:886238. doi: 10.3389/fendo.2022.886238. eCollection 2022.,Vanhevel J,Front Endocrinol (Lausanne),2022,5/7/2022,PMC9248359,,10.3389/fendo.2022.886238,CDK
35917168,Targeting CDK4 and 6 in Cancer Therapy: Emerging Preclinical Insights Related to Abemaciclib,"Wander SA, O'Brien N, Litchfield LM, O'Dea D, Morato Guimaraes C, Slamon DJ, Goel S.",Oncologist. 2022 Oct 1;27(10):811-821. doi: 10.1093/oncolo/oyac138.,Wander SA,Oncologist,2022,2/8/2022,PMC9526495,,10.1093/oncolo/oyac138,CDK
36191999,Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor,"Ozawa H, Higuchi T, Fujimoto Y, Bun A, Fukui R, Kanaoka H, Nagahashi M, Kitajima K, Yamakado K, Miyoshi Y.",Anticancer Res. 2022 Oct;42(10):4813-4824. doi: 10.21873/anticanres.15986.,Ozawa H,Anticancer Res,2022,3/10/2022,,,10.21873/anticanres.15986,CDK
36620595,Case report: (18)F-FES PET/CT predicted treatment responses of second-line and third-line CDK4/6 inhibitors after disease progression on first-line CDK4/6 inhibitor in a HR+/HER2- metastatic breast cancer patient,"Pan B, Hao Z, Xu Y, Wang Z, Yao R, Wang X, Ren C, Zhou Y, Sun Q, Huo L.",Front Oncol. 2022 Dec 23;12:1095779. doi: 10.3389/fonc.2022.1095779. eCollection 2022.,Pan B,Front Oncol,2022,9/1/2023,PMC9816999,,10.3389/fonc.2022.1095779,CDK
37157005,Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer,"Sathe C, Accordino MK, DeStephano D, Shah M, Wright JD, Hershman DL.",Breast Cancer Res Treat. 2023 Jul;200(1):85-92. doi: 10.1007/s10549-023-06957-5. Epub 2023 May 8.,Sathe C,Breast Cancer Res Treat,2023,8/5/2023,,,10.1007/s10549-023-06957-5,CDK
35671774,"Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial","Howell SJ, Casbard A, Carucci M, Ingarfield K, Butler R, Morgan S, Meissner M, Bale C, Bezecny P, Moon S, Twelves C, Venkitaraman R, Waters S, de Bruin EC, Schiavon G, Foxley A, Jones RH.",Lancet Oncol. 2022 Jul;23(7):851-864. doi: 10.1016/S1470-2045(22)00284-4. Epub 2022 Jun 4.,Howell SJ,Lancet Oncol,2022,7/6/2022,PMC9630162,,10.1016/S1470-2045(22)00284-4,CDK
37133743,A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma,"Zuo P, Li Y, Wang T, Lin X, Wu Z, Zhang J, Liao X, Zhang L.",J Neurooncol. 2023 May;163(1):159-171. doi: 10.1007/s11060-023-04323-5. Epub 2023 May 3.,Zuo P,J Neurooncol,2023,3/5/2023,,,10.1007/s11060-023-04323-5,CDK
35911672,Combination Approaches to Target PD-1 Signaling in Cancer,"Moore EK, Strazza M, Mor A.",Front Immunol. 2022 Jul 14;13:927265. doi: 10.3389/fimmu.2022.927265. eCollection 2022.,Moore EK,Front Immunol,2022,1/8/2022,PMC9330480,,10.3389/fimmu.2022.927265,CDK
35545724,Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer,"O'Shaughnessy J, Brufsky A, Rugo HS, Tolaney SM, Punie K, Sardesai S, Hamilton E, Loirat D, Traina T, Leon-Ferre R, Hurvitz SA, Kalinsky K, Bardia A, Henry S, Mayer I, Zhu Y, Phan S, Cortés J.",Breast Cancer Res Treat. 2022 Sep;195(2):127-139. doi: 10.1007/s10549-022-06602-7. Epub 2022 May 11.,O'Shaughnessy J,Breast Cancer Res Treat,2022,11/5/2022,PMC9374646,,10.1007/s10549-022-06602-7,CDK
36688919,PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer,"Ali LR, Garrido-Castro AC, Lenehan PJ, Bollenrucher N, Stump CT, Dougan M, Goel S, Shapiro GI, Tolaney SM, Dougan SK.",J Exp Med. 2023 Apr 3;220(4):e20220729. doi: 10.1084/jem.20220729. Epub 2023 Jan 23.,Ali LR,J Exp Med,2023,23/1/2023,PMC9884581,,10.1084/jem.20220729,CDK
36153348,Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer,"Al-Qasem AJ, Alves CL, Ehmsen S, Tuttolomondo M, Terp MG, Johansen LE, Vever H, Hoeg LVA, Elias D, Bak M, Ditzel HJ.",NPJ Precis Oncol. 2022 Sep 24;6(1):68. doi: 10.1038/s41698-022-00311-6.,Al-Qasem AJ,NPJ Precis Oncol,2022,24/9/2022,PMC9509389,,10.1038/s41698-022-00311-6,CDK
36135712,Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2,"Goel S, Tan AR, Rugo HS, Aftimos P, Andrić Z, Beelen A, Zhang J, Yi JS, Malik R, O'Shaughnessy J.",Future Oncol. 2022 Oct;18(33):3701-3711. doi: 10.2217/fon-2022-0773. Epub 2022 Sep 22.,Goel S,Future Oncol,2022,22/9/2022,,,10.2217/fon-2022-0773,CDK
35923930,Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role,"Lloyd MR, Wander SA, Hamilton E, Razavi P, Bardia A.",Ther Adv Med Oncol. 2022 Jul 30;14:17588359221113694. doi: 10.1177/17588359221113694. eCollection 2022.,Lloyd MR,Ther Adv Med Oncol,2022,4/8/2022,PMC9340905,,10.1177/17588359221113694,CDK
36765923,CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges,"Arsenijevic T, Coulonval K, Raspé E, Demols A, Roger PP, Van Laethem JL.",Cancers (Basel). 2023 Feb 3;15(3):968. doi: 10.3390/cancers15030968.,Arsenijevic T,Cancers (Basel),2023,11/2/2023,PMC9913743,,10.3390/cancers15030968,CDK
35599231,"Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy","Witkiewicz AK, Kumarasamy V, Sanidas I, Knudsen ES.",Trends Cancer. 2022 Sep;8(9):711-725. doi: 10.1016/j.trecan.2022.04.006. Epub 2022 May 20.,Witkiewicz AK,Trends Cancer,2022,22/5/2022,PMC9388619,NIHMS1810625,10.1016/j.trecan.2022.04.006,CDK
37011871,CDK4/6 are necessary for UCP1-mediated thermogenesis of white adipose tissue,"Portales AE, Miguel I, Rodriguez MJ, Novaro V, Gambaro SE, Giovambattista A.",Life Sci. 2023 Jun 1;322:121652. doi: 10.1016/j.lfs.2023.121652. Epub 2023 Apr 1.,Portales AE,Life Sci,2023,3/4/2023,,,10.1016/j.lfs.2023.121652,CDK
37026029,A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor,"Roy T, Barrows E, Mainor C, Collins J, Lynce F, Isaacs C, Pohlmann PR.",Contemp Clin Trials Commun. 2023 Mar 13;33:101110. doi: 10.1016/j.conctc.2023.101110. eCollection 2023 Jun.,Roy T,Contemp Clin Trials Commun,2023,7/4/2023,PMC10070370,,10.1016/j.conctc.2023.101110,CDK
36719686,MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition,"Silvis MR, Silva D, Rohweder R, Schuman S, Gudipaty S, Truong A, Yap J, Affolter K, McMahon M, Kinsey C.",J Exp Med. 2023 Mar 6;220(3):e20221524. doi: 10.1084/jem.20221524. Epub 2023 Jan 31.,Silvis MR,J Exp Med,2023,31/1/2023,PMC9930170,,10.1084/jem.20221524,CDK
35732328,Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma,"Rallis KS, George AM, Wozniak AM, Bigogno CM, Chow B, Hanrahan JG, Sideris M.",Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):390-414. doi: 10.21873/cgp.20328.,Rallis KS,Cancer Genomics Proteomics,2022,22/6/2022,PMC9247880,,10.21873/cgp.20328,CDK
36498861,Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration,"Krasniqi E, Goeman F, Pulito C, Palcau AC, Ciuffreda L, Di Lisa FS, Filomeno L, Barba M, Pizzuti L, Cappuzzo F, Sanguineti G, Maugeri-Saccà M, Ciliberto G, Fanciulli M, Blandino G, Vici P.",Int J Mol Sci. 2022 Nov 22;23(23):14534. doi: 10.3390/ijms232314534.,Krasniqi E,Int J Mol Sci,2022,11/12/2022,PMC9739115,,10.3390/ijms232314534,CDK
35936714,CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells,"Digiacomo G, Fumarola C, La Monica S, Bonelli M, Cavazzoni A, Galetti M, Terenziani R, Eltayeb K, Volta F, Zoppi S, Bertolini P, Missale G, Alfieri R, Petronini PG.",Front Oncol. 2022 Jul 22;12:942341. doi: 10.3389/fonc.2022.942341. eCollection 2022.,Digiacomo G,Front Oncol,2022,8/8/2022,PMC9354684,,10.3389/fonc.2022.942341,CDK
37105116,Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21,"Mortoglou M, Miralles F, Mould RR, Sengupta D, Uysal-Onganer P.",Eur J Cell Biol. 2023 Apr 25;102(2):151318. doi: 10.1016/j.ejcb.2023.151318. Online ahead of print.,Mortoglou M,Eur J Cell Biol,2023,27/4/2023,,,10.1016/j.ejcb.2023.151318,CDK
36778419,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors,"Wang J, Calizo A, Zhang L, Pino JC, Lyu Y, Pollard K, Zhang X, Larsson AT, Conniff E, Llosa N, Wood DK, Largaespada DA, Moody SE, Gosline SJ, Hirbe AC, Pratilas CA.",bioRxiv. 2023 Feb 3:2023.02.02.526674. doi: 10.1101/2023.02.02.526674. Preprint.,Wang J,bioRxiv,2023,13/2/2023,PMC9915673,,10.1101/2023.02.02.526674,CDK
36060981,HER2-low expression does not affect the clinical outcomes of metastatic breast cancer treated with CDK4/6 inhibitor: A real-world study,"Shao Y, Luo Z, Yu Y, Chen Q, He Y, Liu C, Nie B, Zhu F, Liu H.",Front Endocrinol (Lausanne). 2022 Aug 18;13:1000704. doi: 10.3389/fendo.2022.1000704. eCollection 2022.,Shao Y,Front Endocrinol (Lausanne),2022,5/9/2022,PMC9434209,,10.3389/fendo.2022.1000704,CDK
37061331,Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesis,"Rezaeian AH, Inuzuka H, Wei W.",Adv Protein Chem Struct Biol. 2023;135:179-201. doi: 10.1016/bs.apcsb.2022.11.009. Epub 2022 Dec 19.,Rezaeian AH,Adv Protein Chem Struct Biol,2023,15/4/2023,,,10.1016/bs.apcsb.2022.11.009,CDK
36376284,Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer,"Palafox M, Monserrat L, Bellet M, Villacampa G, Gonzalez-Perez A, Oliveira M, Brasó-Maristany F, Ibrahimi N, Kannan S, Mina L, Herrera-Abreu MT, Òdena A, Sánchez-Guixé M, Capelán M, Azaro A, Bruna A, Rodríguez O, Guzmán M, Grueso J, Viaplana C, Hernández J, Su F, Lin K, Clarke RB, Caldas C, Arribas J, Michiels S, García-Sanz A, Turner NC, Prat A, Nuciforo P, Dienstmann R, Verma CS, Lopez-Bigas N, Scaltriti M, Arnedos M, Saura C, Serra V.",Nat Commun. 2022 Nov 14;13(1):6928. doi: 10.1038/s41467-022-34580-3.,Palafox M,Nat Commun,2022,14/11/2022,PMC9663725,,10.1038/s41467-022-34580-3,CDK
36402300,Molecular and clinical diversity in primary central nervous system lymphoma,"Hernández-Verdin I, Kirasic E, Wienand K, Mokhtari K, Eimer S, Loiseau H, Rousseau A, Paillassa J, Ahle G, Lerintiu F, Uro-Coste E, Oberic L, Figarella-Branger D, Chinot O, Gauchotte G, Taillandier L, Marolleau JP, Polivka M, Adam C, Ursu R, Schmitt A, Barillot N, Nichelli L, Lozano-Sánchez F, Ibañez-Juliá MJ, Peyre M, Mathon B, Abada Y, Charlotte F, Davi F, Stewart C, de Reyniès A, Choquet S, Soussain C, Houillier C, Chapuy B, Hoang-Xuan K, Alentorn A.",Ann Oncol. 2023 Feb;34(2):186-199. doi: 10.1016/j.annonc.2022.11.002. Epub 2022 Nov 17.,Hernández-Verdin I,Ann Oncol,2023,19/11/2022,,,10.1016/j.annonc.2022.11.002,CDK
36175617,Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST,"Schaefer IM, Hemming ML, Lundberg MZ, Serrata MP, Goldaracena I, Liu N, Yin P, Paulo JA, Gygi SP, George S, Morgan JA, Bertagnolli MM, Sicinska ET, Chu C, Zheng S, Mariño-Enríquez A, Hornick JL, Raut CP, Ou WB, Demetri GD, Saka SK, Fletcher JA.",Br J Cancer. 2022 Nov;127(11):2072-2085. doi: 10.1038/s41416-022-01990-5. Epub 2022 Sep 29.,Schaefer IM,Br J Cancer,2022,29/9/2022,PMC9681737,,10.1038/s41416-022-01990-5,CDK
36291780,"A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid Tumors","Patnaik A, Hamilton E, Xing Y, Rasco DW, Smith L, Lee YL, Fang S, Wei J, Hui AM.",Cancers (Basel). 2022 Oct 12;14(20):4996. doi: 10.3390/cancers14204996.,Patnaik A,Cancers (Basel),2022,27/10/2022,PMC9599640,,10.3390/cancers14204996,CDK
37190140,The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo,"Saleh L, Ottewell PD, Brown JE, Wood SL, Brown NJ, Wilson C, Park C, Ali S, Holen I.",Cancers (Basel). 2023 Apr 8;15(8):2211. doi: 10.3390/cancers15082211.,Saleh L,Cancers (Basel),2023,16/5/2023,PMC10137281,,10.3390/cancers15082211,CDK
36341983,New treatment options for hormone receptor positive breast cancer in 2023,Lüftner D.,Curr Opin Obstet Gynecol. 2023 Feb 1;35(1):62-66. doi: 10.1097/GCO.0000000000000834. Epub 2022 Nov 7.,Lüftner D,Curr Opin Obstet Gynecol,2023,7/11/2022,,,10.1097/GCO.0000000000000834,CDK
35666660,Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2- Breast Cancer at a Single Cancer Center,"Knudsen ES, Schultz E, Hamilton D, Attwood K, Edge S, O'Connor T, Levine E, Witkiewicz AK.",Oncologist. 2022 Aug 5;27(8):646-654. doi: 10.1093/oncolo/oyac089.,Knudsen ES,Oncologist,2022,6/6/2022,PMC9355808,,10.1093/oncolo/oyac089,CDK
36091147,"CDK4/6 inhibitors versus PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated systematic review and network meta-analysis of 28 randomized controlled trials","Xu H, Wang Y, Han Y, Wu Y, Wang J, Xu B.",Front Oncol. 2022 Aug 24;12:956464. doi: 10.3389/fonc.2022.956464. eCollection 2022.,Xu H,Front Oncol,2022,12/9/2022,PMC9449843,,10.3389/fonc.2022.956464,CDK
36174113,"A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer","Konstantinopoulos PA, Lee EK, Xiong N, Krasner C, Campos S, Kolin DL, Liu JF, Horowitz N, Wright AA, Bouberhan S, Penson RT, Yeku O, Bowes B, Needham H, Hayes M, Sawyer H, Polak M, Shea M, Cheng SC, Castro C, Matulonis UA.",J Clin Oncol. 2023 Jan 20;41(3):599-608. doi: 10.1200/JCO.22.00628. Epub 2022 Sep 29.,Konstantinopoulos PA,J Clin Oncol,2023,29/9/2022,,,10.1200/JCO.22.00628,CDK
35881485,Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibition,"Udden SN, Wang Q, Kumar S, Malladi VS, Wu SY, Wei S, Posner BA, Geboers S, Williams NS, Liu Y, Sharma JK, Mani RS, Malladi S, Parra K, Hofstad M, Raj GV, Larios JM, Jagsi R, Wicha MS, Park BH, Gupta GP, Chinnaiyan AM, Chiang CM, Alluri PG.",JCI Insight. 2022 Sep 8;7(17):e151851. doi: 10.1172/jci.insight.151851.,Udden SN,JCI Insight,2022,26/7/2022,PMC9536271,,10.1172/jci.insight.151851,CDK
36980743,Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel Targets,"Ashai N, Swain SM.",Cancers (Basel). 2023 Mar 20;15(6):1855. doi: 10.3390/cancers15061855.,Ashai N,Cancers (Basel),2023,29/3/2023,PMC10046856,,10.3390/cancers15061855,CDK
36760039,What's the reality for CDK4/6 inhibitors: Clinical trials or real-world evidence?,"Trapani D, Mayer EL.",Cancer. 2023 Apr 1;129(7):986-988. doi: 10.1002/cncr.34672. Epub 2023 Feb 9.,Trapani D,Cancer,2023,10/2/2023,,,10.1002/cncr.34672,CDK
36264143,A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition,"Soto-Feliciano YM, Sánchez-Rivera FJ, Perner F, Barrows DW, Kastenhuber ER, Ho YJ, Carroll T, Xiong Y, Anand D, Soshnev AA, Gates L, Beytagh MC, Cheon D, Gu S, Liu XS, Krivtsov AV, Meneses M, de Stanchina E, Stone RM, Armstrong SA, Lowe SW, Allis CD.",Cancer Discov. 2023 Jan 9;13(1):146-169. doi: 10.1158/2159-8290.CD-22-0416.,Soto-Feliciano YM,Cancer Discov,2023,20/10/2022,PMC9827117,NIHMS1845459,10.1158/2159-8290.CD-22-0416,CDK
36087253,"Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors","Chen W, Zhang W, Chen M, Yang C, Fang T, Wang H, Reid LM, He Z.",Cell Oncol (Dordr). 2022 Dec;45(6):1053-1071. doi: 10.1007/s13402-022-00714-4. Epub 2022 Sep 10.,Chen W,Cell Oncol (Dordr),2022,10/9/2022,,,10.1007/s13402-022-00714-4,CDK
36274096,Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer,"Ding D, Zheng R, Tian Y, Jimenez R, Hou X, Weroha SJ, Wang L, Shi L, Huang H.",Nat Commun. 2022 Oct 23;13(1):6311. doi: 10.1038/s41467-022-34024-y.,Ding D,Nat Commun,2022,23/10/2022,PMC9588789,,10.1038/s41467-022-34024-y,CDK
37101393,"Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor","Karimi L, Alves CL, Terp MG, Tuttolomondo M, Portman N, Ehmsen S, Johansen LE, Bak M, Lim E, Ditzel HJ.",Cancer Commun (Lond). 2023 Apr 26. doi: 10.1002/cac2.12425. Online ahead of print.,Karimi L,Cancer Commun (Lond),2023,27/4/2023,,,10.1002/cac2.12425,CDK
36497412,CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells,"Terenziani R, Galetti M, La Monica S, Fumarola C, Zoppi S, Alfieri R, Digiacomo G, Cavazzoni A, Cavallo D, Corradi M, Tiseo M, Petronini PG, Bonelli M.",Cancers (Basel). 2022 Nov 30;14(23):5925. doi: 10.3390/cancers14235925.,Terenziani R,Cancers (Basel),2022,11/12/2022,PMC9739278,,10.3390/cancers14235925,CDK
36831647,CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients,"Crucitta S, Ruglioni M, Lorenzini G, Bargagna I, Luculli GI, Albanese I, Bilancio D, Patanè F, Fontana A, Danesi R, Del Re M.",Cancers (Basel). 2023 Feb 18;15(4):1306. doi: 10.3390/cancers15041306.,Crucitta S,Cancers (Basel),2023,25/2/2023,PMC9954458,,10.3390/cancers15041306,CDK
36980649,CDK4/6 Inhibitors-Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer,"Nabieva N, Fasching PA.",Cancers (Basel). 2023 Mar 14;15(6):1763. doi: 10.3390/cancers15061763.,Nabieva N,Cancers (Basel),2023,29/3/2023,PMC10046117,,10.3390/cancers15061763,CDK
36349599,Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer,"Visani L, Livi L, Ratosa I, Orazem M, Ribnikar D, Saieva C, Becherini C, Salvestrini V, Scoccimarro E, Valzano M, Cerbai C, Desideri I, Bernini M, Orzalesi L, Nori J, Bianchi S, Morandi A, Meattini I.",Radiother Oncol. 2022 Dec;177:40-45. doi: 10.1016/j.radonc.2022.10.023. Epub 2022 Oct 28.,Visani L,Radiother Oncol,2022,9/11/2022,,,10.1016/j.radonc.2022.10.023,CDK
35936751,CDK 4/6 inhibitors for the treatment of meningioma,"Young JS, Kidwell RL, Zheng A, Haddad AF, Aghi MK, Raleigh DR, Schulte JD, Butowski NA.",Front Oncol. 2022 Jul 22;12:931371. doi: 10.3389/fonc.2022.931371. eCollection 2022.,Young JS,Front Oncol,2022,8/8/2022,PMC9354681,,10.3389/fonc.2022.931371,CDK
35845723,CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors,"Salewski I, Henne J, Engster L, Krone P, Schneider B, Redwanz C, Lemcke H, Henze L, Junghanss C, Maletzki C.",Oncoimmunology. 2022 Jul 11;11(1):2094583. doi: 10.1080/2162402X.2022.2094583. eCollection 2022.,Salewski I,Oncoimmunology,2022,18/7/2022,PMC9278458,,10.1080/2162402X.2022.2094583,CDK
36448571,Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets,"Xiong Y, Zhong Y, Yim H, Yang X, Park KS, Xie L, Poulikakos PI, Han X, Xiong Y, Chen X, Liu J, Jin J.",J Am Chem Soc. 2022 Dec 14;144(49):22622-22632. doi: 10.1021/jacs.2c09255. Epub 2022 Nov 30.,Xiong Y,J Am Chem Soc,2022,30/11/2022,PMC9772293,NIHMS1854211,10.1021/jacs.2c09255,CDK
35917055,CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer,"Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI.",Clin Transl Oncol. 2022 Nov;24(11):2120-2135. doi: 10.1007/s12094-022-02881-0. Epub 2022 Aug 2.,Lin CY,Clin Transl Oncol,2022,2/8/2022,,,10.1007/s12094-022-02881-0,CDK
36949066,The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer,"Grinshpun A, Tolaney SM, Burstein HJ, Jeselsohn R, Mayer EL.",NPJ Breast Cancer. 2023 Mar 22;9(1):15. doi: 10.1038/s41523-023-00520-7.,Grinshpun A,NPJ Breast Cancer,2023,23/3/2023,PMC10033931,,10.1038/s41523-023-00520-7,CDK
34849618,Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degradation of JUN in synovial fibroblasts,"Hosoya T, Saito T, Baba H, Tanaka N, Noda S, Komiya Y, Tagawa Y, Yamamoto A, Mizoguchi F, Kawahata K, Miyasaka N, Kohsaka H, Yasuda S.",Rheumatology (Oxford). 2022 Aug 3;61(8):3427-3438. doi: 10.1093/rheumatology/keab874.,Hosoya T,Rheumatology (Oxford),2022,1/12/2021,PMC9348617,,10.1093/rheumatology/keab874,CDK
35786092,Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition,"Guo X, Chen H, Zhou Y, Shen L, Wu S, Chen Y.",Expert Opin Investig Drugs. 2022 Sep;31(9):933-944. doi: 10.1080/13543784.2022.2097067. Epub 2022 Jul 7.,Guo X,Expert Opin Investig Drugs,2022,5/7/2022,,,10.1080/13543784.2022.2097067,CDK
37131684,ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous Melanoma,"Rebecca V, Jagirdar K, Portuallo M, Wei M, Wilhide M, Bravo J, Robertson B, Alicea G, Aguh C, Xiao M, Godok T, Fingerman D, Brown G, Herlyn M, Guo B, Toska E, Zabransky D, Wubbenhorst B, Nathanson K, Kwatra S, Goyal Y, Ji H, Liu Q.",Res Sq. 2023 Apr 20:rs.3.rs-2817876. doi: 10.21203/rs.3.rs-2817876/v1. Preprint.,Rebecca V,Res Sq,2023,3/5/2023,PMC10153386,,10.21203/rs.3.rs-2817876/v1,CDK
36547170,CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature,"Targato G, Bortot L, Dri A, Bonotto M, Minisini AM, Fasola G, Mansutti M.",Curr Oncol. 2022 Dec 6;29(12):9630-9639. doi: 10.3390/curroncol29120756.,Targato G,Curr Oncol,2022,22/12/2022,PMC9777243,,10.3390/curroncol29120756,CDK
36051751,CDK4: a master regulator of the cell cycle and its role in cancer,"Baker SJ, Poulikakos PI, Irie HY, Parekh S, Reddy EP.",Genes Cancer. 2022 Aug 25;13:21-45. doi: 10.18632/genesandcancer.221. eCollection 2022.,Baker SJ,Genes Cancer,2022,2/9/2022,PMC9426627,,10.18632/genesandcancer.221,CDK
35671543,Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours,"Schubert NA, Chen CY, Rodríguez A, Koster J, Dowless M, Pfister SM, Shields DJ, Stancato LF, Vassal G, Caron HN, van den Boogaard ML, Henssen AG, Molenaar JJ.",Eur J Cancer. 2022 Jul;170:196-208. doi: 10.1016/j.ejca.2022.04.028. Epub 2022 Jun 4.,Schubert NA,Eur J Cancer,2022,7/6/2022,,,10.1016/j.ejca.2022.04.028,CDK
36453028,Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition,"Paternot S, Raspé E, Meiller C, Tarabichi M, Assié JB, Libert F, Remmelink M, Bisteau X, Pauwels P, Blum Y, Le Stang N, Tabone-Eglinger S, Galateau-Sallé F, Blanquart C, Van Meerbeeck JP, Berghmans T, Jean D, Roger PP.",Mol Oncol. 2022 Nov 30. doi: 10.1002/1878-0261.13351. Online ahead of print.,Paternot S,Mol Oncol,2022,1/12/2022,,,10.1002/1878-0261.13351,CDK
37198053,The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis,"Petrelli F, Dottorini L, Di Menna G, Borgonovo K, Parati MC, Rea CG, Ghilardi M, Ghidini A, Luciani A.",Breast. 2023 May 13:S0960-9776(23)00459-9. doi: 10.1016/j.breast.2023.05.002. Online ahead of print.,Petrelli F,Breast,2023,17/5/2023,,,10.1016/j.breast.2023.05.002,CDK
36980794,Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells,"Gallanis GT, Sharif GM, Schmidt MO, Friedland BN, Battina R, Rahhal R, Davis JE Jr, Khan IS, Wellstein A, Riegel AT.",Cancers (Basel). 2023 Mar 22;15(6):1908. doi: 10.3390/cancers15061908.,Gallanis GT,Cancers (Basel),2023,29/3/2023,PMC10046966,,10.3390/cancers15061908,CDK
35804935,Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer,"Lee JS, Yost SE, Li SM, Cui Y, Frankel PH, Yuan YC, Schmolze D, Egelston CA, Guo W, Murga M, Chang H, Bosserman L, Yuan Y.",Cancers (Basel). 2022 Jun 28;14(13):3159. doi: 10.3390/cancers14133159.,Lee JS,Cancers (Basel),2022,9/7/2022,PMC9264913,,10.3390/cancers14133159,CDK
37063263,"A mass balance study of [(14)C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans","Zhang H, Yan S, Zhan Y, Ma S, Bian Y, Li S, Tian J, Li G, Zhong D, Diao X, Miao L.",Front Pharmacol. 2023 Mar 31;14:1116073. doi: 10.3389/fphar.2023.1116073. eCollection 2023.,Zhang H,Front Pharmacol,2023,17/4/2023,PMC10102643,,10.3389/fphar.2023.1116073,CDK
34937317,Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia,"Bride KL, Hu H, Tikhonova A, Fuller TJ, Vincent TL, Shraim R, Li MM, Carroll WL, Raetz EA, Aifantis I, Teachey DT.",Haematologica. 2022 Aug 1;107(8):1746-1757. doi: 10.3324/haematol.2021.279410.,Bride KL,Haematologica,2022,23/12/2021,PMC9335101,,10.3324/haematol.2021.279410,CDK
36186151,Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT,"Engler T, Fasching PA, Lüftner D, Hartkopf AD, Müller V, Kolberg HC, Hadji P, Tesch H, Häberle L, Ettl J, Wallwiener M, Beckmann MW, Hein A, Belleville E, Uhrig S, Wimberger P, Hielscher C, Kurbacher CM, Wuerstlein R, Untch M, Taran FA, Enzinger HM, Krabisch P, Welslau M, Maasberg M, Hempel D, Lux MP, Michel LL, Janni W, Wallwiener D, Brucker SY, Fehm TN, Schneeweiss A.",Geburtshilfe Frauenheilkd. 2022 Jul 12;82(10):1055-1067. doi: 10.1055/a-1880-0087. eCollection 2022 Oct.,Engler T,Geburtshilfe Frauenheilkd,2022,3/10/2022,PMC9525148,,10.1055/a-1880-0087,CDK
37074587,Mathematically Modeling the Effect of Endocrine and Cdk4/6 Inhibitor Therapies on Breast Cancer Cells,"He W, Shajahan-Haq AN, Baumann WT.",Methods Mol Biol. 2023;2634:337-355. doi: 10.1007/978-1-0716-3008-2_16.,He W,Methods Mol Biol,2023,19/4/2023,,,10.1007/978-1-0716-3008-2_16,CDK
36200010,CDK 4/6 inhibitors for adjuvant therapy in early breast cancer-Do we have a clear winner?,"Akhade A, Van Wambeke S, Gyawali B.",Ecancermedicalscience. 2022 Aug 30;16:ed124. doi: 10.3332/ecancer.2022.ed124. eCollection 2022.,Akhade A,Ecancermedicalscience,2022,6/10/2022,PMC9470169,,10.3332/ecancer.2022.ed124,CDK
37132760,CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas,"Duah E, Seligson ND, Persaud AK, Dam Q, Pabla N, Rocco JW, Li J, Poi M.",Mol Carcinog. 2023 May 3. doi: 10.1002/mc.23556. Online ahead of print.,Duah E,Mol Carcinog,2023,3/5/2023,,,10.1002/mc.23556,CDK
35989152,Radiotherapy and CDK inhibitors: Opportunities and risks,"Brion T, Quéro L.",Cancer Radiother. 2022 Oct;26(6-7):968-972. doi: 10.1016/j.canrad.2022.06.017. Epub 2022 Aug 18.,Brion T,Cancer Radiother,2022,21/8/2022,,,10.1016/j.canrad.2022.06.017,CDK
36628275,Non-canonical approaches to targeting hypoxic tumors,"Zhao S, El-Deiry WS.",Am J Cancer Res. 2022 Dec 15;12(12):5351-5374. eCollection 2022.,Zhao S,Am J Cancer Res,2022,11/1/2023,PMC9827096,,,CDK
36945886,"CDK4/6 inhibitors in metastatic breast cancer, a comparison of toxicity and efficacy across agents in a real-world dataset","Buller W, Pallan L, Chu T, Khoja L.",J Oncol Pharm Pract. 2023 Mar 22:10781552231163121. doi: 10.1177/10781552231163121. Online ahead of print.,Buller W,J Oncol Pharm Pract,2023,22/3/2023,,,10.1177/10781552231163121,CDK
36396665,A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer,"Niu N, Qiu F, Xu Q, He G, Gu X, Guo W, Zhang D, Li Z, Zhao Y, Li Y, Li K, Zhang H, Zhang P, Huang Y, Zhang G, Han H, Cai Z, Li P, Xu H, Chen G, Xue J, Jiang X, Jahromi AH, Li J, Zhao Y, de Faria Castro Fleury E, Huo S, Li H, Jerusalem G, Tripodi D, Liu T, Zheng X, Liu C.",Nat Commun. 2022 Nov 17;13(1):7043. doi: 10.1038/s41467-022-34838-w.,Niu N,Nat Commun,2022,17/11/2022,PMC9672048,,10.1038/s41467-022-34838-w,CDK
36825764,Carboxypeptidase vitellogenic like facilitates resistance to CDK4/6 inhibitors in breast cancer,"Zhu X, Xu X, Zhang L, Yang X.",Thorac Cancer. 2023 Apr;14(11):983-991. doi: 10.1111/1759-7714.14829. Epub 2023 Feb 24.,Zhu X,Thorac Cancer,2023,24/2/2023,PMC10101830,,10.1111/1759-7714.14829,CDK
35535675,"Real world incidence and management of adverse events in patients with HR+, HER2- metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting","Price GL, Sudharshan L, Ryan P, Rajkumar J, Sheffield KM, Nash Smyth E, Morato Guimaraes C, Rybowski S, Cuyun Carter G, Gathirua-Mwangi WG, Huang YJ.",Curr Med Res Opin. 2022 Aug;38(8):1319-1331. doi: 10.1080/03007995.2022.2073122. Epub 2022 May 13.,Price GL,Curr Med Res Opin,2022,10/5/2022,,,10.1080/03007995.2022.2073122,CDK
36635998,"Efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, advanced breast cancer: a systematic review and meta-analysis","Dai Q, Wang Y, Liao M, Chen H.",Ann Palliat Med. 2022 Dec;11(12):3727-3742. doi: 10.21037/apm-22-1306.,Dai Q,Ann Palliat Med,2022,13/1/2023,,,10.21037/apm-22-1306,CDK
36876172,CDK4/6 Inhibitors in Advanced HR+/HER2 - Breast Cancer: A Multicenter Real-World Data Analysis,"Müller C, Kiver V, Solomayer EF, Wagenpfeil G, Neeb C, Blohmer JU, Abramian AV, Maass N, Schütz F, Kolberg-Liedtke C, Ralser DJ, Rambow AC.",Breast Care (Basel). 2023 Feb;18(1):31-41. doi: 10.1159/000527917. Epub 2022 Dec 6.,Müller C,Breast Care (Basel),2023,6/3/2023,PMC9982335,,10.1159/000527917,CDK
35738597,Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract,"Zeng F, Zhou Y, Khowtanapanich T, Saengboonmee C.",In Vivo. 2022 Jul-Aug;36(4):1580-1590. doi: 10.21873/invivo.12868.,Zeng F,In Vivo,2022,23/6/2022,PMC9301412,,10.21873/invivo.12868,CDK
36033522,Investigational cyclin-dependent kinase 4/6 inhibitor GLR2007 demonstrates activity against isocitrate dehydrogenase wild-type glioblastoma and other solid tumors in mice xenograft models,"Yin L, Yao Z, Wang Y, Mazuranic M.",Front Oncol. 2022 Aug 11;12:915862. doi: 10.3389/fonc.2022.915862. eCollection 2022.,Yin L,Front Oncol,2022,29/8/2022,PMC9403987,,10.3389/fonc.2022.915862,CDK
36350721,"Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer","Chen W, Ji M, Cheng H, Zheng M, Xia F, Min W, Yang H, Wang X, Wang L, Cao L, Yuan K, Yang P.",J Med Chem. 2022 Nov 24;65(22):15102-15122. doi: 10.1021/acs.jmedchem.2c00947. Epub 2022 Nov 9.,Chen W,J Med Chem,2022,9/11/2022,,,10.1021/acs.jmedchem.2c00947,CDK
36938944,Role of identified proteins in the proteome profiles of CDK4/6 inhibitor-resistant breast cancer cell lines,"Kumar B, Prasad P, Singh R, Sahu RK, Singh A, Magani SJ, Hedau S.",Mol Omics. 2023 Mar 20. doi: 10.1039/d2mo00285j. Online ahead of print.,Kumar B,Mol Omics,2023,20/3/2023,,,10.1039/d2mo00285j,CDK
35817775,Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition,"Beykou M, Arias-Garcia M, Roumeliotis TI, Choudhary JS, Moser N, Georgiou P, Bakal C.",Sci Data. 2022 Jul 11;9(1):395. doi: 10.1038/s41597-022-01512-1.,Beykou M,Sci Data,2022,11/7/2022,PMC9273754,,10.1038/s41597-022-01512-1,CDK
36446794,Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy,"Gharbi SI, Pelletier LA, Espada A, Gutiérrez J, Sanfeliciano SMG, Rauch CT, Ganado MP, Baquero C, Zapatero E, Zhang A, Benach J, Russell AM, Cano L, Gomez S, Broughton H, Pulliam N, Perez CM, Torres R, Debets MF, de Dios A, Puig O, Hilgers MT, Lallena MJ.",NPJ Breast Cancer. 2022 Nov 29;8(1):126. doi: 10.1038/s41523-022-00494-y.,Gharbi SI,NPJ Breast Cancer,2022,29/11/2022,PMC9709041,,10.1038/s41523-022-00494-y,CDK
37240281,Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition,"Hu Q, Huang T.",Int J Mol Sci. 2023 May 18;24(10):8939. doi: 10.3390/ijms24108939.,Hu Q,Int J Mol Sci,2023,27/5/2023,PMC10219488,,10.3390/ijms24108939,CDK
36563600,Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer,"Falato C, Schettini F, Pascual T, Brasó-Maristany F, Prat A.",Cancer Treat Rev. 2023 Jan;112:102496. doi: 10.1016/j.ctrv.2022.102496. Epub 2022 Dec 9.,Falato C,Cancer Treat Rev,2023,23/12/2022,,,10.1016/j.ctrv.2022.102496,CDK
37230983,CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer,"Shrestha M, Wang DY, Ben-David Y, Zacksenhaus E.",Oncogenesis. 2023 May 26;12(1):29. doi: 10.1038/s41389-023-00475-1.,Shrestha M,Oncogenesis,2023,25/5/2023,PMC10213015,,10.1038/s41389-023-00475-1,CDK
36400926,Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia,"Ling VY, Straube J, Godfrey W, Haldar R, Janardhanan Y, Cooper L, Bruedigam C, Cooper E, Tavakoli Shirazi P, Jacquelin S, Tey SK, Baell J, Huang F, Jin J, Zhao Y, Bullinger L, Bywater MJ, Lane SW.",Leukemia. 2023 Jan;37(1):143-153. doi: 10.1038/s41375-022-01755-2. Epub 2022 Nov 18.,Ling VY,Leukemia,2023,18/11/2022,,,10.1038/s41375-022-01755-2,CDK
35670349,Cyclin-Dependent Kinase 4/6 Inhibitors Against Breast Cancer,"Hassan MA, Ates-Alagoz Z.",Mini Rev Med Chem. 2023;23(4):412-428. doi: 10.2174/1389557522666220606095540.,Hassan MA,Mini Rev Med Chem,2023,7/6/2022,,,10.2174/1389557522666220606095540,CDK
36733112,[A Case of Recurrent Breast Cancer with Multiple Bone Metastasis Effectively Treated by CDK4/6 Inhibitor in Addition to Aromatase Inhibitor],"Satoh E, Hara M, Uehira D, Yonekura K, Murakata A, Ohinata R, Toyofuku Y, Tanami H, Osanai T, Sugano N, Sakoma T.",Gan To Kagaku Ryoho. 2022 Dec;49(13):1491-1493.,Satoh E,Gan To Kagaku Ryoho,2022,3/2/2023,,,,CDK
37090582,"Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance","Geller C, Maddela J, Tuplano R, Runa F, Adamian Y, Güth R, Soto GO, Tomaneng L, Cantor J, Kelber JA.",bioRxiv. 2023 Apr 16:2023.04.13.536765. doi: 10.1101/2023.04.13.536765. Preprint.,Geller C,bioRxiv,2023,24/4/2023,PMC10120696,,10.1101/2023.04.13.536765,CDK
37160904,Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer,"Yang Z, Feng J, Jing J, Huang Y, Ye WW, Lei L, Wang XJ, Cao WM.",NPJ Breast Cancer. 2023 May 9;9(1):36. doi: 10.1038/s41523-023-00542-1.,Yang Z,NPJ Breast Cancer,2023,10/5/2023,PMC10170158,,10.1038/s41523-023-00542-1,CDK
36985460,Virtual Screening for Identification of Dual Inhibitors against CDK4/6 and Aromatase Enzyme,"Adon T, Shanmugarajan D, Ather H, Ansari SMA, Hani U, Madhunapantula SV, Honnavalli YK.",Molecules. 2023 Mar 8;28(6):2490. doi: 10.3390/molecules28062490.,Adon T,Molecules,2023,29/3/2023,PMC10058413,,10.3390/molecules28062490,CDK
35656884,β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells,"Ham A, Cho MH, Won HS, Jo J, Lee KE.",Oncol Rep. 2022 Jul;48(1):130. doi: 10.3892/or.2022.8341. Epub 2022 Jun 3.,Ham A,Oncol Rep,2022,3/6/2022,,,10.3892/or.2022.8341,CDK
36130661,"Design, synthesis and biological evaluation of pteridine-7(8H)-one derivatives as potent and selective CDK4/6 inhibitors","He H, Liu Q, Chen L, Wang J, Yuan Y, Li H, Qian X, Zhao Z, Chen Z.",Bioorg Med Chem Lett. 2022 Nov 15;76:128991. doi: 10.1016/j.bmcl.2022.128991. Epub 2022 Sep 18.,He H,Bioorg Med Chem Lett,2022,21/9/2022,,,10.1016/j.bmcl.2022.128991,CDK
35878668,Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications,"Yousuf M, Alam M, Shamsi A, Khan P, Hasan GM, Rizwanul Haque QM, Hassan MI.",Int J Biol Macromol. 2022 Oct 1;218:394-408. doi: 10.1016/j.ijbiomac.2022.07.156. Epub 2022 Jul 22.,Yousuf M,Int J Biol Macromol,2022,25/7/2022,,,10.1016/j.ijbiomac.2022.07.156,CDK
36914658,Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer,"Patterson-Fortin J, Jadhav H, Pantelidou C, Phan T, Grochala C, Mehta AK, Guerriero JL, Wulf GM, Wolpin BM, Stanger BZ, Aguirre AJ, Cleary JM, D'Andrea AD, Shapiro GI.",Nat Commun. 2023 Mar 13;14(1):1390. doi: 10.1038/s41467-023-37096-6.,Patterson-Fortin J,Nat Commun,2023,14/3/2023,PMC10011609,,10.1038/s41467-023-37096-6,CDK
36570409,Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia,"Low JL, Lim E, Bharwani L, Wong A, Wong K, Ow S, Lim SE, Lee M, Choo J, Lim J, Chan G, Walsh RJ, Muthu V, Ngoi N, Chong W, Tan SH, Lee SC.",Ther Adv Med Oncol. 2022 Dec 18;14:17588359221139678. doi: 10.1177/17588359221139678. eCollection 2022.,Low JL,Ther Adv Med Oncol,2022,26/12/2022,PMC9772978,,10.1177/17588359221139678,CDK
37080859,"[Biological, preclinical and clinical aspects of the association between radiation therapy and CDK4/6 inhibitors]","Beddok A, Porte B, Cottu P, Fourquet A, Kirova Y.",Cancer Radiother. 2023 May;27(3):240-248. doi: 10.1016/j.canrad.2022.11.003. Epub 2023 Apr 18.,Beddok A,Cancer Radiother,2023,20/4/2023,,,10.1016/j.canrad.2022.11.003,CDK
35872339,Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia,"Qi K, Hu X, Yu X, Cheng H, Wang C, Wang S, Wang Y, Li Y, Cao J, Pan B, Wu Q, Qiao J, Zeng L, Li Z, Xu K, Fu C.",Leuk Res. 2022 Sep;120:106920. doi: 10.1016/j.leukres.2022.106920. Epub 2022 Jul 19.,Qi K,Leuk Res,2022,25/7/2022,,,10.1016/j.leukres.2022.106920,CDK
35844619,CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment,"Liu J, Lin J, Wang X, Zheng X, Gao X, Huang Y, Chen G, Xiong J, Lan B, Chen C, Si L, Chen Y.",Front Immunol. 2022 Jul 1;13:725679. doi: 10.3389/fimmu.2022.725679. eCollection 2022.,Liu J,Front Immunol,2022,18/7/2022,PMC9285001,,10.3389/fimmu.2022.725679,CDK
37046675,Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer,"Mittal A, Molto Valiente C, Tamimi F, Schlam I, Sammons S, Tolaney SM, Tarantino P.",Cancers (Basel). 2023 Mar 28;15(7):2015. doi: 10.3390/cancers15072015.,Mittal A,Cancers (Basel),2023,13/4/2023,PMC10093251,,10.3390/cancers15072015,CDK
36765359,Commentary: locating the restriction point,Brooks RF.,Cell Div. 2023 Feb 10;18(1):2. doi: 10.1186/s13008-023-00085-8.,Brooks RF,Cell Div,2023,11/2/2023,PMC9912616,,10.1186/s13008-023-00085-8,CDK
36900131,Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature,"Stanciu IM, Parosanu AI, Orlov-Slavu C, Iaciu IC, Popa AM, Olaru CM, Pirlog CF, Vrabie RC, Nitipir C.",Diagnostics (Basel). 2023 Mar 5;13(5):987. doi: 10.3390/diagnostics13050987.,Stanciu IM,Diagnostics (Basel),2023,11/3/2023,PMC10000620,,10.3390/diagnostics13050987,CDK
35920011,[Endocrine Treatments in Breast Cancer],"Stettler S, Aebi S.",Praxis (Bern 1994). 2022 Aug;111(10):550-556. doi: 10.1024/1661-8157/a003878.,Stettler S,Praxis (Bern 1994),2022,3/8/2022,,,10.1024/1661-8157/a003878,CDK
35583393,A patent review of anticancer CDK2 inhibitors (2017-present),"Said MA, Abdelrahman MA, Abourehab MAS, Fares M, Eldehna WM.",Expert Opin Ther Pat. 2022 Aug;32(8):885-898. doi: 10.1080/13543776.2022.2078193. Epub 2022 May 26.,Said MA,Expert Opin Ther Pat,2022,18/5/2022,,,10.1080/13543776.2022.2078193,CDK
37129836,Novel Estrogen Receptor-Targeted Agents for Breast Cancer,"Shastry M, Hamilton E.",Curr Treat Options Oncol. 2023 May 2. doi: 10.1007/s11864-023-01079-y. Online ahead of print.,Shastry M,Curr Treat Options Oncol,2023,2/5/2023,,,10.1007/s11864-023-01079-y,CDK
36901954,Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer,"Alves CL, Ditzel HJ.",Int J Mol Sci. 2023 Feb 24;24(5):4522. doi: 10.3390/ijms24054522.,Alves CL,Int J Mol Sci,2023,11/3/2023,PMC10003259,,10.3390/ijms24054522,CDK
35633421,Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors,"Schreier A, Munoz-Arcos L, Alvarez A, Sparano JA, Anampa JD.",Breast Cancer Res Treat. 2022 Jul;194(2):337-351. doi: 10.1007/s10549-022-06574-8. Epub 2022 May 28.,Schreier A,Breast Cancer Res Treat,2022,28/5/2022,,,10.1007/s10549-022-06574-8,CDK
36765430,Cellular senescence in the response of HR(+) breast cancer to radiotherapy and CDK4/6 inhibitors,"Klapp V, Buqué A, Bloy N, Sato A, Yamazaki T, Zhou XK, Formenti SC, Galluzzi L, Petroni G.",J Transl Med. 2023 Feb 10;21(1):110. doi: 10.1186/s12967-023-03964-4.,Klapp V,J Transl Med,2023,11/2/2023,PMC9921325,,10.1186/s12967-023-03964-4,CDK
36760031,Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer in the United States: A SEER-Medicare population-based study,"Goyal RK, Chen H, Abughosh SM, Holmes HM, Candrilli SD, Johnson ML.",Cancer. 2023 Apr 1;129(7):1051-1063. doi: 10.1002/cncr.34675. Epub 2023 Feb 9.,Goyal RK,Cancer,2023,10/2/2023,,,10.1002/cncr.34675,CDK
36806942,p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer,"Mouron S, Bueno MJ, Muñoz M, Torres R, Rodríguez S, Apala JV, Silva J, Sánchez-Bayona R, Manso L, Guerra J, Rodriguez-Lajusticia L, Malon D, Malumbres M, Quintela-Fandino M.",JNCI Cancer Spectr. 2023 Mar 1;7(2):pkad014. doi: 10.1093/jncics/pkad014.,Mouron S,JNCI Cancer Spectr,2023,22/2/2023,PMC10035773,,10.1093/jncics/pkad014,CDK
36003783,Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition,"Vorwerk J, Sun K, Frank D, Neumann F, Hüve J, Budde PM, Liu L, Xie X, Patnana PK, Ahmed HMM, Opalka B, Lenz G, Jayavelu AK, Khandanpour C.",Front Oncol. 2022 Aug 8;12:903691. doi: 10.3389/fonc.2022.903691. eCollection 2022.,Vorwerk J,Front Oncol,2022,25/8/2022,PMC9393725,,10.3389/fonc.2022.903691,CDK
36087247,Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer,"Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI.",Clin Transl Oncol. 2022 Nov;24(11):2251-2253. doi: 10.1007/s12094-022-02928-2.,Lin CY,Clin Transl Oncol,2022,10/9/2022,,,10.1007/s12094-022-02928-2,CDK
37256976,Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer,"Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group.",N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131.,Turner NC,N Engl J Med,2023,31/5/2023,,,10.1056/NEJMoa2214131,CDK
36318650,Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo,"Jonchere B, Williams J, Zindy F, Liu J, Robinson S, Farmer DM, Min J, Yang L, Stripay JL, Wang Y, Freeman BB, Yu J, Shelat AA, Rankovic Z, Roussel MF.",Mol Cancer Ther. 2023 Jan 3;22(1):37-51. doi: 10.1158/1535-7163.MCT-21-0896.,Jonchere B,Mol Cancer Ther,2023,1/11/2022,PMC9808370,NIHMS1846989,10.1158/1535-7163.MCT-21-0896,CDK
36562384,Combined inhibition of ACLY and CDK4/6 reduces cancer cell growth and invasion,"Velez BC, Petrella CP, DiSalvo KH, Cheng K, Kravtsov R, Krasniqi D, Krucher NA.",Oncol Rep. 2023 Feb;49(2):32. doi: 10.3892/or.2022.8469. Epub 2022 Dec 23.,Velez BC,Oncol Rep,2023,23/12/2022,PMC9827262,,10.3892/or.2022.8469,CDK
36031754,Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use,"Endo Y, Yoshimura A, Sawaki M, Hattori M, Kotani H, Kataoka A, Horisawa N, Ozaki Y, Nozawa K, Takatsuka D, Isogai A, Iwata H.",J Breast Cancer. 2022 Aug;25(4):296-306. doi: 10.4048/jbc.2022.25.e34.,Endo Y,J Breast Cancer,2022,29/8/2022,PMC9411029,,10.4048/jbc.2022.25.e34,CDK
36399634,Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer,"Wildey G, Shay AM, McColl KS, Yoon S, Shatat MA, Perwez A, Spainhower KB, Kresak AM, Lipka M, Yang M, Behtaj M, Fu P, Alahmadi A, Mneimneh W, Abbas A, Dowlati A.",Mol Cancer Ther. 2023 Feb 1;22(2):264-273. doi: 10.1158/1535-7163.MCT-22-0365.,Wildey G,Mol Cancer Ther,2023,18/11/2022,PMC9898162,NIHMS1853161,10.1158/1535-7163.MCT-22-0365,CDK
37185034,The prognostic indicator in breast cancer treated with CDK4/6 inhibitors: the prognostic nutritional index,"Keskinkilic M, Semiz HS, Polat G, Arayici ME, Yavuzsen T, Oztop I.",Future Oncol. 2023 Apr 26. doi: 10.2217/fon-2022-1023. Online ahead of print.,Keskinkilic M,Future Oncol,2023,15/5/2023,,,10.2217/fon-2022-1023,CDK
36455506,Targeting the FGF/FGFR axis and its co-alteration allies,"Uehara Y, Ikeda S, Kim KH, Lim HJ, Adashek JJ, Persha HE, Okamura R, Lee S, Sicklick JK, Kato S, Kurzrock R.",ESMO Open. 2022 Dec;7(6):100647. doi: 10.1016/j.esmoop.2022.100647. Epub 2022 Nov 29.,Uehara Y,ESMO Open,2022,1/12/2022,PMC9808461,,10.1016/j.esmoop.2022.100647,CDK
36609900,Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+/HER2- metastatic breast cancer in the United States,"Goyal RK, Holmes HM, Chen H, Abughosh S, Candrilli SD, Johnson ML.",Breast Cancer Res Treat. 2023 Feb;198(1):159-166. doi: 10.1007/s10549-022-06845-4. Epub 2023 Jan 7.,Goyal RK,Breast Cancer Res Treat,2023,7/1/2023,,,10.1007/s10549-022-06845-4,CDK
36852326,P16(INK4a) Regulates ROS-Related Autophagy and CDK4/6-Mediated Proliferation: A New Target of Myocardial Regeneration Therapy,"Sun J, Zhou L, Yang T, Deng B, Bao Y, Gu L, Wang H, Wang L.",Oxid Med Cell Longev. 2023 Feb 18;2023:1696190. doi: 10.1155/2023/1696190. eCollection 2023.,Sun J,Oxid Med Cell Longev,2023,28/2/2023,PMC9966567,,10.1155/2023/1696190,CDK
36710654,Adjuvant CDK4/6 inhibitors: can they improve clinical outcomes in hormone receptor-positive (HR+) early breast cancer?,Johnston SRD.,Ann Palliat Med. 2023 Mar;12(2):421-426. doi: 10.21037/apm-22-981. Epub 2023 Jan 16.,Johnston SRD,Ann Palliat Med,2023,30/1/2023,,,10.21037/apm-22-981,CDK
35702037,The pharmacotherapeutic management of nail unit and acral melanomas,"Falotico JM, Lipner SR.",Expert Opin Pharmacother. 2022 Aug;23(11):1273-1289. doi: 10.1080/14656566.2022.2088279. Epub 2022 Jun 14.,Falotico JM,Expert Opin Pharmacother,2022,15/6/2022,,,10.1080/14656566.2022.2088279,CDK
36342342,Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1,"Toi M, Boyle F, Im YH, Reinisch M, Molthrop D, Jiang Z, Wei R, Sapunar F, Grimes BR, Nabinger SC, Johnston SRD.",Oncologist. 2023 Jan 18;28(1):e77-e81. doi: 10.1093/oncolo/oyac234.,Toi M,Oncologist,2023,7/11/2022,PMC9847542,,10.1093/oncolo/oyac234,CDK
36920662,Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA,"Masurkar PP, Damgacioglu H, Deshmukh AA, Trivedi MV.",Pharmacoeconomics. 2023 Jun;41(6):709-718. doi: 10.1007/s40273-023-01245-y. Epub 2023 Mar 15.,Masurkar PP,Pharmacoeconomics,2023,15/3/2023,,,10.1007/s40273-023-01245-y,CDK
35891353,"Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors","Kostopoulou ON, Zupancic M, Pont M, Papin E, Lukoseviciute M, Mikelarena BA, Holzhauser S, Dalianis T.",Viruses. 2022 Jun 23;14(7):1372. doi: 10.3390/v14071372.,Kostopoulou ON,Viruses,2022,27/7/2022,PMC9320646,,10.3390/v14071372,CDK
37024934,"1,6-Hexanediol regulates angiogenesis via suppression of cyclin A1-mediated endothelial function","Jiang Y, Lei G, Lin T, Zhou N, Wu J, Wang Z, Fan Y, Sheng H, Mao R.",BMC Biol. 2023 Apr 7;21(1):75. doi: 10.1186/s12915-023-01580-8.,Jiang Y,BMC Biol,2023,6/4/2023,PMC10080975,,10.1186/s12915-023-01580-8,CDK
36315915,APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy,"Sammons S, Raskina K, Danziger N, Alder L, Schrock AB, Venstrom JM, Knutson KL, Thompson EA, McGregor K, Sokol E, Chumsri S.",JCO Precis Oncol. 2022 Oct;6:e2200149. doi: 10.1200/PO.22.00149.,Sammons S,JCO Precis Oncol,2022,31/10/2022,PMC9666120,,10.1200/PO.22.00149,CDK
36907286,"Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling","Lee HJ, Hoe HS.",Pharmacol Res. 2023 Apr;190:106725. doi: 10.1016/j.phrs.2023.106725. Epub 2023 Mar 11.,Lee HJ,Pharmacol Res,2023,12/3/2023,,,10.1016/j.phrs.2023.106725,CDK
37183684,Evaluating everolimus for the treatment of breast cancer,"Moreau-Bachelard C, Robert M, Gourmelon C, Bourbouloux E, Patsouris A, Frenel JS, Campone M.",Expert Opin Pharmacother. 2023 May 18:1-7. doi: 10.1080/14656566.2023.2214677. Online ahead of print.,Moreau-Bachelard C,Expert Opin Pharmacother,2023,15/5/2023,,,10.1080/14656566.2023.2214677,CDK
36123181,Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma,"Kreuger IZM, Slieker RC, van Groningen T, van Doorn R.",J Invest Dermatol. 2023 Jan;143(1):18-25.e1. doi: 10.1016/j.jid.2022.07.016. Epub 2022 Sep 16.,Kreuger IZM,J Invest Dermatol,2023,19/9/2022,,,10.1016/j.jid.2022.07.016,CDK
37109654,Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature Review,"Stanciu IM, Pirlog CF, Anghel AW, Parosanu AI, Olaru CM, Orlov-Slavu C, Iaciu IC, Popa AM, Vrabie RC, Nitipir C.",Medicina (Kaunas). 2023 Apr 1;59(4):696. doi: 10.3390/medicina59040696.,Stanciu IM,Medicina (Kaunas),2023,28/4/2023,PMC10145154,,10.3390/medicina59040696,CDK
36508589,Capivasertib Doubles PFS in Some Breast Cancers,,Cancer Discov. 2023 Feb 6;13(2):250. doi: 10.1158/2159-8290.CD-NB2022-0078.,,Cancer Discov,2023,12/12/2022,,,10.1158/2159-8290.CD-NB2022-0078,CDK
35742993,Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity,"Koirala N, Dey N, Aske J, De P.",Int J Mol Sci. 2022 Jun 11;23(12):6547. doi: 10.3390/ijms23126547.,Koirala N,Int J Mol Sci,2022,24/6/2022,PMC9224522,,10.3390/ijms23126547,CDK
35938171,Recent advances in targeting protein kinases and pseudokinases in cancer biology,"Riegel K, Vijayarangakannan P, Kechagioglou P, Bogucka K, Rajalingam K.",Front Cell Dev Biol. 2022 Jul 22;10:942500. doi: 10.3389/fcell.2022.942500. eCollection 2022.,Riegel K,Front Cell Dev Biol,2022,8/8/2022,PMC9354965,,10.3389/fcell.2022.942500,CDK
35974168,Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib,"Zhu Z, Turner NC, Loi S, André F, Martin M, Diéras V, Gelmon KA, Harbeck N, Zhang C, Cao JQ, Yan Z, Lu DR, Wei P, VanArsdale TL, Rejto PA, Huang X, Rugo HS, Loibl S, Cristofanilli M, Finn RS, Liu Y.",NPJ Precis Oncol. 2022 Aug 16;6(1):56. doi: 10.1038/s41698-022-00297-1.,Zhu Z,NPJ Precis Oncol,2022,16/8/2022,PMC9381541,,10.1038/s41698-022-00297-1,CDK
36575782,[Expert consensus on the management of adverse events of CDK4/6 inhibitors in breast cancer],"Ge R, Wang BY, Jiang ZF; Expert Group of Chinese Society of Clinical Oncology Breast Cancer.",Zhonghua Zhong Liu Za Zhi. 2022 Dec 23;44(12):1296-1304. doi: 10.3760/cma.j.cn112152-20220825-00578.,Ge R,Zhonghua Zhong Liu Za Zhi,2022,28/12/2022,,,10.3760/cma.j.cn112152-20220825-00578,CDK
36007246,Redirecting the Neo-Substrate Specificity of Cereblon-Targeting PROTACs to Helios,"Verano AL, You I, Donovan KA, Mageed N, Yue H, Nowak RP, Fischer ES, Wang ES, Gray NS.",ACS Chem Biol. 2022 Sep 16;17(9):2404-2410. doi: 10.1021/acschembio.2c00439. Epub 2022 Aug 25.,Verano AL,ACS Chem Biol,2022,25/8/2022,,,10.1021/acschembio.2c00439,CDK
36612173,Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management,"Yuan J, Guo Y.",Cancers (Basel). 2022 Dec 28;15(1):179. doi: 10.3390/cancers15010179.,Yuan J,Cancers (Basel),2022,8/1/2023,PMC9818071,,10.3390/cancers15010179,CDK
35021603,"Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade","Woess K, Macho-Maschler S, Van Ingen Schenau DS, Butler M, Lassnig C, Valcanover D, Poelzl A, Meissl K, Maurer B, Brandstoetter T, Vogl C, Koren A, Kubicek S, Orlova A, Moriggl R, Strobl B, Sexl V, Van Leeuwen FN, Kuiper RP, Mueller M.",Haematologica. 2023 Apr 1;108(4):993-1005. doi: 10.3324/haematol.2021.279848.,Woess K,Haematologica,2023,13/1/2022,PMC10071116,,10.3324/haematol.2021.279848,CDK
35711853,In vivo visualization of fluorescence reflecting CDK4 activity in a breast cancer mouse model,"Gao YY, Yang RQ, Lou KL, Dang YY, Dong YY, He YY, Huang WH, Chen M, Zhang GJ.",MedComm (2020). 2022 Jun 10;3(3):e136. doi: 10.1002/mco2.136. eCollection 2022 Sep.,Gao YY,MedComm (2020),2022,17/6/2022,PMC9187519,,10.1002/mco2.136,CDK
36628851,"Discovery of the GSH responsive ""Y-PROTACs"" targeting ALK and CDK4/6 as a potential treatment for cancer","Wang S, Luo D, Pu C, Ma X, Zhang H, Feng Z, Deng R, Yu S, Liu Y, Huang Q, Li R.",Eur J Med Chem. 2023 Feb 15;248:115082. doi: 10.1016/j.ejmech.2022.115082. Epub 2023 Jan 1.,Wang S,Eur J Med Chem,2023,11/1/2023,,,10.1016/j.ejmech.2022.115082,CDK
36139701,Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs,"Gámez-Chiachio M, Sarrió D, Moreno-Bueno G.",Cancers (Basel). 2022 Sep 19;14(18):4543. doi: 10.3390/cancers14184543.,Gámez-Chiachio M,Cancers (Basel),2022,23/9/2022,PMC9496705,,10.3390/cancers14184543,CDK
37252349,Rational Chemical Design of Molecular Glue Degraders,"Toriki ES, Papatzimas JW, Nishikawa K, Dovala D, Frank AO, Hesse MJ, Dankova D, Song JG, Bruce-Smythe M, Struble H, Garcia FJ, Brittain SM, Kile AC, McGregor LM, McKenna JM, Tallarico JA, Schirle M, Nomura DK.",ACS Cent Sci. 2023 Apr 11;9(5):915-926. doi: 10.1021/acscentsci.2c01317. eCollection 2023 May 24.,Toriki ES,ACS Cent Sci,2023,30/5/2023,PMC10214506,,10.1021/acscentsci.2c01317,CDK
37137501,The Breast Cancer Proteome and Precision Oncology,"Lei JT, Jaehnig EJ, Smith H, Holt MV, Li X, Anurag M, Ellis MJ, Mills GB, Zhang B, Labrie M.",Cold Spring Harb Perspect Med. 2023 May 3:a041323. doi: 10.1101/cshperspect.a041323. Online ahead of print.,Lei JT,Cold Spring Harb Perspect Med,2023,3/5/2023,,,10.1101/cshperspect.a041323,CDK
36612312,Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study,"Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A, Dolcan A, Sarivalasis A, Zurcher JP, Aedo-Lopez V, Dotta-Celio J, Peters S, Guidi M, Wagner AD, Csajka C, Schneider MP.",Cancers (Basel). 2023 Jan 3;15(1):316. doi: 10.3390/cancers15010316.,Bandiera C,Cancers (Basel),2023,8/1/2023,PMC9818079,,10.3390/cancers15010316,CDK
36060025,Effect of Bevacizumab on a Human Breast Cancer Model that Exhibited Palbociclib-resistance by RB Knockout,"Ishikura N, Sugimoto M, Yorozu K, Kurasawa M, Wakita D, Kondoh O.",Cancer Diagn Progn. 2022 Sep 3;2(5):533-541. doi: 10.21873/cdp.10138. eCollection 2022 Sep-Oct.,Ishikura N,Cancer Diagn Progn,2022,5/9/2022,PMC9425587,,10.21873/cdp.10138,CDK
35570741,Vortex keratopathy associated with ribociclib,"Türkel A, Özdoğan S, Yekedüz E, Şeyran E, Karaçin C, Ateş Ö.",J Oncol Pharm Pract. 2023 Jan;29(1):230-232. doi: 10.1177/10781552221101799. Epub 2022 May 16.,Türkel A,J Oncol Pharm Pract,2023,16/5/2022,,,10.1177/10781552221101799,CDK
36125617,Advanced Acral Melanoma Therapies: Current Status and Future Directions,"Zhang Y, Lan S, Wu D.",Curr Treat Options Oncol. 2022 Oct;23(10):1405-1427. doi: 10.1007/s11864-022-01007-6. Epub 2022 Sep 20.,Zhang Y,Curr Treat Options Oncol,2022,20/9/2022,PMC9526689,,10.1007/s11864-022-01007-6,CDK
34592265,Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant Mesothelioma,"Jang HJ, Truong CY, Lo EM, Holmes HM, Ramos D, Ramineni M, Lee JS, Wang DY, Pietropaolo M, Ripley RT, Burt BM, Lee HS.",Ann Thorac Surg. 2022 Nov;114(5):1842-1852. doi: 10.1016/j.athoracsur.2021.08.054. Epub 2021 Sep 27.,Jang HJ,Ann Thorac Surg,2022,30/9/2021,PMC8957629,NIHMS1745335,10.1016/j.athoracsur.2021.08.054,CDK
37222206,New targeted treatments for advanced sarcomas,"Li CC, Chen TW.",Curr Opin Oncol. 2023 May 4. doi: 10.1097/CCO.0000000000000955. Online ahead of print.,Li CC,Curr Opin Oncol,2023,24/5/2023,,,10.1097/CCO.0000000000000955,CDK
36746967,Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers,"Harding JJ, Piha-Paul SA, Shah RH, Murphy JJ, Cleary JM, Shapiro GI, Quinn DI, Braña I, Moreno V, Borad M, Loi S, Spanggaard I, Park H, Ford JM, Arnedos M, Stemmer SM, de la Fouchardiere C, Fountzilas C, Zhang J, DiPrimeo D, Savin C, Duygu Selcuklu S, Berger MF, Eli LD, Meric-Bernstam F, Jhaveri K, Solit DB, Abou-Alfa GK.",Nat Commun. 2023 Feb 6;14(1):630. doi: 10.1038/s41467-023-36399-y.,Harding JJ,Nat Commun,2023,6/2/2023,PMC9902444,,10.1038/s41467-023-36399-y,CDK
36358625,Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies,"Ozyurt R, Ozpolat B.",Cancers (Basel). 2022 Oct 24;14(21):5206. doi: 10.3390/cancers14215206.,Ozyurt R,Cancers (Basel),2022,11/11/2022,PMC9655708,,10.3390/cancers14215206,CDK
36595763,"Facing the CDK4/6i resistance dilemma in patients with breast cancer, exploration of the resistance mechanism and possible reverse strategy: A narrative review","Wu J, Wang W, Shao X, Lin G, Wang X.",Medicine (Baltimore). 2022 Dec 23;101(51):e32238. doi: 10.1097/MD.0000000000032238.,Wu J,Medicine (Baltimore),2022,3/1/2023,PMC9794308,,10.1097/MD.0000000000032238,CDK
36060026,Prognostic Significance of Low HER2 Expression in Patients With Metastatic Hormone Receptor-positive Breast Cancer Treated With First Line CDK4/6 Inhibitors: A Greek Multicenter Real-world Data Analysis,"Douganiotis G, Kesisis G, Lalla E, Korantzis I, Boukovinas I, Papazisis K.",Cancer Diagn Progn. 2022 Sep 3;2(5):585-591. doi: 10.21873/cdp.10146. eCollection 2022 Sep-Oct.,Douganiotis G,Cancer Diagn Progn,2022,5/9/2022,PMC9425579,,10.21873/cdp.10146,CDK
36091173,"Design, synthesis, and anticancer activity of three novel palbociclib derivatives","Li T, Zhou AD, Bai LF, Zhang XY, Zhou YT, Yang HL, Xu LT, Guo XQ, Zhu XY, Wang DJ, Gu HW, Wang XM.",Front Oncol. 2022 Aug 25;12:959322. doi: 10.3389/fonc.2022.959322. eCollection 2022.,Li T,Front Oncol,2022,12/9/2022,PMC9453454,,10.3389/fonc.2022.959322,CDK
35304677,Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis,"Guan Y, Shen G, Fang Q, Xin Y, Huo X, Li J, Zhao F, Ren D, Liu Z, Li Z, Zhao J.",Clin Exp Med. 2023 Jun;23(2):245-254. doi: 10.1007/s10238-022-00814-3. Epub 2022 Mar 19.,Guan Y,Clin Exp Med,2023,19/3/2022,,,10.1007/s10238-022-00814-3,CDK
36752207,Developing SHP2-based combination therapy for KRAS-amplified cancer,"Li T, Kikuchi O, Zhou J, Wang Y, Pokharel B, Bastl K, Gokhale P, Knott A, Zhang Y, Doench JG, Ho ZV, Catenacci DV, Bass AJ.",JCI Insight. 2023 Feb 8;8(3):e152714. doi: 10.1172/jci.insight.152714.,Li T,JCI Insight,2023,8/2/2023,PMC9977440,,10.1172/jci.insight.152714,CDK
36716649,Computational analysis of protein-ligand interaction by targeting a cell cycle restrainer,"Singh R, Purohit R.",Comput Methods Programs Biomed. 2023 Apr;231:107367. doi: 10.1016/j.cmpb.2023.107367. Epub 2023 Jan 24.,Singh R,Comput Methods Programs Biomed,2023,30/1/2023,,,10.1016/j.cmpb.2023.107367,CDK
35785151,Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future,"Huang W, Hao Z, Mao F, Guo D.",Front Oncol. 2022 Jun 17;12:911876. doi: 10.3389/fonc.2022.911876. eCollection 2022.,Huang W,Front Oncol,2022,5/7/2022,PMC9247310,,10.3389/fonc.2022.911876,CDK
36716534,Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil,"Queiroz MM, Sacardo KP, Ribeiro MF, Gadotti LL, Saddi R, Oliveira LJC, Linck RDM, Cruz MRS, Barroso-Sousa R, Sahade M, Correa TS, Mano MS, Suzuki DA, Shimada AK, Katz A.",Cancer Treat Res Commun. 2023;35:100683. doi: 10.1016/j.ctarc.2023.100683. Epub 2023 Jan 19.,Queiroz MM,Cancer Treat Res Commun,2023,30/1/2023,,,10.1016/j.ctarc.2023.100683,CDK
37266562,CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan,"Blume J, Claus L, Isermann T, Dickmanns A, Conradi LC, Schulz-Heddergott R, Dobbelstein M.",Cell Cycle. 2023 Jun 2:1-20. doi: 10.1080/15384101.2023.2217003. Online ahead of print.,Blume J,Cell Cycle,2023,2/6/2023,,,10.1080/15384101.2023.2217003,CDK
36192009,Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors,"Kanaoka H, Nagahashi M, Atake Y, Hattori A, Bun A, Fukui R, Ozawa H, Fujimoto Y, Higuchi T, Natori K, Imamura M, Murase K, Takatsuka Y, Miyoshi Y.",Anticancer Res. 2022 Oct;42(10):4867-4878. doi: 10.21873/anticanres.15992.,Kanaoka H,Anticancer Res,2022,3/10/2022,,,10.21873/anticanres.15992,CDK
37004700,Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer,"Ziyeh S, Wong L, Basho RK.",Curr Oncol Rep. 2023 Apr 1. doi: 10.1007/s11912-023-01393-6. Online ahead of print.,Ziyeh S,Curr Oncol Rep,2023,2/4/2023,,,10.1007/s11912-023-01393-6,CDK
36978140,HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma,"Li Z, Zhou H, Xia Z, Xia T, Du G, Franziska SD, Li X, Zhai X, Jin B.",Biomark Res. 2023 Mar 29;11(1):33. doi: 10.1186/s40364-023-00473-w.,Li Z,Biomark Res,2023,28/3/2023,PMC10053751,,10.1186/s40364-023-00473-w,CDK
36661374,Second Oral SERD Shines in ER+ Breast Cancer,,Cancer Discov. 2023 Mar 1;13(3):522. doi: 10.1158/2159-8290.CD-NB2023-0005.,,Cancer Discov,2023,20/1/2023,,,10.1158/2159-8290.CD-NB2023-0005,CDK
36831045,"Shifting Treatment Paradigms: Improvements in HR-Positive, HER-2- Negative Breast Cancer Care in Poland from a Clinical Perspective","Ziobro M, Grela-Wojewoda A.",Biomedicines. 2023 Feb 10;11(2):510. doi: 10.3390/biomedicines11020510.,Ziobro M,Biomedicines,2023,25/2/2023,PMC9953114,,10.3390/biomedicines11020510,CDK
35709750,Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma,"Pribnow A, Jonchere B, Liu J, Smith KS, Campagne O, Xu K, Robinson S, Patel Y, Onar-Thomas A, Wu G, Stewart CF, Northcott PA, Yu J, Robinson GW, Roussel MF.",Mol Cancer Ther. 2022 Aug 2;21(8):1306-1317. doi: 10.1158/1535-7163.MCT-21-0598.,Pribnow A,Mol Cancer Ther,2022,16/6/2022,PMC9578677,NIHMS1839047,10.1158/1535-7163.MCT-21-0598,CDK
37129951,Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer,"Peng WT, Jin X, Xu XE, Yang YS, Ma D, Shao ZM, Jiang YZ.",Cancer Res. 2023 May 15;83(10):1711-1724. doi: 10.1158/0008-5472.CAN-22-2143.,Peng WT,Cancer Res,2023,2/5/2023,,,10.1158/0008-5472.CAN-22-2143,CDK
35896230,Everolimus for Treating Hormone Receptor-positive Metastatic Breast Cancer Previously Treated With Cyclin-dependent Kinase 4/6 Inhibitors,"Kitano S, Honda A, Itoi N, Lee T.",Anticancer Res. 2022 Aug;42(8):3913-3919. doi: 10.21873/anticanres.15885.,Kitano S,Anticancer Res,2022,27/7/2022,,,10.21873/anticanres.15885,CDK
37068524,Overview of the therapeutic strategies for ER positive breast cancer,"Blakely B, Shin S, Jin K.",Biochem Pharmacol. 2023 Jun;212:115552. doi: 10.1016/j.bcp.2023.115552. Epub 2023 Apr 15.,Blakely B,Biochem Pharmacol,2023,17/4/2023,,,10.1016/j.bcp.2023.115552,CDK
35906806,Work productivity among patients with metastatic breast cancer in the United States,"Durgapal S, Hanson K, Kurosky SK, Kautz S, Sison S, Cool C.",Expert Rev Pharmacoecon Outcomes Res. 2022 Oct;22(7):1137-1145. doi: 10.1080/14737167.2022.2108409. Epub 2022 Aug 4.,Durgapal S,Expert Rev Pharmacoecon Outcomes Res,2022,30/7/2022,,,10.1080/14737167.2022.2108409,CDK
36118250,"The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors","Sottotetti F, Ferraris E, Tagliaferri B, Palumbo R, Quaquarini E, Teragni C, Balletti E, Leli C, Premoli A, Mollica L, Puglisi S, Sardi S, Malovini A, Pedrazzoli P, Bernardo A.",Drugs Context. 2022 Sep 5;11:2022-1-3. doi: 10.7573/dic.2022-1-3. eCollection 2022.,Sottotetti F,Drugs Context,2022,19/9/2022,PMC9451191,,10.7573/dic.2022-1-3,CDK
35942220,An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer,"Roncato R, Gerratana L, Palmero L, Gagno S, Poetto AS, Peruzzi E, Zanchetta M, Posocco B, De Mattia E, Canil G, Alberti M, Orleni M, Toffoli G, Puglisi F, Cecchin E.",Front Pharmacol. 2022 Jul 22;13:897951. doi: 10.3389/fphar.2022.897951. eCollection 2022.,Roncato R,Front Pharmacol,2022,9/8/2022,PMC9356076,,10.3389/fphar.2022.897951,CDK
37070653,"Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment","Turner N, Huang-Bartlett C, Kalinsky K, Cristofanilli M, Bianchini G, Chia S, Iwata H, Janni W, Ma CX, Mayer EL, Park YH, Fox S, Liu X, McClain S, Bidard FC.",Future Oncol. 2023 Mar;19(8):559-573. doi: 10.2217/fon-2022-1196. Epub 2023 Apr 18.,Turner N,Future Oncol,2023,18/4/2023,,,10.2217/fon-2022-1196,CDK
35834030,Molecular perspective on targeted therapy in breast cancer: a review of current status,"Demir Cetinkaya B, Biray Avci C.",Med Oncol. 2022 Jul 14;39(10):149. doi: 10.1007/s12032-022-01749-1.,Demir Cetinkaya B,Med Oncol,2022,14/7/2022,PMC9281252,,10.1007/s12032-022-01749-1,CDK
36045271,"Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study","Choong GM, Liddell S, Ferre RAL, O'Sullivan CC, Ruddy KJ, Haddad TC, Hobday TJ, Peethambaram PP, Liu MC, Goetz MP, Giridhar KV.",Breast Cancer Res Treat. 2022 Nov;196(1):229-237. doi: 10.1007/s10549-022-06713-1. Epub 2022 Aug 31.,Choong GM,Breast Cancer Res Treat,2022,31/8/2022,PMC9829187,NIHMS1856531,10.1007/s10549-022-06713-1,CDK
34665067,A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population,"Olazagasti C, Lee CS, Liu A, Stefanov D, Cheng K.",J Oncol Pharm Pract. 2023 Jan;29(1):14-21. doi: 10.1177/10781552211050106. Epub 2021 Oct 19.,Olazagasti C,J Oncol Pharm Pract,2023,19/10/2021,,,10.1177/10781552211050106,CDK
36755269,The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma,"Feng M, Xu H, Zhou W, Pan Y.",J Exp Clin Cancer Res. 2023 Feb 9;42(1):44. doi: 10.1186/s13046-023-02615-2.,Feng M,J Exp Clin Cancer Res,2023,9/2/2023,PMC9909925,,10.1186/s13046-023-02615-2,CDK
36085411,Arthralgia induced by endocrine therapy with or without cyclin-dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta-analysis,"Takatsuka D, Sawaki M, Hattori M, Yoshimura A, Kotani H, Kataoka A, Horisawa N, Ozaki Y, Endo Y, Nozawa K, Iwata H.",Asia Pac J Clin Oncol. 2022 Sep 9. doi: 10.1111/ajco.13840. Online ahead of print.,Takatsuka D,Asia Pac J Clin Oncol,2022,10/9/2022,,,10.1111/ajco.13840,CDK
36908287,Update Breast Cancer 2022 Part 6 - Advanced-Stage Breast Cancer,"Lüftner D, Lux MP, Fehm TN, Welslau M, Müller V, Schütz F, Fasching PA, Janni W, Thomssen C, Witzel I, Beierlein M, Belleville E, Untch M, Thill M, Ditsch N, Aktas B, Banys-Paluchowski M, Kolberg-Liedtke C, Wöckel A, Kolberg HC, Harbeck N, Stickeler E, Tesch H, Hartkopf AD.",Geburtshilfe Frauenheilkd. 2023 Mar 9;83(3):299-309. doi: 10.1055/a-2018-9184. eCollection 2023 Mar.,Lüftner D,Geburtshilfe Frauenheilkd,2023,13/3/2023,PMC9998183,,10.1055/a-2018-9184,CDK
37230537,Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses,"Kumar A, Ramani V, Bharti V, de Lima Bellan D, Saleh N, Uzhachenko R, Shen C, Arteaga C, Richmond A, Reddy SM, Vilgelm A.",J Immunother Cancer. 2023 May;11(5):e006019. doi: 10.1136/jitc-2022-006019.,Kumar A,J Immunother Cancer,2023,25/5/2023,PMC10231009,,10.1136/jitc-2022-006019,CDK
36358806,The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance,"Abdelmalak M, Singh R, Anwer M, Ivanchenko P, Randhawa A, Ahmed M, Ashton AW, Du Y, Jiao X, Pestell R.",Cancers (Basel). 2022 Nov 1;14(21):5388. doi: 10.3390/cancers14215388.,Abdelmalak M,Cancers (Basel),2022,11/11/2022,PMC9655989,,10.3390/cancers14215388,CDK
37189701,Clinical Review on the Management of Breast Cancer Visceral Crisis,"Benvenuti C, Gaudio M, Jacobs F, Saltalamacchia G, De Sanctis R, Torrisi R, Santoro A, Zambelli A.",Biomedicines. 2023 Apr 3;11(4):1083. doi: 10.3390/biomedicines11041083.,Benvenuti C,Biomedicines,2023,16/5/2023,PMC10136132,,10.3390/biomedicines11041083,CDK
37186799,Prognostic Parameters of Palbociclib in HR+/HER2- Advanced Breast Cancer: A Narrative Review,"Wang W, Wu J, Chen K, Wang X, Shao X.",Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231173504. doi: 10.1177/15330338231173504.,Wang W,Technol Cancer Res Treat,2023,15/5/2023,PMC10192799,,10.1177/15330338231173504,CDK
36405937,Efficacy of cyclin-dependent kinase 4/6 inhibitors in patients with metastatic hormone positive breast cancer: a single institutional study from India,"Ganguly S, Mukherjee N, Mandal S, Roy S, Agarwal S, Biswas B, Ghosh J.",Ecancermedicalscience. 2022 Sep 26;16:1450. doi: 10.3332/ecancer.2022.1450. eCollection 2022.,Ganguly S,Ecancermedicalscience,2022,21/11/2022,PMC9666281,,10.3332/ecancer.2022.1450,CDK
37219458,Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication,"Ehrenfeld M, Segeth F, Mantwill K, Brockhaus C, Zhao Y, Ploner C, Kolk A, Gschwend JE, Nawroth R, Holm PS.",J Virol. 2023 May 23:e0037023. doi: 10.1128/jvi.00370-23. Online ahead of print.,Ehrenfeld M,J Virol,2023,23/5/2023,,,10.1128/jvi.00370-23,CDK
35962417,Regression of choroidal metastasis from breast carcinoma with palbociclib,"Parakh S, Das S, Maheshwari S, Gupta V, Luthra G, Luthra S.",Int J Retina Vitreous. 2022 Aug 12;8(1):54. doi: 10.1186/s40942-022-00398-w.,Parakh S,Int J Retina Vitreous,2022,12/8/2022,PMC9373398,,10.1186/s40942-022-00398-w,CDK
36768557,Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment,"Pandey P, Khan F, Upadhyay TK, Sharangi AB.",Int J Mol Sci. 2023 Jan 23;24(3):2236. doi: 10.3390/ijms24032236.,Pandey P,Int J Mol Sci,2023,11/2/2023,PMC9916547,,10.3390/ijms24032236,CDK
36728357,"Development and Validation of a Quantitative LC-MS/MS Method for CDK4/6 Inhibitors Palbociclib, Ribociclib, Abemaciclib, and Abemaciclib-M2 in Human Plasma","Burke SM, Kamal M, Goey AKL.",Ther Drug Monit. 2023 Jun 1;45(3):327-336. doi: 10.1097/FTD.0000000000001063. Epub 2023 Jan 10.,Burke SM,Ther Drug Monit,2023,2/2/2023,PMC10175095,NIHMS1849297,10.1097/FTD.0000000000001063,CDK
37011445,"Palbociclib and Michael-acceptor hybrid compounds as CDK4/6 covalent inhibitors: Improved potency, broad anticancer spectrum and overcoming drug resistance","Fang L, Chu M, Yan C, Liu Y, Zhao Z.",Bioorg Med Chem. 2023 Apr 15;84:117263. doi: 10.1016/j.bmc.2023.117263. Epub 2023 Mar 26.,Fang L,Bioorg Med Chem,2023,3/4/2023,,,10.1016/j.bmc.2023.117263,CDK
37190065,"Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy","Wu Q, Sharma D.",Cells. 2023 Apr 14;12(8):1156. doi: 10.3390/cells12081156.,Wu Q,Cells,2023,16/5/2023,PMC10136604,,10.3390/cells12081156,CDK
35972646,Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis,"Bas O, Erul E, Guven DC, Aksoy S.",Support Care Cancer. 2022 Nov;30(11):9071-9078. doi: 10.1007/s00520-022-07320-y. Epub 2022 Aug 16.,Bas O,Support Care Cancer,2022,16/8/2022,,,10.1007/s00520-022-07320-y,CDK
36813612,Identification of the KIF and MCM protein families as novel targets for combination therapy with CDK4/6 inhibitors in bladder cancer,"Kositza J, Nguyen J, Hong T, Mantwill K, Nawroth R.",Urol Oncol. 2023 May;41(5):253.e11-253.e20. doi: 10.1016/j.urolonc.2023.01.010. Epub 2023 Feb 21.,Kositza J,Urol Oncol,2023,22/2/2023,,,10.1016/j.urolonc.2023.01.010,CDK
36539670,Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer,"Franks J, Caston NE, Elkhanany A, Gerke T, Azuero A, Rocque GB.",Breast Cancer Res Treat. 2023 Feb;197(3):673-681. doi: 10.1007/s10549-022-06823-w. Epub 2022 Dec 21.,Franks J,Breast Cancer Res Treat,2023,20/12/2022,PMC9883320,,10.1007/s10549-022-06823-w,CDK
36005200,Palbociclib Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells via RB-Independent STAT3 Phosphorylation,"Xiang W, Qi W, Li H, Sun J, Dong C, Ou H, Liu B.",Curr Oncol. 2022 Aug 18;29(8):5855-5868. doi: 10.3390/curroncol29080462.,Xiang W,Curr Oncol,2022,25/8/2022,PMC9406926,,10.3390/curroncol29080462,CDK
36792625,Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models,"Rodriguez MJ, Perrone MC, Riggio M, Palafox M, Salinas V, Elia A, Salgueiro ND, Werbach AE, Marks MP, Kauffman MA, Vellón L, Serra V, Novaro V.",Sci Rep. 2023 Feb 15;13(1):2710. doi: 10.1038/s41598-023-29425-y.,Rodriguez MJ,Sci Rep,2023,15/2/2023,PMC9932145,,10.1038/s41598-023-29425-y,CDK
36082097,Advances in neoadjuvant therapy for HER2-positive breast cancers: a narrative review,"Wang Q, Wang X, Yang Y.",Gland Surg. 2022 Aug;11(8):1415-1423. doi: 10.21037/gs-22-439.,Wang Q,Gland Surg,2022,9/9/2022,PMC9445724,,10.21037/gs-22-439,CDK
35527301,Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib,"Maeda A, Ando H, Irie K, Hashimoto N, Morishige JI, Fukushima S, Okada A, Ebi H, Matsuzaki M, Iwata H, Sawaki M.",Eur J Clin Pharmacol. 2022 Aug;78(8):1239-1247. doi: 10.1007/s00228-022-03331-0. Epub 2022 May 9.,Maeda A,Eur J Clin Pharmacol,2022,8/5/2022,,,10.1007/s00228-022-03331-0,CDK
36067171,Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity,"Pogacar Z, Johnson JL, Krenning L, De Conti G, Jochems F, Lieftink C, Velds A, Wardak L, Groot K, Schepers A, Wang L, Song JY, van de Ven M, van Tellingen O, Medema RH, Beijersbergen RL, Bernards R, Leite de Oliveira R.",PLoS One. 2022 Sep 6;17(9):e0273182. doi: 10.1371/journal.pone.0273182. eCollection 2022.,Pogacar Z,PLoS One,2022,6/9/2022,PMC9447877,,10.1371/journal.pone.0273182,CDK
36528759,Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study,"Kawamoto T, Shikama N, Imano N, Kubota H, Kosugi T, Sekii S, Harada H, Yamada K, Naoi Y, Miyazawa K, Hirano Y, Wada Y, Tonari A, Saito T, Uchida N, Araki N, Nakamura N.",Breast Cancer. 2023 Mar;30(2):282-292. doi: 10.1007/s12282-022-01422-5. Epub 2022 Dec 17.,Kawamoto T,Breast Cancer,2023,17/12/2022,,,10.1007/s12282-022-01422-5,CDK
37069173,Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors,"Zattarin E, Presti D, Mariani L, Sposetti C, Leporati R, Menichetti A, Corti C, Benvenuti C, Fucà G, Lobefaro R, Ligorio F, Provenzano L, Vingiani A, Del Vecchio M, Griguolo G, Sirico M, Bernocchi O, Marra A, Zagami P, Agostinetto E, Jacobs F, Di Mauro P, Esposito A, Giorgi CA, Lalli L, Boldrini L, Giacchetti PPB, Schianca AC, Guarneri V, Pedersini R, Losurdo A, Zambelli A, Generali D, Criscitiello C, Curigliano G, Pruneri G, de Braud F, Dieci MV, Vernieri C.",NPJ Breast Cancer. 2023 Apr 17;9(1):27. doi: 10.1038/s41523-023-00534-1.,Zattarin E,NPJ Breast Cancer,2023,17/4/2023,PMC10110597,,10.1038/s41523-023-00534-1,CDK
35349366,A Novel External Auditory Canal Squamous Cell Carcinoma Cell Line Sensitive to CDK4/6 Inhibition,"García-Marín R, Cabal VN, Fernández-Cedrón Bermejo C, Riobello C, Suárez-Fernández L, Codina-Martínez H, Navarro-García A, Lorenzo-Guerra SL, García-Martínez J, Vivanco B, López F, Llorente JL, Hermsen MA.",Otolaryngol Head Neck Surg. 2023 Apr;168(4):729-737. doi: 10.1177/01945998221089186. Epub 2023 Feb 5.,García-Marín R,Otolaryngol Head Neck Surg,2023,29/3/2022,,,10.1177/01945998221089186,CDK
36884374,CDK6 activity in a recurring convergent kinase network motif,"Gangemi CG, Sabapathy RT, Janovjak H.",FASEB J. 2023 Apr;37(4):e22845. doi: 10.1096/fj.202201344R.,Gangemi CG,FASEB J,2023,8/3/2023,,,10.1096/fj.202201344R,CDK
36000362,Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment,"Garcia-Fructuoso I, Gomez-Bravo R, Schettini F.",Curr Opin Oncol. 2022 Nov 1;34(6):635-642. doi: 10.1097/CCO.0000000000000892. Epub 2022 Aug 24.,Garcia-Fructuoso I,Curr Opin Oncol,2022,24/8/2022,,,10.1097/CCO.0000000000000892,CDK
36051470,Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer,"Denault E, Nakajima E, Naranbhai V, Hutchinson JA, Mortensen L, Neihoff E, Barabell C, Comander A, Juric D, Kuter I, Mulvey T, Peppercorn J, Rosenstock AS, Shin J, Vidula N, Wander SA, Moy B, Ellisen LW, Isakoff SJ, Iafrate AJ, Gainor JF, Bardia A, Spring LM.",Ther Adv Med Oncol. 2022 Aug 22;14:17588359221119370. doi: 10.1177/17588359221119370. eCollection 2022.,Denault E,Ther Adv Med Oncol,2022,2/9/2022,PMC9425892,,10.1177/17588359221119370,CDK
36307325,[Therapeutic strategies for the treatment of endocrine resistant hormone receptor positive advanced breast cancer],"Grellety T, Hajjaji N, Petit T, Bailleux C.",Bull Cancer. 2023 Jan;110(1):69-87. doi: 10.1016/j.bulcan.2022.09.007. Epub 2022 Oct 25.,Grellety T,Bull Cancer,2023,28/10/2022,,,10.1016/j.bulcan.2022.09.007,CDK
36902831,Efficacy of CDK 4/6 Inhibitors and Radiotherapy in Breast Cancer Patients with Brain Metastases,"Kubeczko M, Jarząb M, Krzywon A, Gräupner D, Polakiewicz-Gilowska A, Gabryś D.",J Clin Med. 2023 Mar 4;12(5):2044. doi: 10.3390/jcm12052044.,Kubeczko M,J Clin Med,2023,11/3/2023,PMC10004463,,10.3390/jcm12052044,CDK
36675501,Prognostic Potential of Cyclin D1 Expression in Colorectal Cancer,"Jun SY, Kim J, Yoon N, Maeng LS, Byun JH.",J Clin Med. 2023 Jan 10;12(2):572. doi: 10.3390/jcm12020572.,Jun SY,J Clin Med,2023,21/1/2023,PMC9867305,,10.3390/jcm12020572,CDK
36551586,Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis,"Wang J, Han Y, Wang J, Li Q, Xu B.",Cancers (Basel). 2022 Dec 11;14(24):6100. doi: 10.3390/cancers14246100.,Wang J,Cancers (Basel),2022,23/12/2022,PMC9776369,,10.3390/cancers14246100,CDK
36414498,Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak,"Martin S, Pflumio C, Trensz P, Schaff-Wendling F, Weindling MK, Fischbach C, Pierard L, Limacher JM, Nader R, Velten M, Petit T.",Clin Breast Cancer. 2023 Jan;23(1):32-37. doi: 10.1016/j.clbc.2022.10.006. Epub 2022 Oct 13.,Martin S,Clin Breast Cancer,2023,22/11/2022,PMC9558751,,10.1016/j.clbc.2022.10.006,CDK
36035756,miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models,"Callegari E, Guerriero P, Bassi C, D'Abundo L, Frassoldati A, Simoni E, Astolfi L, Silini EM, Sabbioni S, Negrini M.",Mol Ther Nucleic Acids. 2022 Jul 20;29:538-549. doi: 10.1016/j.omtn.2022.07.015. eCollection 2022 Sep 13.,Callegari E,Mol Ther Nucleic Acids,2022,29/8/2022,PMC9395755,,10.1016/j.omtn.2022.07.015,CDK
37038927,Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?,"Perrone M, Giuliani F, Sanna V, Bruno S, Melaccio A, Santoro AN, Laface C, Maselli FM, Iaia ML, Guarini C, Fancellu A, Fedele P.",Expert Opin Pharmacother. 2023 Jun;24(8):887-900. doi: 10.1080/14656566.2023.2201373. Epub 2023 Apr 12.,Perrone M,Expert Opin Pharmacother,2023,11/4/2023,,,10.1080/14656566.2023.2201373,CDK
36704980,"The effect and safety of CDK4/6 inhibitors combined endocrine therapy on HR+, HER2-breast cancer: a meta-analysis of randomized controlled trials","Huang T, He Y, Yu C, Mao F, Si Y.",Endokrynol Pol. 2023;74(1):89-105. doi: 10.5603/EP.a2023.0007. Epub 2023 Jan 27.,Huang T,Endokrynol Pol,2023,27/1/2023,,,10.5603/EP.a2023.0007,CDK
35870712,Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study,"Al-Rashdan A, Quirk S, Roumeliotis M, Abedin T, Amaro CP, Barbera L, Lupichuk S, Cao JQ.",Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):399-408. doi: 10.1016/j.ijrobp.2022.07.005. Epub 2022 Jul 21.,Al-Rashdan A,Int J Radiat Oncol Biol Phys,2022,23/7/2022,,,10.1016/j.ijrobp.2022.07.005,CDK
35813283,Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation,"Torres-Guzmán R, Ganado MP, Mur C, Marugan C, Baquero C, Yang Y, Zeng Y, Bian H, Du J, de Dios A, Puig O, Lallena MJ.",Oncotarget. 2022 Jul 2;13:864-875. doi: 10.18632/oncotarget.28249. eCollection 2022.,Torres-Guzmán R,Oncotarget,2022,11/7/2022,PMC9255995,,10.18632/oncotarget.28249,CDK
35732146,Optimizing hormone therapy for breast cancer: Translating gains to the early-stage setting,"Chien AJ, Kyalwazi B, Esserman LJ.",Cell Rep Med. 2022 Jun 21;3(6):100664. doi: 10.1016/j.xcrm.2022.100664.,Chien AJ,Cell Rep Med,2022,22/6/2022,PMC9245052,,10.1016/j.xcrm.2022.100664,CDK
35294522,Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma,"Schuler M, Zimmer L, Kim KB, Sosman JA, Ascierto PA, Postow MA, De Vos FYFL, van Herpen CML, Carlino MS, Johnson DB, Berking C, Reddy MB, Harney AS, Berlin JD, Amaria RN.",Clin Cancer Res. 2022 Jul 15;28(14):3002-3010. doi: 10.1158/1078-0432.CCR-21-3872.,Schuler M,Clin Cancer Res,2022,16/3/2022,PMC9365377,,10.1158/1078-0432.CCR-21-3872,CDK
37141550,A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression,"Brett JO, Dubash TD, Johnson GN, Niemierko A, Mariotti V, Kim LSL, Xi J, Pandey A, Dunne S, Nasrazadani A, Lloyd MR, Kambadakone A, Spring LM, Micalizzi DS, Onozato ML, Che D, Nayar U, Brufsky A, Kalinsky K, Ma CX, O'Shaughnessy J, Han HS, Iafrate AJ, Ryan LY, Juric D, Moy B, Ellisen LW, Maheswaran S, Wagle N, Haber DA, Bardia A, Wander SA.",JCO Precis Oncol. 2023 May;7:e2200532. doi: 10.1200/PO.22.00532.,Brett JO,JCO Precis Oncol,2023,4/5/2023,,,10.1200/PO.22.00532,CDK
36003796,Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: A strategy for clinical application,"Higuchi T, Igarashi K, Yamamoto N, Hayashi K, Kimura H, Miwa S, Bouvet M, Tsuchiya H, Hoffman RM.",Front Oncol. 2022 Aug 8;12:957844. doi: 10.3389/fonc.2022.957844. eCollection 2022.,Higuchi T,Front Oncol,2022,25/8/2022,PMC9393494,,10.3389/fonc.2022.957844,CDK
37017995,Emerging predictive biomarkers in the management of bone and soft tissue sarcomas,"Haddox CL, Riedel RF.",Expert Rev Anticancer Ther. 2023 May;23(5):495-502. doi: 10.1080/14737140.2023.2200169. Epub 2023 Apr 10.,Haddox CL,Expert Rev Anticancer Ther,2023,5/4/2023,,,10.1080/14737140.2023.2200169,CDK
36656642,Effect of adenosine triphosphate on ribociclib-induced skin toxicity in rats,"Akbaş N, Akbaş EM, Süleyman Z, Çiçek B, Ağgül AG, Mokhtare B, Süleyman H.",Cutan Ocul Toxicol. 2023 Mar;42(1):32-37. doi: 10.1080/15569527.2023.2166524. Epub 2023 Jan 19.,Akbaş N,Cutan Ocul Toxicol,2023,19/1/2023,,,10.1080/15569527.2023.2166524,CDK
36551637,Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade,"Sinha D, Moseley P, Lu X, Wright Q, Gabrielli B, Frazer IH, Cruz JLG.",Cancers (Basel). 2022 Dec 13;14(24):6150. doi: 10.3390/cancers14246150.,Sinha D,Cancers (Basel),2022,23/12/2022,PMC9776741,,10.3390/cancers14246150,CDK
36765293,Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy,"Karacin C, Oksuzoglu B, Demirci A, Keskinkılıç M, Baytemür NK, Yılmaz F, Selvi O, Erdem D, Avşar E, Paksoy N, Demir N, Göksu SS, Türker S, Bayram E, Çelebi A, Yılmaz H, Kuzu ÖF, Kahraman S, Gökmen İ, Sakin A, Alkan A, Nayır E, Uğraklı M, Acar Ö, Ertürk İ, Demir H, Aslan F, Sönmez Ö, Korkmaz T, Celayir ÖM, Karadağ İ, Kayıkçıoğlu E, Şakalar T, Öktem İN, Eren T, Erul E, Mocan EE, Kalkan Z, Yıldırım N, Ergün Y, Akagündüz B, Karakaya S, Kut E, Teker F, Demirel BÇ, Karaboyun K, Almuradova E, Ünal OÜ, Oyman A, Işık D, Okutur K, Öztosun B, Gülbağcı BB, Kalender ME, Şahin E, Seyyar M, Özdemir Ö, Selçukbiricik F, Kanıtez M, Dede İ, Gümüş M, Gökmen E, Yaren A, Menekşe S, Ebinç S, Aksoy S, İmamoğlu Gİ, Altınbaş M, Çetin B, Uluç BO, Er Ö, Karadurmuş N, Erdoğan AP, Artaç M, Tanrıverdi Ö, Çiçin İ, Şendur MAN, Oktay E, Bayoğlu İV, Paydaş S, Aydıner A, Salim DK, Geredeli Ç, Yavuzşen T, Doğan M, Hacıbekiroğlu İ.",BMC Cancer. 2023 Feb 10;23(1):136. doi: 10.1186/s12885-023-10609-8.,Karacin C,BMC Cancer,2023,11/2/2023,PMC9912535,,10.1186/s12885-023-10609-8,CDK
36926051,HR(+)/HER2(-) de novo metastatic breast cancer: a true peculiar entity?,"Torrisi R, Jacobs F, Miggiano C, De Sanctis R, Santoro A.",Drugs Context. 2023 Mar 6;12:2022-12-2. doi: 10.7573/dic.2022-12-2. eCollection 2023.,Torrisi R,Drugs Context,2023,17/3/2023,PMC10012832,,10.7573/dic.2022-12-2,CDK
35617640,Economic Cost and Sustainability of Oral Therapies in Precision Oncology,"Desai AP, Scheckel CJ, Soderberg LC, Jensen CJ, Orme JJ, Tella SH, Kommalapati A, Pritchett JC, Khera N, Mahipal A, Go RS; Mayo Clinic Hematology and ONcology Outcomes Research (HONOR) Group.",JCO Oncol Pract. 2022 Aug;18(8):e1247-e1254. doi: 10.1200/OP.21.00847. Epub 2022 May 26.,Desai AP,JCO Oncol Pract,2022,26/5/2022,,,10.1200/OP.21.00847,CDK
37074594,Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review,"Zhao M, Hanson KA, Zhang Y, Zhou A, Cha-Silva AS.",Target Oncol. 2023 May;18(3):327-358. doi: 10.1007/s11523-023-00957-7. Epub 2023 Apr 19.,Zhao M,Target Oncol,2023,19/4/2023,PMC10191980,,10.1007/s11523-023-00957-7,CDK
36706608,"2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluation","Fanta BS, Mekonnen L, Basnet SKC, Teo T, Lenjisa J, Khair NZ, Kou L, Tadesse S, Sykes MJ, Yu M, Wang S.",Bioorg Med Chem. 2023 Feb 15;80:117158. doi: 10.1016/j.bmc.2023.117158. Epub 2023 Jan 11.,Fanta BS,Bioorg Med Chem,2023,27/1/2023,,,10.1016/j.bmc.2023.117158,CDK
36335120,"Abemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study","Rugo HS, Kabos P, Beck JT, Jerusalem G, Wildiers H, Sevillano E, Paz-Ares L, Chisamore MJ, Chapman SC, Hossain AM, Chen Y, Tolaney SM.",NPJ Breast Cancer. 2022 Nov 5;8(1):118. doi: 10.1038/s41523-022-00482-2.,Rugo HS,NPJ Breast Cancer,2022,6/11/2022,PMC9637121,,10.1038/s41523-022-00482-2,CDK
35972817,Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer,"Coffman LG, Orellana TJ, Liu T, Frisbie LG, Normolle D, Griffith K, Uppal S, McLean K, Berger J, Boisen M, Courtney-Brooks M, Edwards RP, Lesnock J, Mahdi H, Olawaiye A, Sukumvanich P, Taylor SE, Buckanovich R.",JCI Insight. 2022 Sep 22;7(18):e160573. doi: 10.1172/jci.insight.160573.,Coffman LG,JCI Insight,2022,16/8/2022,PMC9675476,,10.1172/jci.insight.160573,CDK
36110891,Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer,"Aktas B, Fehm TN, Welslau M, Müller V, Lüftner D, Schütz F, Fasching PA, Janni W, Thomssen C, Witzel I, Belleville E, Untch M, Thill M, Tesch H, Ditsch N, Lux MP, Banys-Paluchowski M, Kolberg-Liedtke C, Hartkopf AD, Wöckel A, Kolberg HC, Stickeler E, Harbeck N, Schneeweiss A.",Geburtshilfe Frauenheilkd. 2022 Sep 13;82(9):922-931. doi: 10.1055/a-1912-7362. eCollection 2022 Sep.,Aktas B,Geburtshilfe Frauenheilkd,2022,16/9/2022,PMC9470282,,10.1055/a-1912-7362,CDK
35484313,Cytokinetic-driven myeloprotection after cytotoxic chemotherapy: from an old idea to a new clinical approach,"Sbrana A, Antonuzzo A, Danova M.",Support Care Cancer. 2022 Sep;30(9):7057-7060. doi: 10.1007/s00520-022-07084-5. Epub 2022 Apr 28.,Sbrana A,Support Care Cancer,2022,28/4/2022,,,10.1007/s00520-022-07084-5,CDK
35903715,Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer,"Müller V, Welslau M, Lüftner D, Schütz F, Stickeler E, Fasching PA, Janni W, Thomssen C, Witzel I, Fehm TN, Belleville E, Bader S, Seitz K, Untch M, Thill M, Tesch H, Ditsch N, Lux MP, Aktas B, Banys-Paluchowski M, Schneeweiss A, Harbeck N, Würstlein R, Hartkopf AD, Kolberg HC, Wöckel A.",Geburtshilfe Frauenheilkd. 2022 Jun 3;82(6):590-600. doi: 10.1055/a-1811-6148. eCollection 2022 Jun.,Müller V,Geburtshilfe Frauenheilkd,2022,29/7/2022,PMC9315399,,10.1055/a-1811-6148,CDK
36017825,SHR6390 combined with cabozantinib inhibits tumor progression in hepatocellular carcinoma mouse model,"Liu C, Shi J, Lin B, Zhou M, Shan D, Nie J, Wang Y, Zhang Y, Han P, Zheng T.",Curr Gene Ther. 2022 Aug 25. doi: 10.2174/1566523222666220825110147. Online ahead of print.,Liu C,Curr Gene Ther,2022,26/8/2022,,,10.2174/1566523222666220825110147,CDK
36746338,Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment,"Melnyk T, Masiá E, Zagorodko O, Conejos-Sánchez I, Vicent MJ.",J Control Release. 2023 Mar;355:385-394. doi: 10.1016/j.jconrel.2023.01.079. Epub 2023 Feb 10.,Melnyk T,J Control Release,2023,6/2/2023,,,10.1016/j.jconrel.2023.01.079,CDK
36826463,Abemaciclib: A Review in Early Breast Cancer with a High Risk of Recurrence,"Fung S, Blair HA.",Target Oncol. 2023 Mar;18(2):287-294. doi: 10.1007/s11523-023-00952-y. Epub 2023 Feb 24.,Fung S,Target Oncol,2023,24/2/2023,,,10.1007/s11523-023-00952-y,CDK
36428573,Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects,"Gulde S, Foscarini A, April-Monn SL, Genio E, Marangelo A, Satam S, Helbling D, Falconi M, Toledo RA, Schrader J, Perren A, Marinoni I, Pellegata NS.",Cancers (Basel). 2022 Nov 8;14(22):5481. doi: 10.3390/cancers14225481.,Gulde S,Cancers (Basel),2022,26/11/2022,PMC9688197,,10.3390/cancers14225481,CDK
36982482,"MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma Cells","De Rosa P, Severi F, Zadran SK, Russo M, Aloisi S, Rigamonti A, Capranico G, Milazzo G, Perini G.",Int J Mol Sci. 2023 Mar 12;24(6):5408. doi: 10.3390/ijms24065408.,De Rosa P,Int J Mol Sci,2023,29/3/2023,PMC10049239,,10.3390/ijms24065408,CDK
35767226,Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer,"Watson NW, Wander SA, Shatzel JJ, Al-Samkari H.",Cancer. 2022 Sep 1;128(17):3224-3232. doi: 10.1002/cncr.34367. Epub 2022 Jun 29.,Watson NW,Cancer,2022,29/6/2022,PMC10042227,NIHMS1815884,10.1002/cncr.34367,CDK
36913303,"Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells",Blagosklonny MV.,Oncotarget. 2023 Mar 11;14:193-206. doi: 10.18632/oncotarget.28382.,Blagosklonny MV,Oncotarget,2023,13/3/2023,PMC10010629,,10.18632/oncotarget.28382,CDK
36093588,Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis,"Cheung AH, Hui CH, Wong KY, Liu X, Chen B, Kang W, To KF.",Int J Cancer. 2023 Apr 15;152(8):1510-1525. doi: 10.1002/ijc.34288. Epub 2022 Sep 26.,Cheung AH,Int J Cancer,2023,12/9/2022,,,10.1002/ijc.34288,CDK
36959160,An Overview of CDK Enzyme Inhibitors in Cancer Therapy,"Mounika P, Gurupadayya BM, Yogish Kumar H, Namitha BM.",Curr Cancer Drug Targets. 2023 Mar 20. doi: 10.2174/1568009623666230320144713. Online ahead of print.,Mounika P,Curr Cancer Drug Targets,2023,24/3/2023,,,10.2174/1568009623666230320144713,CDK
37258566,Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer,"Belli S, Esposito D, Allotta A, Servetto A, Ciciola P, Pesapane A, Ascione CM, Napolitano F, Di Mauro C, Vigliar E, Iaccarino A, De Angelis C, Bianco R, Formisano L.",NPJ Breast Cancer. 2023 May 31;9(1):48. doi: 10.1038/s41523-023-00556-9.,Belli S,NPJ Breast Cancer,2023,31/5/2023,PMC10232479,,10.1038/s41523-023-00556-9,CDK
36364432,"Rapid Capillary Electrophoresis Method for Simultaneous Determination of Abemaciclib, Ribociclib, and Palbociclib in Pharmaceutical Dosage Forms: A Green Approach","Mlinarić Z, Turković L, Begović I, Nigović B, Sertić M.",Molecules. 2022 Nov 6;27(21):7603. doi: 10.3390/molecules27217603.,Mlinarić Z,Molecules,2022,11/11/2022,PMC9657767,,10.3390/molecules27217603,CDK
36033888,EmCyclinD-EmCDK4/6 complex is involved in the host EGF-mediated proliferation of Echinococcus multilocularis germinative cells via the EGFR-ERK pathway,"Feng C, Cheng Z, Xu Z, Tian Y, Tian H, Liu F, Luo D, Wang Y.",Front Microbiol. 2022 Aug 4;13:968872. doi: 10.3389/fmicb.2022.968872. eCollection 2022.,Feng C,Front Microbiol,2022,29/8/2022,PMC9410764,,10.3389/fmicb.2022.968872,CDK
37108359,An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia,"Patel J, Gao X, Wang H.",Int J Mol Sci. 2023 Apr 13;24(8):7201. doi: 10.3390/ijms24087201.,Patel J,Int J Mol Sci,2023,28/4/2023,PMC10139433,,10.3390/ijms24087201,CDK
36733049,[Eight Cases of Breast Cancer That Relapsed More Than Ten Years after Initial Treatment],"Yoshimura A, Ueda T, Tanaka T, Kirihataya Y, Soga M, Yokotani T.",Gan To Kagaku Ryoho. 2022 Dec;49(13):1935-1937.,Yoshimura A,Gan To Kagaku Ryoho,2022,3/2/2023,,,,CDK
36414795,"Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database","Kawai M, Takada M, Nakayama T, Masuda N, Shiheido H, Cai Z, Huang YJ, Kawaguchi T, Tanizawa Y.",Breast Cancer Res Treat. 2023 Jan;197(2):435-447. doi: 10.1007/s10549-022-06816-9. Epub 2022 Nov 21.,Kawai M,Breast Cancer Res Treat,2023,22/11/2022,PMC9823084,,10.1007/s10549-022-06816-9,CDK
35783158,"Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD(3)+CD(56)+ NKT-Like Cells","Zhu S, Zhang C, Sun Q, Wang Y, Yu W, Wei F, Ren X.",J Oncol. 2022 Jun 23;2022:8724933. doi: 10.1155/2022/8724933. eCollection 2022.,Zhu S,J Oncol,2022,5/7/2022,PMC9246603,,10.1155/2022/8724933,CDK
37060423,"New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer","Brett JO, Mayer EL.",Curr Treat Options Oncol. 2023 Jun;24(6):594-610. doi: 10.1007/s11864-023-01082-3. Epub 2023 Apr 15.,Brett JO,Curr Treat Options Oncol,2023,15/4/2023,,,10.1007/s11864-023-01082-3,CDK
36260177,Risk factors associated with palbociclib-induced neutropenia in patients with metastatic breast cancer,"Lavery L, DiSogra K, Lea J, Trufan SJ, Symanowski JT, Roberts A, Moore DC, Heeke A, Pal S.",Support Care Cancer. 2022 Dec;30(12):9803-9809. doi: 10.1007/s00520-022-07400-z. Epub 2022 Oct 19.,Lavery L,Support Care Cancer,2022,19/10/2022,,,10.1007/s00520-022-07400-z,CDK
37162105,Less necessity of adjuvant S-1 treatment in non-monarchE-eligible patients,"Yu M, Takada M, Yamada H, Fujimoto H, Sakakibara J, Yamamoto H, Nagashima T, Ohtsuka M.",Cancer Med. 2023 May 10. doi: 10.1002/cam4.6006. Online ahead of print.,Yu M,Cancer Med,2023,10/5/2023,,,10.1002/cam4.6006,CDK
37247903,Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib,"Morita M, Ooe A, Ishii W, Watanabe A, Matsui C, Okuyama Y, Kitano S, Kato C, Onishi M, Sakaguchi K, Naoi Y.",Anticancer Res. 2023 Jun;43(6):2783-2789. doi: 10.21873/anticanres.16447.,Morita M,Anticancer Res,2023,29/5/2023,,,10.21873/anticanres.16447,CDK
37127652,Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition,"Vo T, Balderson B, Jones K, Ni G, Crawford J, Millar A, Tolson E, Singleton M, Kojic M, Robertson T, Walters S, Mulay O, Bhuva DD, Davis MJ, Wainwright BJ, Nguyen Q, Genovesi LA.",Genome Med. 2023 May 1;15(1):29. doi: 10.1186/s13073-023-01185-4.,Vo T,Genome Med,2023,1/5/2023,PMC10150495,,10.1186/s13073-023-01185-4,CDK
36967633,Palbociclib blocks neutrophilic phosphatidylinositol 3-kinase activity to alleviate psoriasiform dermatitis,"Chen PJ, Tseng HH, Wang YH, Fang SY, Chen SH, Chen CH, Tsai SC, Chang YC, Tsai YF, Hwang TL.",Br J Pharmacol. 2023 Mar 26. doi: 10.1111/bph.16080. Online ahead of print.,Chen PJ,Br J Pharmacol,2023,27/3/2023,,,10.1111/bph.16080,CDK
35597806,Inability to phosphorylate Y88 of p27(Kip1) enforces reduced p27 protein levels and accelerates leukemia progression,"Jäkel H, Taschler M, Jung K, Weinl C, Pegka F, Kullmann MK, Podmirseg SR, Dutta S, Moser M, Hengst L.",Leukemia. 2022 Jul;36(7):1916-1925. doi: 10.1038/s41375-022-01598-x. Epub 2022 May 21.,Jäkel H,Leukemia,2022,21/5/2022,PMC9252907,,10.1038/s41375-022-01598-x,CDK
36980685,"Do Not Forget about Hormonal Therapy for Recurrent Endometrial Cancer: A Review of Options, Updates, and New Combinations","Wagner VM, Backes FJ.",Cancers (Basel). 2023 Mar 16;15(6):1799. doi: 10.3390/cancers15061799.,Wagner VM,Cancers (Basel),2023,29/3/2023,PMC10046539,,10.3390/cancers15061799,CDK
36603395,"Therapeutic drug monitoring in breast cancer therapy - LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serum","Habler K, Kalla AS, Rychlik M, Vogeser M, Teupser D.",J Pharm Biomed Anal. 2023 Feb 20;225:115211. doi: 10.1016/j.jpba.2022.115211. Epub 2022 Dec 20.,Habler K,J Pharm Biomed Anal,2023,5/1/2023,,,10.1016/j.jpba.2022.115211,CDK
36341371,Hsp90β inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumors,"Rahmy S, Mishra SJ, Murphy S, Blagg BSJ, Lu X.",Front Immunol. 2022 Oct 20;13:1005045. doi: 10.3389/fimmu.2022.1005045. eCollection 2022.,Rahmy S,Front Immunol,2022,7/11/2022,PMC9630337,,10.3389/fimmu.2022.1005045,CDK
35705252,Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression,"Thompson PK, Chen ELY, de Pooter RF, Frelin C, Vogel WK, Lee CR, Venables T, Shah DK, Iscove NN, Leid M, Anderson MK, Zúñiga-Pflücker JC.",J Immunol. 2022 Jul 1;209(1):77-92. doi: 10.4049/jimmunol.2100366. Epub 2022 Jun 15.,Thompson PK,J Immunol,2022,15/6/2022,PMC9248976,NIHMS1803537,10.4049/jimmunol.2100366,CDK
36743215,Investigation on acquired palbociclib resistance by LC-MS based multi-omics analysis,"Xue Z, Zeng J, Yin X, Li Y, Meng B, Zhao Y, Fang X, Gong X, Dai X.",Front Mol Biosci. 2023 Jan 19;10:1116398. doi: 10.3389/fmolb.2023.1116398. eCollection 2023.,Xue Z,Front Mol Biosci,2023,6/2/2023,PMC9892630,,10.3389/fmolb.2023.1116398,CDK
37264081,A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer,"Meng D, Zhao X, Yang YC, Navickas A, Helland C, Goodarzi H, Singh M, Bandyopadhyay S.",Oncogene. 2023 Jun 1. doi: 10.1038/s41388-023-02737-z. Online ahead of print.,Meng D,Oncogene,2023,1/6/2023,,,10.1038/s41388-023-02737-z,CDK
36901951,Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma,"Krebs FS, Moura B, Missiaglia E, Aedo-Lopez V, Michielin O, Tsantoulis P, Bisig B, Trimech M, Zoete V, Homicsko K.",Int J Mol Sci. 2023 Feb 24;24(5):4520. doi: 10.3390/ijms24054520.,Krebs FS,Int J Mol Sci,2023,11/3/2023,PMC10003177,,10.3390/ijms24054520,CDK
36123435,Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel,"Plett R, Mellor P, Kendall S, Hammond SA, Boulet A, Plaza K, Vizeacoumar FS, Vizeacoumar FJ, Anderson DH.",Sci Rep. 2022 Sep 19;12(1):15663. doi: 10.1038/s41598-022-19621-7.,Plett R,Sci Rep,2022,19/9/2022,PMC9485251,,10.1038/s41598-022-19621-7,CDK
36795415,"Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands","Luyendijk M, Blommestein H, Uyl-de Groot C, Siesling S, Jager A.",JAMA Netw Open. 2023 Feb 1;6(2):e2256170. doi: 10.1001/jamanetworkopen.2022.56170.,Luyendijk M,JAMA Netw Open,2023,16/2/2023,PMC9936344,,10.1001/jamanetworkopen.2022.56170,CDK
36151018,"Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer","Wong V, de Boer R, Baron-Hay S, Blum R, Boyle F, Chua S, Clarke K, Cuff K, Green M, Lim E, Mok K, Nott L, Nottage M, Tafreshi A, Tsoi D, Uccellini A, Hong W, Gibbs P, Lok SW.",Clin Breast Cancer. 2022 Dec;22(8):792-800. doi: 10.1016/j.clbc.2022.08.011. Epub 2022 Aug 30.,Wong V,Clin Breast Cancer,2022,23/9/2022,,,10.1016/j.clbc.2022.08.011,CDK
35941421,Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study,"Terada M, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Hisada T, Uemoto Y, Akiko Kato, Yamanaka N, Sugiura H, Mita K, Wada A, Takahashi E, Saito K, Yoshioka R, Toyama T.",Breast Cancer Res Treat. 2022 Oct;195(3):311-323. doi: 10.1007/s10549-022-06693-2. Epub 2022 Aug 8.,Terada M,Breast Cancer Res Treat,2022,8/8/2022,PMC9360656,,10.1007/s10549-022-06693-2,CDK
35903919,A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions,"Musicco F, Lasala R, Santoleri F, Costantini A, Abrate P, Carretta MT, Proli EM, Romagnoli A, Petragnani N, Vita F, Zeuli M, Vici P, Sansone M, Pasquantonio M, La Malfa A, Fulgenzio C.",J Oncol Pharm Pract. 2022 Jul 29:10781552221117135. doi: 10.1177/10781552221117135. Online ahead of print.,Musicco F,J Oncol Pharm Pract,2022,29/7/2022,,,10.1177/10781552221117135,CDK
36565895,CDK inhibitors from past to present: A new wave of cancer therapy,"Mughal MJ, Bhadresha K, Kwok HF.",Semin Cancer Biol. 2023 Jan;88:106-122. doi: 10.1016/j.semcancer.2022.12.006. Epub 2022 Dec 21.,Mughal MJ,Semin Cancer Biol,2023,24/12/2022,,,10.1016/j.semcancer.2022.12.006,CDK
35930715,"18F-FDG PET/CT Metabolic Response With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent 4/6 Kinase Inhibitors","Filizoglu N, Ozguven S, Erdil TY.",Clin Nucl Med. 2022 Sep 1;47(9):e605-e606. doi: 10.1097/RLU.0000000000004177. Epub 2022 Apr 5.,Filizoglu N,Clin Nucl Med,2022,5/8/2022,,,10.1097/RLU.0000000000004177,CDK
36164576,Cost-effectiveness of Ribociclib in HER2- negative breast cancer: A synthesis of current evidence,"Alotaibi WH, Alhamdan MM, Balkhi B.",Saudi Pharm J. 2022 Aug;30(8):1113-1119. doi: 10.1016/j.jsps.2022.06.002. Epub 2022 Jun 13.,Alotaibi WH,Saudi Pharm J,2022,27/9/2022,PMC9508637,,10.1016/j.jsps.2022.06.002,CDK
37060933,Synthesis and biological evaluation of novel pteridin-7(8H)-one derivatives as potent CDK2 inhibitors,"Wang X, Ding L, Jiang H, Yuan X, Xiang L, Tang C.",Bioorg Med Chem Lett. 2023 May 15;88:129284. doi: 10.1016/j.bmcl.2023.129284. Epub 2023 Apr 13.,Wang X,Bioorg Med Chem Lett,2023,15/4/2023,,,10.1016/j.bmcl.2023.129284,CDK
37071495,Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer,"Gou X, Kim BJ, Anurag M, Lei JT, Young MN, Holt MV, Fandino D, Vollert CT, Singh P, Alzubi MA, Malovannaya A, Dobrolecki LE, Lewis MT, Li S, Foulds CE, Ellis MJ.",Cancer Res. 2023 Apr 18:CAN-22-3484. doi: 10.1158/0008-5472.CAN-22-3484. Online ahead of print.,Gou X,Cancer Res,2023,18/4/2023,,,10.1158/0008-5472.CAN-22-3484,CDK
36128594,Prospective Cohort Study of Combination Therapy With Abemaciclib and Hormonal Therapy for Chemotherapy-Treated Patients With Hormone Receptor-Positive Metastatic Breast Cancer,"Miyahara K, Narui K, Uemura Y, Yamada A, Araki K, Fujisawa F, Nakayama T, Ishikawa T, Taira N, Kikawa Y, Aihara T, Mukai H.",World J Oncol. 2022 Aug;13(4):216-221. doi: 10.14740/wjon1511. Epub 2022 Aug 23.,Miyahara K,World J Oncol,2022,21/9/2022,PMC9451572,,10.14740/wjon1511,CDK
36598514,Novel combination treatment of CDK 4/6 inhibitors with PARP inhibitors in triple negative breast cancer cells,"Guney Eskiler G, Ozman Z, Haciefendi A, Cansaran-Duman D.",Naunyn Schmiedebergs Arch Pharmacol. 2023 May;396(5):1031-1041. doi: 10.1007/s00210-022-02375-4. Epub 2023 Jan 4.,Guney Eskiler G,Naunyn Schmiedebergs Arch Pharmacol,2023,4/1/2023,,,10.1007/s00210-022-02375-4,CDK
36522339,Inhibition of p21 activates Akt kinase to trigger ROS-induced autophagy and impacts on tumor growth rate,"Maheshwari M, Yadav N, Hasanain M, Pandey P, Sahai R, Choyal K, Singh A, Nengroo MA, Saini KK, Kumar D, Mitra K, Datta D, Sarkar J.",Cell Death Dis. 2022 Dec 15;13(12):1045. doi: 10.1038/s41419-022-05486-1.,Maheshwari M,Cell Death Dis,2022,15/12/2022,PMC9755229,,10.1038/s41419-022-05486-1,CDK
36817127,Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy,"Arndt C, Tunger A, Wehner R, Rothe R, Kourtellari E, Luttosch S, Hannemann K, Koristka S, Loureiro LR, Feldmann A, Tonn T, Link T, Kuhlmann JD, Wimberger P, Bachmann MP, Schmitz M.",Front Pharmacol. 2023 Feb 3;14:970457. doi: 10.3389/fphar.2023.970457. eCollection 2023.,Arndt C,Front Pharmacol,2023,23/2/2023,PMC9935825,,10.3389/fphar.2023.970457,CDK
36539444,Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies,"Mouabbi JA, Raghavendra AS, Bassett RL Jr, Hassan A, Tripathy D, Layman RM.",NPJ Breast Cancer. 2022 Dec 20;8(1):131. doi: 10.1038/s41523-022-00499-7.,Mouabbi JA,NPJ Breast Cancer,2022,20/12/2022,PMC9768132,,10.1038/s41523-022-00499-7,CDK
36529792,Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity,"Li CX, Wang JS, Wang WN, Xu DK, Zhou YT, Sun FZ, Li YQ, Guo FZ, Ma JL, Zhang XY, Chang MJ, Xu BH, Ma F, Qian HL.",Mil Med Res. 2022 Dec 19;9(1):71. doi: 10.1186/s40779-022-00432-w.,Li CX,Mil Med Res,2022,18/12/2022,PMC9762028,,10.1186/s40779-022-00432-w,CDK
36028783,Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer,"Whitaker KD, Wang X, Ascha M, Showalter TN, Lewin HG, Calip GS, Goldstein LJ.",Breast Cancer Res Treat. 2022 Nov;196(1):163-173. doi: 10.1007/s10549-022-06701-5. Epub 2022 Aug 26.,Whitaker KD,Breast Cancer Res Treat,2022,26/8/2022,PMC9550747,,10.1007/s10549-022-06701-5,CDK
36643309,Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model,"Villanueva H, Wells GA, Miller MT, Villanueva M, Pathak R, Castro P, Ittmann MM, Sikora AG, Lerner SP.",Heliyon. 2022 Dec 24;8(12):e12570. doi: 10.1016/j.heliyon.2022.e12570. eCollection 2022 Dec.,Villanueva H,Heliyon,2022,16/1/2023,PMC9834740,,10.1016/j.heliyon.2022.e12570,CDK
36605432,Symptomatic bone marrow metastases in breast cancer: A retrospective cohort study,"Yang R, Jia L, Lu G, Lv Z, Cui J.",Front Oncol. 2022 Dec 19;12:1042773. doi: 10.3389/fonc.2022.1042773. eCollection 2022.,Yang R,Front Oncol,2022,6/1/2023,PMC9808780,,10.3389/fonc.2022.1042773,CDK
36278961,Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer,"Peng K, Zhang F, Wang Y, Sahgal P, Li T, Zhou J, Liang X, Zhang Y, Sethi N, Liu T, Zhang H, Bass AJ.",Clin Cancer Res. 2023 Jan 4;29(1):197-208. doi: 10.1158/1078-0432.CCR-22-1609.,Peng K,Clin Cancer Res,2023,24/10/2022,PMC9812865,NIHMS1846103,10.1158/1078-0432.CCR-22-1609,CDK
36060324,Efficacy of Abemaciclib in the Management of Refractory Metastatic Extramammary Paget's Disease,"Takahashi GW, Vetto J, Leitenberger JJ, Hung A.",Cureus. 2022 Jul 31;14(7):e27534. doi: 10.7759/cureus.27534. eCollection 2022 Jul.,Takahashi GW,Cureus,2022,5/9/2022,PMC9428388,,10.7759/cureus.27534,CDK
37061333,"Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting","Gupta A, Dagar G, Chauhan R, Sadida HQ, Almarzooqi SK, Hashem S, Uddin S, Macha MA, Akil ASA, Pandita TK, Bhat AA, Singh M.",Adv Protein Chem Struct Biol. 2023;135:21-55. doi: 10.1016/bs.apcsb.2023.02.001. Epub 2023 Mar 16.,Gupta A,Adv Protein Chem Struct Biol,2023,15/4/2023,,,10.1016/bs.apcsb.2023.02.001,CDK
36446866,Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer,"Pancholi S, Simigdala N, Ribas R, Schuster E, Leal MF, Nikitorowicz-Buniak J, Rega C, Bihani T, Patel H, Johnston SR, Dowsett M, Martin LA.",NPJ Breast Cancer. 2022 Nov 29;8(1):125. doi: 10.1038/s41523-022-00483-1.,Pancholi S,NPJ Breast Cancer,2022,29/11/2022,PMC9709100,,10.1038/s41523-022-00483-1,CDK
36129131,Anti-breast cancer drugs targeting cell-surface glucose-regulated protein 78: a drug repositioning in silico study,"Abu-Mahfouz A, Ali M, Elfiky A.",J Biomol Struct Dyn. 2022 Sep 21:1-15. doi: 10.1080/07391102.2022.2125076. Online ahead of print.,Abu-Mahfouz A,J Biomol Struct Dyn,2022,21/9/2022,,,10.1080/07391102.2022.2125076,CDK
36722142,Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer,"Prabhu SA, Moussa O, Gonçalves C, LaPierre JH, Chou H, Huang F, Richard VR, Ferruzo PYM, Guettler EM, Soria-Bretones I, Kirby L, Gagnon N, Su J, Silvester J, Krisna SS, Rose AAN, Sheppard KE, Cescon DW, Mallette FA, Zahedi RP, Borchers CH, Del Rincon SV, Miller WH.",Mol Cancer Ther. 2023 Feb 1;22(2):192-204. doi: 10.1158/1535-7163.MCT-22-0092.,Prabhu SA,Mol Cancer Ther,2023,1/2/2023,,,10.1158/1535-7163.MCT-22-0092,CDK
35982453,3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumor,"Tatum JL, Kalen JD, Jacobs PM, Riffle LA, James A, Thang L, Sanders C, Hollingshead MG, Basuli F, Shi J, Doroshow JH.",J Transl Med. 2022 Aug 18;20(1):375. doi: 10.1186/s12967-022-03580-8.,Tatum JL,J Transl Med,2022,18/8/2022,PMC9389794,,10.1186/s12967-022-03580-8,CDK
35358627,Palbociclib in combination with sunitinib exerts a synergistic anti-cancer effect in patient-derived xenograft models of various human cancers types,"Moskovits N, Peretz I, Chausky E, Itzhaki E, Shmuel N, Meerson R, Tarasenko N, Kaufman A, Stemmer A, Yaﬀe R, Bareket-Samish A, Edison N, Goldman T, Stemmer SM.",Cancer Lett. 2022 Jun 28;536:215665. doi: 10.1016/j.canlet.2022.215665. Epub 2022 Mar 28.,Moskovits N,Cancer Lett,2022,31/3/2022,,,10.1016/j.canlet.2022.215665,CDK
36127291,PFKFB4 facilitates palbociclib resistance in oestrogen receptor-positive breast cancer by enhancing stemness,"Wang S, Bei Y, Tian Q, He J, Wang R, Wang Q, Sun L, Ke J, Xie C, Shen P.",Cell Prolif. 2023 Jan;56(1):e13337. doi: 10.1111/cpr.13337. Epub 2022 Sep 20.,Wang S,Cell Prolif,2023,20/9/2022,PMC9816941,,10.1111/cpr.13337,CDK
35737886,"Efficacy, safety and toxicity management of adjuvant abemaciclib in early stage HR+/HER2- high-risk breast cancer","Sammons S, Moore H, Cushman J, Hamilton E.",Expert Rev Anticancer Ther. 2022 Aug;22(8):805-814. doi: 10.1080/14737140.2022.2093719. Epub 2022 Jun 30.,Sammons S,Expert Rev Anticancer Ther,2022,23/6/2022,,,10.1080/14737140.2022.2093719,CDK
36172919,miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions,"Zhu W, Yu Y, Fang K, Xiao S, Ni L, Yin C, Huang X, Wang X, Zhang Y, Le HB, Cui R.",Cancer Med. 2023 Feb;12(4):4590-4604. doi: 10.1002/cam4.5309. Epub 2022 Sep 29.,Zhu W,Cancer Med,2023,29/9/2022,PMC9972157,,10.1002/cam4.5309,CDK
37234088,"Modeling breast cancer proliferation, drug synergies, and alternating therapies","He W, Demas DM, Shajahan-Haq AN, Baumann WT.",iScience. 2023 Apr 23;26(5):106714. doi: 10.1016/j.isci.2023.106714. eCollection 2023 May 19.,He W,iScience,2023,26/5/2023,PMC10206440,,10.1016/j.isci.2023.106714,CDK
36146552,Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents,"Zagouri F, Papatheodoridi A, Liontos M, Briasoulis A, Sklirou AD, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Koutsoukos K, Kaparelou M, Gkogkou E, Trougakos IP, Dimopoulos MA, Terpos E.",Vaccines (Basel). 2022 Sep 5;10(9):1474. doi: 10.3390/vaccines10091474.,Zagouri F,Vaccines (Basel),2022,23/9/2022,PMC9505348,,10.3390/vaccines10091474,CDK
36923916,Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design,"Yu Y, Huang J, He H, Han J, Ye G, Xu T, Sun X, Chen X, Ren X, Li C, Li H, Huang W, Liu Y, Wang X, Gao Y, Cheng N, Guo N, Chen X, Feng J, Hua Y, Liu C, Zhu G, Xie Z, Yao L, Zhong W, Chen X, Liu W, Li H.",ACS Med Chem Lett. 2023 Feb 8;14(3):297-304. doi: 10.1021/acsmedchemlett.2c00515. eCollection 2023 Mar 9.,Yu Y,ACS Med Chem Lett,2023,16/3/2023,PMC10009793,,10.1021/acsmedchemlett.2c00515,CDK
36872049,"[Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression]","Guo J, Mu D, Yu W, Sun L, Zhang J, Ren X, Han Y.",Zhongguo Fei Ai Za Zhi. 2023 Feb 20;26(2):105-112. doi: 10.3779/j.issn.1009-3419.2023.106.04.,Guo J,Zhongguo Fei Ai Za Zhi,2023,5/3/2023,PMC10033240,,10.3779/j.issn.1009-3419.2023.106.04,CDK
35957711,Palbociclib regulates the expression of dihydrofolate reductase and the cell cycle to inhibit t (11;14) multiple myeloma,"Wang Y, Wang H, Wang X.",Ann Transl Med. 2022 Jul;10(13):746. doi: 10.21037/atm-22-2830.,Wang Y,Ann Transl Med,2022,12/8/2022,PMC9358508,,10.21037/atm-22-2830,CDK
37055530,Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation,"Xu YJ, Zeng K, Ren Y, Mao CY, Ye YH, Zhu XT, Sun ZY, Cao BY, Zhang ZB, Xu GQ, Huang ZQ, Mao XL.",Acta Pharmacol Sin. 2023 Apr 13. doi: 10.1038/s41401-023-01083-w. Online ahead of print.,Xu YJ,Acta Pharmacol Sin,2023,13/4/2023,,,10.1038/s41401-023-01083-w,CDK
37061330,CDK regulators-Cell cycle progression or apoptosis-Scenarios in normal cells and cancerous cells,"Nilmani, D'costa M, Bothe A, Das S, Udhaya Kumar S, Gnanasambandan R, George Priya Doss C.",Adv Protein Chem Struct Biol. 2023;135:125-177. doi: 10.1016/bs.apcsb.2022.11.008. Epub 2023 Feb 6.,Nilmani,Adv Protein Chem Struct Biol,2023,15/4/2023,,,10.1016/bs.apcsb.2022.11.008,CDK
36330468,Different treatment regimens in breast cancer visceral crisis: A retrospective cohort study,"Yang R, Lu G, Lv Z, Jia L, Cui J.",Front Oncol. 2022 Oct 18;12:1048781. doi: 10.3389/fonc.2022.1048781. eCollection 2022.,Yang R,Front Oncol,2022,4/11/2022,PMC9623315,,10.3389/fonc.2022.1048781,CDK
37141549,Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis,"Gerratana L, Davis AA, Velimirovic M, Reduzzi C, Clifton K, Bucheit L, Hensing WL, Shah AN, Pivetta T, Dai CS, D'Amico P, Wehbe F, Medford A, Wander SA, Gradishar WJ, Behdad A, Ma CX, Puglisi F, Bardia A, Cristofanilli M.",JCO Precis Oncol. 2023 May;7:e2200531. doi: 10.1200/PO.22.00531.,Gerratana L,JCO Precis Oncol,2023,4/5/2023,,,10.1200/PO.22.00531,CDK
35784572,Prognostic and Predictive Value of CCND1/Cyclin D1 Amplification in Breast Cancer With a Focus on Postmenopausal Patients: A Systematic Review and Meta-Analysis,"Jeffreys SA, Becker TM, Khan S, Soon P, Neubauer H, de Souza P, Powter B.",Front Endocrinol (Lausanne). 2022 Jun 17;13:895729. doi: 10.3389/fendo.2022.895729. eCollection 2022.,Jeffreys SA,Front Endocrinol (Lausanne),2022,5/7/2022,PMC9249016,,10.3389/fendo.2022.895729,CDK
36497361,Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study,"López González A, Del Barco Berrón S, Grau I, Galan M, Castelo Fernández B, Cortés A, Sánchez Rovira P, Martinez-Bueno A, Gonzalez X, García A, Gener P, Mina L, Alcalá-López D, Sampayo M, Cortés J, Pérez-Garcia JM, Llombart-Cussac A, López-Miranda E.",Cancers (Basel). 2022 Nov 29;14(23):5880. doi: 10.3390/cancers14235880.,López González A,Cancers (Basel),2022,11/12/2022,PMC9737152,,10.3390/cancers14235880,CDK
36279618,"A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma","Dennis MJ, Sacco AG, Qi Y, Bykowski J, Pittman E, Chen R, Messer K, Cohen EEW, Gold KA.",Oral Oncol. 2022 Dec;135:106219. doi: 10.1016/j.oraloncology.2022.106219. Epub 2022 Oct 21.,Dennis MJ,Oral Oncol,2022,24/10/2022,,,10.1016/j.oraloncology.2022.106219,CDK
35864412,Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis,"Luger AL, König S, Samp PF, Urban H, Divé I, Burger MC, Voss M, Franz K, Fokas E, Filipski K, Demes MC, Stenzinger A, Sahm F, Reuss DE, Harter PN, Wagner S, Hattingen E, Wichert J, Lapa C, Fröhling S, Steinbach JP, Ronellenfitsch MW.",J Neurooncol. 2022 Sep;159(2):243-259. doi: 10.1007/s11060-022-04049-w. Epub 2022 Jul 21.,Luger AL,J Neurooncol,2022,21/7/2022,PMC9424147,,10.1007/s11060-022-04049-w,CDK
36635767,On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates,"Kim CG, Kim MH, Kim JH, Kim SG, Kim GM, Kim TY, Ryu WJ, Kim JY, Park HS, Park S, Cho YU, Park BW, Kim SI, Jeong J, Sohn J.",Breast Cancer Res. 2023 Jan 12;25(1):4. doi: 10.1186/s13058-022-01601-4.,Kim CG,Breast Cancer Res,2023,12/1/2023,PMC9838072,,10.1186/s13058-022-01601-4,CDK
35977509,Induced pluripotent stem cells display a distinct set of MHC I-associated peptides shared by human cancers,"Apavaloaei A, Hesnard L, Hardy MP, Benabdallah B, Ehx G, Thériault C, Laverdure JP, Durette C, Lanoix J, Courcelles M, Noronha N, Chauhan KD, Lemieux S, Beauséjour C, Bhatia M, Thibault P, Perreault C.",Cell Rep. 2022 Aug 16;40(7):111241. doi: 10.1016/j.celrep.2022.111241.,Apavaloaei A,Cell Rep,2022,17/8/2022,,,10.1016/j.celrep.2022.111241,CDK
36660646,A rapid reduction in tumor size by cyclin-dependent kinase inhibition in hormone receptor-positive postpartum breast cancer: a case report of two patients and a review of the literature,"Han L, Wang N, Li Y, Jiang S, Gu Y.",Ann Transl Med. 2022 Dec;10(24):1413. doi: 10.21037/atm-22-5201.,Han L,Ann Transl Med,2022,20/1/2023,PMC9843329,,10.21037/atm-22-5201,CDK
36877344,The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells,"Abutorabi ES, Poursheikhani A, Kashani B, Shamsaiegahkani S, Haghpanah V, Bashash D, Mousavi SA, Momeny M, Ghaffari SH.",Mol Biol Rep. 2023 May;50(5):4073-4082. doi: 10.1007/s11033-023-08255-1. Epub 2023 Mar 6.,Abutorabi ES,Mol Biol Rep,2023,6/3/2023,,,10.1007/s11033-023-08255-1,CDK
37146385,"Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?","Corti C, De Angelis C, Bianchini G, Malorni L, Giuliano M, Hamilton E, Jeselsohn R, Jhaveri K, Curigliano G, Criscitiello C.",Cancer Treat Rev. 2023 Jun;117:102569. doi: 10.1016/j.ctrv.2023.102569. Epub 2023 Apr 28.,Corti C,Cancer Treat Rev,2023,5/5/2023,,,10.1016/j.ctrv.2023.102569,CDK
36292649,Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment,"Raphael A, Salmon-Divon M, Epstein J, Zahavi T, Sonnenblick A, Shachar SS.",Genes (Basel). 2022 Sep 29;13(10):1763. doi: 10.3390/genes13101763.,Raphael A,Genes (Basel),2022,27/10/2022,PMC9601363,,10.3390/genes13101763,CDK
36993871,"Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date","Varella L, Cristofanilli M.",Onco Targets Ther. 2023 Mar 23;16:189-196. doi: 10.2147/OTT.S400563. eCollection 2023.,Varella L,Onco Targets Ther,2023,30/3/2023,PMC10041978,,10.2147/OTT.S400563,CDK
35278028,mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders,"Hirabayashi M, Chambers JK, Tani A, Tomiyasu H, Motegi T, Rimpo K, Nakayama H, Uchida K.",Vet Comp Oncol. 2022 Sep;20(3):587-601. doi: 10.1111/vco.12812. Epub 2022 Mar 17.,Hirabayashi M,Vet Comp Oncol,2022,12/3/2022,,,10.1111/vco.12812,CDK
35133007,Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study,"Ha MJ, Singareeka Raghavendra A, Kettner NM, Qiao W, Damodaran S, Layman RM, Hunt KK, Shen Y, Tripathy D, Keyomarsi K.",Int J Cancer. 2022 Jun 15;150(12):2025-2037. doi: 10.1002/ijc.33959. Epub 2022 Mar 3.,Ha MJ,Int J Cancer,2022,8/2/2022,PMC9018572,NIHMS1778187,10.1002/ijc.33959,CDK
36916190,Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells,"Xie X, Zhang W, Zhou X, Ye Z, Wang H, Qiu Y, Pan Y, Hu Y, Li L, Chen Z, Yang W, Lu Y, Zou S, Li Y, Bai X.",Br J Haematol. 2023 Jun;201(5):940-953. doi: 10.1111/bjh.18735. Epub 2023 Mar 14.,Xie X,Br J Haematol,2023,14/3/2023,,,10.1111/bjh.18735,CDK
36562909,"Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer","Alvarez A, Bernal AM, Anampa J.",Breast Cancer Res Treat. 2023 Feb;198(1):75-88. doi: 10.1007/s10549-022-06847-2. Epub 2022 Dec 23.,Alvarez A,Breast Cancer Res Treat,2023,23/12/2022,,,10.1007/s10549-022-06847-2,CDK
37041169,Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors,"Zhang X, Wang Y, Zhang X, Shen Y, Yang K, Ma Q, Qiao Y, Shi J, Wang Y, Xu L, Yang B, Ge G, Hu L, Kong X, Yang C, Chen Y, Ding J, Meng L.",Signal Transduct Target Ther. 2023 Apr 12;8(1):153. doi: 10.1038/s41392-023-01359-x.,Zhang X,Signal Transduct Target Ther,2023,11/4/2023,PMC10090078,,10.1038/s41392-023-01359-x,CDK
36450591,"Decreased sensitivity of cyclin-dependent kinase 4/6 inhibitors, palbociclib and abemaciclib to canine lymphoma cells with high p16 protein expression and low retinoblastoma protein phosphorylation","Maylina L, Kambayashi S, Baba K, Igase M, Mizuno T, Okuda M.",J Vet Med Sci. 2023 Jan 20;85(1):99-104. doi: 10.1292/jvms.22-0498. Epub 2022 Nov 29.,Maylina L,J Vet Med Sci,2023,30/11/2022,PMC9887221,,10.1292/jvms.22-0498,CDK
37211680,Current progress in the targeted therapy of breast cancer: Structure-activity correlation and docking studies (2015-2021),"Pandey S, Mondal S, Kajal K, Kurmi BD, Verma SK, Patel P.",Arch Pharm (Weinheim). 2023 May 21:e2200602. doi: 10.1002/ardp.202200602. Online ahead of print.,Pandey S,Arch Pharm (Weinheim),2023,22/5/2023,,,10.1002/ardp.202200602,CDK
35915198,"An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer","Lim E, Boyle F, Okera M, Loi S, Goksu SS, van Hal G, Chapman SC, Gable JC, Chen Y, Price GL, Hossain AM, Gainford MC, Ezquerra MB.",Breast Cancer Res Treat. 2022 Oct;195(3):275-287. doi: 10.1007/s10549-022-06690-5. Epub 2022 Aug 1.,Lim E,Breast Cancer Res Treat,2022,1/8/2022,PMC9464758,,10.1007/s10549-022-06690-5,CDK
36859416,Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer,"Prat A, Brasó-Maristany F, Martínez-Sáez O, Sanfeliu E, Xia Y, Bellet M, Galván P, Martínez D, Pascual T, Marín-Aguilera M, Rodríguez A, Chic N, Adamo B, Paré L, Vidal M, Margelí M, Ballana E, Gómez-Rey M, Oliveira M, Felip E, Matito J, Sánchez-Bayona R, Suñol A, Saura C, Ciruelos E, Tolosa P, Muñoz M, González-Farré B, Villagrasa P, Parker JS, Perou CM, Vivancos A.",Nat Commun. 2023 Mar 1;14(1):1157. doi: 10.1038/s41467-023-36801-9.,Prat A,Nat Commun,2023,1/3/2023,PMC9977734,,10.1038/s41467-023-36801-9,CDK
35534752,"Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women","Gupta N, Gupta D, Dixit J, Mehra N, Singh A, Krishnamurthy MN, Jyani G, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A, Malhotra P, Gupta S, Kumar L, Kataki A, Prinja S.",Appl Health Econ Health Policy. 2022 Jul;20(4):609-621. doi: 10.1007/s40258-022-00731-2. Epub 2022 May 10.,Gupta N,Appl Health Econ Health Policy,2022,9/5/2022,,,10.1007/s40258-022-00731-2,CDK
36059685,Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms,"Walker CJ, Chang H, Henegar L, Kashyap T, Shacham S, Sommer J, Wick MJ, Levy J, Landesman Y.",Front Oncol. 2022 Aug 18;12:808021. doi: 10.3389/fonc.2022.808021. eCollection 2022.,Walker CJ,Front Oncol,2022,5/9/2022,PMC9434827,,10.3389/fonc.2022.808021,CDK
36826152,Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients,"Falcone R, Lombardi P, Filetti M, Fabi A, Altamura V, Scambia G, Daniele G.",Curr Oncol. 2023 Feb 18;30(2):2501-2509. doi: 10.3390/curroncol30020191.,Falcone R,Curr Oncol,2023,24/2/2023,PMC9954949,,10.3390/curroncol30020191,CDK
37170613,Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab,"Bayram D, Aktürk Esen S, Uçar G, Köş FT.",J Oncol Pharm Pract. 2023 May 11:10781552231174593. doi: 10.1177/10781552231174593. Online ahead of print.,Bayram D,J Oncol Pharm Pract,2023,12/5/2023,,,10.1177/10781552231174593,CDK
36271947,Starting dose selection of palbociclib in Chinese patients with breast cancer based on population kinetic-pharmacodynamic model of neutropenia,"Jian W, Xue J, Yao Q, Chen R, Yao Y, Wang M, Zhou T.",Cancer Chemother Pharmacol. 2022 Dec;90(6):489-497. doi: 10.1007/s00280-022-04484-6. Epub 2022 Oct 22.,Jian W,Cancer Chemother Pharmacol,2022,22/10/2022,,,10.1007/s00280-022-04484-6,CDK
36823129,Effectiveness of Changing the Class of Molecularly Targeted Agent after Disease Progression during Initial Molecularly Targeted Therapy for Luminal Advanced/Metastatic Breast Cancer,"Nakano S, Mibu A, Kato S, Yamaguchi S, Suzuki Y, Tanimura K, Sano M.",J Nippon Med Sch. 2023 May 30;90(2):179-185. doi: 10.1272/jnms.JNMS.2023_90-205. Epub 2023 Feb 21.,Nakano S,J Nippon Med Sch,2023,23/2/2023,,,10.1272/jnms.JNMS.2023_90-205,CDK
37225761,Ambra1 modulates the sensitivity of mantle cell lymphoma to palbociclib by regulating cyclin D1,"Jiang Z, Zhang A, Wei W, Li S.",Sci Rep. 2023 May 24;13(1):8389. doi: 10.1038/s41598-023-35096-6.,Jiang Z,Sci Rep,2023,24/5/2023,PMC10209061,,10.1038/s41598-023-35096-6,CDK
37049714,"Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation","Fanta BS, Lenjisa J, Teo T, Kou L, Mekonnen L, Yang Y, Basnet SKC, Hassankhani R, Sykes MJ, Yu M, Wang S.",Molecules. 2023 Mar 25;28(7):2951. doi: 10.3390/molecules28072951.,Fanta BS,Molecules,2023,13/4/2023,PMC10096391,,10.3390/molecules28072951,CDK
37181790,Palbociclib Enhances Migration and Invasion of Cancer Cells via Senescence-Associated Secretory Phenotype-Related CCL5 in Non-Small-Cell Lung Cancer,"Kong P, Yang X, Zhang Y, Dong H, Liu X, Xu X, Zhang X, Shi Y, Hou M, Song B.",J Oncol. 2022 Sep 27;2022:2260625. doi: 10.1155/2022/2260625. eCollection 2022.,Kong P,J Oncol,2022,14/5/2023,PMC10175017,,10.1155/2022/2260625,CDK
36823372,[New treatment approaches for and ongoing trials in metastatic hormone-sensitive prostate cancer],"Isgandarov A, Darr C, Posdzich P, Hermann K, Hadaschik BA, Grünwald V.",Urologie. 2023 Apr;62(4):369-375. doi: 10.1007/s00120-023-02046-z. Epub 2023 Feb 23.,Isgandarov A,Urologie,2023,24/2/2023,,,10.1007/s00120-023-02046-z,CDK
35929120,Severe acute radiation dermatitis after palbociclib therapy in the setting of palliative radiotherapy,"Kim KN, Salerno M, Shah PD, Matro J, LaRiviere MJ.",J Oncol Pharm Pract. 2023 Apr;29(3):764-767. doi: 10.1177/10781552221118841. Epub 2022 Aug 5.,Kim KN,J Oncol Pharm Pract,2023,5/8/2022,,,10.1177/10781552221118841,CDK
36040373,High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities,"Roh W, Geffen Y, Cha H, Miller M, Anand S, Kim J, Heiman DI, Gainor JF, Laird PW, Cherniack AD, Ock CY, Lee SH, Getz G; National Cancer Institute Center for Cancer Genomics Tumor Molecular Pathology (TMP) Analysis Working Group.",Cancer Res. 2022 Nov 2;82(21):3917-3931. doi: 10.1158/0008-5472.CAN-22-0432.,Roh W,Cancer Res,2022,30/8/2022,PMC9718502,NIHMS1834142,10.1158/0008-5472.CAN-22-0432,CDK
37133230,Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer,"Kahraman S, Erul E, Seyyar M, Gumusay O, Bayram E, Demirel BC, Acar O, Aksoy S, Baytemur NK, Sahin E, Cabuk D, Basaran G, Paydas S, Yaren A, Guven DC, Erdogan AP, Demirci U, Yasar A, Bayoglu İV, Hizal M, Gulbagci B, Paksoy N, Davarci SE, Yilmaz F, Dogan O, Orhan SO, Kayikcioglu E, Aytac A, Keskinkilic M, Mocan EE, Unal OU, Aydin E, Yucel H, Isik D, Eren O, Uluc BO, Ozcelik M, Hacibekiroglu I, Aydiner A, Demir H, Oksuzoglu B, Cilbir E, Cubukcu E, Cetin B, Oktay E, Erol C, Okutur SK, Yildirim N, Alkan A, Selcukbiricik F, Aksoy A, Karakas Y, Ozkanli G, Duman BB, Aydin D, Dulgar O, Er MM, Teker F, Yavuzsen T, Aykan MB, Inal A, Iriagac Y, Kalkan NO, Keser M, Sakalar T, Menekse S, Kut E, Bilgin B, Karaoglanoglu M, Sunar V, Ozdemir O, Turhal NS, Karadurmus N, Yalcin B, Nahit Sendur MA.",Future Oncol. 2023 Mar;19(10):727-736. doi: 10.2217/fon-2022-1287. Epub 2023 May 3.,Kahraman S,Future Oncol,2023,3/5/2023,,,10.2217/fon-2022-1287,CDK
36060015,KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib,"Fleisher B, Werkman C, Jacobs B, Varkey J, Taha K, Ait-Oudhia S.",Cancer Diagn Progn. 2022 Sep 3;2(5):525-532. doi: 10.21873/cdp.10137. eCollection 2022 Sep-Oct.,Fleisher B,Cancer Diagn Progn,2022,5/9/2022,PMC9425577,,10.21873/cdp.10137,CDK
35643624,Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis,"Patt D, Liu X, Li B, McRoy L, Layman RM, Brufsky A.",Clin Breast Cancer. 2022 Aug;22(6):601-610. doi: 10.1016/j.clbc.2022.05.002. Epub 2022 May 5.,Patt D,Clin Breast Cancer,2022,1/6/2022,,,10.1016/j.clbc.2022.05.002,CDK
36031605,Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response,"Persha HE, Kato S, De P, Adashek JJ, Sicklick JK, Subbiah V, Kurzrock R.",J Hematol Oncol. 2022 Aug 28;15(1):119. doi: 10.1186/s13045-022-01344-x.,Persha HE,J Hematol Oncol,2022,28/8/2022,PMC9420268,,10.1186/s13045-022-01344-x,CDK
36794339,Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review,"Gao S, Li Y, He Z, Zhu J, Liang D, Yang S, Mo J, Lam K, Yu X, Huang M, Wu J.",Expert Opin Drug Saf. 2023 Feb 23:1-11. doi: 10.1080/14740338.2023.2181338. Online ahead of print.,Gao S,Expert Opin Drug Saf,2023,16/2/2023,,,10.1080/14740338.2023.2181338,CDK
36750040,Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer,"Muendlein A, Heinzle C, Brandtner EM, Leiherer A, Drexel H, Dechow T, Decker T.",Oncol Res Treat. 2023;46(4):151-156. doi: 10.1159/000529547. Epub 2023 Feb 7.,Muendlein A,Oncol Res Treat,2023,7/2/2023,,,10.1159/000529547,CDK
34781820,Dysregulated endolysosomal trafficking in cells arrested in the G(1) phase of the host cell cycle impairs Salmonella vacuolar replication,"Lisowski C, Dias J, Costa S, Silva RJ, Mano M, Eulalio A.",Autophagy. 2022 Aug;18(8):1785-1800. doi: 10.1080/15548627.2021.1999561. Epub 2021 Nov 15.,Lisowski C,Autophagy,2022,16/11/2021,PMC9450962,,10.1080/15548627.2021.1999561,CDK
37026492,Second-line Endocrine Therapy of Hormone Receptor-Positive/HER2-negative Advanced Breast Cancer: A Systematic Review and Network Meta-analysis,"Wang T, Shen G, Li J, Huo X, Wang M, Liu Z, Zhao F, Ren D, Zhao J.",Curr Cancer Drug Targets. 2023 Apr 7. doi: 10.2174/1568009623666230407101128. Online ahead of print.,Wang T,Curr Cancer Drug Targets,2023,7/4/2023,,,10.2174/1568009623666230407101128,CDK
36206609,"Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial","Salvador Bofill J, Moreno Anton F, Rodriguez Sanchez CA, Galve Calvo E, Hernando Melia C, Ciruelos Gil EM, Vidal M, Jiménez-Rodriguez B, De la Cruz Merino L, Martínez Jañez N, Villanueva Vazquez R, de Toro Salas R, Anton Torres A, Alvarez Lopez IM, Gavila Gregori J, Quiroga Garcia V, Vicente Rubio E, De la Haba-Rodriguez J, Gonzalez-Santiago S, Diaz Fernandez N, Barnadas Molins A, Cantos Sanchez de Ibargüen B, Delgado Mingorance JI, Bellet Ezquerra M, de Casa S, Gimeno A, Martin M.",Breast. 2022 Dec;66:77-84. doi: 10.1016/j.breast.2022.09.006. Epub 2022 Sep 28.,Salvador Bofill J,Breast,2022,7/10/2022,PMC9535465,,10.1016/j.breast.2022.09.006,CDK
35986800,Treatment of HR+/HER2- breast cancer in urban mainland China: results from the CancerMPact Survey 2019,"Murali B, Durbin L, Vijaykumar S, Yang L, Li S, Zhao L, Hawthorne S, Kanas G, Davis C, Clark O.",Breast Cancer Res Treat. 2022 Oct;195(3):441-451. doi: 10.1007/s10549-022-06709-x. Epub 2022 Aug 20.,Murali B,Breast Cancer Res Treat,2022,20/8/2022,PMC9464725,,10.1007/s10549-022-06709-x,CDK
35969265,[Predictive molecular diagnostics in breast cancer : What are the requirements for pathology today and in the future?],"Wild PJ, Denkert C, Jackisch C.",Pathologie (Heidelb). 2022 Sep;43(5):388-398. doi: 10.1007/s00292-022-01096-y. Epub 2022 Aug 15.,Wild PJ,Pathologie (Heidelb),2022,15/8/2022,PMC9402728,,10.1007/s00292-022-01096-y,CDK
37046638,Prognostic Relevance and In Vitro Targeting of Concomitant PTEN and p16 Deficiency in Chordomas,"Seeling C, Mosca E, Mantel E, Möller P, Barth TFE, Mellert K.",Cancers (Basel). 2023 Mar 26;15(7):1977. doi: 10.3390/cancers15071977.,Seeling C,Cancers (Basel),2023,13/4/2023,PMC10093147,,10.3390/cancers15071977,CDK
37079999,A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia,"Wilde L, Porazzi P, Trotta R, De Dominici M, Palmisiano N, Keiffer G, Rancani K, Yingling K, Calabretta B, Kasner M.",Leuk Res. 2023 Jun;129:107075. doi: 10.1016/j.leukres.2023.107075. Epub 2023 Apr 6.,Wilde L,Leuk Res,2023,20/4/2023,,,10.1016/j.leukres.2023.107075,CDK
36765648,Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer,"Kubeczko M, Gabryś D, Gawkowska M, Polakiewicz-Gilowska A, Cortez AJ, Krzywon A, Woźniak G, Latusek T, Leśniak A, Świderska K, Mianowska-Malec M, Łanoszka B, Chomik K, Gajek M, Michalik A, Nowicka E, Tarnawski R, Rutkowski T, Jarząb M.",Cancers (Basel). 2023 Jan 22;15(3):690. doi: 10.3390/cancers15030690.,Kubeczko M,Cancers (Basel),2023,11/2/2023,PMC9913652,,10.3390/cancers15030690,CDK
36721000,Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction,"Tong J, Tan X, Hao S, Ermine K, Lu X, Liu Z, Jha A, Yu J, Zhang L.",Oncogene. 2023 Mar;42(12):869-880. doi: 10.1038/s41388-023-02598-6. Epub 2023 Jan 31.,Tong J,Oncogene,2023,31/1/2023,,,10.1038/s41388-023-02598-6,CDK
36097254,"Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib","Smyth EN, Beyrer J, Saverno KR, Hadden E, Abedtash H, DeLuca A, Lawrence GW, Rybowski S.",Drugs Real World Outcomes. 2022 Dec;9(4):681-693. doi: 10.1007/s40801-022-00327-1. Epub 2022 Sep 12.,Smyth EN,Drugs Real World Outcomes,2022,13/9/2022,PMC9712844,,10.1007/s40801-022-00327-1,CDK
37239834,"Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer","Cejuela M, Gil-Torralvo A, Castilla MÁ, Domínguez-Cejudo MÁ, Falcón A, Benavent M, Molina-Pinelo S, Ruiz-Borrego M, Salvador Bofill J.",Int J Mol Sci. 2023 May 9;24(10):8488. doi: 10.3390/ijms24108488.,Cejuela M,Int J Mol Sci,2023,27/5/2023,PMC10217927,,10.3390/ijms24108488,CDK
36749874,CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer,"Guerrero-Zotano Á, Belli S, Zielinski C, Gil-Gil M, Fernandez-Serra A, Ruiz-Borrego M, Ciruelos Gil EM, Pascual J, Muñoz-Mateu M, Bermejo B, Margeli Vila M, Antón A, Murillo L, Nissenbaum B, Liu Y, Herranz J, Fernández-García D, Caballero R, López-Guerrero JA, Bianco R, Formisano L, Turner N, Martín M.",Clin Cancer Res. 2023 Apr 14;29(8):1557-1568. doi: 10.1158/1078-0432.CCR-22-2206.,Guerrero-Zotano Á,Clin Cancer Res,2023,7/2/2023,PMC10102847,,10.1158/1078-0432.CCR-22-2206,CDK
36068244,STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer,"Pantelidou C, Jadhav H, Kothari A, Liu R, Wulf GM, Guerriero JL, Shapiro GI.",NPJ Breast Cancer. 2022 Sep 6;8(1):102. doi: 10.1038/s41523-022-00471-5.,Pantelidou C,NPJ Breast Cancer,2022,6/9/2022,PMC9448789,,10.1038/s41523-022-00471-5,CDK
36799136,Palbociclib (PD 0332991) Interaction with Kinases. Theoretical and Comparative Molecular Docking Study,"Aceves-Hernández JM, Inés Nicolás Vázquez M, Luis Garza Rivera J, Espinoza Godínez A, Mateo Flores J, de Jesús Cruz Guzmán J, Castaño VM.",Chem Biodivers. 2023 Mar;20(3):e202200554. doi: 10.1002/cbdv.202200554. Epub 2023 Feb 17.,Aceves-Hernández JM,Chem Biodivers,2023,17/2/2023,,,10.1002/cbdv.202200554,CDK
36709169,[In vitro pharmacodynamic studies of novel class Ⅰ and Ⅱb selective histone deacetylase inhibitor purinostat mesylate in the treatment of diffuse large B-cell lymphoma and its mechanism],"Wang J, Zhao AL, Li H, Yang LY, Chen LJ, Niu T.",Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):753-759. doi: 10.3760/cma.j.issn.0253-2727.2022.09.007.,Wang J,Zhonghua Xue Ye Xue Za Zhi,2022,28/1/2023,PMC9613491,,10.3760/cma.j.issn.0253-2727.2022.09.007,CDK
36234774,"Design, Synthesis, and Biological Evaluation of Novel Dihydropyridine and Pyridine Analogs as Potent Human Tissue Nonspecific Alkaline Phosphatase Inhibitors with Anticancer Activity: ROS and DNA Damage-Induced Apoptosis","Khan NA, Rashid F, Jadoon MSK, Jalil S, Khan ZA, Orfali R, Perveen S, Al-Taweel A, Iqbal J, Shahzad SA.",Molecules. 2022 Sep 22;27(19):6235. doi: 10.3390/molecules27196235.,Khan NA,Molecules,2022,14/10/2022,PMC9570995,,10.3390/molecules27196235,CDK
36059094,A rapidly growing cutaneous malignant glomus tumor with a CCND3 mutation,"Kitz R, Leung O, Royer M.",J Cutan Pathol. 2023 Feb;50(2):113-117. doi: 10.1111/cup.14324. Epub 2022 Sep 19.,Kitz R,J Cutan Pathol,2023,5/9/2022,,,10.1111/cup.14324,CDK
36603130,Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time,"Nguyen TDT, Wang Y, Bui TN, Lazcano R, Ingram DR, Yi M, Vakulabharanam V, Luo L, Pina MA, Karakas C, Li M, Kettner NM, Somaiah N, Hougton PJ, Mawlawi O, Lazar AJ, Hunt KK, Keyomarsi K.",Cancer Res. 2023 Mar 15;83(6):939-955. doi: 10.1158/0008-5472.CAN-22-2258.,Nguyen TDT,Cancer Res,2023,5/1/2023,PMC10023441,NIHMS1864750,10.1158/0008-5472.CAN-22-2258,CDK
36970055,A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas,"Hidalgo M, Garcia-Carbonero R, Lim KH, Messersmith WA, Garrido-Laguna I, Borazanci E, Lowy AM, Medina Rodriguez L, Laheru D, Salvador-Barbero B, Malumbres M, Shields DJ, Grossman JE, Huang X, Tammaro M, Martini JF, Yu Y, Kern K, Macarulla T.",Cancer Res Commun. 2022 Nov 2;2(11):1326-1333. doi: 10.1158/2767-9764.CRC-22-0072. eCollection 2022 Nov.,Hidalgo M,Cancer Res Commun,2022,27/3/2023,PMC10035387,,10.1158/2767-9764.CRC-22-0072,CDK
36597263,Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells,"Bhat TA, Dheeraj A, Nambiar DK, Singh SP, Yim DS, Singh RP.",Prostate. 2023 May;83(6):534-546. doi: 10.1002/pros.24482. Epub 2023 Jan 3.,Bhat TA,Prostate,2023,4/1/2023,,,10.1002/pros.24482,CDK
36872218,Prostaglandin E2 prevents radiotherapy-induced alopecia by attenuating transit amplifying cell apoptosis through promoting G1 arrest,"Lai SF, Huang WY, Wang WH, Hong JB, Kuo SH, Lin SJ.",J Dermatol Sci. 2023 Mar;109(3):117-126. doi: 10.1016/j.jdermsci.2023.02.005. Epub 2023 Feb 20.,Lai SF,J Dermatol Sci,2023,5/3/2023,,,10.1016/j.jdermsci.2023.02.005,CDK
37205634,Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway,"Ludwig MP, Galbraith MD, Eduthan NP, Hill AA, Clay MR, Moreno Tellez C, Wilky BA, Elias A, Espinosa JM, Sullivan KD.",Cancer Res. 2023 May 19:CAN-22-3173. doi: 10.1158/0008-5472.CAN-22-3173. Online ahead of print.,Ludwig MP,Cancer Res,2023,19/5/2023,,,10.1158/0008-5472.CAN-22-3173,CDK
36158652,Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach,"Fabi A, Buono G, Bria E, Bianchini G, Curigliano G, De Laurentiis M, De Placido S, Del Mastro L, Guarneri V, Generali D, Livi L, Lorusso V, Montemurro F, Puglisi F, Vigneri P, Zambelli A, Arpino G.",Front Oncol. 2022 Sep 9;12:950861. doi: 10.3389/fonc.2022.950861. eCollection 2022.,Fabi A,Front Oncol,2022,26/9/2022,PMC9501706,,10.3389/fonc.2022.950861,CDK
35676324,RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models,"Kumarasamy V, Nambiar R, Wang J, Rosenheck H, Witkiewicz AK, Knudsen ES.",Oncogene. 2022 Jul;41(27):3524-3538. doi: 10.1038/s41388-022-02362-2. Epub 2022 Jun 9.,Kumarasamy V,Oncogene,2022,8/6/2022,,,10.1038/s41388-022-02362-2,CDK
37234717,"Identification of abemaciclib derivatives targeting cyclin-dependent kinase 4 and 6 using molecular dynamics, binding free energy calculation, synthesis, and pharmacological evaluation","Zhou Y, Li X, Luo P, Chen H, Zhou Y, Zheng X, Yin Y, Wei H, Liu H, Xia W, Shi M, Li X.",Front Pharmacol. 2023 May 10;14:1154654. doi: 10.3389/fphar.2023.1154654. eCollection 2023.,Zhou Y,Front Pharmacol,2023,26/5/2023,PMC10206264,,10.3389/fphar.2023.1154654,CDK
37207300,"Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial","Kalinsky K, Accordino MK, Chiuzan C, Mundi PS, Sakach E, Sathe C, Ahn H, Trivedi MS, Novik Y, Tiersten A, Raptis G, Baer LN, Oh SY, Zelnak AB, Wisinski KB, Andreopoulou E, Gradishar WJ, Stringer-Reasor E, Reid SA, O'Dea A, O'Regan R, Crew KD, Hershman DL.",J Clin Oncol. 2023 May 19:JCO2202392. doi: 10.1200/JCO.22.02392. Online ahead of print.,Kalinsky K,J Clin Oncol,2023,19/5/2023,,,10.1200/JCO.22.02392,CDK
36180417,Population pharmacokinetics and exposure-response of trilaciclib in extensive-stage small cell lung cancer and triple-negative breast cancer,"Li C, Rich B, Bullock JM, Barrière O, Marier JF, Beelen A.",Br J Clin Pharmacol. 2023 Mar;89(3):1067-1079. doi: 10.1111/bcp.15549. Epub 2022 Oct 19.,Li C,Br J Clin Pharmacol,2023,30/9/2022,,,10.1111/bcp.15549,CDK
37146968,The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activity,"Awadia S, Sitto M, Ram S, Ji W, Liu Y, Damani R, Ray D, Lawrence TS, Galban CJ, Cappell SD, Rehemtulla A.",J Biol Chem. 2023 May 3:104786. doi: 10.1016/j.jbc.2023.104786. Online ahead of print.,Awadia S,J Biol Chem,2023,5/5/2023,,,10.1016/j.jbc.2023.104786,CDK
36741704,The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer,"Finnegan RM, Elshazly AM, Patel NH, Tyutyunyk-Massey L, Tran TH, Kumarasamy V, Knudsen ES, Gewirtz DA.",Front Oncol. 2023 Jan 18;12:966441. doi: 10.3389/fonc.2022.966441. eCollection 2022.,Finnegan RM,Front Oncol,2023,6/2/2023,PMC9890056,,10.3389/fonc.2022.966441,CDK
36436423,Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer,"Pellicane JV, Beitsch PD, Rock DT, Budway RJ, Dul CL, Kelemen PR, Ashikari AY, Baron PL, Weinstein PD, Mislowsky A, Lee LA, Beatty J, Murray MK, Dupree BB, Finn C, Corcoran K, Wang S, Menicucci AR, Yoder EB, Blumencranz LE, Dauer P, Audeh W, Whitworth PW; NBRST Investigators Group.",Surg Oncol. 2022 Dec;45:101885. doi: 10.1016/j.suronc.2022.101885. Epub 2022 Nov 22.,Pellicane JV,Surg Oncol,2022,27/11/2022,,,10.1016/j.suronc.2022.101885,CDK
36611120,Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program,"Bello Roufai D, Gonçalves A, De La Motte Rouge T, Akla S, Blonz C, Grenier J, Gligorov J, Saghatchian M, Bailleux C, Simon H, Desmoulins I, Tharin Z, Renaud E, Bertho M, Benderra MA, Delaloge S, Robert L, Cottu P, Pierga JY, Loirat D, Bertucci A, Renouf B, Bidard FC, Lerebours F.",Oncogene. 2023 Jan 7. doi: 10.1038/s41388-022-02585-3. Online ahead of print.,Bello Roufai D,Oncogene,2023,7/1/2023,,,10.1038/s41388-022-02585-3,CDK
36861085,Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2- advanced breast cancer: a matching-adjusted indirect comparison,"Rugo HS, Harmer V, O'Shaughnessy J, Jhaveri K, Tolaney SM, Cardoso F, Bardia A, Maheshwari VK, Tripathi S, Haftchenary S, Pathak P, Fasching PA.",Ther Adv Med Oncol. 2023 Feb 24;15:17588359231152843. doi: 10.1177/17588359231152843. eCollection 2023.,Rugo HS,Ther Adv Med Oncol,2023,2/3/2023,PMC9969464,,10.1177/17588359231152843,CDK
37250148,"Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial","Xu B, Zhang Q, Hu X, Li Q, Sun T, Li W, Ouyang Q, Wang J, Tong Z, Yan M, Li H, Zeng X, Shan C, Wang X, Yan X, Zhang J, Zhang Y, Wang J, Zhang L, Lin Y, Feng J, Chen Q, Huang J, Zhang L, Yang L, Tian Y, Shang H.",Acta Pharm Sin B. 2023 May;13(5):2250-2258. doi: 10.1016/j.apsb.2023.02.001. Epub 2023 Feb 9.,Xu B,Acta Pharm Sin B,2023,30/5/2023,PMC10213795,,10.1016/j.apsb.2023.02.001,CDK
37046661,"Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors","Saavedra C, Vallejo A, Longo F, Serrano JJ, Fernández M, Gion M, López-Miranda E, Martínez-Jáñez N, Guerra E, Chamorro J, Rosero D, Velasco H, Martín A, Carrato A, Casado JL, Cortés A.",Cancers (Basel). 2023 Mar 27;15(7):2000. doi: 10.3390/cancers15072000.,Saavedra C,Cancers (Basel),2023,13/4/2023,PMC10093435,,10.3390/cancers15072000,CDK
36388043,A patient with stage IIIB advanced breast cancer who is still alive 24 years after surgery: a case report and remarks on the treatment strategies,"Yoneto T, Hasumi K, Fujii Y, Takahashi N, Seki N, Yoshimoto T, Takeda Y.",Transl Cancer Res. 2022 Oct;11(10):3903-3911. doi: 10.21037/tcr-22-1363.,Yoneto T,Transl Cancer Res,2022,17/11/2022,PMC9641138,,10.21037/tcr-22-1363,CDK
36688062,Carrier-free nanomedicines self-assembled from palbociclib dimers and Ce6 for enhanced combined chemo-photodynamic therapy of breast cancer,"Huang Z, Hu H, Xian T, Xu Z, Tang D, Wang B, Zhang Y.",RSC Adv. 2023 Jan 9;13(3):1617-1626. doi: 10.1039/d2ra05932k. eCollection 2023 Jan 6.,Huang Z,RSC Adv,2023,23/1/2023,PMC9827281,,10.1039/d2ra05932k,CDK
36713467,The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis,"Mastrantoni L, Orlandi A, Palazzo A, Garufi G, Fabi A, Daniele G, Giannarelli D, Tortora G, Bria E.",EClinicalMedicine. 2023 Jan 20;56:101824. doi: 10.1016/j.eclinm.2023.101824. eCollection 2023 Feb.,Mastrantoni L,EClinicalMedicine,2023,30/1/2023,PMC9874016,,10.1016/j.eclinm.2023.101824,CDK
36847915,Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs,"Guillen VS, Ziegler Y, Gopinath C, Kumar S, Dey P, Plotner BN, Dawson NZ, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS.",Breast Cancer Res Treat. 2023 Apr;198(3):607-621. doi: 10.1007/s10549-023-06878-3. Epub 2023 Feb 27.,Guillen VS,Breast Cancer Res Treat,2023,27/2/2023,,,10.1007/s10549-023-06878-3,CDK
34739192,"Lactic acidosis, a potential toxicity from drug-drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report","Lagampan C, Poovorawan N, Parinyanitikul N.",Cancer Rep (Hoboken). 2022 Aug;5(8):e1575. doi: 10.1002/cnr2.1575. Epub 2021 Nov 5.,Lagampan C,Cancer Rep (Hoboken),2022,5/11/2021,PMC9351659,,10.1002/cnr2.1575,CDK
36164943,Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response,"Hong JY, Cho HJ, Yun KH, Lee YH, Kim SH, Baek W, Kim SK, Lee Y, Choi YL, Kwon M, Kim HS, Lee J.",Cancer Res Treat. 2023 Apr;55(2):671-683. doi: 10.4143/crt.2022.251. Epub 2022 Sep 27.,Hong JY,Cancer Res Treat,2023,27/9/2022,PMC10101793,,10.4143/crt.2022.251,CDK
36520173,The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer,"Çağlayan D, Koçak MZ, Geredeli Ç, Tatlı AM, Göksu SS, Eryılmaz MK, Araz M, Artaç M.",Eur J Clin Pharmacol. 2023 Feb;79(2):243-248. doi: 10.1007/s00228-022-03435-7. Epub 2022 Dec 15.,Çağlayan D,Eur J Clin Pharmacol,2023,15/12/2022,,,10.1007/s00228-022-03435-7,CDK
36790603,Cyclin-dependent kinase (CDK) 4/6 inhibition in non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations,"Osoegawa A, Takumi Y, Hashimoto T, Nakatsuji S, Hori M, Sakai M, Karashima T, Abe M, Miyawaki M, Sugio K.",Invest New Drugs. 2023 Apr;41(2):183-192. doi: 10.1007/s10637-023-01337-8. Epub 2023 Feb 15.,Osoegawa A,Invest New Drugs,2023,15/2/2023,,,10.1007/s10637-023-01337-8,CDK
37174019,"A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors","Richardson GE, Al-Rajabi R, Uprety D, Hamid A, Williamson SK, Baranda J, Mamdani H, Lee YL, Nitika, Li L, Wang X, Dong X.",Cancers (Basel). 2023 Apr 29;15(9):2553. doi: 10.3390/cancers15092553.,Richardson GE,Cancers (Basel),2023,13/5/2023,PMC10177510,,10.3390/cancers15092553,CDK
36617361,Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1/S phase,"Rahimi Lifshagerd M, Safari F.",Clin Transl Oncol. 2023 Jun;25(6):1702-1709. doi: 10.1007/s12094-022-03067-4. Epub 2023 Jan 8.,Rahimi Lifshagerd M,Clin Transl Oncol,2023,8/1/2023,,,10.1007/s12094-022-03067-4,CDK
37184422,Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer,"Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW.",Clin Cancer Res. 2023 May 15:CCR-23-0112. doi: 10.1158/1078-0432.CCR-23-0112. Online ahead of print.,Schwartz GN,Clin Cancer Res,2023,15/5/2023,,,10.1158/1078-0432.CCR-23-0112,CDK
36797664,Cost-effectiveness of ribociclib versus palbociclib in combination with an aromatase inhibitor as first-line treatment of postmenopausal women with HR+/HER2- advanced breast cancer: analysis based on final OS results of MONALEESA-2 and PALOMA-2,"Cameron D, Kumar Sharma V, Biswas C, Clarke C, Chandiwana D, Pathak P.",J Med Econ. 2023 Jan-Dec;26(1):357-365. doi: 10.1080/13696998.2023.2182051.,Cameron D,J Med Econ,2023,16/2/2023,,,10.1080/13696998.2023.2182051,CDK
36425558,Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report,"Schettini F, Seguí E, Conte B, Sanfeliu E, Gonzalez-Farre B, Jares P, Vidal-Sicart S, Ganau S, Cebrecos I, Brasó-Maristany F, Muñoz M, Prat A, Vidal M.",Front Oncol. 2022 Nov 8;12:1009352. doi: 10.3389/fonc.2022.1009352. eCollection 2022.,Schettini F,Front Oncol,2022,25/11/2022,PMC9679790,,10.3389/fonc.2022.1009352,CDK
37166793,Survival Outcomes in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy,"Mouabbi JA, Singareeka Raghavendra A, Bassett RL Jr, Hassan A, Tripathy D, Layman RM.",JAMA Netw Open. 2023 May 1;6(5):e2313017. doi: 10.1001/jamanetworkopen.2023.13017.,Mouabbi JA,JAMA Netw Open,2023,11/5/2023,PMC10176119,,10.1001/jamanetworkopen.2023.13017,CDK
37166557,Copy number aberrations in ctDNA enables prognosis prediction and molecular characterization of breast cancer,"Kim MH, Kim GM, Ahn JM, Ryu WJ, Kim SG, Kim JH, Kim TY, Han HJ, Kim JY, Park HS, Park S, Park BW, Kim SI, Jeong J, Lee J, Paik S, Kim S, Jung KH, Cho EH, Sohn J.",J Natl Cancer Inst. 2023 May 11:djad080. doi: 10.1093/jnci/djad080. Online ahead of print.,Kim MH,J Natl Cancer Inst,2023,11/5/2023,,,10.1093/jnci/djad080,CDK
36853016,"Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B","Clark AS, Hong F, Finn RS, DeMichele AM, Mitchell EP, Zwiebel J, Arnaldez FI, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Copur MS, Kasbari SS, Thind R, Conley BA, Arteaga CL, O'Dwyer PJ, Harris LN, Chen AP, Flaherty KT.",Clin Cancer Res. 2023 Apr 14;29(8):1477-1483. doi: 10.1158/1078-0432.CCR-22-2150.,Clark AS,Clin Cancer Res,2023,28/2/2023,PMC10102836,,10.1158/1078-0432.CCR-22-2150,CDK
36696417,Phylogenetic analysis of the MCL1 BH3 binding groove and rBH3 sequence motifs in the p53 and INK4 protein families,"McGriff A, Placzek WJ.",PLoS One. 2023 Jan 25;18(1):e0277726. doi: 10.1371/journal.pone.0277726. eCollection 2023.,McGriff A,PLoS One,2023,25/1/2023,PMC9876281,,10.1371/journal.pone.0277726,CDK
35809862,"Artemidubolides A-T, cytotoxic unreported guaiane-type sesquiterpenoid dimers against three hepatoma cell lines from Artemisia dubia","Gao Z, Ma WJ, Li TZ, Ma YB, Hu J, Huang XY, Geng CA, He XF, Zhang XM, Chen JJ.",Phytochemistry. 2022 Oct;202:113299. doi: 10.1016/j.phytochem.2022.113299. Epub 2022 Jul 7.,Gao Z,Phytochemistry,2022,9/7/2022,,,10.1016/j.phytochem.2022.113299,CDK
36986799,Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype,"de Nonneville A, Finetti P, Boudin L, Denicolaï E, Birnbaum D, Mamessier E, Bertucci F.",Pharmaceutics. 2023 Mar 14;15(3):938. doi: 10.3390/pharmaceutics15030938.,de Nonneville A,Pharmaceutics,2023,29/3/2023,PMC10058875,,10.3390/pharmaceutics15030938,CDK
36975446,Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force,"Faragalla H, Plotkin A, Barnes P, Lu FI, Kos Z, Mulligan AM, Bane A, Nofech Mozes S.",Curr Oncol. 2023 Mar 6;30(3):3079-3090. doi: 10.3390/curroncol30030233.,Faragalla H,Curr Oncol,2023,28/3/2023,PMC10047249,,10.3390/curroncol30030233,CDK
37142078,"Mechanisms of hedgehog, calcium and retinoic acid signalling pathway inhibitors: Plausible modes of action along the MLL-EZH2-p53 axis in cellular growth control","Manna S, Kirtana R, Roy A, Baral T, Patra SK.",Arch Biochem Biophys. 2023 Jul 1;742:109600. doi: 10.1016/j.abb.2023.109600. Epub 2023 May 2.,Manna S,Arch Biochem Biophys,2023,4/5/2023,,,10.1016/j.abb.2023.109600,CDK
36698413,"Hormone receptor-positive, HER2-negative, metastatic breast cancer responded well to abemaciclib and exemestane after palbociclib and fulvestrant failure: A case report and literature review","Mao Y, Lv M, Wang Y, Cao W, Li W.",Front Oncol. 2023 Jan 9;12:1022913. doi: 10.3389/fonc.2022.1022913. eCollection 2022.,Mao Y,Front Oncol,2023,26/1/2023,PMC9869123,,10.3389/fonc.2022.1022913,CDK
36717797,Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China,"Yang J, Zhao B, Ling X, Li D, Zhao J, Lv Y, Wang G, Liu X, Li N, Yang J.",BMC Cancer. 2023 Jan 30;23(1):103. doi: 10.1186/s12885-023-10568-0.,Yang J,BMC Cancer,2023,30/1/2023,PMC9885675,,10.1186/s12885-023-10568-0,CDK
37013197,Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy,"Colombo GL, Valentino MC, Fabi A, Dieci MV, Caruggi M, Bruno GM, Lombardi G, Di Matteo S.",Ther Clin Risk Manag. 2023 Mar 28;19:301-312. doi: 10.2147/TCRM.S391769. eCollection 2023.,Colombo GL,Ther Clin Risk Manag,2023,4/4/2023,PMC10066701,,10.2147/TCRM.S391769,CDK
36778271,Identification and characterization of a proliferative cell population in estrogen receptor-positive metastatic breast cancer through spatial and single-cell transcriptomics,"Yoshitake R, Mori H, Ha D, Wu X, Wang J, Wang X, Saeki K, Chang G, Shim HJ, Chan Y, Chen S.",bioRxiv. 2023 Feb 3:2023.01.31.526403. doi: 10.1101/2023.01.31.526403. Preprint.,Yoshitake R,bioRxiv,2023,13/2/2023,PMC9915610,,10.1101/2023.01.31.526403,CDK
37003098,Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial,"Malorni L, Bianchini G, Caputo R, Zambelli A, Puglisi F, Bianchi GV, Del Mastro L, Paris I, Montemurro F, Allegrini G, Colleoni M, Tamberi S, Zamagni C, Cazzaniga ME, Orditura M, Guarneri V, Castelletti D, Benelli M, Di Marino M, Arpino G, De Laurentiis M.",Eur J Cancer. 2023 Jun;186:1-11. doi: 10.1016/j.ejca.2023.03.001. Epub 2023 Mar 8.,Malorni L,Eur J Cancer,2023,1/4/2023,,,10.1016/j.ejca.2023.03.001,CDK
36618786,Targeting chromosome 12q amplification in relapsed glioblastoma: the use of computational biological modeling to identify effective therapy-a case report,"Castro MP, Khanlou N, Fallah A, Pampana A, Alam A, Lala DA, Roy KGG, Amara ARR, Prakash A, Singh D, Behura L, Kumar A, Kapoor S.",Ann Transl Med. 2022 Dec;10(23):1289. doi: 10.21037/atm-2022-62.,Castro MP,Ann Transl Med,2022,9/1/2023,PMC9816820,,10.21037/atm-2022-62,CDK
36592515,Effects of melatonin on development and hormone secretion of sheep theca cells in vitro,"Ma J, Wang J, Hu S, Li Y, Zhang Y, Yang Y, Yang C, Huo S, Yang Y, Zhaxi Y, Luo W.",Theriogenology. 2023 Mar 1;198:172-182. doi: 10.1016/j.theriogenology.2022.12.036. Epub 2022 Dec 27.,Ma J,Theriogenology,2023,2/1/2023,,,10.1016/j.theriogenology.2022.12.036,CDK
36267663,"Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial","Caputo R, Fabi A, Romagnoli E, Baldini E, Grasso D, Fenderico N, Michelotti A.",Breast Cancer (Dove Med Press). 2022 Oct 18;14:351-362. doi: 10.2147/BCTT.S376902. eCollection 2022.,Caputo R,Breast Cancer (Dove Med Press),2022,21/10/2022,PMC9576937,,10.2147/BCTT.S376902,CDK
36630025,Role of synaptotagmin 13 (SYT13) in promoting breast cancer and signaling pathways,"Zhang YD, Zhong R, Liu JQ, Sun ZX, Wang T, Liu JT.",Clin Transl Oncol. 2023 Jun;25(6):1629-1640. doi: 10.1007/s12094-022-03058-5. Epub 2023 Jan 11.,Zhang YD,Clin Transl Oncol,2023,11/1/2023,,,10.1007/s12094-022-03058-5,CDK
36698435,A Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib,"Fan W, Wang C, Zhong X, Zheng Y, Chen T, Huang M, Su S.",Onco Targets Ther. 2023 Jan 19;16:23-29. doi: 10.2147/OTT.S390458. eCollection 2023.,Fan W,Onco Targets Ther,2023,26/1/2023,PMC9869796,,10.2147/OTT.S390458,CDK
36741710,Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors,"Rottier P, Emile G, Johnson A, Levy C, Allouache D, Hrab I, Segura C, Morel A, Villemin M, Dubot-Poitelon C, Boismoreau L, Cherifi F, Lequesne J, Da Silva A.",Front Oncol. 2023 Jan 19;12:1105587. doi: 10.3389/fonc.2022.1105587. eCollection 2022.,Rottier P,Front Oncol,2023,6/2/2023,PMC9893782,,10.3389/fonc.2022.1105587,CDK
36915147,Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells,"Wu M, Zhang X, Zhang W, Yan L, Liu X, Zhang M, Pan Y, Lobie PE, Han X, Zhu T.",Cell Commun Signal. 2023 Mar 13;21(1):59. doi: 10.1186/s12964-023-01068-6.,Wu M,Cell Commun Signal,2023,14/3/2023,PMC10009947,,10.1186/s12964-023-01068-6,CDK
37012318,Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation,"Frenel JS, Lusque A, Delaloge S, Ferrero JM, Bachelot T, Desmoulins I, Levy C, Eymard JC, Gonçalves A, Patsouris A, Reynier MAM, Thery MJ, Petit T, Cabel L, Uwer L, Debled M, Chevrot M, Mailliez A, Jacot W, de La Motte Rouge T.",Br J Cancer. 2023 Jun;128(11):2072-2080. doi: 10.1038/s41416-023-02248-4. Epub 2023 Apr 3.,Frenel JS,Br J Cancer,2023,3/4/2023,PMC10205708,,10.1038/s41416-023-02248-4,CDK
35978957,Hydroxy-γ-sanshool from Zanthoxylum bungeanum (prickly ash) induces apoptosis of human colorectal cancer cell by activating P53 and Caspase 8,"Zhaojun C, Lulin T, Xin F, Abdel-Nasser S, Zunguo L, Xiong L.",Front Nutr. 2022 Aug 1;9:914638. doi: 10.3389/fnut.2022.914638. eCollection 2022.,Zhaojun C,Front Nutr,2022,18/8/2022,PMC9376619,,10.3389/fnut.2022.914638,CDK
36136211,Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene,"Fischer A, Bankel L, Hiltbrunner S, Rechsteiner M, Rüschoff JH, Rushing EJ, Britschgi C, Curioni-Fontecedro A.",Target Oncol. 2022 Nov;17(6):683-694. doi: 10.1007/s11523-022-00918-6. Epub 2022 Sep 22.,Fischer A,Target Oncol,2022,22/9/2022,PMC9684265,,10.1007/s11523-022-00918-6,CDK
36895447,"Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE Registry","Meegdes M, Geurts SME, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Peters NAJB, Tol J, Heijns JB, van de Wouw AJ, de Fallois AJO, van Kats MACE, Tjan-Heijnen VCG.",Lancet Reg Health Eur. 2023 Jan 6;26:100573. doi: 10.1016/j.lanepe.2022.100573. eCollection 2023 Mar.,Meegdes M,Lancet Reg Health Eur,2023,10/3/2023,PMC9989628,,10.1016/j.lanepe.2022.100573,CDK
36743520,Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial,"Tibau A, Martínez MT, Ramos M, De La Cruz-Merino L, Santaballa A, O'Connor M, Martínez-Jañez N, Moreno F, Fernández I, Virizuela JA, Alarcón J, de La Haba-Rodríguez J, Sánchez-Rovira P, Albacar CR, Bueno Muiño C, Kelly C, Casas M, Bezares S, Rosell L, Albanell J.",Ther Adv Med Oncol. 2023 Jan 19;15:17588359221148921. doi: 10.1177/17588359221148921. eCollection 2023.,Tibau A,Ther Adv Med Oncol,2023,6/2/2023,PMC9893357,,10.1177/17588359221148921,CDK
37201751,Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial,"Harbeck N, Fasching PA, Würstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators.",Ann Oncol. 2023 May 16:S0923-7534(23)00684-1. doi: 10.1016/j.annonc.2023.05.003. Online ahead of print.,Harbeck N,Ann Oncol,2023,18/5/2023,,,10.1016/j.annonc.2023.05.003,CDK
36969030,Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response,"Pasqualoni M, Orlandi A, Palazzo A, Garufi G, Cannizzaro MC, Pontolillo L, Pannunzio S, Cutigni C, Sollena P, Federico F, Bria E, Tortora G.",Front Oncol. 2023 Mar 9;13:1067264. doi: 10.3389/fonc.2023.1067264. eCollection 2023.,Pasqualoni M,Front Oncol,2023,27/3/2023,PMC10034067,,10.3389/fonc.2023.1067264,CDK
36902563,Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib,"Jacobs F, Agostinetto E, Solferino A, Torrisi R, Masci G, Santoro A, De Sanctis R.",J Clin Med. 2023 Feb 23;12(5):1775. doi: 10.3390/jcm12051775.,Jacobs F,J Clin Med,2023,11/3/2023,PMC10003298,,10.3390/jcm12051775,CDK
36624321,Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer,"Loft M, Lok SW, De Boer R, Malik L, Greenberg S, Yeo B, Anton A, Nottage M, Wong V, Nott L, Collins IM, Torres J, Barnett F, Lombard JM, Gibbs P, Gately L.",Breast Cancer Res Treat. 2023 Feb;198(1):67-74. doi: 10.1007/s10549-022-06856-1. Epub 2023 Jan 9.,Loft M,Breast Cancer Res Treat,2023,9/1/2023,,,10.1007/s10549-022-06856-1,CDK
37078217,[Treatment of palbociclib in hormone receptor positive breast cancer: a real-world study and efficacy prediction model],"Yang YQ, Sun CX, Huang X, Li W, Yin YM.",Zhonghua Zhong Liu Za Zhi. 2023 Apr 23;45(4):348-357. doi: 10.3760/cma.j.cn112152-20210811-00606.,Yang YQ,Zhonghua Zhong Liu Za Zhi,2023,20/4/2023,,,10.3760/cma.j.cn112152-20210811-00606,CDK
37260292,Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer,"Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW.",Clin Cancer Res. 2023 Jun 1:OF1-OF7. doi: 10.1158/1078-0432.CCR-23-0112. Online ahead of print.,Schwartz GN,Clin Cancer Res,2023,1/6/2023,,,10.1158/1078-0432.CCR-23-0112,CDK
36356410,"A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)","Schmidt M, Lübbe K, Decker T, Thill M, Bauer L, Müller V, Link T, Furlanetto J, Reinisch M, Mundhenke C, Hoffmann O, Zahn MO, Müller L, Denkert C, van Mackelenbergh M, Fasching PA, Burchardi N, Nekljudova V, Loibl S.",ESMO Open. 2022 Dec;7(6):100601. doi: 10.1016/j.esmoop.2022.100601. Epub 2022 Nov 7.,Schmidt M,ESMO Open,2022,10/11/2022,PMC9832733,,10.1016/j.esmoop.2022.100601,CDK
36077869,"Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study","Wagner MJ, Hennessy C, Beeghly A, French B, Shah DP, Croessmann S, Vilar-Compte D, Ruiz-Garcia E, Ingham M, Schwartz GK, Painter CA, Chugh R, Fecher L, Park C, Zamulko O, Trent JC, Subbiah V, Khaki AR, Tachiki L, Nakasone ES, Loggers ET, Labaki C, Saliby RM, McKay RR, Ajmera A, Griffiths EA, Puzanov I, Tap WD, Hwang C, Tejwani S, Jhawar SR, Hayes-Lattin B, Wulff-Burchfield E, Kasi A, Reuben DY, Nagaraj G, Joshi M, Polimera H, Kulkarni AA, Esfahani K, Kwon DH, Paoluzzi L, Bilen MA, Durbin EB, Grivas P, Warner JL, Davis EJ; COVID-19 and Cancer Consortium.",Cancers (Basel). 2022 Sep 5;14(17):4334. doi: 10.3390/cancers14174334.,Wagner MJ,Cancers (Basel),2022,9/9/2022,PMC9454925,,10.3390/cancers14174334,CDK
36982902,In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis,"Fatoki TH, Chukwuejim S, Udenigwe CC, Aluko RE.",Int J Mol Sci. 2023 Mar 18;24(6):5828. doi: 10.3390/ijms24065828.,Fatoki TH,Int J Mol Sci,2023,29/3/2023,PMC10058213,,10.3390/ijms24065828,CDK
37158934,Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report,"Yoneto T, Hasumi K, Takahashi N, Seki N, Takeda Y, Yoshimoto T.",J Med Case Rep. 2023 May 9;17(1):190. doi: 10.1186/s13256-023-03902-4.,Yoneto T,J Med Case Rep,2023,9/5/2023,PMC10169494,,10.1186/s13256-023-03902-4,CDK
36335217,A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer,"Curigliano G, Shapiro GI, Kristeleit RS, Abdul Razak AR, Leong S, Alsina M, Giordano A, Gelmon KA, Stringer-Reasor E, Vaishampayan UN, Middleton M, Olszanski AJ, Rugo HS, Kern KA, Pathan N, Perea R, Pierce KJ, Mutka SC, Wainberg ZA.",Br J Cancer. 2023 Jan;128(1):30-41. doi: 10.1038/s41416-022-02025-9. Epub 2022 Nov 5.,Curigliano G,Br J Cancer,2023,6/11/2022,PMC9814742,,10.1038/s41416-022-02025-9,CDK
37182538,"Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","Zhang P, Zhang Q, Tong Z, Sun T, Li W, Ouyang Q, Hu X, Cheng Y, Yan M, Pan Y, Teng Y, Yan X, Wang Y, Xie W, Zeng X, Wang X, Hu C, Geng C, Zhang H, Li W, Wu X, Zhong J, Xu J, Shi Y, Wei W, Bayaxi N, Zhu X, Xu B.",Lancet Oncol. 2023 May 11:S1470-2045(23)00172-9. doi: 10.1016/S1470-2045(23)00172-9. Online ahead of print.,Zhang P,Lancet Oncol,2023,14/5/2023,,,10.1016/S1470-2045(23)00172-9,CDK
33220539,"FtsZ dynamics in bacterial division: What, how, and why?","Barrows JM, Goley ED.",Curr Opin Cell Biol. 2021 Feb;68:163-172. doi: 10.1016/j.ceb.2020.10.013. Epub 2020 Nov 18.,Barrows JM,Curr Opin Cell Biol,2021,21/11/2020,PMC7925355,NIHMS1649079,10.1016/j.ceb.2020.10.013,FtsZ
35246355,Spotlight on FtsZ-based cell division in Archaea,"Ithurbide S, Gribaldo S, Albers SV, Pende N.",Trends Microbiol. 2022 Jul;30(7):665-678. doi: 10.1016/j.tim.2022.01.005. Epub 2022 Mar 1.,Ithurbide S,Trends Microbiol,2022,5/3/2022,,,10.1016/j.tim.2022.01.005,FtsZ
33806332,FtsZ Interactions and Biomolecular Condensates as Potential Targets for New Antibiotics,"Zorrilla S, Monterroso B, Robles-Ramos MÁ, Margolin W, Rivas G.",Antibiotics (Basel). 2021 Mar 4;10(3):254. doi: 10.3390/antibiotics10030254.,Zorrilla S,Antibiotics (Basel),2021,3/4/2021,PMC7999717,,10.3390/antibiotics10030254,FtsZ
31398602,FtsZ inhibitors as a new genera of antibacterial agents,"Tripathy S, Sahu SK.",Bioorg Chem. 2019 Oct;91:103169. doi: 10.1016/j.bioorg.2019.103169. Epub 2019 Jul 30.,Tripathy S,Bioorg Chem,2019,10/8/2019,,,10.1016/j.bioorg.2019.103169,FtsZ
31268666,FtsZ as an Antibacterial Target: Status and Guidelines for Progressing This Avenue,"Kusuma KD, Payne M, Ung AT, Bottomley AL, Harry EJ.",ACS Infect Dis. 2019 Aug 9;5(8):1279-1294. doi: 10.1021/acsinfecdis.9b00055. Epub 2019 Jul 17.,Kusuma KD,ACS Infect Dis,2019,4/7/2019,,,10.1021/acsinfecdis.9b00055,FtsZ
31209564,Regulation of cytokinesis: FtsZ and its accessory proteins,"Wang M, Fang C, Ma B, Luo X, Hou Z.",Curr Genet. 2020 Feb;66(1):43-49. doi: 10.1007/s00294-019-01005-6. Epub 2019 Jun 17.,Wang M,Curr Genet,2020,19/6/2019,,,10.1007/s00294-019-01005-6,FtsZ
32681661,Recent progress of bacterial FtsZ inhibitors with a focus on peptides,"Han H, Wang Z, Li T, Teng D, Mao R, Hao Y, Yang N, Wang X, Wang J.",FEBS J. 2021 Feb;288(4):1091-1106. doi: 10.1111/febs.15489. Epub 2020 Aug 2.,Han H,FEBS J,2021,19/7/2020,,,10.1111/febs.15489,FtsZ
34566937,Targeting the Achilles Heel of FtsZ: The Interdomain Cleft,"Pradhan P, Margolin W, Beuria TK.",Front Microbiol. 2021 Sep 8;12:732796. doi: 10.3389/fmicb.2021.732796. eCollection 2021.,Pradhan P,Front Microbiol,2021,27/9/2021,PMC8456036,,10.3389/fmicb.2021.732796,FtsZ
35059602,FtsZ-mediated fission of a cuboid bacterial symbiont,"Weber PM, Paredes GF, Viehboeck T, Pende N, Volland JM, Gros O, VanNieuwenhze M, Ott J, Bulgheresi S.",iScience. 2021 Dec 2;25(1):103552. doi: 10.1016/j.isci.2021.103552. eCollection 2022 Jan 21.,Weber PM,iScience,2021,21/1/2022,PMC8760462,,10.1016/j.isci.2021.103552,FtsZ
36103222,Bacterial FtsZ inhibition by benzo[d]imidazole-2-carboxamide derivative with anti-TB activity,"Dhameliya TM, Tiwari R, Patel KI, Vagolu SK, Panda D, Sriram D, Chakraborti AK.",Future Med Chem. 2022 Oct;14(19):1361-1373. doi: 10.4155/fmc-2022-0120. Epub 2022 Sep 14.,Dhameliya TM,Future Med Chem,2022,14/9/2022,,,10.4155/fmc-2022-0120,FtsZ
36695643,Models versus pathogens: how conserved is the FtsZ in bacteria?,"Battaje RR, Piyush R, Pratap V, Panda D.",Biosci Rep. 2023 Feb 27;43(2):BSR20221664. doi: 10.1042/BSR20221664.,Battaje RR,Biosci Rep,2023,25/1/2023,PMC9939409,,10.1042/BSR20221664,FtsZ
32692252,Cell division protein FtsZ: from structure and mechanism to antibiotic target,"Silber N, Matos de Opitz CL, Mayer C, Sass P.",Future Microbiol. 2020 Jun;15:801-831. doi: 10.2217/fmb-2019-0348. Epub 2020 Jul 21.,Silber N,Future Microbiol,2020,22/7/2020,,,10.2217/fmb-2019-0348,FtsZ
35592002,How Does the Spatial Confinement of FtsZ to a Membrane Surface Affect Its Polymerization Properties and Function?,Vélez M.,Front Microbiol. 2022 May 3;13:757711. doi: 10.3389/fmicb.2022.757711. eCollection 2022.,Vélez M,Front Microbiol,2022,20/5/2022,PMC9111741,,10.3389/fmicb.2022.757711,FtsZ
32540934,Division without Binary Fission: Cell Division in the FtsZ-Less Chlamydia,"Ouellette SP, Lee J, Cox JV.",J Bacteriol. 2020 Aug 10;202(17):e00252-20. doi: 10.1128/JB.00252-20. Print 2020 Aug 10.,Ouellette SP,J Bacteriol,2020,17/6/2020,PMC7417837,,10.1128/JB.00252-20,FtsZ
32092282,"Insights into the Structure, Function, and Dynamics of the Bacterial Cytokinetic FtsZ-Ring","McQuillen R, Xiao J.",Annu Rev Biophys. 2020 May 6;49:309-341. doi: 10.1146/annurev-biophys-121219-081703. Epub 2020 Feb 24.,McQuillen R,Annu Rev Biophys,2020,25/2/2020,PMC8610174,NIHMS1755263,10.1146/annurev-biophys-121219-081703,FtsZ
36009372,The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites,"Andreu JM, Huecas S, Araújo-Bazán L, Vázquez-Villa H, Martín-Fontecha M.",Biomedicines. 2022 Jul 28;10(8):1825. doi: 10.3390/biomedicines10081825.,Andreu JM,Biomedicines,2022,26/8/2022,PMC9405007,,10.3390/biomedicines10081825,FtsZ
32020845,A key bacterial cytoskeletal cell division protein FtsZ as a novel therapeutic antibacterial drug target,"Ur Rahman M, Wang P, Wang N, Chen Y.",Bosn J Basic Med Sci. 2020 Aug 3;20(3):310-318. doi: 10.17305/bjbms.2020.4597.,Ur Rahman M,Bosn J Basic Med Sci,2020,6/2/2020,PMC7416170,,10.17305/bjbms.2020.4597,FtsZ
35679326,FtsZ at mid-cell is essential in Escherichia coli until the late stage of constriction,"Corbin Goodman LC, Erickson HP.",Microbiology (Reading). 2022 Jun;168(6). doi: 10.1099/mic.0.001194.,Corbin Goodman LC,Microbiology (Reading),2022,9/6/2022,,,10.1099/mic.0.001194,FtsZ
37158088,Escherichia coli FtsZ molecular dynamics simulations,Muthukumar VC.,J Biomol Struct Dyn. 2023 May 9:1-14. doi: 10.1080/07391102.2023.2206917. Online ahead of print.,Muthukumar VC,J Biomol Struct Dyn,2023,9/5/2023,,,10.1080/07391102.2023.2206917,FtsZ
34083531,FtsZ induces membrane deformations via torsional stress upon GTP hydrolysis,"Ramirez-Diaz DA, Merino-Salomón A, Meyer F, Heymann M, Rivas G, Bramkamp M, Schwille P.",Nat Commun. 2021 Jun 3;12(1):3310. doi: 10.1038/s41467-021-23387-3.,Ramirez-Diaz DA,Nat Commun,2021,4/6/2021,PMC8175707,,10.1038/s41467-021-23387-3,FtsZ
32066012,The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens,"Buroni S, Makarov V, Scoffone VC, Trespidi G, Riccardi G, Chiarelli LR.",Eur J Med Chem. 2020 Mar 15;190:112132. doi: 10.1016/j.ejmech.2020.112132. Epub 2020 Feb 8.,Buroni S,Eur J Med Chem,2020,18/2/2020,,,10.1016/j.ejmech.2020.112132,FtsZ
32046082,Targeting Bacterial Cell Division: A Binding Site-Centered Approach to the Most Promising Inhibitors of the Essential Protein FtsZ,"Casiraghi A, Suigo L, Valoti E, Straniero V.",Antibiotics (Basel). 2020 Feb 7;9(2):69. doi: 10.3390/antibiotics9020069.,Casiraghi A,Antibiotics (Basel),2020,13/2/2020,PMC7167804,,10.3390/antibiotics9020069,FtsZ
35202441,Retraction: Novel Role of Phosphorylation-Dependent Interaction between FtsZ and FipA in Mycobacterial Cell Division,PLOS ONE Editors.,PLoS One. 2022 Feb 24;17(2):e0264672. doi: 10.1371/journal.pone.0264672. eCollection 2022.,PLOS ONE Editors,PLoS One,2022,24/2/2022,PMC8870568,,10.1371/journal.pone.0264672,FtsZ
31172911,The Cell Wall of Streptococcus pneumoniae,"Vollmer W, Massidda O, Tomasz A.",Microbiol Spectr. 2019 May;7(3). doi: 10.1128/microbiolspec.GPP3-0018-2018.,Vollmer W,Microbiol Spectr,2019,8/6/2019,,,10.1128/microbiolspec.GPP3-0018-2018,FtsZ
35312677,FtsZ filament structures in different nucleotide states reveal the mechanism of assembly dynamics,"Ruiz FM, Huecas S, Santos-Aledo A, Prim EA, Andreu JM, Fernández-Tornero C.",PLoS Biol. 2022 Mar 21;20(3):e3001497. doi: 10.1371/journal.pbio.3001497. eCollection 2022 Mar.,Ruiz FM,PLoS Biol,2022,21/3/2022,PMC8936486,,10.1371/journal.pbio.3001497,FtsZ
30376053,Bacterial cell division: modeling FtsZ assembly and force generation from single filament experimental data,"Mateos-Gil P, Tarazona P, Vélez M.",FEMS Microbiol Rev. 2019 Jan 1;43(1):73-87. doi: 10.1093/femsre/fuy039.,Mateos-Gil P,FEMS Microbiol Rev,2019,31/10/2018,,,10.1093/femsre/fuy039,FtsZ
34358036,Antistaphylococcal Activity of the FtsZ Inhibitor C109,"Trespidi G, Scoffone VC, Barbieri G, Marchesini F, Abualsha'ar A, Coenye T, Ungaro F, Makarov V, Migliavacca R, De Rossi E, Buroni S.",Pathogens. 2021 Jul 13;10(7):886. doi: 10.3390/pathogens10070886.,Trespidi G,Pathogens,2021,6/8/2021,PMC8308607,,10.3390/pathogens10070886,FtsZ
34351794,Growth and Division of the Peptidoglycan Matrix,"Rohs PDA, Bernhardt TG.",Annu Rev Microbiol. 2021 Oct 8;75:315-336. doi: 10.1146/annurev-micro-020518-120056. Epub 2021 Aug 5.,Rohs PDA,Annu Rev Microbiol,2021,5/8/2021,,,10.1146/annurev-micro-020518-120056,FtsZ
35967845,Investigating the effect of bacteriophages on bacterial FtsZ localisation,"Dhanoa GK, Kushnir I, Qimron U, Roper DI, Sagona AP.",Front Cell Infect Microbiol. 2022 Jul 29;12:863712. doi: 10.3389/fcimb.2022.863712. eCollection 2022.,Dhanoa GK,Front Cell Infect Microbiol,2022,15/8/2022,PMC9372555,,10.3389/fcimb.2022.863712,FtsZ
36296585,"Discovery of 2',6-Bis(4-hydroxybenzyl)-2-acetylcyclohexanone, a Novel FtsZ Inhibitor","Lin HJ, Battaje RR, Tan J, Doddareddy M, Dhaked HPS, Srivastava S, Hawkins BA, Al-Shdifat LMH, Hibbs DE, Panda D, Groundwater PW.",Molecules. 2022 Oct 18;27(20):6993. doi: 10.3390/molecules27206993.,Lin HJ,Molecules,2022,27/10/2022,PMC9610434,,10.3390/molecules27206993,FtsZ
34383913,Novel FtsZ inhibitor with potent activity against Staphylococcus aureus,"Kumar M, Mathur T, Barman TK, Chaira T, Kumar R, Joshi V, Pandya M, Sharma L, Fujii K, Bandgar M, Jadhav B, Bambal R, Upadhyay D, Masuda N, Verma AK, Bhatnagar PK.",J Antimicrob Chemother. 2021 Oct 11;76(11):2867-2874. doi: 10.1093/jac/dkab270.,Kumar M,J Antimicrob Chemother,2021,12/8/2021,,,10.1093/jac/dkab270,FtsZ
32735732,FtsZ Reorganization Facilitates Deformation of Giant Vesicles in Microfluidic Traps*,"Ganzinger KA, Merino-Salomón A, García-Soriano DA, Butterfield AN, Litschel T, Siedler F, Schwille P.",Angew Chem Int Ed Engl. 2020 Nov 23;59(48):21372-21376. doi: 10.1002/anie.202001928. Epub 2020 Sep 17.,Ganzinger KA,Angew Chem Int Ed Engl,2020,1/8/2020,PMC7756778,,10.1002/anie.202001928,FtsZ
33504807,Treadmilling FtsZ polymers drive the directional movement of sPG-synthesis enzymes via a Brownian ratchet mechanism,"McCausland JW, Yang X, Squyres GR, Lyu Z, Bruce KE, Lamanna MM, Söderström B, Garner EC, Winkler ME, Xiao J, Liu J.",Nat Commun. 2021 Jan 27;12(1):609. doi: 10.1038/s41467-020-20873-y.,McCausland JW,Nat Commun,2021,28/1/2021,PMC7840769,,10.1038/s41467-020-20873-y,FtsZ
36142700,Protealysin Targets the Bacterial Housekeeping Proteins FtsZ and RecA,"Tsaplina O, Khaitlina S, Chukhontseva K, Karaseva M, Demidyuk I, Bakhlanova I, Baitin D, Artamonova T, Vedyaykin A, Khodorkovskii M, Vishnyakov I.",Int J Mol Sci. 2022 Sep 15;23(18):10787. doi: 10.3390/ijms231810787.,Tsaplina O,Int J Mol Sci,2022,23/9/2022,PMC9505478,,10.3390/ijms231810787,FtsZ
30275322,FtsZ filaments have the opposite kinetic polarity of microtubules,"Du S, Pichoff S, Kruse K, Lutkenhaus J.",Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10768-10773. doi: 10.1073/pnas.1811919115. Epub 2018 Oct 1.,Du S,Proc Natl Acad Sci U S A,2018,3/10/2018,PMC6196554,,10.1073/pnas.1811919115,FtsZ
34903053,ZipA Uses a Two-Pronged FtsZ-Binding Mechanism Necessary for Cell Division,"Cameron TA, Vega DE, Yu C, Xiao H, Margolin W.",mBio. 2021 Dec 21;12(6):e0252921. doi: 10.1128/mbio.02529-21. Epub 2021 Dec 14.,Cameron TA,mBio,2021,14/12/2021,PMC8669495,,10.1128/mbio.02529-21,FtsZ
35224498,Discovery of FtsZ inhibitors by virtual screening as antibacterial agents and study of the inhibition mechanism,"Du RL, Sun N, Fung YH, Zheng YY, Chen YW, Chan PH, Wong WL, Wong KY.",RSC Med Chem. 2021 Nov 15;13(1):79-89. doi: 10.1039/d1md00249j. eCollection 2022 Jan 27.,Du RL,RSC Med Chem,2021,28/2/2022,PMC8792978,,10.1039/d1md00249j,FtsZ
33907196,FtsZ treadmilling is essential for Z-ring condensation and septal constriction initiation in Bacillus subtilis cell division,"Whitley KD, Jukes C, Tregidgo N, Karinou E, Almada P, Cesbron Y, Henriques R, Dekker C, Holden S.",Nat Commun. 2021 Apr 27;12(1):2448. doi: 10.1038/s41467-021-22526-0.,Whitley KD,Nat Commun,2021,28/4/2021,PMC8079713,,10.1038/s41467-021-22526-0,FtsZ
33199285,Simulations of Proposed Mechanisms of FtsZ-Driven Cell Constriction,"Nguyen LT, Oikonomou CM, Jensen GJ.",J Bacteriol. 2021 Jan 11;203(3):e00576-20. doi: 10.1128/JB.00576-20. Print 2021 Jan 11.,Nguyen LT,J Bacteriol,2021,17/11/2020,PMC7811198,,10.1128/JB.00576-20,FtsZ
35789252,"Vitamin K3 inhibits FtsZ assembly, disrupts the Z-ring in Streptococcus pneumoniae and displays anti-pneumococcal activity","Pushpakaran A, Battaje RR, Panda D.",Biochem J. 2022 Jul 29;479(14):1543-1558. doi: 10.1042/BCJ20220077.,Pushpakaran A,Biochem J,2022,5/7/2022,,,10.1042/BCJ20220077,FtsZ
33531398,Noc Corrals Migration of FtsZ Protofilaments during Cytokinesis in Bacillus subtilis,"Yu Y, Zhou J, Gueiros-Filho FJ, Kearns DB, Jacobson SC.",mBio. 2021 Feb 2;12(1):e02964-20. doi: 10.1128/mBio.02964-20.,Yu Y,mBio,2021,3/2/2021,PMC7858058,,10.1128/mBio.02964-20,FtsZ
31717975,Recent Progress in the Development of Small-Molecule FtsZ Inhibitors as Chemical Tools for the Development of Novel Antibiotics,Carro L.,Antibiotics (Basel). 2019 Nov 11;8(4):217. doi: 10.3390/antibiotics8040217.,Carro L,Antibiotics (Basel),2019,14/11/2019,PMC6963470,,10.3390/antibiotics8040217,FtsZ
35618784,"Evaluation of 2,6-difluoro-3-(oxazol-2-ylmethoxy)benzamide chemotypes as Gram-negative FtsZ inhibitors","Rosado-Lugo JD, Sun Y, Banerjee A, Cao Y, Datta P, Zhang Y, Yuan Y, Parhi AK.",J Antibiot (Tokyo). 2022 Jul;75(7):385-395. doi: 10.1038/s41429-022-00531-9. Epub 2022 May 26.,Rosado-Lugo JD,J Antibiot (Tokyo),2022,26/5/2022,,,10.1038/s41429-022-00531-9,FtsZ
36490318,MipZ caps the plus-end of FtsZ polymers to promote their rapid disassembly,"Corrales-Guerrero L, Steinchen W, Ramm B, Mücksch J, Rosum J, Refes Y, Heimerl T, Bange G, Schwille P, Thanbichler M.",Proc Natl Acad Sci U S A. 2022 Dec 13;119(50):e2208227119. doi: 10.1073/pnas.2208227119. Epub 2022 Dec 9.,Corrales-Guerrero L,Proc Natl Acad Sci U S A,2022,9/12/2022,PMC9897490,,10.1073/pnas.2208227119,FtsZ
36349414,Conserved GTPase mechanism in bacterial FtsZ and archaeal tubulin filaments,"Andreu JM, Ruiz FM, Fernández-Tornero C.",FEBS J. 2022 Nov 8. doi: 10.1111/febs.16675. Online ahead of print.,Andreu JM,FEBS J,2022,9/11/2022,,,10.1111/febs.16675,FtsZ
35934107,The division protein FtsZ interacts with the small heat shock protein IbpA in Acholeplasma laidlawii,"Chernova LS, Vedyaykin AD, Bogachev MI, Fedorova MS, Ivanov VA, Vishnyakov IE, Kayumov AR.",Biochim Biophys Acta Gen Subj. 2022 Dec;1866(12):130220. doi: 10.1016/j.bbagen.2022.130220. Epub 2022 Aug 5.,Chernova LS,Biochim Biophys Acta Gen Subj,2022,7/8/2022,,,10.1016/j.bbagen.2022.130220,FtsZ
34938281,FtsZ-Ring Regulation and Cell Division Are Mediated by Essential EzrA and Accessory Proteins ZapA and ZapJ in Streptococcus pneumoniae,"Perez AJ, Villicana JB, Tsui HT, Danforth ML, Benedet M, Massidda O, Winkler ME.",Front Microbiol. 2021 Dec 2;12:780864. doi: 10.3389/fmicb.2021.780864. eCollection 2021.,Perez AJ,Front Microbiol,2021,23/12/2021,PMC8687745,,10.3389/fmicb.2021.780864,FtsZ
30523075,Bacterial FtsZ protein forms phase-separated condensates with its nucleoid-associated inhibitor SlmA,"Monterroso B, Zorrilla S, Sobrinos-Sanguino M, Robles-Ramos MA, López-Álvarez M, Margolin W, Keating CD, Rivas G.",EMBO Rep. 2019 Jan;20(1):e45946. doi: 10.15252/embr.201845946. Epub 2018 Dec 6.,Monterroso B,EMBO Rep,2019,8/12/2018,PMC6322363,,10.15252/embr.201845946,FtsZ
36383329,"FtsZ phosphorylation pleiotropically affects Z-ladder formation, antibiotic production, and morphogenesis in Streptomyces coelicolor","Yagüe P, Willemse J, Xiao X, Zhang L, Manteca A, van Wezel GP.",Antonie Van Leeuwenhoek. 2023 Jan;116(1):1-19. doi: 10.1007/s10482-022-01778-w. Epub 2022 Nov 16.,Yagüe P,Antonie Van Leeuwenhoek,2023,16/11/2022,PMC9823044,,10.1007/s10482-022-01778-w,FtsZ
36214571,GTP-Bound Escherichia coli FtsZ Filaments Are Composed of Tense Monomers: a Dynamic Nuclear Polarization-Nuclear Magnetic Resonance Study Using Interface Detection,"McCoy KM, Fritzsching KJ, McDermott AE.",mBio. 2022 Dec 20;13(6):e0235822. doi: 10.1128/mbio.02358-22. Epub 2022 Oct 10.,McCoy KM,mBio,2022,10/10/2022,PMC9765660,,10.1128/mbio.02358-22,FtsZ
31978334,Transient Membrane-Linked FtsZ Assemblies Precede Z-Ring Formation in Escherichia coli,"Walker BE, Männik J, Männik J.",Curr Biol. 2020 Feb 3;30(3):499-508.e6. doi: 10.1016/j.cub.2019.12.023. Epub 2020 Jan 23.,Walker BE,Curr Biol,2020,25/1/2020,PMC7190073,NIHMS1569586,10.1016/j.cub.2019.12.023,FtsZ
33341988,Evidence of conformational switch in Streptococcus pneumoniae FtsZ during polymerization,"Battaje RR, Bhondwe P, Dhaked HPS, Panda D.",Protein Sci. 2021 Mar;30(3):523-530. doi: 10.1002/pro.4015. Epub 2021 Jan 5.,Battaje RR,Protein Sci,2021,20/12/2020,PMC7888577,,10.1002/pro.4015,FtsZ
34088904,"SepF is the FtsZ anchor in archaea, with features of an ancestral cell division system","Pende N, Sogues A, Megrian D, Sartori-Rupp A, England P, Palabikyan H, Rittmann SKR, Graña M, Wehenkel AM, Alzari PM, Gribaldo S.",Nat Commun. 2021 Jun 4;12(1):3214. doi: 10.1038/s41467-021-23099-8.,Pende N,Nat Commun,2021,5/6/2021,PMC8178401,,10.1038/s41467-021-23099-8,FtsZ
32184253,The Min System Disassembles FtsZ Foci and Inhibits Polar Peptidoglycan Remodeling in Bacillus subtilis,"Yu Y, Zhou J, Dempwolff F, Baker JD, Kearns DB, Jacobson SC.",mBio. 2020 Mar 17;11(2):e03197-19. doi: 10.1128/mBio.03197-19.,Yu Y,mBio,2020,19/3/2020,PMC7078482,,10.1128/mBio.03197-19,FtsZ
32605984,Cell Division Protein FtsZ Is Unfolded for N-Terminal Degradation by Antibiotic-Activated ClpP,"Silber N, Pan S, Schäkermann S, Mayer C, Brötz-Oesterhelt H, Sass P.",mBio. 2020 Jun 30;11(3):e01006-20. doi: 10.1128/mBio.01006-20.,Silber N,mBio,2020,2/7/2020,PMC7327170,,10.1128/mBio.01006-20,FtsZ
31413605,Indole-core-based novel antibacterial agent targeting FtsZ,"Yuan W, Yu Z, Song W, Li Y, Fang Z, Zhu B, Li X, Wang H, Hong W, Sun N.",Infect Drug Resist. 2019 Jul 24;12:2283-2296. doi: 10.2147/IDR.S208757. eCollection 2019.,Yuan W,Infect Drug Resist,2019,16/8/2019,PMC6662167,,10.2147/IDR.S208757,FtsZ
34031040,Impact of FtsZ Inhibition on the Localization of the Penicillin Binding Proteins in Methicillin-Resistant Staphylococcus aureus,"Ferrer-González E, Huh H, Al-Tameemi HM, Boyd JM, Lee SH, Pilch DS.",J Bacteriol. 2021 Jul 22;203(16):e0020421. doi: 10.1128/JB.00204-21. Epub 2021 Jul 22.,Ferrer-González E,J Bacteriol,2021,25/5/2021,PMC8297533,,10.1128/JB.00204-21,FtsZ
35752634,Assembly dynamics of FtsZ and DamX during infection-related filamentation and division in uropathogenic E. coli,"Söderström B, Pittorino MJ, Daley DO, Duggin IG.",Nat Commun. 2022 Jun 25;13(1):3648. doi: 10.1038/s41467-022-31378-1.,Söderström B,Nat Commun,2022,25/6/2022,PMC9233674,,10.1038/s41467-022-31378-1,FtsZ
31881789,"The FtsZ Homolog, FszB, Inhibits Mitochondrial Dynamics in Dictyostelium discoideum","Vogel E, Pittman PB, Naylor K.",Cells. 2019 Dec 25;9(1):64. doi: 10.3390/cells9010064.,Vogel E,Cells,2019,29/12/2019,PMC7016976,,10.3390/cells9010064,FtsZ
32242019,Essential dynamic interdependence of FtsZ and SepF for Z-ring and septum formation in Corynebacterium glutamicum,"Sogues A, Martinez M, Gaday Q, Ben Assaya M, Graña M, Voegele A, VanNieuwenhze M, England P, Haouz A, Chenal A, Trépout S, Duran R, Wehenkel AM, Alzari PM.",Nat Commun. 2020 Apr 2;11(1):1641. doi: 10.1038/s41467-020-15490-8.,Sogues A,Nat Commun,2020,4/4/2020,PMC7118173,,10.1038/s41467-020-15490-8,FtsZ
36643897,FtsZ phosphorylation brings about growth arrest upon DNA damage in Deinococcus radiodurans,"Chaudhary R, Mishra S, Maurya GK, Rajpurohit YS, Misra HS.",FASEB Bioadv. 2022 Oct 31;5(1):27-42. doi: 10.1096/fba.2022-00082. eCollection 2023 Jan.,Chaudhary R,FASEB Bioadv,2022,16/1/2023,PMC9832530,,10.1096/fba.2022-00082,FtsZ
37065467,Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant Staphylococcus aureus,"Kaul M, Ferrer-González E, Mark L, Parhi AK, LaVoie EJ, Pilch DS.",Med Chem Res. 2022 Oct;31(10):1705-1715. doi: 10.1007/s00044-022-02960-5. Epub 2022 Sep 5.,Kaul M,Med Chem Res,2022,17/4/2023,PMC10104549,NIHMS1841714,10.1007/s00044-022-02960-5,FtsZ
32591587,The speed of FtsZ treadmilling is tightly regulated by membrane binding,"García-Soriano DA, Heermann T, Raso A, Rivas G, Schwille P.",Sci Rep. 2020 Jun 26;10(1):10447. doi: 10.1038/s41598-020-67224-x.,García-Soriano DA,Sci Rep,2020,28/6/2020,PMC7320174,,10.1038/s41598-020-67224-x,FtsZ
36215496,Connecting sequence features within the disordered C-terminal linker of Bacillus subtilis FtsZ to functions and bacterial cell division,"Shinn MK, Cohan MC, Bullock JL, Ruff KM, Levin PA, Pappu RV.",Proc Natl Acad Sci U S A. 2022 Oct 18;119(42):e2211178119. doi: 10.1073/pnas.2211178119. Epub 2022 Oct 10.,Shinn MK,Proc Natl Acad Sci U S A,2022,10/10/2022,PMC9586301,,10.1073/pnas.2211178119,FtsZ
35104502,Assembly and architecture of Escherichia coli divisome proteins FtsA and FtsZ,"Morrison JJ, Conti J, Camberg JL.",J Biol Chem. 2022 Mar;298(3):101663. doi: 10.1016/j.jbc.2022.101663. Epub 2022 Jan 29.,Morrison JJ,J Biol Chem,2022,1/2/2022,PMC8897712,,10.1016/j.jbc.2022.101663,FtsZ
31997533,Nucleotide-induced folding of cell division protein FtsZ from Staphylococcus aureus,"Huecas S, Canosa-Valls AJ, Araújo-Bazán L, Ruiz FM, Laurents DV, Fernández-Tornero C, Andreu JM.",FEBS J. 2020 Sep;287(18):4048-4067. doi: 10.1111/febs.15235. Epub 2020 Feb 24.,Huecas S,FEBS J,2020,31/1/2020,,,10.1111/febs.15235,FtsZ
33581219,Assembly of bacterial cell division protein FtsZ into dynamic biomolecular condensates,"Robles-Ramos MÁ, Zorrilla S, Alfonso C, Margolin W, Rivas G, Monterroso B.",Biochim Biophys Acta Mol Cell Res. 2021 Apr;1868(5):118986. doi: 10.1016/j.bbamcr.2021.118986. Epub 2021 Feb 11.,Robles-Ramos MÁ,Biochim Biophys Acta Mol Cell Res,2021,13/2/2021,PMC8529516,NIHMS1746243,10.1016/j.bbamcr.2021.118986,FtsZ
35453046,Exploration of the inhibitory mechanism of PC190723 on FtsZ protein by molecular dynamics simulation,"Ma Y, Zhang S, Zhou L, Zhang L, Zhang P, Ma S.",J Mol Graph Model. 2022 Jul;114:108189. doi: 10.1016/j.jmgm.2022.108189. Epub 2022 Apr 14.,Ma Y,J Mol Graph Model,2022,22/4/2022,,,10.1016/j.jmgm.2022.108189,FtsZ
36704558,Early origin and evolution of the FtsZ/tubulin protein family,"Santana-Molina C, Del Saz-Navarro D, Devos DP.",Front Microbiol. 2023 Jan 10;13:1100249. doi: 10.3389/fmicb.2022.1100249. eCollection 2022.,Santana-Molina C,Front Microbiol,2023,27/1/2023,PMC9871819,,10.3389/fmicb.2022.1100249,FtsZ
29921670,Escherichia coli ZipA Organizes FtsZ Polymers into Dynamic Ring-Like Protofilament Structures,"Krupka M, Sobrinos-Sanguino M, Jiménez M, Rivas G, Margolin W.",mBio. 2018 Jun 19;9(3):e01008-18. doi: 10.1128/mBio.01008-18.,Krupka M,mBio,2018,21/6/2018,PMC6016244,,10.1128/mBio.01008-18,FtsZ
35218317,Streptococcus mutans cell division protein FtsZ has higher GTPase and polymerization activities in acidic environment,"Chen Y, Li Y, Yuan C, Liu S, Xin F, Deng X, Wang X.",Mol Oral Microbiol. 2022 Jun;37(3):97-108. doi: 10.1111/omi.12364. Epub 2022 Mar 13.,Chen Y,Mol Oral Microbiol,2022,26/2/2022,,,10.1111/omi.12364,FtsZ
36358226,Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii,"Scoffone VC, Irudal S, AbuAlshaar A, Piazza A, Trespidi G, Barbieri G, Makarov V, Migliavacca R, De Rossi E, Buroni S.",Antibiotics (Basel). 2022 Nov 8;11(11):1571. doi: 10.3390/antibiotics11111571.,Scoffone VC,Antibiotics (Basel),2022,11/11/2022,PMC9687021,,10.3390/antibiotics11111571,FtsZ
31790740,FtsA-FtsZ interaction in Vibrio cholerae causes conformational change of FtsA resulting in inhibition of ATP hydrolysis and polymerization,"Nag D, Chatterjee A, Chakrabarti G.",Int J Biol Macromol. 2020 Jan 1;142:18-32. doi: 10.1016/j.ijbiomac.2019.11.217. Epub 2019 Nov 29.,Nag D,Int J Biol Macromol,2020,3/12/2019,,,10.1016/j.ijbiomac.2019.11.217,FtsZ
33567659,Dynamic Assembly/Disassembly of Staphylococcus aureus FtsZ Visualized by High-Speed Atomic Force Microscopy,"Fujita J, Sugiyama S, Terakado H, Miyazaki M, Ozawa M, Ueda N, Kuroda N, Tanaka SI, Yoshizawa T, Uchihashi T, Matsumura H.",Int J Mol Sci. 2021 Feb 8;22(4):1697. doi: 10.3390/ijms22041697.,Fujita J,Int J Mol Sci,2021,11/2/2021,PMC7914567,,10.3390/ijms22041697,FtsZ
34208230,Interaction of Temporin-L Analogues with the E. coli FtsZ Protein,"Di Somma A, Canè C, Moretta A, Duilio A.",Antibiotics (Basel). 2021 Jun 11;10(6):704. doi: 10.3390/antibiotics10060704.,Di Somma A,Antibiotics (Basel),2021,2/7/2021,PMC8230800,,10.3390/antibiotics10060704,FtsZ
35798943,Min waves without MinC can pattern FtsA-anchored FtsZ filaments on model membranes,"Godino E, Doerr A, Danelon C.",Commun Biol. 2022 Jul 7;5(1):675. doi: 10.1038/s42003-022-03640-1.,Godino E,Commun Biol,2022,7/7/2022,PMC9262947,,10.1038/s42003-022-03640-1,FtsZ
35799411,Structural Insights into the Interaction between Bacillus subtilis SepF Assembly and FtsZ by Solid-State NMR Spectroscopy,"Zhang C, Liu W, Deng J, Ma S, Chang Z, Yang J.",J Phys Chem B. 2022 Jul 21;126(28):5219-5230. doi: 10.1021/acs.jpcb.2c02810. Epub 2022 Jul 7.,Zhang C,J Phys Chem B,2022,8/7/2022,,,10.1021/acs.jpcb.2c02810,FtsZ
35763867,"Design, synthesis and biological evaluation of biphenyl-benzamides as potent FtsZ inhibitors","Deng J, Zhang T, Li B, Xu M, Wang Y.",Eur J Med Chem. 2022 Sep 5;239:114553. doi: 10.1016/j.ejmech.2022.114553. Epub 2022 Jun 21.,Deng J,Eur J Med Chem,2022,28/6/2022,,,10.1016/j.ejmech.2022.114553,FtsZ
32198113,Dissecting the Functional Contributions of the Intrinsically Disordered C-terminal Tail of Bacillus subtilis FtsZ,"Cohan MC, Eddelbuettel AMP, Levin PA, Pappu RV.",J Mol Biol. 2020 May 1;432(10):3205-3221. doi: 10.1016/j.jmb.2020.03.008. Epub 2020 Mar 18.,Cohan MC,J Mol Biol,2020,22/3/2020,PMC8922553,NIHMS1784998,10.1016/j.jmb.2020.03.008,FtsZ
32648693,FtsZ-Independent Mechanism of Division Inhibition by the Small Molecule PC190723 in Escherichia coli,"Khare S, Hsin J, Sorto NA, Nepomuceno GM, Shaw JT, Shi H, Huang KC.",Adv Biosyst. 2019 Nov;3(11):e1900021. doi: 10.1002/adbi.201900021. Epub 2019 Jun 21.,Khare S,Adv Biosyst,2019,11/7/2020,,,10.1002/adbi.201900021,FtsZ
36338044,"Complete identity and expression of StfZ, the cis-antisense RNA to the mRNA of the cell division gene ftsZ, in Escherichia coli","Anand D, Jakkala K, Nair RR, Sharan D, Pradhan A, Mukkayyan N, Ajitkumar P.",Front Microbiol. 2022 Oct 19;13:920117. doi: 10.3389/fmicb.2022.920117. eCollection 2022.,Anand D,Front Microbiol,2022,7/11/2022,PMC9628754,,10.3389/fmicb.2022.920117,FtsZ
33649500,Progression of the late-stage divisome is unaffected by the depletion of the cytoplasmic FtsZ pool,"Silber N, Mayer C, Matos de Opitz CL, Sass P.",Commun Biol. 2021 Mar 1;4(1):270. doi: 10.1038/s42003-021-01789-9.,Silber N,Commun Biol,2021,2/3/2021,PMC7921118,,10.1038/s42003-021-01789-9,FtsZ
35481648,An enhancer sequence in the intrinsically disordered region of FtsZ promotes polymer-guided substrate processing by ClpXP protease,"Viola MG, Perdikari TM, Trebino CE, Rahmani N, Mathews KL, Pena CM, Chua XY, Xuan B, LaBreck CJ, Fawzi NL, Camberg JL.",Protein Sci. 2022 May;31(5):e4306. doi: 10.1002/pro.4306.,Viola MG,Protein Sci,2022,28/4/2022,PMC8996474,,10.1002/pro.4306,FtsZ
33729912,A conserved cell division protein directly regulates FtsZ dynamics in filamentous and unicellular actinobacteria,"Ramos-León F, Bush MJ, Sallmen JW, Chandra G, Richardson J, Findlay KC, McCormick JR, Schlimpert S.",Elife. 2021 Mar 17;10:e63387. doi: 10.7554/eLife.63387.,Ramos-León F,Elife,2021,17/3/2021,PMC7968930,,10.7554/eLife.63387,FtsZ
31405912,¡vIVA la DivIVA!,"Hammond LR, White ML, Eswara PJ.",J Bacteriol. 2019 Oct 4;201(21):e00245-19. doi: 10.1128/JB.00245-19. Print 2019 Nov 1.,Hammond LR,J Bacteriol,2019,14/8/2019,PMC6779457,,10.1128/JB.00245-19,FtsZ
33908781,"Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery","Huecas S, Araújo-Bazán L, Ruiz FM, Ruiz-Ávila LB, Martínez RF, Escobar-Peña A, Artola M, Vázquez-Villa H, Martín-Fontecha M, Fernández-Tornero C, López-Rodríguez ML, Andreu JM.",J Med Chem. 2021 May 13;64(9):5730-5745. doi: 10.1021/acs.jmedchem.0c02207. Epub 2021 Apr 28.,Huecas S,J Med Chem,2021,28/4/2021,PMC8478281,,10.1021/acs.jmedchem.0c02207,FtsZ
32039891,High-resolution crystal structures of Escherichia coli FtsZ bound to GDP and GTP,"Schumacher MA, Ohashi T, Corbin L, Erickson HP.",Acta Crystallogr F Struct Biol Commun. 2020 Feb 1;76(Pt 2):94-102. doi: 10.1107/S2053230X20001132. Epub 2020 Feb 5.,Schumacher MA,Acta Crystallogr F Struct Biol Commun,2020,11/2/2020,PMC7010359,,10.1107/S2053230X20001132,FtsZ
30337533,Cell shape-independent FtsZ dynamics in synthetically remodeled bacterial cells,"Söderström B, Badrutdinov A, Chan H, Skoglund U.",Nat Commun. 2018 Oct 18;9(1):4323. doi: 10.1038/s41467-018-06887-7.,Söderström B,Nat Commun,2018,20/10/2018,PMC6193997,,10.1038/s41467-018-06887-7,FtsZ
35328438,The Longitudinal Dividing Bacterium Candidatus Thiosymbion Oneisti Has a Natural Temperature-Sensitive FtsZ Protein with Low GTPase Activity,"Wang J, Bulgheresi S, den Blaauwen T.",Int J Mol Sci. 2022 Mar 10;23(6):3016. doi: 10.3390/ijms23063016.,Wang J,Int J Mol Sci,2022,25/3/2022,PMC8953583,,10.3390/ijms23063016,FtsZ
35421657,Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study,"Zhong DX, She MT, Guo XC, Zheng BX, Huang XH, Zhang YH, Ser HL, Wong WL, Sun N, Lu YJ.",Eur J Med Chem. 2022 Jun 5;236:114360. doi: 10.1016/j.ejmech.2022.114360. Epub 2022 Apr 7.,Zhong DX,Eur J Med Chem,2022,14/4/2022,,,10.1016/j.ejmech.2022.114360,FtsZ
35267210,"Acridinium-conjugated aromatic heterocycles as highly potent FtsZ inhibitors: Design, synthesis, and biological evaluation","Song D, Zhang N, Ma Y, Zhang S, Chen W, Guo T, Ma S.",Arch Pharm (Weinheim). 2022 Jun;355(6):e2100400. doi: 10.1002/ardp.202100400. Epub 2022 Mar 10.,Song D,Arch Pharm (Weinheim),2022,10/3/2022,,,10.1002/ardp.202100400,FtsZ
33859629,The Assembly Switch Mechanism of FtsZ Filament Revealed by All-Atom Molecular Dynamics Simulations and Coarse-Grained Models,"Lv D, Li J, Ye S.",Front Microbiol. 2021 Mar 30;12:639883. doi: 10.3389/fmicb.2021.639883. eCollection 2021.,Lv D,Front Microbiol,2021,16/4/2021,PMC8042166,,10.3389/fmicb.2021.639883,FtsZ
33112491,The role of the cytoskeletal proteins MreB and FtsZ in multicellular cyanobacteria,"Springstein BL, Weissenbach J, Koch R, Stücker F, Stucken K.",FEBS Open Bio. 2020 Dec;10(12):2510-2531. doi: 10.1002/2211-5463.13016. Epub 2020 Nov 13.,Springstein BL,FEBS Open Bio,2020,28/10/2020,PMC7714070,,10.1002/2211-5463.13016,FtsZ
32039890,Crystal structures of the cell-division protein FtsZ from Klebsiella pneumoniae and Escherichia coli,"Yoshizawa T, Fujita J, Terakado H, Ozawa M, Kuroda N, Tanaka SI, Uehara R, Matsumura H.",Acta Crystallogr F Struct Biol Commun. 2020 Feb 1;76(Pt 2):86-93. doi: 10.1107/S2053230X2000076X. Epub 2020 Feb 5.,Yoshizawa T,Acta Crystallogr F Struct Biol Commun,2020,11/2/2020,PMC7010355,,10.1107/S2053230X2000076X,FtsZ
36593513,Gene-Directed FtsZ Ring Assembly Generates Constricted Liposomes with Stable Membrane Necks,"Godino E, Danelon C.",Adv Biol (Weinh). 2023 Mar;7(3):e2200172. doi: 10.1002/adbi.202200172. Epub 2023 Jan 2.,Godino E,Adv Biol (Weinh),2023,2/1/2023,,,10.1002/adbi.202200172,FtsZ
32763138,A Unified Model for Treadmilling and Nucleation of Single-Stranded FtsZ Protofilaments,"Corbin LC, Erickson HP.",Biophys J. 2020 Aug 18;119(4):792-805. doi: 10.1016/j.bpj.2020.05.041. Epub 2020 Jul 17.,Corbin LC,Biophys J,2020,9/8/2020,PMC7451871,,10.1016/j.bpj.2020.05.041,FtsZ
34023403,Conformational Flexibility of A Highly Conserved Helix Controls Cryptic Pocket Formation in FtsZ,"Alnami A, Norton RS, Pena HP, Haider S, Kozielski F.",J Mol Biol. 2021 Jul 23;433(15):167061. doi: 10.1016/j.jmb.2021.167061. Epub 2021 May 21.,Alnami A,J Mol Biol,2021,23/5/2021,,,10.1016/j.jmb.2021.167061,FtsZ
35932806,"Screening of plant-based natural compounds as an inhibitor of FtsZ from Salmonella Typhi using the computational, biochemical and in vitro cell-based studies","Naz F, Kumar M, Koley T, Sharma P, Haque MA, Kapil A, Kumar M, Kaur P, Ethayathulla AS.",Int J Biol Macromol. 2022 Oct 31;219:428-437. doi: 10.1016/j.ijbiomac.2022.07.241. Epub 2022 Aug 4.,Naz F,Int J Biol Macromol,2022,6/8/2022,,,10.1016/j.ijbiomac.2022.07.241,FtsZ
33596109,Investigating the Involvement of Cytoskeletal Proteins MreB and FtsZ in the Origin of Legume-Rhizobial Symbiosis,"Zhao W, Zhu H, Wei F, Zhou D, Li Y, Zhang XX.",Mol Plant Microbe Interact. 2021 May;34(5):547-559. doi: 10.1094/MPMI-10-20-0299-FI. Epub 2021 May 20.,Zhao W,Mol Plant Microbe Interact,2021,17/2/2021,,,10.1094/MPMI-10-20-0299-FI,FtsZ
34340044,Modification of 5-methylphenanthridium from benzothiazoles to indoles as potent FtsZ inhibitors: Broadening the antibacterial spectrum toward vancomycin-resistant enterococci,"Zhang N, Song D, Chen W, Zhang S, Zhang P, Zhang N, Ma S.",Eur J Med Chem. 2021 Nov 15;224:113723. doi: 10.1016/j.ejmech.2021.113723. Epub 2021 Jul 26.,Zhang N,Eur J Med Chem,2021,2/8/2021,,,10.1016/j.ejmech.2021.113723,FtsZ
33588048,"M. jannaschii FtsZ, a key protein in bacterial cell division, is inactivated by peroxyl radical-mediated methionine oxidation","Reyes JS, Fuentes-Lemus E, Aspée A, Davies MJ, Monasterio O, López-Alarcón C.",Free Radic Biol Med. 2021 Apr;166:53-66. doi: 10.1016/j.freeradbiomed.2021.02.003. Epub 2021 Feb 13.,Reyes JS,Free Radic Biol Med,2021,15/2/2021,,,10.1016/j.freeradbiomed.2021.02.003,FtsZ
34700238,The natural anthraquinone dye purpurin exerts antibacterial activity by perturbing the FtsZ assembly,"Mahanty S, Rathinasamy K.",Bioorg Med Chem. 2021 Nov 15;50:116463. doi: 10.1016/j.bmc.2021.116463. Epub 2021 Oct 11.,Mahanty S,Bioorg Med Chem,2021,26/10/2021,,,10.1016/j.bmc.2021.116463,FtsZ
34296514,The developmental regulator PatD modulates assembly of the cell-division protein FtsZ in the cyanobacterium Anabaena sp. PCC 7120,"Wang L, Niu TC, Valladares A, Lin GM, Zhang JY, Herrero A, Chen WL, Zhang CC.",Environ Microbiol. 2021 Aug;23(8):4823-4837. doi: 10.1111/1462-2920.15682. Epub 2021 Aug 1.,Wang L,Environ Microbiol,2021,23/7/2021,,,10.1111/1462-2920.15682,FtsZ
30636070,Synthetic developmental regulator MciZ targets FtsZ across Bacillus species and inhibits bacterial division,"Araújo-Bazán L, Huecas S, Valle J, Andreu D, Andreu JM.",Mol Microbiol. 2019 Apr;111(4):965-980. doi: 10.1111/mmi.14198. Epub 2019 Feb 17.,Araújo-Bazán L,Mol Microbiol,2019,13/1/2019,,,10.1111/mmi.14198,FtsZ
32617695,A stochastic model for dynamics of FtsZ filaments and the formation of Z -ring,"Swain A, Anil Kumar AV, Sumedha.",Eur Phys J E Soft Matter. 2020 Jul 2;43(7):43. doi: 10.1140/epje/i2020-11967-6.,Swain A,Eur Phys J E Soft Matter,2020,4/7/2020,,,10.1140/epje/i2020-11967-6,FtsZ
31036719,Multi-functional regulator MapZ controls both positioning and timing of FtsZ polymerization,"Feng Z, Zhang J, Xu D, Jiang YL, Zhou CZ, Chen Y.",Biochem J. 2019 May 21;476(10):1433-1444. doi: 10.1042/BCJ20190138.,Feng Z,Biochem J,2019,1/5/2019,,,10.1042/BCJ20190138,FtsZ
31871036,Peptide Linkers within the Essential FtsZ Membrane Tethers ZipA and FtsA Are Nonessential for Cell Division,"Schoenemann KM, Vega DE, Margolin W.",J Bacteriol. 2020 Feb 25;202(6):e00720-19. doi: 10.1128/JB.00720-19. Print 2020 Feb 25.,Schoenemann KM,J Bacteriol,2020,25/12/2019,PMC7043674,,10.1128/JB.00720-19,FtsZ
36315857,Lipid Surfaces and Glutamate Anions Enhance Formation of Dynamic Biomolecular Condensates Containing Bacterial Cell Division Protein FtsZ and Its DNA-Bound Regulator SlmA,"Paccione G, Robles-Ramos MÁ, Alfonso C, Sobrinos-Sanguino M, Margolin W, Zorrilla S, Monterroso B, Rivas G.",Biochemistry. 2022 Nov 15;61(22):2482-2489. doi: 10.1021/acs.biochem.2c00424. Epub 2022 Oct 31.,Paccione G,Biochemistry,2022,31/10/2022,PMC9670838,,10.1021/acs.biochem.2c00424,FtsZ
34046600,"Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting Mtb-FtsZ as antitubercular agents","Haranahalli K, Tong S, Kim S, Awwa M, Chen L, Knudson SE, Slayden RA, Singleton E, Russo R, Connell N, Ojima I.",RSC Med Chem. 2020 Oct 16;12(1):78-94. doi: 10.1039/d0md00256a. eCollection 2021 Jan 1.,Haranahalli K,RSC Med Chem,2020,28/5/2021,PMC8132993,,10.1039/d0md00256a,FtsZ
30230648,Cell cycle-dependent regulation of FtsZ in Escherichia coli in slow growth conditions,"Männik J, Walker BE, Männik J.",Mol Microbiol. 2018 Dec;110(6):1030-1044. doi: 10.1111/mmi.14135. Epub 2018 Oct 29.,Männik J,Mol Microbiol,2018,20/9/2018,PMC6311098,NIHMS993627,10.1111/mmi.14135,FtsZ
31390865,Reversible Membrane Tethering by ZipA Determines FtsZ Polymerization in Two and Three Dimensions,"Sobrinos-Sanguino M, Vélez M, Richter RP, Rivas G.",Biochemistry. 2019 Sep 24;58(38):4003-4015. doi: 10.1021/acs.biochem.9b00378. Epub 2019 Sep 9.,Sobrinos-Sanguino M,Biochemistry,2019,9/8/2019,,,10.1021/acs.biochem.9b00378,FtsZ
32269092,Bacterial cell division at a glance,"Mahone CR, Goley ED.",J Cell Sci. 2020 Apr 8;133(7):jcs237057. doi: 10.1242/jcs.237057.,Mahone CR,J Cell Sci,2020,10/4/2020,PMC7157936,,10.1242/jcs.237057,FtsZ
33920895,Computational Design and Development of Benzodioxane-Benzamides as Potent Inhibitors of FtsZ by Exploring the Hydrophobic Subpocket,"Straniero V, Sebastián-Pérez V, Suigo L, Margolin W, Casiraghi A, Hrast M, Zanotto C, Zdovc I, Radaelli A, Valoti E.",Antibiotics (Basel). 2021 Apr 15;10(4):442. doi: 10.3390/antibiotics10040442.,Straniero V,Antibiotics (Basel),2021,30/4/2021,PMC8071314,,10.3390/antibiotics10040442,FtsZ
31232008,"[Bacterial expression, preparation and identification of polyclonal antibody against Escherichia coli FtsZ]","Chen Y, Niu X, Li M, Li N, Liu X.",Sheng Wu Gong Cheng Xue Bao. 2019 Jun 25;35(6):1117-1125. doi: 10.13345/j.cjb.190011.,Chen Y,Sheng Wu Gong Cheng Xue Bao,2019,25/6/2019,,,10.13345/j.cjb.190011,FtsZ
31160467,"Hsp90 of E. coli modulates assembly of FtsZ, the bacterial tubulin homolog","Balasubramanian A, Markovski M, Hoskins JR, Doyle SM, Wickner S.",Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12285-12294. doi: 10.1073/pnas.1904014116. Epub 2019 Jun 3.,Balasubramanian A,Proc Natl Acad Sci U S A,2019,5/6/2019,PMC6589665,,10.1073/pnas.1904014116,FtsZ
32417543,Drug repurposing approach to target FtsZ cell division protein from Salmonella Typhi,"Naz F, Mashkoor M, Sharma P, Haque MA, Kapil A, Kumar M, Kaur P, Abdul Samath E.",Int J Biol Macromol. 2020 Sep 15;159:1073-1083. doi: 10.1016/j.ijbiomac.2020.05.063. Epub 2020 May 15.,Naz F,Int J Biol Macromol,2020,18/5/2020,,,10.1016/j.ijbiomac.2020.05.063,FtsZ
31355691,"Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation","Qiu Y, Zhou L, Hu Y, Bao Y.",J Recept Signal Transduct Res. 2019 Apr;39(2):154-166. doi: 10.1080/10799893.2019.1638404. Epub 2019 Jul 29.,Qiu Y,J Recept Signal Transduct Res,2019,30/7/2019,,,10.1080/10799893.2019.1638404,FtsZ
30397005,Synthesis and degradation of FtsZ quantitatively predict the first cell division in starved bacteria,"Sekar K, Rusconi R, Sauls JT, Fuhrer T, Noor E, Nguyen J, Fernandez VI, Buffing MF, Berney M, Jun S, Stocker R, Sauer U.",Mol Syst Biol. 2018 Nov 5;14(11):e8623. doi: 10.15252/msb.20188623.,Sekar K,Mol Syst Biol,2018,7/11/2018,PMC6217170,,10.15252/msb.20188623,FtsZ
37250168,Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe,"Zhang H, Chen Y, Zhang Y, Qiao L, Chi X, Han Y, Lin Y, Si S, Jiang J.",Acta Pharm Sin B. 2023 May;13(5):2056-2070. doi: 10.1016/j.apsb.2023.01.022. Epub 2023 Feb 4.,Zhang H,Acta Pharm Sin B,2023,30/5/2023,PMC10213792,,10.1016/j.apsb.2023.01.022,FtsZ
34421877,A Novel Z-Ring Associated Protein ZapA-Like Protein (PA5407) From Pseudomonas aeruginosa Promotes FtsZ to Form Double Filaments,"Wang X, Ma X, Li Z, Niu M, Zhai M, Chen Y.",Front Microbiol. 2021 Aug 4;12:717013. doi: 10.3389/fmicb.2021.717013. eCollection 2021.,Wang X,Front Microbiol,2021,23/8/2021,PMC8371321,,10.3389/fmicb.2021.717013,FtsZ
31134430,Molecular association of FtsZ with the intrabacterial nanotransportation system for urease in Helicobacter pylori,"Wu H, Iwai N, Suzuki Y, Nakano T.",Med Mol Morphol. 2019 Dec;52(4):226-234. doi: 10.1007/s00795-019-00225-6. Epub 2019 May 27.,Wu H,Med Mol Morphol,2019,29/5/2019,,,10.1007/s00795-019-00225-6,FtsZ
30333801,"FtsZ of Filamentous, Heterocyst-Forming Cyanobacteria Has a Conserved N-Terminal Peptide Required for Normal FtsZ Polymerization and Cell Division","Corrales-Guerrero L, Camargo S, Valladares A, Picossi S, Luque I, Ochoa de Alda JAG, Herrero A.",Front Microbiol. 2018 Oct 2;9:2260. doi: 10.3389/fmicb.2018.02260. eCollection 2018.,Corrales-Guerrero L,Front Microbiol,2018,19/10/2018,PMC6175996,,10.3389/fmicb.2018.02260,FtsZ
30343895,Bifunctional Immunity Proteins Protect Bacteria against FtsZ-Targeting ADP-Ribosylating Toxins,"Ting SY, Bosch DE, Mangiameli SM, Radey MC, Huang S, Park YJ, Kelly KA, Filip SK, Goo YA, Eng JK, Allaire M, Veesler D, Wiggins PA, Peterson SB, Mougous JD.",Cell. 2018 Nov 15;175(5):1380-1392.e14. doi: 10.1016/j.cell.2018.09.037. Epub 2018 Oct 18.,Ting SY,Cell,2018,23/10/2018,PMC6239978,NIHMS1509221,10.1016/j.cell.2018.09.037,FtsZ
32132631,Structural features of the interaction of MapZ with FtsZ and membranes in Streptococcus pneumoniae,"Hosek T, Bougault CM, Lavergne JP, Martinez D, Ayala I, Fenel D, Restelli M, Morlot C, Habenstein B, Grangeasse C, Simorre JP.",Sci Rep. 2020 Mar 4;10(1):4051. doi: 10.1038/s41598-020-61036-9.,Hosek T,Sci Rep,2020,6/3/2020,PMC7055233,,10.1038/s41598-020-61036-9,FtsZ
31090151,Regulation of Streptococcus pneumoniae FtsZ assembly by divalent cations: paradoxical effects of Ca(2+) on the nucleation and bundling of FtsZ polymers,"Dhaked HPS, Ray S, Battaje RR, Banerjee A, Panda D.",FEBS J. 2019 Sep;286(18):3629-3646. doi: 10.1111/febs.14928. Epub 2019 Jun 6.,Dhaked HPS,FEBS J,2019,16/5/2019,,,10.1111/febs.14928,FtsZ
30021877,Phosphorylation of FtsZ and FtsA by a DNA Damage-Responsive Ser/Thr Protein Kinase Affects Their Functional Interactions in Deinococcus radiodurans,"Maurya GK, Modi K, Banerjee M, Chaudhary R, Rajpurohit YS, Misra HS.",mSphere. 2018 Jul 18;3(4):e00325-18. doi: 10.1128/mSphere.00325-18.,Maurya GK,mSphere,2018,20/7/2018,PMC6052341,,10.1128/mSphere.00325-18,FtsZ
33288818,Assembly properties of bacterial tubulin homolog FtsZ regulated by the positive regulator protein ZipA and ZapA from Pseudomonas aeruginosa,"Rahman MU, Li Z, Zhang T, Du S, Ma X, Wang P, Chen Y.",Sci Rep. 2020 Dec 7;10(1):21369. doi: 10.1038/s41598-020-78431-x.,Rahman MU,Sci Rep,2020,8/12/2020,PMC7721900,,10.1038/s41598-020-78431-x,FtsZ
33731468,Streptococcus suis MsmK: Novel Cell Division Protein Interacting with FtsZ and Maintaining Cell Shape,"Tan MF, Hu Q, Hu Z, Zhang CY, Liu WQ, Gao T, Zhang LS, Yao L, Li HQ, Zeng YB, Zhou R.",mSphere. 2021 Mar 17;6(2):e00119-21. doi: 10.1128/mSphere.00119-21.,Tan MF,mSphere,2021,18/3/2021,PMC8546688,,10.1128/mSphere.00119-21,FtsZ
31841523,Comparative in silico analysis of ftsZ gene from different bacteria reveals the preference for core set of codons in coding sequence structuring and secondary structural elements determination,"Pal A, Saha BK, Saha J.",PLoS One. 2019 Dec 16;14(12):e0219231. doi: 10.1371/journal.pone.0219231. eCollection 2019.,Pal A,PLoS One,2019,17/12/2019,PMC6913975,,10.1371/journal.pone.0219231,FtsZ
31822696,"Nano-encapsulated Escherichia coli Divisome Anchor ZipA, and in Complex with FtsZ","Lee SC, Collins R, Lin YP, Jamshad M, Broughton C, Harris SA, Hanson BS, Tognoloni C, Parslow RA, Terry AE, Rodger A, Smith CJ, Edler KJ, Ford R, Roper DI, Dafforn TR.",Sci Rep. 2019 Dec 10;9(1):18712. doi: 10.1038/s41598-019-54999-x.,Lee SC,Sci Rep,2019,12/12/2019,PMC6904479,,10.1038/s41598-019-54999-x,FtsZ
31959972,Diffusion and capture permits dynamic coupling between treadmilling FtsZ filaments and cell division proteins,"Baranova N, Radler P, Hernández-Rocamora VM, Alfonso C, López-Pelegrín M, Rivas G, Vollmer W, Loose M.",Nat Microbiol. 2020 Mar;5(3):407-417. doi: 10.1038/s41564-019-0657-5. Epub 2020 Jan 20.,Baranova N,Nat Microbiol,2020,22/1/2020,PMC7048620,EMS85137,10.1038/s41564-019-0657-5,FtsZ
31539529,Quantification of Predictive Uncertainty in Models of FtsZ ring assembly in Escherichia coli,"Ye Y, Ruiz-Martinez A, Wang P, Tartakovsky DM.",J Theor Biol. 2020 Jan 7;484:110006. doi: 10.1016/j.jtbi.2019.110006. Epub 2019 Sep 17.,Ye Y,J Theor Biol,2020,21/9/2019,,,10.1016/j.jtbi.2019.110006,FtsZ
33291418,Antimicrobial Action and Reversal of Resistance in MRSA by Difluorobenzamide Derivatives Targeted at FtsZ,"Chai WC, Whittall JJ, Song D, Polyak SW, Ogunniyi AD, Wang Y, Bi F, Ma S, Semple SJ, Venter H.",Antibiotics (Basel). 2020 Dec 5;9(12):873. doi: 10.3390/antibiotics9120873.,Chai WC,Antibiotics (Basel),2020,9/12/2020,PMC7762090,,10.3390/antibiotics9120873,FtsZ
30542089,Author Correction: Chloroplast FtsZ assembles into a contractible ring via tubulin-like heteropolymerization,"Yoshida Y, Mogi Y, TerBush AD, Osteryoung KW.",Nat Plants. 2019 Jan;5(1):119. doi: 10.1038/s41477-018-0341-4.,Yoshida Y,Nat Plants,2019,14/12/2018,,,10.1038/s41477-018-0341-4,FtsZ
30824505,ARC3 Activation by PARC6 Promotes FtsZ-Ring Remodeling at the Chloroplast Division Site,"Chen C, Cao L, Yang Y, Porter KJ, Osteryoung KW.",Plant Cell. 2019 Apr;31(4):862-885. doi: 10.1105/tpc.18.00948. Epub 2019 Mar 1.,Chen C,Plant Cell,2019,3/3/2019,PMC6501610,,10.1105/tpc.18.00948,FtsZ
34375286,Structure Based in Silico Screening Revealed a Potent Acinetobacter Baumannii Ftsz Inhibitor From Asinex Antibacterial Library,"Navid A, Ahmad S, Sajjad R, Raza S, Azam SS.",IEEE/ACM Trans Comput Biol Bioinform. 2022 Sep-Oct;19(5):3008-3018. doi: 10.1109/TCBB.2021.3103899. Epub 2022 Oct 10.,Navid A,IEEE/ACM Trans Comput Biol Bioinform,2022,10/8/2021,,,10.1109/TCBB.2021.3103899,FtsZ
30455283,"MinC N- and C-Domain Interactions Modulate FtsZ Assembly, Division Site Selection, and MinD-Dependent Oscillation in Escherichia coli","LaBreck CJ, Conti J, Viola MG, Camberg JL.",J Bacteriol. 2019 Jan 28;201(4):e00374-18. doi: 10.1128/JB.00374-18. Print 2019 Feb 15.,LaBreck CJ,J Bacteriol,2019,21/11/2018,PMC6351743,,10.1128/JB.00374-18,FtsZ
30052954,On the maverick Planctomycetes,"Wiegand S, Jogler M, Jogler C.",FEMS Microbiol Rev. 2018 Nov 1;42(6):739-760. doi: 10.1093/femsre/fuy029.,Wiegand S,FEMS Microbiol Rev,2018,28/7/2018,,,10.1093/femsre/fuy029,FtsZ
34646253,The Stress-Active Cell Division Protein ZapE Alters FtsZ Filament Architecture to Facilitate Division in Escherichia coli,"DiBiasio EC, Dickinson RA, Trebino CE, Ferreira CN, Morrison JJ, Camberg JL.",Front Microbiol. 2021 Sep 27;12:733085. doi: 10.3389/fmicb.2021.733085. eCollection 2021.,DiBiasio EC,Front Microbiol,2021,14/10/2021,PMC8503651,,10.3389/fmicb.2021.733085,FtsZ
33021149,Computational studies of the properties and activities of selected trisubstituted benzimidazoles as potential antitubercular drugs inhibiting MTB-FtsZ polymerization,"Akinpelu OI, Lawal MM, Kumalo HM, Mhlongo NN.",J Biomol Struct Dyn. 2022 Mar;40(4):1558-1570. doi: 10.1080/07391102.2020.1830176. Epub 2020 Oct 6.,Akinpelu OI,J Biomol Struct Dyn,2022,6/10/2020,,,10.1080/07391102.2020.1830176,FtsZ
34910337,Identifying the analogues of berberine as promising antitubercular drugs targeting Mtb-FtsZ polymerisation through ligand-based virtual screening and molecular dynamics simulations,"Akinpelu OI, Kumalo HM, Mhlongo SI, Mhlongo NN.",J Mol Recognit. 2022 Feb;35(2):e2940. doi: 10.1002/jmr.2940. Epub 2021 Dec 15.,Akinpelu OI,J Mol Recognit,2022,15/12/2021,,,10.1002/jmr.2940,FtsZ
35081523,Cytoskeletal proteins: lessons learned from bacteria,"Ramos-León F, Ramamurthi KS.",Phys Biol. 2022 Feb 17;19(2). doi: 10.1088/1478-3975/ac4ef0.,Ramos-León F,Phys Biol,2022,26/1/2022,,,10.1088/1478-3975/ac4ef0,FtsZ
33256135,Proposal of Potent Inhibitors for a Bacterial Cell Division Protein FtsZ: Molecular Simulations Based on Molecular Docking and ab Initio Molecular Orbital Calculations,"Yamamoto S, Saito R, Nakamura S, Sogawa H, Karpov P, Shulga S, Blume Y, Kurita N.",Antibiotics (Basel). 2020 Nov 26;9(12):846. doi: 10.3390/antibiotics9120846.,Yamamoto S,Antibiotics (Basel),2020,1/12/2020,PMC7761175,,10.3390/antibiotics9120846,FtsZ
31848350,Cooperative ordering of treadmilling filaments in cytoskeletal networks of FtsZ and its crosslinker ZapA,"Caldas P, López-Pelegrín M, Pearce DJG, Budanur NB, Brugués J, Loose M.",Nat Commun. 2019 Dec 17;10(1):5744. doi: 10.1038/s41467-019-13702-4.,Caldas P,Nat Commun,2019,19/12/2019,PMC6917738,,10.1038/s41467-019-13702-4,FtsZ
31932314,FtsA Regulates Z-Ring Morphology and Cell Wall Metabolism in an FtsZ C-Terminal Linker-Dependent Manner in Caulobacter crescentus,"Barrows JM, Sundararajan K, Bhargava A, Goley ED.",J Bacteriol. 2020 Mar 11;202(7):e00693-19. doi: 10.1128/JB.00693-19. Print 2020 Mar 11.,Barrows JM,J Bacteriol,2020,15/1/2020,PMC7167480,,10.1128/JB.00693-19,FtsZ
30085414,Purification and characterization of FtsZ from the citrus canker pathogen Xanthomonas citri subsp. citri,"Kopacz MM, Lorenzoni ASG, Polaquini CR, Regasini LO, Scheffers DJ.",Microbiologyopen. 2019 May;8(5):e00706. doi: 10.1002/mbo3.706. Epub 2018 Aug 7.,Kopacz MM,Microbiologyopen,2019,8/8/2018,PMC6528577,,10.1002/mbo3.706,FtsZ
35676800,"1,3,4-oxadiazole derivatives as potential antimicrobial agents","Tiwari D, Narang R, Sudhakar K, Singh V, Lal S, Devgun M.",Chem Biol Drug Des. 2022 Dec;100(6):1086-1121. doi: 10.1111/cbdd.14100. Epub 2022 Jun 27.,Tiwari D,Chem Biol Drug Des,2022,9/6/2022,,,10.1111/cbdd.14100,FtsZ
32071268,Chlamydial MreB Directs Cell Division and Peptidoglycan Synthesis in Escherichia coli in the Absence of FtsZ Activity,"Ranjit DK, Liechti GW, Maurelli AT.",mBio. 2020 Feb 18;11(1):e03222-19. doi: 10.1128/mBio.03222-19.,Ranjit DK,mBio,2020,20/2/2020,PMC7029139,,10.1128/mBio.03222-19,FtsZ
36854145,Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus,"Bryan E, Ferrer-González E, Sagong HY, Fujita J, Mark L, Kaul M, LaVoie EJ, Matsumura H, Pilch DS.",ACS Chem Biol. 2023 Mar 17;18(3):629-642. doi: 10.1021/acschembio.2c00934. Epub 2023 Feb 28.,Bryan E,ACS Chem Biol,2023,28/2/2023,,,10.1021/acschembio.2c00934,FtsZ
30006469,Mutation of G51 in SepF impairs FtsZ assembly promoting ability of SepF and retards the division of Mycobacterium smegmatis cells,"Bhattacharya D, Sinha K, Panda D.",Biochem J. 2018 Aug 14;475(15):2473-2489. doi: 10.1042/BCJ20180281.,Bhattacharya D,Biochem J,2018,15/7/2018,,,10.1042/BCJ20180281,FtsZ
31519752,Assembly properties of the bacterial tubulin homolog FtsZ from the cyanobacterium Synechocystis sp. PCC 6803,"Wang N, Bian L, Ma X, Meng Y, Chen CS, Rahman MU, Zhang T, Li Z, Wang P, Chen Y.",J Biol Chem. 2019 Nov 1;294(44):16309-16319. doi: 10.1074/jbc.RA119.009621. Epub 2019 Sep 13.,Wang N,J Biol Chem,2019,15/9/2019,PMC6827301,,10.1074/jbc.RA119.009621,FtsZ
33964649,"Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents","Song D, Zhang N, Zhang P, Zhang N, Chen W, Zhang L, Guo T, Gu X, Ma S.",Eur J Med Chem. 2021 Oct 5;221:113480. doi: 10.1016/j.ejmech.2021.113480. Epub 2021 Apr 28.,Song D,Eur J Med Chem,2021,8/5/2021,,,10.1016/j.ejmech.2021.113480,FtsZ
33146872,The lack of the cell division protein FtsZ induced generation of giant cells under acidic stress in cyanobacterium Synechocystis sp. PCC6803,"Kohga H, Saito Y, Kanamaru M, Uchiyama J, Ohta H.",Photosynth Res. 2021 Dec;150(1-3):343-356. doi: 10.1007/s11120-020-00792-1. Epub 2020 Nov 4.,Kohga H,Photosynth Res,2021,4/11/2020,,,10.1007/s11120-020-00792-1,FtsZ
32365857,The Antitumor Agent Ansamitocin P-3 Binds to Cell Division Protein FtsZ in Actinosynnema pretiosum,"Wang X, Wang R, Kang Q, Bai L.",Biomolecules. 2020 Apr 30;10(5):699. doi: 10.3390/biom10050699.,Wang X,Biomolecules,2020,6/5/2020,PMC7277737,,10.3390/biom10050699,FtsZ
30808920,ZipN is an essential FtsZ membrane tether and contributes to the septal localization of SepJ in the filamentous cyanobacterium Anabaena,"Camargo S, Picossi S, Corrales-Guerrero L, Valladares A, Arévalo S, Herrero A.",Sci Rep. 2019 Feb 26;9(1):2744. doi: 10.1038/s41598-019-39336-6.,Camargo S,Sci Rep,2019,28/2/2019,PMC6391411,,10.1038/s41598-019-39336-6,FtsZ
32318042,"Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia","Chiarelli LR, Scoffone VC, Trespidi G, Barbieri G, Riabova O, Monakhova N, Porta A, Manina G, Riccardi G, Makarov V, Buroni S.",Front Microbiol. 2020 Apr 7;11:562. doi: 10.3389/fmicb.2020.00562. eCollection 2020.,Chiarelli LR,Front Microbiol,2020,23/4/2020,PMC7154053,,10.3389/fmicb.2020.00562,FtsZ
31750973,Benzodioxane-Benzamides as Antibacterial Agents: Computational and SAR Studies to Evaluate the Influence of the 7-Substitution in FtsZ Interaction,"Straniero V, Sebastián-Pérez V, Hrast M, Zanotto C, Casiraghi A, Suigo L, Zdovc I, Radaelli A, De Giuli Morghen C, Valoti E.",ChemMedChem. 2020 Jan 17;15(2):195-209. doi: 10.1002/cmdc.201900537. Epub 2019 Dec 11.,Straniero V,ChemMedChem,2020,22/11/2019,,,10.1002/cmdc.201900537,FtsZ
30727908,Target Based Virtual Screening of New Leads Inhibitor against Bacterial Cell Division Protein FtsZ for the Discovery of Antibacterial Agents,"Mishra RC, Kumari R, Yadav S, Yadav JP.",Med Chem. 2020;16(2):169-175. doi: 10.2174/1573406415666190206233448.,Mishra RC,Med Chem,2020,8/2/2019,,,10.2174/1573406415666190206233448,FtsZ
30010220,Species- and C-terminal linker-dependent variations in the dynamic behavior of FtsZ on membranes in vitro,"Sundararajan K, Vecchiarelli A, Mizuuchi K, Goley ED.",Mol Microbiol. 2018 Oct;110(1):47-63. doi: 10.1111/mmi.14081. Epub 2018 Oct 8.,Sundararajan K,Mol Microbiol,2018,17/7/2018,PMC6195856,NIHMS981368,10.1111/mmi.14081,FtsZ
32900832,ylm Has More than a (Z Anchor) Ring to It!,"White ML, Eswara PJ.",J Bacteriol. 2021 Jan 11;203(3):e00460-20. doi: 10.1128/JB.00460-20. Print 2021 Jan 11.,White ML,J Bacteriol,2021,9/9/2020,PMC7811201,,10.1128/JB.00460-20,FtsZ
29920253,Differential impacts of FtsZ proteins on plastid division in the shoot apex of Arabidopsis,"Swid N, Nevo R, Kiss V, Kapon R, Dagan S, Snir O, Adam Z, Falconet D, Reich Z, Charuvi D.",Dev Biol. 2018 Sep 1;441(1):83-94. doi: 10.1016/j.ydbio.2018.06.010. Epub 2018 Jun 18.,Swid N,Dev Biol,2018,20/6/2018,,,10.1016/j.ydbio.2018.06.010,FtsZ
36854378,Bacterial division ring stabilizing ZapA versus destabilizing SlmA modulate FtsZ switching between biomolecular condensates and polymers,"Monterroso B, Robles-Ramos MÁ, Sobrinos-Sanguino M, Luque-Ortega JR, Alfonso C, Margolin W, Rivas G, Zorrilla S.",Open Biol. 2023 Mar;13(3):220324. doi: 10.1098/rsob.220324. Epub 2023 Mar 1.,Monterroso B,Open Biol,2023,28/2/2023,PMC9974302,,10.1098/rsob.220324,FtsZ
31031115,An Essential Regulator of Bacterial Division Links FtsZ to Cell Wall Synthase Activation,"Lariviere PJ, Mahone CR, Santiago-Collazo G, Howell M, Daitch AK, Zeinert R, Chien P, Brown PJB, Goley ED.",Curr Biol. 2019 May 6;29(9):1460-1470.e4. doi: 10.1016/j.cub.2019.03.066. Epub 2019 Apr 25.,Lariviere PJ,Curr Biol,2019,30/4/2019,PMC6504580,NIHMS1526015,10.1016/j.cub.2019.03.066,FtsZ
36652338,A mechanism of salt bridge-mediated resistance to FtsZ inhibitor PC190723 revealed by a cell-based screen,"Sharma AK, Poddar SM, Chakraborty J, Nayak BS, Kalathil S, Mitra N, Gayathri P, Srinivasan R.",Mol Biol Cell. 2023 Mar 1;34(3):ar16. doi: 10.1091/mbc.E22-12-0538. Epub 2023 Jan 18.,Sharma AK,Mol Biol Cell,2023,18/1/2023,PMC10011733,,10.1091/mbc.E22-12-0538,FtsZ
31126285,Synthetic cell division via membrane-transforming molecular assemblies,"Kretschmer S, Ganzinger KA, Franquelim HG, Schwille P.",BMC Biol. 2019 May 24;17(1):43. doi: 10.1186/s12915-019-0665-1.,Kretschmer S,BMC Biol,2019,26/5/2019,PMC6533746,,10.1186/s12915-019-0665-1,FtsZ
31137602,Surface Orientation and Binding Strength Modulate Shape of FtsZ on Lipid Surfaces,"Márquez I, Díaz-Haro G, Vélez M.",Int J Mol Sci. 2019 May 24;20(10):2545. doi: 10.3390/ijms20102545.,Márquez I,Int J Mol Sci,2019,30/5/2019,PMC6566678,,10.3390/ijms20102545,FtsZ
32260339,Benzamide Derivatives Targeting the Cell Division Protein FtsZ: Modifications of the Linker and the Benzodioxane Scaffold and Their Effects on Antimicrobial Activity,"Straniero V, Suigo L, Casiraghi A, Sebastián-Pérez V, Hrast M, Zanotto C, Zdovc I, De Giuli Morghen C, Radaelli A, Valoti E.",Antibiotics (Basel). 2020 Apr 4;9(4):160. doi: 10.3390/antibiotics9040160.,Straniero V,Antibiotics (Basel),2020,9/4/2020,PMC7235863,,10.3390/antibiotics9040160,FtsZ
34092960,"Design, synthesis, docking, Hirshfeld surface analysis and DFT calculations of 2-methylxanthen-9-with the FtsZ protein from Staphylococcus aureus","Ranganatha VL, C M, S JC, Ramu R, Shirahatti PS, Kumar N, Bp S, Khamees HA, Madegowda M, Khanum SA.",Bioinformation. 2021 Mar 31;17(3):393-403. doi: 10.6026/97320630017393. eCollection 2021.,Ranganatha VL,Bioinformation,2021,7/6/2021,PMC8131576,,10.6026/97320630017393,FtsZ
33921011,"Targeting of the Essential acpP, ftsZ, and rne Genes in Carbapenem-Resistant Acinetobacter baumannii by Antisense PNA Precision Antibacterials","Nejad AJ, Shahrokhi N, Nielsen PE.",Biomedicines. 2021 Apr 15;9(4):429. doi: 10.3390/biomedicines9040429.,Nejad AJ,Biomedicines,2021,30/4/2021,PMC8071358,,10.3390/biomedicines9040429,FtsZ
31669084,PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection,"Costabile G, Provenzano R, Azzalin A, Scoffone VC, Chiarelli LR, Rondelli V, Grillo I, Zinn T, Lepioshkin A, Savina S, Miro A, Quaglia F, Makarov V, Coenye T, Brocca P, Riccardi G, Buroni S, Ungaro F.",Nanomedicine. 2020 Jan;23:102113. doi: 10.1016/j.nano.2019.102113. Epub 2019 Oct 25.,Costabile G,Nanomedicine,2020,1/11/2019,,,10.1016/j.nano.2019.102113,FtsZ
30057277,A quinoline-based FtsZ inhibitor for the study of antimicrobial activity and synergistic effects with β-lactam antibiotics,"Fang Z, Ban L, Li Y, Yuan W, Liu Z, Liu T, Li X, Wong KY, Lu Y, Sun N, Yao X.",J Pharmacol Sci. 2018 Jul;137(3):283-289. doi: 10.1016/j.jphs.2018.07.005. Epub 2018 Jul 17.,Fang Z,J Pharmacol Sci,2018,31/7/2018,,,10.1016/j.jphs.2018.07.005,FtsZ
30277210,An essential Staphylococcus aureus cell division protein directly regulates FtsZ dynamics,"Eswara PJ, Brzozowski RS, Viola MG, Graham G, Spanoudis C, Trebino C, Jha J, Aubee JI, Thompson KM, Camberg JL, Ramamurthi KS.",Elife. 2018 Oct 2;7:e38856. doi: 10.7554/eLife.38856.,Eswara PJ,Elife,2018,3/10/2018,PMC6168285,,10.7554/eLife.38856,FtsZ
31171437,At the Heart of Bacterial Cytokinesis: The Z Ring,"Du S, Lutkenhaus J.",Trends Microbiol. 2019 Sep;27(9):781-791. doi: 10.1016/j.tim.2019.04.011. Epub 2019 Jun 3.,Du S,Trends Microbiol,2019,8/6/2019,PMC6831097,NIHMS1528655,10.1016/j.tim.2019.04.011,FtsZ
30474628,Photobleaching Enables Super-resolution Imaging of the FtsZ Ring in the Cyanobacterium Prochlorococcus,"Zhan Y, Liu Y, Zeng Q.",J Vis Exp. 2018 Nov 6;(141). doi: 10.3791/58603.,Zhan Y,J Vis Exp,2018,27/11/2018,,,10.3791/58603,FtsZ
34301354,Discovery of a novel plant-derived agent against Ralstonia solanacearum by targeting the bacterial division protein FtsZ,"Yang L, Wang Y, He X, Xiao Q, Han S, Jia Z, Li S, Ding W.",Pestic Biochem Physiol. 2021 Aug;177:104892. doi: 10.1016/j.pestbp.2021.104892. Epub 2021 Jun 5.,Yang L,Pestic Biochem Physiol,2021,24/7/2021,,,10.1016/j.pestbp.2021.104892,FtsZ
34373624,CcrZ is a pneumococcal spatiotemporal cell cycle regulator that interacts with FtsZ and controls DNA replication by modulating the activity of DnaA,"Gallay C, Sanselicio S, Anderson ME, Soh YM, Liu X, Stamsås GA, Pelliciari S, van Raaphorst R, Dénéréaz J, Kjos M, Murray H, Gruber S, Grossman AD, Veening JW.",Nat Microbiol. 2021 Sep;6(9):1175-1187. doi: 10.1038/s41564-021-00949-1. Epub 2021 Aug 9.,Gallay C,Nat Microbiol,2021,10/8/2021,PMC8387234,EMS130218,10.1038/s41564-021-00949-1,FtsZ
31949054,"Erratum for the Report: ""Treadmilling by FtsZ filaments drives peptidoglycan synthesis and bacterial cell division"" by A. W. Bisson-Filho, Y.-P. Hsu, G. R. Squyres, E. Kuru, F. Wu, C. Jukes, Y. Sun, C. Dekker, S. Holden, M. S. VanNieuwenhze, Y. V. Brun, E. C. Garner",,Science. 2020 Jan 17;367(6475):eaba6311. doi: 10.1126/science.aba6311.,,Science,2020,18/1/2020,,,10.1126/science.aba6311,FtsZ
31002418,Specific amino acid substitutions in β strand S2 of FtsZ cause spiraling septation and impair assembly cooperativity in Streptomyces spp,"Sen BC, Wasserstrom S, Findlay K, Söderholm N, Sandblad L, von Wachenfeldt C, Flärdh K.",Mol Microbiol. 2019 Jul;112(1):184-198. doi: 10.1111/mmi.14262. Epub 2019 May 17.,Sen BC,Mol Microbiol,2019,20/4/2019,,,10.1111/mmi.14262,FtsZ
36622182,Antibacterial Activity of an FtsZ Inhibitor Celastrol and Its Synergistic Effect with Vancomycin against Enterococci In Vitro and In Vivo,"Lu X, Wang Y, Guo W, Zhang Z, Hu X, Nie T, Yang X, Li C, Wang X, Li X, Lu Y, Li G, Zhang Y, Sun L, Pang J, You X.",Microbiol Spectr. 2023 Feb 14;11(1):e0369922. doi: 10.1128/spectrum.03699-22. Epub 2023 Jan 9.,Lu X,Microbiol Spectr,2023,9/1/2023,PMC9927571,,10.1128/spectrum.03699-22,FtsZ
29812902,MapZ Forms a Stable Ring Structure That Acts As a Nanotrack for FtsZ Treadmilling in Streptococcus mutans,"Li Y, Shao S, Xu X, Su X, Sun Y, Wei S.",ACS Nano. 2018 Jun 26;12(6):6137-6146. doi: 10.1021/acsnano.8b02469. Epub 2018 Jun 12.,Li Y,ACS Nano,2018,30/5/2018,,,10.1021/acsnano.8b02469,FtsZ
33903747,Cell division in the archaeon Haloferax volcanii relies on two FtsZ proteins with distinct functions in division ring assembly and constriction,"Liao Y, Ithurbide S, Evenhuis C, Löwe J, Duggin IG.",Nat Microbiol. 2021 May;6(5):594-605. doi: 10.1038/s41564-021-00894-z. Epub 2021 Apr 26.,Liao Y,Nat Microbiol,2021,27/4/2021,PMC7611241,EMS129338,10.1038/s41564-021-00894-z,FtsZ
33622102,Ectopic positioning of the cell division plane is associated with single amino acid substitutions in the FtsZ-recruiting SsgB in Streptomyces,"Xiao X, Willemse J, Voskamp P, Li X, Prota AE, Lamers M, Pannu N, Abrahams JP, van Wezel GP.",Open Biol. 2021 Feb;11(2):200409. doi: 10.1098/rsob.200409. Epub 2021 Feb 24.,Xiao X,Open Biol,2021,24/2/2021,PMC8061694,,10.1098/rsob.200409,FtsZ
36657643,Dynamics of the Synechococcus elongatus cytoskeletal GTPase FtsZ yields mechanistic and evolutionary insight into cyanobacterial and chloroplast FtsZs,"Porter KJ, Cao L, Osteryoung KW.",J Biol Chem. 2023 Mar;299(3):102917. doi: 10.1016/j.jbc.2023.102917. Epub 2023 Jan 16.,Porter KJ,J Biol Chem,2023,19/1/2023,PMC9975276,,10.1016/j.jbc.2023.102917,FtsZ
30602415,"2/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives","Ahamad S, Islam A, Ahmad F, Dwivedi N, Hassan MI.",Comput Biol Chem. 2019 Feb;78:398-413. doi: 10.1016/j.compbiolchem.2018.12.017. Epub 2018 Dec 27.,Ahamad S,Comput Biol Chem,2019,4/1/2019,,,10.1016/j.compbiolchem.2018.12.017,FtsZ
36495774,Implementation of a mycobacterial CRISPRi platform in Mycobacterium abscessus and demonstration of the essentiality of ftsZ(Mab),"Gupta R, Rohde KH.",Tuberculosis (Edinb). 2023 Jan;138:102292. doi: 10.1016/j.tube.2022.102292. Epub 2022 Dec 2.,Gupta R,Tuberculosis (Edinb),2023,10/12/2022,,,10.1016/j.tube.2022.102292,FtsZ
31882782,Structure-Guided Design of a Fluorescent Probe for the Visualization of FtsZ in Clinically Important Gram-Positive and Gram-Negative Bacterial Pathogens,"Ferrer-González E, Fujita J, Yoshizawa T, Nelson JM, Pilch AJ, Hillman E, Ozawa M, Kuroda N, Al-Tameemi HM, Boyd JM, LaVoie EJ, Matsumura H, Pilch DS.",Sci Rep. 2019 Dec 27;9(1):20092. doi: 10.1038/s41598-019-56557-x.,Ferrer-González E,Sci Rep,2019,29/12/2019,PMC6934700,,10.1038/s41598-019-56557-x,FtsZ
29889022,Lateral interactions between protofilaments of the bacterial tubulin homolog FtsZ are essential for cell division,"Guan F, Yu J, Yu J, Liu Y, Li Y, Feng XH, Huang KC, Chang Z, Ye S.",Elife. 2018 Jun 11;7:e35578. doi: 10.7554/eLife.35578.,Guan F,Elife,2018,12/6/2018,PMC6050046,,10.7554/eLife.35578,FtsZ
33193251,Exploring Spiroplasma Biology: Opportunities and Challenges,"Harne S, Gayathri P, Béven L.",Front Microbiol. 2020 Oct 21;11:589279. doi: 10.3389/fmicb.2020.589279. eCollection 2020.,Harne S,Front Microbiol,2020,16/11/2020,PMC7609405,,10.3389/fmicb.2020.589279,FtsZ
34512611,"Elongation at Midcell in Preparation of Cell Division Requires FtsZ, but Not MreB nor PBP2 in Caulobacter crescentus",van Teeseling MCF.,Front Microbiol. 2021 Aug 27;12:732031. doi: 10.3389/fmicb.2021.732031. eCollection 2021.,van Teeseling MCF,Front Microbiol,2021,13/9/2021,PMC8429850,,10.3389/fmicb.2021.732031,FtsZ
32279872,"Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations","Akinpelu OI, Lawal MM, Kumalo HM, Mhlongo NN.",Tuberculosis (Edinb). 2020 Mar;121:101920. doi: 10.1016/j.tube.2020.101920. Epub 2020 Mar 6.,Akinpelu OI,Tuberculosis (Edinb),2020,14/4/2020,,,10.1016/j.tube.2020.101920,FtsZ
33255486,Molecular Characterization of the Burkholderia cenocepacia dcw Operon and FtsZ Interactors as New Targets for Novel Antimicrobial Design,"Trespidi G, Scoffone VC, Barbieri G, Riccardi G, De Rossi E, Buroni S.",Antibiotics (Basel). 2020 Nov 24;9(12):841. doi: 10.3390/antibiotics9120841.,Trespidi G,Antibiotics (Basel),2020,1/12/2020,PMC7761207,,10.3390/antibiotics9120841,FtsZ
29995995,Gain-of-function variants of FtsA form diverse oligomeric structures on lipids and enhance FtsZ protofilament bundling,"Schoenemann KM, Krupka M, Rowlett VW, Distelhorst SL, Hu B, Margolin W.",Mol Microbiol. 2018 Sep;109(5):676-693. doi: 10.1111/mmi.14069. Epub 2018 Aug 1.,Schoenemann KM,Mol Microbiol,2018,12/7/2018,PMC6181759,NIHMS978891,10.1111/mmi.14069,FtsZ
32229224,The antimicrobial peptide Temporin L impairs E. coli cell division by interacting with FtsZ and the divisome complex,"Di Somma A, Avitabile C, Cirillo A, Moretta A, Merlino A, Paduano L, Duilio A, Romanelli A.",Biochim Biophys Acta Gen Subj. 2020 Jul;1864(7):129606. doi: 10.1016/j.bbagen.2020.129606. Epub 2020 Mar 27.,Di Somma A,Biochim Biophys Acta Gen Subj,2020,2/4/2020,,,10.1016/j.bbagen.2020.129606,FtsZ
34399108,Self-organized protein patterns: The MinCDE and ParABS systems,"Merino-Salomón A, Babl L, Schwille P.",Curr Opin Cell Biol. 2021 Oct;72:106-115. doi: 10.1016/j.ceb.2021.07.001. Epub 2021 Aug 13.,Merino-Salomón A,Curr Opin Cell Biol,2021,16/8/2021,,,10.1016/j.ceb.2021.07.001,FtsZ
36713210,Gossypol acetate: A natural polyphenol derivative with antimicrobial activities against the essential cell division protein FtsZ,"Du RL, Chow HY, Chen YW, Chan PH, Daniel RA, Wong KY.",Front Microbiol. 2023 Jan 12;13:1080308. doi: 10.3389/fmicb.2022.1080308. eCollection 2022.,Du RL,Front Microbiol,2023,30/1/2023,PMC9878342,,10.3389/fmicb.2022.1080308,FtsZ
35907702,Cellular mechanics during division of a genomically minimal cell,"Pelletier JF, Glass JI, Strychalski EA.",Trends Cell Biol. 2022 Nov;32(11):900-907. doi: 10.1016/j.tcb.2022.06.009. Epub 2022 Jul 27.,Pelletier JF,Trends Cell Biol,2022,30/7/2022,,,10.1016/j.tcb.2022.06.009,FtsZ
29967285,MCD1 Associates with FtsZ Filaments via the Membrane-Tethering Protein ARC6 to Guide Chloroplast Division,"Chen L, Sun B, Gao W, Zhang QY, Yuan H, Zhang M.",Plant Cell. 2018 Aug;30(8):1807-1823. doi: 10.1105/tpc.18.00189. Epub 2018 Jul 2.,Chen L,Plant Cell,2018,4/7/2018,PMC6139695,,10.1105/tpc.18.00189,FtsZ
33523162,Division in synthetic cells,Schwille P.,Emerg Top Life Sci. 2019 Nov 11;3(5):551-558. doi: 10.1042/ETLS20190023.,Schwille P,Emerg Top Life Sci,2019,1/2/2021,,,10.1042/ETLS20190023,FtsZ
30249365,Probing the benzofuroquinolinium derivative as a potent antibacterial agent through the inhibition of FtsZ activity,"Sun N, Ban L, Li M, Fang Z, Li X, Yao W, Pan J, Lu Y, Liu Z, Wong WL.",J Pharmacol Sci. 2018 Sep;138(1):83-85. doi: 10.1016/j.jphs.2018.09.001. Epub 2018 Sep 10.,Sun N,J Pharmacol Sci,2018,26/9/2018,,,10.1016/j.jphs.2018.09.001,FtsZ
37060755,Design and synthesis of fascaplysin derivatives as inhibitors of FtsZ with potent antibacterial activity and mechanistic study,"Qiu H, Zhao X, Jiang Y, Liang W, Wang W, Jiang X, Jiang M, Wang X, Cui W, Li Y, Tang K, Zhang T, Zhao L, Liang H.",Eur J Med Chem. 2023 Jun 5;254:115348. doi: 10.1016/j.ejmech.2023.115348. Epub 2023 Apr 11.,Qiu H,Eur J Med Chem,2023,15/4/2023,,,10.1016/j.ejmech.2023.115348,FtsZ
36936991,"Homology modeling, virtual screening, molecular docking, and dynamics studies for discovering Staphylococcus epidermidis FtsZ inhibitors","Vemula D, Maddi DR, Bhandari V.",Front Mol Biosci. 2023 Mar 3;10:1087676. doi: 10.3389/fmolb.2023.1087676. eCollection 2023.,Vemula D,Front Mol Biosci,2023,20/3/2023,PMC10020519,,10.3389/fmolb.2023.1087676,FtsZ
31034983,Pharmacophore based approach to screen and evaluate novel Mycobacterium cell division inhibitors targeting FtsZ - A modelling and experimental study,"Mitra K, Chadha A, Doble M.",Eur J Pharm Sci. 2019 Jul 1;135:103-112. doi: 10.1016/j.ejps.2019.04.023. Epub 2019 Apr 26.,Mitra K,Eur J Pharm Sci,2019,30/4/2019,,,10.1016/j.ejps.2019.04.023,FtsZ
31382874,The conserved actinobacterial transcriptional regulator FtsR controls expression of ftsZ and further target genes and influences growth and cell division in Corynebacterium glutamicum,"Kraxner KJ, Polen T, Baumgart M, Bott M.",BMC Microbiol. 2019 Aug 5;19(1):179. doi: 10.1186/s12866-019-1553-0.,Kraxner KJ,BMC Microbiol,2019,7/8/2019,PMC6683498,,10.1186/s12866-019-1553-0,FtsZ
36982749,A Comparative Study of the Inhibitory Action of Berberine Derivatives on the Recombinant Protein FtsZ of E. coli,"Di Somma A, Canè C, Rotondo NP, Cavalluzzi MM, Lentini G, Duilio A.",Int J Mol Sci. 2023 Mar 16;24(6):5674. doi: 10.3390/ijms24065674.,Di Somma A,Int J Mol Sci,2023,29/3/2023,PMC10057996,,10.3390/ijms24065674,FtsZ
35977922,Halogenation of tyrosine perturbs large-scale protein self-organization,"Sun H, Jia H, Kendall O, Dragelj J, Kubyshkin V, Baumann T, Mroginski MA, Schwille P, Budisa N.",Nat Commun. 2022 Aug 17;13(1):4843. doi: 10.1038/s41467-022-32535-2.,Sun H,Nat Commun,2022,17/8/2022,PMC9385671,,10.1038/s41467-022-32535-2,FtsZ
33065440,"Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus","Song D, Bi F, Zhang N, Qin Y, Liu X, Teng Y, Ma S.",Bioorg Med Chem. 2020 Nov 1;28(21):115729. doi: 10.1016/j.bmc.2020.115729. Epub 2020 Aug 27.,Song D,Bioorg Med Chem,2020,16/10/2020,,,10.1016/j.bmc.2020.115729,FtsZ
30261644,Mapping the Contact Sites of the Escherichia coli Division-Initiating Proteins FtsZ and ZapA by BAMG Cross-Linking and Site-Directed Mutagenesis,"Roseboom W, Nazir MG, Meiresonne NY, Mohammadi T, Verheul J, Buncherd H, Bonvin AMJJ, de Koning LJ, de Koster CG, de Jong L, den Blaauwen T.",Int J Mol Sci. 2018 Sep 26;19(10):2928. doi: 10.3390/ijms19102928.,Roseboom W,Int J Mol Sci,2018,29/9/2018,PMC6213154,,10.3390/ijms19102928,FtsZ
30466358,"Molecular dynamics analysis of the effects of GTP, GDP and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from Mycobacterium tuberculosis","Hakeem S, Singh I, Sharma P, Uppal A, Khajuria Y, Verma V, Uversky VN, Chandra R.",J Biomol Struct Dyn. 2019 Oct;37(16):4361-4373. doi: 10.1080/07391102.2018.1548979. Epub 2019 Jan 11.,Hakeem S,J Biomol Struct Dyn,2019,24/11/2018,,,10.1080/07391102.2018.1548979,FtsZ
31249557,Inhibition of Escherichia coli and Bacillus subtilis FtsZ Polymerization and Bacillus subtilis Growth by Dihydroxynaphtyl Aryl Ketones,"Araya G, Benites J, Reyes JS, Marcoleta AE, Valderrama JA, Lagos R, Monasterio O.",Front Microbiol. 2019 Jun 12;10:1225. doi: 10.3389/fmicb.2019.01225. eCollection 2019.,Araya G,Front Microbiol,2019,29/6/2019,PMC6582257,,10.3389/fmicb.2019.01225,FtsZ
31672986,De novo synthesized Min proteins drive oscillatory liposome deformation and regulate FtsA-FtsZ cytoskeletal patterns,"Godino E, López JN, Foschepoth D, Cleij C, Doerr A, Castellà CF, Danelon C.",Nat Commun. 2019 Oct 31;10(1):4969. doi: 10.1038/s41467-019-12932-w.,Godino E,Nat Commun,2019,2/11/2019,PMC6823393,,10.1038/s41467-019-12932-w,FtsZ
32357366,Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)-A cell division protein,"Ravindran R, Chakrapani G, Mitra K, Doble M.",PLoS One. 2020 May 1;15(5):e0232482. doi: 10.1371/journal.pone.0232482. eCollection 2020.,Ravindran R,PLoS One,2020,2/5/2020,PMC7195194,,10.1371/journal.pone.0232482,FtsZ
33348886,Structural Determinants and Their Role in Cyanobacterial Morphogenesis,"Springstein BL, Nürnberg DJ, Weiss GL, Pilhofer M, Stucken K.",Life (Basel). 2020 Dec 17;10(12):355. doi: 10.3390/life10120355.,Springstein BL,Life (Basel),2020,22/12/2020,PMC7766704,,10.3390/life10120355,FtsZ
30542616,Recent advances in cytokinesis: understanding the molecular underpinnings,"Liu Y, Robinson D.",F1000Res. 2018 Nov 26;7:F1000 Faculty Rev-1849. doi: 10.12688/f1000research.16502.1. eCollection 2018.,Liu Y,F1000Res,2018,14/12/2018,PMC6259594,,10.12688/f1000research.16502.1,FtsZ
31200986,"Discovery of 1,3,4-oxadiazol-2-one-containing benzamide derivatives targeting FtsZ as highly potent agents of killing a variety of MDR bacteria strains","Bi F, Song D, Qin Y, Liu X, Teng Y, Zhang N, Zhang P, Zhang N, Ma S.",Bioorg Med Chem. 2019 Jul 15;27(14):3179-3193. doi: 10.1016/j.bmc.2019.06.010. Epub 2019 Jun 7.,Bi F,Bioorg Med Chem,2019,16/6/2019,,,10.1016/j.bmc.2019.06.010,FtsZ
29774437,LexA Binds to Transcription Regulatory Site of Cell Division Gene ftsZ in Toxic Cyanobacterium Microcystis aeruginosa,"Honda T, Morimoto D, Sako Y, Yoshida T.",Mar Biotechnol (NY). 2018 Aug;20(4):549-556. doi: 10.1007/s10126-018-9826-4. Epub 2018 May 17.,Honda T,Mar Biotechnol (NY),2018,19/5/2018,,,10.1007/s10126-018-9826-4,FtsZ
30268826,"Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators","Bi F, Song D, Zhang N, Liu Z, Gu X, Hu C, Cai X, Venter H, Ma S.",Eur J Med Chem. 2018 Nov 5;159:90-103. doi: 10.1016/j.ejmech.2018.09.053. Epub 2018 Sep 22.,Bi F,Eur J Med Chem,2018,1/10/2018,,,10.1016/j.ejmech.2018.09.053,FtsZ
36903302,"Importance of the 2,6-Difluorobenzamide Motif for FtsZ Allosteric Inhibition: Insights from Conformational Analysis, Molecular Docking and Structural Modifications","Barbier T, Dumitrescu O, Lina G, Queneau Y, Soulère L.",Molecules. 2023 Feb 22;28(5):2055. doi: 10.3390/molecules28052055.,Barbier T,Molecules,2023,11/3/2023,PMC10003973,,10.3390/molecules28052055,FtsZ
36441529,Synthetic Membrane Shaper for Controlled Liposome Deformation,"De Franceschi N, Pezeshkian W, Fragasso A, Bruininks BMH, Tsai S, Marrink SJ, Dekker C.",ACS Nano. 2022 Nov 28;17(2):966-78. doi: 10.1021/acsnano.2c06125. Online ahead of print.,De Franceschi N,ACS Nano,2022,28/11/2022,PMC9878720,,10.1021/acsnano.2c06125,FtsZ
30003661,An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors,"Khadkikar P, Goud NS, Mohammed A, Ramamoorthy G, Ananthathatmula R, Doble M, Rizvi A, Banerjee S, Ravi A, Alvala M.",Chem Biol Drug Des. 2018 Dec;92(6):1933-1939. doi: 10.1111/cbdd.13363. Epub 2018 Oct 11.,Khadkikar P,Chem Biol Drug Des,2018,14/7/2018,,,10.1111/cbdd.13363,FtsZ
30174667,Study of Benzofuroquinolinium Derivatives as a New Class of Potent Antibacterial Agent and the Mode of Inhibition Targeting FtsZ,"Zheng YY, Du RL, Cai SY, Liu ZH, Fang ZY, Liu T, So LY, Lu YJ, Sun N, Wong KY.",Front Microbiol. 2018 Aug 17;9:1937. doi: 10.3389/fmicb.2018.01937. eCollection 2018.,Zheng YY,Front Microbiol,2018,4/9/2018,PMC6107709,,10.3389/fmicb.2018.01937,FtsZ
30503946,"Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor","Lui HK, Gao W, Cheung KC, Jin WB, Sun N, Kan JWY, Wong ILK, Chiou J, Lin D, Chan EWC, Leung YC, Chan TH, Chen S, Chan KF, Wong KY.",Eur J Med Chem. 2019 Feb 1;163:95-115. doi: 10.1016/j.ejmech.2018.11.052. Epub 2018 Nov 24.,Lui HK,Eur J Med Chem,2019,4/12/2018,,,10.1016/j.ejmech.2018.11.052,FtsZ
34755875,A novel amphiphilic motif at the C-terminus of FtsZ1 facilitates chloroplast division,"Liu X, An J, Wang L, Sun Q, An C, Wu B, Hong C, Wang X, Dong S, Guo J, Feng Y, Gao H.",Plant Cell. 2022 Jan 20;34(1):419-432. doi: 10.1093/plcell/koab272.,Liu X,Plant Cell,2022,10/11/2021,PMC8773991,,10.1093/plcell/koab272,FtsZ
31773394,"Computer-aided identification of lead compounds as Staphylococcal epidermidis FtsZ inhibitors using molecular docking, virtual screening, DFT analysis, and molecular dynamic simulation","Tripathy S, Sahu SK, Azam MA, Jupudi S.",J Mol Model. 2019 Nov 26;25(12):360. doi: 10.1007/s00894-019-4238-6.,Tripathy S,J Mol Model,2019,28/11/2019,,,10.1007/s00894-019-4238-6,FtsZ
33155720,Fine-Tuning Protein Self-Organization by Orthogonal Chemo-Optogenetic Tools,"Sun H, Jia H, Ramirez-Diaz DA, Budisa N, Schwille P.",Angew Chem Int Ed Engl. 2021 Feb 23;60(9):4501-4506. doi: 10.1002/anie.202008691. Epub 2021 Jan 7.,Sun H,Angew Chem Int Ed Engl,2021,6/11/2020,PMC7986231,,10.1002/anie.202008691,FtsZ
34737730,The Pneumococcal Divisome: Dynamic Control of Streptococcus pneumoniae Cell Division,"Briggs NS, Bruce KE, Naskar S, Winkler ME, Roper DI.",Front Microbiol. 2021 Oct 18;12:737396. doi: 10.3389/fmicb.2021.737396. eCollection 2021.,Briggs NS,Front Microbiol,2021,5/11/2021,PMC8563077,,10.3389/fmicb.2021.737396,FtsZ
36680940,The SepF-like proteins SflA and SflB prevent ectopic localization of FtsZ and DivIVA during sporulation of Streptomyces coelicolor,"Zhang L, Willemse J, Yagüe P, de Waal E, Claessen D, van Wezel GP.",Biochem Biophys Res Commun. 2023 Feb 19;645:79-87. doi: 10.1016/j.bbrc.2023.01.021. Epub 2023 Jan 14.,Zhang L,Biochem Biophys Res Commun,2023,21/1/2023,,,10.1016/j.bbrc.2023.01.021,FtsZ
31122668,Microtubule Assembly from Single Flared Protofilaments-Forget the Cozy Corner?,Erickson HP.,Biophys J. 2019 Jun 18;116(12):2240-2245. doi: 10.1016/j.bpj.2019.05.005. Epub 2019 May 8.,Erickson HP,Biophys J,2019,25/5/2019,PMC6588822,,10.1016/j.bpj.2019.05.005,FtsZ
35303931,Canine microfilaraemia in some regions of Iran,"Hosseini SH, Manshori-Ghaishghorshagh F, Ramezani M, Nayebzadeh H, Ahoo MB, Eslamian A, Soltani M, Jamshidi S, Bezerra-Santos MA, Jalousian F, Sazmand A, Otranto D.",Parasit Vectors. 2022 Mar 18;15(1):90. doi: 10.1186/s13071-022-05209-7.,Hosseini SH,Parasit Vectors,2022,19/3/2022,PMC8932200,,10.1186/s13071-022-05209-7,FtsZ
35550516,In vitro reconstitution of Escherichia coli divisome activation,"Radler P, Baranova N, Caldas P, Sommer C, López-Pelegrín M, Michalik D, Loose M.",Nat Commun. 2022 May 12;13(1):2635. doi: 10.1038/s41467-022-30301-y.,Radler P,Nat Commun,2022,13/5/2022,PMC9098913,,10.1038/s41467-022-30301-y,FtsZ
34910577,"Localization, Assembly, and Activation of the Escherichia coli Cell Division Machinery","Levin PA, Janakiraman A.",EcoSal Plus. 2021 Dec 15;9(2):eESP00222021. doi: 10.1128/ecosalplus.ESP-0022-2021. Epub 2021 Dec 13.,Levin PA,EcoSal Plus,2021,15/12/2021,PMC8919703,NIHMS1785006,10.1128/ecosalplus.ESP-0022-2021,FtsZ
31829405,The evolution of spherical cell shape; progress and perspective,"Yulo PRJ, Hendrickson HL.",Biochem Soc Trans. 2019 Dec 20;47(6):1621-1634. doi: 10.1042/BST20180634.,Yulo PRJ,Biochem Soc Trans,2019,13/12/2019,PMC6925525,,10.1042/BST20180634,FtsZ
31165765,"New antimicrobial compounds produced by Seltsamia galinsogisoli sp. nov., isolated from Galinsoga parviflora as potential inhibitors of FtsZ","Zhang TY, Wu YY, Zhang MY, Cheng J, Dube B, Yu HJ, Zhang YX.",Sci Rep. 2019 Jun 5;9(1):8319. doi: 10.1038/s41598-019-44810-2.,Zhang TY,Sci Rep,2019,6/6/2019,PMC6549247,,10.1038/s41598-019-44810-2,FtsZ
30272542,Corrigendum: Essential protein SepF of mycobacteria interacts with FtsZ and MurG to regulate cell growth and division,"Gupta S, Banerjee SK, Chatterjee A, Sharma AK, Kundu M, Basu J.",Microbiology (Reading). 2018 Oct;164(10):1326. doi: 10.1099/mic.0.000712.,Gupta S,Microbiology (Reading),2018,2/10/2018,,,10.1099/mic.0.000712,FtsZ
35042922,Membrane rigidity regulates E. coli proliferation rates,"Salinas-Almaguer S, Mell M, Almendro-Vedia VG, Calero M, Robledo-Sánchez KCM, Ruiz-Suarez C, Alarcón T, Barrio RA, Hernández-Machado A, Monroy F.",Sci Rep. 2022 Jan 18;12(1):933. doi: 10.1038/s41598-022-04970-0.,Salinas-Almaguer S,Sci Rep,2022,19/1/2022,PMC8766614,,10.1038/s41598-022-04970-0,FtsZ
31915748,RodZ: a key-player in cell elongation and cell division in Escherichia coli,"Ago R, Shiomi D.",AIMS Microbiol. 2019 Nov 7;5(4):358-367. doi: 10.3934/microbiol.2019.4.358. eCollection 2019.,Ago R,AIMS Microbiol,2019,10/1/2020,PMC6946637,,10.3934/microbiol.2019.4.358,FtsZ
29451601,Cell Division in genus Corynebacterium: protein-protein interaction and molecular docking of SepF and FtsZ in the understanding of cytokinesis in pathogenic species,"Oliveira AF Jr, Folador EL, Gomide ACP, Goes-Neto A, Azevedo VAC, Wattam AR.",An Acad Bras Cienc. 2018 Aug;90(2 suppl 1):2179-2188. doi: 10.1590/0001-3765201820170385. Epub 2018 Feb 15.,Oliveira AF Jr,An Acad Bras Cienc,2018,17/2/2018,,,10.1590/0001-3765201820170385,FtsZ
34248920,Metabolic Control of Cell Elongation and Cell Division in Bacillus subtilis,"Galinier A, Foulquier E, Pompeo F.",Front Microbiol. 2021 Jun 25;12:697930. doi: 10.3389/fmicb.2021.697930. eCollection 2021.,Galinier A,Front Microbiol,2021,12/7/2021,PMC8270655,,10.3389/fmicb.2021.697930,FtsZ
35968943,Cell Cycle-Dependent Recruitment of FtsN to the Divisome in Escherichia coli,"Männik J, Pichoff S, Lutkenhaus J, Männik J.",mBio. 2022 Aug 30;13(4):e0201722. doi: 10.1128/mbio.02017-22. Epub 2022 Aug 15.,Männik J,mBio,2022,15/8/2022,PMC9426451,,10.1128/mbio.02017-22,FtsZ
30855188,Asymmetric cell division during Bacillus subtilis sporulation,"Barák I, Muchová K, Labajová N.",Future Microbiol. 2019 Mar;14:353-363. doi: 10.2217/fmb-2018-0338. Epub 2019 Mar 11.,Barák I,Future Microbiol,2019,12/3/2019,,,10.2217/fmb-2018-0338,FtsZ
32599022,How similar or dissimilar cells are produced by bacterial cell division?,"Singhi D, Srivastava P.",Biochimie. 2020 Sep;176:71-84. doi: 10.1016/j.biochi.2020.06.005. Epub 2020 Jun 26.,Singhi D,Biochimie,2020,30/6/2020,,,10.1016/j.biochi.2020.06.005,FtsZ
30149132,"Synthesis, screening and docking analysis of novel benzimidazolium compounds as potent anti microbial agents targeting FtsZ protein","Sangeeta GPV, Purna Nagasree K, Risy Namratha J, Krishna Kumar MM.",Microb Pathog. 2018 Nov;124:258-265. doi: 10.1016/j.micpath.2018.08.046. Epub 2018 Aug 25.,Sangeeta GPV,Microb Pathog,2018,28/8/2018,,,10.1016/j.micpath.2018.08.046,FtsZ
37057268,Filamentous temperature sensitive mutant Z: a putative target to combat antibacterial resistance,"Kifayat S, Yele V, Ashames A, Sigalapalli DK, Bhandare RR, Shaik AB, Nasipireddy V, Sanapalli BKR.",RSC Adv. 2023 Apr 11;13(17):11368-11384. doi: 10.1039/d3ra00013c. eCollection 2023 Apr 11.,Kifayat S,RSC Adv,2023,14/4/2023,PMC10089256,,10.1039/d3ra00013c,FtsZ
31862126,Vibrio taketomensis sp. nov. by genome taxonomy,"Tanaka M, Hongyu B, Jiang C, Mino S, Milet Meirelles P, Thompson F, Gomez-Gil B, Sawabe T.",Syst Appl Microbiol. 2020 Jan;43(1):126048. doi: 10.1016/j.syapm.2019.126048. Epub 2019 Dec 10.,Tanaka M,Syst Appl Microbiol,2020,22/12/2019,,,10.1016/j.syapm.2019.126048,FtsZ
29864480,An endophytic Fungi of Ginkgo biloba L. produces antimicrobial metabolites as potential inhibitors of FtsZ of Staphylococcus aureus,"Wu YY, Zhang TY, Zhang MY, Cheng J, Zhang YX.",Fitoterapia. 2018 Jul;128:265-271. doi: 10.1016/j.fitote.2018.05.033. Epub 2018 Jun 1.,Wu YY,Fitoterapia,2018,5/6/2018,,,10.1016/j.fitote.2018.05.033,FtsZ
30297366,Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ,"Hogan AM, Scoffone VC, Makarov V, Gislason AS, Tesfu H, Stietz MS, Brassinga AKC, Domaratzki M, Li X, Azzalin A, Biggiogera M, Riabova O, Monakhova N, Chiarelli LR, Riccardi G, Buroni S, Cardona ST.",Antimicrob Agents Chemother. 2018 Nov 26;62(12):e01231-18. doi: 10.1128/AAC.01231-18. Print 2018 Dec.,Hogan AM,Antimicrob Agents Chemother,2018,10/10/2018,PMC6256756,,10.1128/AAC.01231-18,FtsZ
36707350,Cap-tivating findings provide insight into bacterial cell division,"Sallmen JW, Schlimpert S.",Trends Microbiol. 2023 Mar;31(3):219-221. doi: 10.1016/j.tim.2023.01.005. Epub 2023 Jan 25.,Sallmen JW,Trends Microbiol,2023,27/1/2023,,,10.1016/j.tim.2023.01.005,FtsZ
30996302,Spatiotemporal control of coacervate formation within liposomes,"Deshpande S, Brandenburg F, Lau A, Last MGF, Spoelstra WK, Reese L, Wunnava S, Dogterom M, Dekker C.",Nat Commun. 2019 Apr 17;10(1):1800. doi: 10.1038/s41467-019-09855-x.,Deshpande S,Nat Commun,2019,19/4/2019,PMC6470218,,10.1038/s41467-019-09855-x,FtsZ
30291967,New antimicrobial compounds produced by endophytic Penicillium janthinellum isolated from Panax notoginseng as potential inhibitors of FtsZ,"Xie J, Wu YY, Zhang TY, Zhang MY, Peng F, Lin B, Zhang YX.",Fitoterapia. 2018 Nov;131:35-43. doi: 10.1016/j.fitote.2018.10.006. Epub 2018 Oct 3.,Xie J,Fitoterapia,2018,7/10/2018,,,10.1016/j.fitote.2018.10.006,FtsZ
28938860,"Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors","Tripathy S, Azam MA, Jupudi S, Sahu SK.",J Biomol Struct Dyn. 2018 Sep;36(12):3218-3230. doi: 10.1080/07391102.2017.1384401. Epub 2017 Oct 11.,Tripathy S,J Biomol Struct Dyn,2018,24/9/2017,,,10.1080/07391102.2017.1384401,FtsZ
30808703,Checks and Balances in Bacterial Cell Division,"den Blaauwen T, Luirink J.",mBio. 2019 Feb 26;10(1):e00149-19. doi: 10.1128/mBio.00149-19.,den Blaauwen T,mBio,2019,28/2/2019,PMC6391918,,10.1128/mBio.00149-19,FtsZ
35408901,An Updated Model of the Divisome: Regulation of the Septal Peptidoglycan Synthesis Machinery by the Divisome,"Attaibi M, den Blaauwen T.",Int J Mol Sci. 2022 Mar 24;23(7):3537. doi: 10.3390/ijms23073537.,Attaibi M,Int J Mol Sci,2022,12/4/2022,PMC8998562,,10.3390/ijms23073537,FtsZ
33024847,Enhancing single-cell hyaluronic acid biosynthesis by microbial morphology engineering,"Zheng Y, Cheng F, Zheng B, Yu H.",Synth Syst Biotechnol. 2020 Sep 30;5(4):316-323. doi: 10.1016/j.synbio.2020.09.002. eCollection 2020 Dec.,Zheng Y,Synth Syst Biotechnol,2020,7/10/2020,PMC7530263,,10.1016/j.synbio.2020.09.002,FtsZ
30128891,Prokaryotic cytoskeletons: in situ and ex situ structures and cellular locations,Kim KW.,Antonie Van Leeuwenhoek. 2019 Feb;112(2):145-157. doi: 10.1007/s10482-018-1142-5. Epub 2018 Aug 20.,Kim KW,Antonie Van Leeuwenhoek,2019,22/8/2018,,,10.1007/s10482-018-1142-5,FtsZ
30730266,False Negative Results in Bartonellosis Diagnosis,"Drummond MR, Dos Santos LS, Silva MND, Almeida AR, Diniz PPVP, Angerami R, Velho PENF.",Vector Borne Zoonotic Dis. 2019 Jun;19(6):453-454. doi: 10.1089/vbz.2018.2378. Epub 2019 Feb 7.,Drummond MR,Vector Borne Zoonotic Dis,2019,8/2/2019,,,10.1089/vbz.2018.2378,FtsZ
30718427,Movement dynamics of divisome proteins and PBP2x:FtsW in cells of Streptococcus pneumoniae,"Perez AJ, Cesbron Y, Shaw SL, Bazan Villicana J, Tsui HT, Boersma MJ, Ye ZA, Tovpeko Y, Dekker C, Holden S, Winkler ME.",Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3211-3220. doi: 10.1073/pnas.1816018116. Epub 2019 Feb 4.,Perez AJ,Proc Natl Acad Sci U S A,2019,6/2/2019,PMC6386697,,10.1073/pnas.1816018116,FtsZ
30347327,"Design, synthesis and antibacterial evaluation of 2,4-disubstituted-6-thiophenyl-pyrimidines","Fang Z, Zheng S, Chan KF, Yuan W, Guo Q, Wu W, Lui HK, Lu Y, Leung YC, Chan TH, Wong KY, Sun N.",Eur J Med Chem. 2019 Jan 1;161:141-153. doi: 10.1016/j.ejmech.2018.10.039. Epub 2018 Oct 17.,Fang Z,Eur J Med Chem,2019,23/10/2018,,,10.1016/j.ejmech.2018.10.039,FtsZ
32017878,Bacterial Division: Journey to the Center of the Cell,Margolin W.,Curr Biol. 2020 Feb 3;30(3):R114-R116. doi: 10.1016/j.cub.2019.12.048.,Margolin W,Curr Biol,2020,5/2/2020,,,10.1016/j.cub.2019.12.048,FtsZ
30056491,Super-resolution images of peptidoglycan remodelling enzymes at the division site of Escherichia coli,"Söderström B, Chan H, Daley DO.",Curr Genet. 2019 Feb;65(1):99-101. doi: 10.1007/s00294-018-0869-x. Epub 2018 Jul 28.,Söderström B,Curr Genet,2019,30/7/2018,PMC6342862,,10.1007/s00294-018-0869-x,FtsZ
31160399,A DNA-Binding Protein Tunes Septum Placement during Bacillus subtilis Sporulation,"Brown EE, Miller AK, Krieger IV, Otto RM, Sacchettini JC, Herman JK.",J Bacteriol. 2019 Jul 24;201(16):e00287-19. doi: 10.1128/JB.00287-19. Print 2019 Aug 15.,Brown EE,J Bacteriol,2019,5/6/2019,PMC6657595,,10.1128/JB.00287-19,FtsZ
30958258,L form bacteria growth in low-osmolality medium,"Osawa M, Erickson HP.",Microbiology (Reading). 2019 Aug;165(8):842-851. doi: 10.1099/mic.0.000799. Epub 2019 Apr 8.,Osawa M,Microbiology (Reading),2019,9/4/2019,PMC7008213,,10.1099/mic.0.000799,FtsZ
35625352,Filamentous Thermosensitive Mutant Z: An Appealing Target for Emerging Pathogens and a Trek on Its Natural Inhibitors,"Gurnani M, Chauhan A, Ranjan A, Tuli HS, Alkhanani MF, Haque S, Dhama K, Lal R, Jindal T.",Biology (Basel). 2022 Apr 20;11(5):624. doi: 10.3390/biology11050624.,Gurnani M,Biology (Basel),2022,28/5/2022,PMC9138142,,10.3390/biology11050624,FtsZ
35065768,Bacterial developmental checkpoint that directly monitors cell surface morphogenesis,"Delerue T, Anantharaman V, Gilmore MC, Popham DL, Cava F, Aravind L, Ramamurthi KS.",Dev Cell. 2022 Feb 7;57(3):344-360.e6. doi: 10.1016/j.devcel.2021.12.021. Epub 2022 Jan 21.,Delerue T,Dev Cell,2022,23/1/2022,PMC8991396,NIHMS1781239,10.1016/j.devcel.2021.12.021,FtsZ
31254421,Keeping replication on par with division in Bacillus,"Haeusser DP, Levin PA.",Mol Microbiol. 2019 Sep;112(3):747-750. doi: 10.1111/mmi.14338. Epub 2019 Jul 16.,Haeusser DP,Mol Microbiol,2019,30/6/2019,PMC8967261,NIHMS1785004,10.1111/mmi.14338,FtsZ
33453926,"Reconstituting bacterial cell division assemblies in crowded, phase-separated media","Monterroso B, Robles-Ramos MÁ, Zorrilla S, Rivas G.",Methods Enzymol. 2021;646:19-49. doi: 10.1016/bs.mie.2020.06.012. Epub 2020 Jul 9.,Monterroso B,Methods Enzymol,2021,17/1/2021,,,10.1016/bs.mie.2020.06.012,FtsZ
31317204,The E. coli MinCDE system in the regulation of protein patterns and gradients,"Ramm B, Heermann T, Schwille P.",Cell Mol Life Sci. 2019 Nov;76(21):4245-4273. doi: 10.1007/s00018-019-03218-x. Epub 2019 Jul 17.,Ramm B,Cell Mol Life Sci,2019,19/7/2019,PMC6803595,,10.1007/s00018-019-03218-x,FtsZ
36005297,Engineering cell morphology by CRISPR interference in Acinetobacter baylyi ADP1,"Luo J, Efimova E, Volke DC, Santala V, Santala S.",Microb Biotechnol. 2022 Nov;15(11):2800-2818. doi: 10.1111/1751-7915.14133. Epub 2022 Aug 25.,Luo J,Microb Biotechnol,2022,25/8/2022,PMC9618324,,10.1111/1751-7915.14133,FtsZ
30051597,A simplified curcumin targets the membrane of Bacillus subtilis,"Morão LG, Polaquini CR, Kopacz M, Torrezan GS, Ayusso GM, Dilarri G, Cavalca LB, Zielińska A, Scheffers DJ, Regasini LO, Ferreira H.",Microbiologyopen. 2019 Apr;8(4):e00683. doi: 10.1002/mbo3.683. Epub 2018 Jul 26.,Morão LG,Microbiologyopen,2019,28/7/2018,PMC6460283,,10.1002/mbo3.683,FtsZ
34589065,Functional Characterization of the Cell Division Gene Cluster of the Wall-less Bacterium Mycoplasma genitalium,"Martínez-Torró C, Torres-Puig S, Marcos-Silva M, Huguet-Ramón M, Muñoz-Navarro C, Lluch-Senar M, Serrano L, Querol E, Piñol J, Pich OQ.",Front Microbiol. 2021 Sep 13;12:695572. doi: 10.3389/fmicb.2021.695572. eCollection 2021.,Martínez-Torró C,Front Microbiol,2021,30/9/2021,PMC8475190,,10.3389/fmicb.2021.695572,FtsZ
35411648,SepF supports the recruitment of the DNA translocase SftA to the Z-ring,"Saaki TNV, Teng Z, Wenzel M, Ventroux M, Carballido-Lόpez R, Noirot-Gros MF, Hamoen LW.",Mol Microbiol. 2022 May;117(5):1263-1274. doi: 10.1111/mmi.14906. Epub 2022 Apr 30.,Saaki TNV,Mol Microbiol,2022,12/4/2022,PMC9320952,,10.1111/mmi.14906,FtsZ
32999429,Cell-free biogenesis of bacterial division proto-rings that can constrict liposomes,"Godino E, López JN, Zarguit I, Doerr A, Jimenez M, Rivas G, Danelon C.",Commun Biol. 2020 Sep 30;3(1):539. doi: 10.1038/s42003-020-01258-9.,Godino E,Commun Biol,2020,1/10/2020,PMC7527988,,10.1038/s42003-020-01258-9,FtsZ
33443155,Control of septum thickness by the curvature of SepF polymers,"Wenzel M, Celik Gulsoy IN, Gao Y, Teng Z, Willemse J, Middelkamp M, van Rosmalen MGM, Larsen PWB, van der Wel NN, Wuite GJL, Roos WH, Hamoen LW.",Proc Natl Acad Sci U S A. 2021 Jan 12;118(2):e2002635118. doi: 10.1073/pnas.2002635118.,Wenzel M,Proc Natl Acad Sci U S A,2021,14/1/2021,PMC7812789,,10.1073/pnas.2002635118,FtsZ
30478085,Direct Interaction between the Two Z Ring Membrane Anchors FtsA and ZipA,"Vega DE, Margolin W.",J Bacteriol. 2019 Jan 28;201(4):e00579-18. doi: 10.1128/JB.00579-18. Print 2019 Feb 15.,Vega DE,J Bacteriol,2019,28/11/2018,PMC6351747,,10.1128/JB.00579-18,FtsZ
32456552,C-terminal eYFP fusion impairs Escherichia coli MinE function,"Palanisamy N, Öztürk MA, Akmeriç EB, Di Ventura B.",Open Biol. 2020 May;10(5):200010. doi: 10.1098/rsob.200010. Epub 2020 May 27.,Palanisamy N,Open Biol,2020,28/5/2020,PMC7276532,,10.1098/rsob.200010,FtsZ
35704023,DNA damage-induced block of sporulation in Streptomyces venezuelae involves downregulation of ssgB,"Falguera JVT, Stratton KJ, Bush MJ, Jani C, Findlay KC, Nodwell JR, Schlimpert S.",Microbiology (Reading). 2022 Jun;168(6). doi: 10.1099/mic.0.001198.,Falguera JVT,Microbiology (Reading),2022,15/6/2022,,,10.1099/mic.0.001198,FtsZ
36304570,Outer membrane-anchoring enables LpoB to regulate peptidoglycan synthesis rate,"Kermani AA, Biboy J, Vollmer D, Vollmer W.",Cell Surf. 2022 Oct 20;8:100086. doi: 10.1016/j.tcsw.2022.100086. eCollection 2022 Dec.,Kermani AA,Cell Surf,2022,28/10/2022,PMC9593243,,10.1016/j.tcsw.2022.100086,FtsZ
31984664,Mechanistic insight into the effect of BT-benzo-29 on the Z-ring in Bacillus subtilis,"Kunal K, Tiwari R, Dhaked HPS, Surolia A, Panda D.",IUBMB Life. 2020 May;72(5):978-990. doi: 10.1002/iub.2234. Epub 2020 Jan 26.,Kunal K,IUBMB Life,2020,28/1/2020,,,10.1002/iub.2234,FtsZ
32173527,SulA is able to block cell division in Escherichia coli by a mechanism different from sequestration,"Vedyaykin A, Rumyantseva N, Khodorkovskii M, Vishnyakov I.",Biochem Biophys Res Commun. 2020 May 14;525(4):948-953. doi: 10.1016/j.bbrc.2020.03.012. Epub 2020 Mar 12.,Vedyaykin A,Biochem Biophys Res Commun,2020,17/3/2020,,,10.1016/j.bbrc.2020.03.012,FtsZ
31925496,"SosA in Staphylococci: an addition to the paradigm of membrane-localized, SOS-induced cell division inhibition in bacteria","Bojer MS, Frees D, Ingmer H.",Curr Genet. 2020 Jun;66(3):495-499. doi: 10.1007/s00294-019-01052-z. Epub 2020 Jan 10.,Bojer MS,Curr Genet,2020,12/1/2020,,,10.1007/s00294-019-01052-z,FtsZ
35590245,Localization of EccA(3) at the growing pole in Mycobacterium smegmatis,"Kriel NL, Newton-Foot M, Bennion OT, Aldridge BB, Mehaffy C, Belisle JT, Walzl G, Warren RM, Sampson SL, Gey van Pittius NC.",BMC Microbiol. 2022 May 19;22(1):140. doi: 10.1186/s12866-022-02554-6.,Kriel NL,BMC Microbiol,2022,19/5/2022,PMC9118679,,10.1186/s12866-022-02554-6,FtsZ
35038905,lon Deletion Impairs Persister Cell Resuscitation in Escherichia coli,"Mohiuddin SG, Massahi A, Orman MA.",mBio. 2022 Feb 22;13(1):e0218721. doi: 10.1128/mbio.02187-21. Epub 2022 Jan 18.,Mohiuddin SG,mBio,2022,18/1/2022,PMC8764555,,10.1128/mbio.02187-21,FtsZ
36243816,"In vitro assembly, positioning and contraction of a division ring in minimal cells","Kohyama S, Merino-Salomón A, Schwille P.",Nat Commun. 2022 Oct 15;13(1):6098. doi: 10.1038/s41467-022-33679-x.,Kohyama S,Nat Commun,2022,15/10/2022,PMC9569390,,10.1038/s41467-022-33679-x,FtsZ
31456563,Surface-to-volume scaling and aspect ratio preservation in rod-shaped bacteria,"Ojkic N, Serbanescu D, Banerjee S.",Elife. 2019 Aug 28;8:e47033. doi: 10.7554/eLife.47033.,Ojkic N,Elife,2019,29/8/2019,PMC6742476,,10.7554/eLife.47033,FtsZ
32133408,Nitric oxide disrupts bacterial cytokinesis by poisoning purine metabolism,"Jones-Carson J, Yahashiri A, Kim JS, Liu L, Fitzsimmons LF, Weiss DS, Vázquez-Torres A.",Sci Adv. 2020 Feb 26;6(9):eaaz0260. doi: 10.1126/sciadv.aaz0260. eCollection 2020 Feb.,Jones-Carson J,Sci Adv,2020,6/3/2020,PMC7043908,,10.1126/sciadv.aaz0260,FtsZ
36087777,"Membrane Tethering of SepF, a Membrane Anchor for the Mycobacterium tuberculosis Z-ring","Dey S, Zhou HX.",J Mol Biol. 2022 Sep 8;434(21):167817. doi: 10.1016/j.jmb.2022.167817. Online ahead of print.,Dey S,J Mol Biol,2022,10/9/2022,PMC9992448,NIHMS1841167,10.1016/j.jmb.2022.167817,FtsZ
34904333,Experimental evolution of Pseudomonas putida under silver ion versus nanoparticle stress,"Dong F, Quevedo AC, Wang X, Valsami-Jones E, Kreft JU.",Environ Microbiol. 2022 Feb;24(2):905-918. doi: 10.1111/1462-2920.15854. Epub 2021 Dec 13.,Dong F,Environ Microbiol,2022,14/12/2021,,,10.1111/1462-2920.15854,FtsZ
33288679,Degradation of MinD oscillator complexes by Escherichia coli ClpXP,"LaBreck CJ, Trebino CE, Ferreira CN, Morrison JJ, DiBiasio EC, Conti J, Camberg JL.",J Biol Chem. 2021 Jan-Jun;296:100162. doi: 10.1074/jbc.RA120.013866. Epub 2020 Dec 10.,LaBreck CJ,J Biol Chem,2021,8/12/2020,PMC7857489,,10.1074/jbc.RA120.013866,FtsZ
32423647,Computational analysis of filament polymerization dynamics in cytoskeletal networks,"Caldas P, Radler P, Sommer C, Loose M.",Methods Cell Biol. 2020;158:145-161. doi: 10.1016/bs.mcb.2020.01.006. Epub 2020 Feb 27.,Caldas P,Methods Cell Biol,2020,20/5/2020,,,10.1016/bs.mcb.2020.01.006,FtsZ
35333570,Structure and dynamics of Odinarchaeota tubulin and the implications for eukaryotic microtubule evolution,"Akıl C, Ali S, Tran LT, Gaillard J, Li W, Hayashida K, Hirose M, Kato T, Oshima A, Fujishima K, Blanchoin L, Narita A, Robinson RC.",Sci Adv. 2022 Mar 25;8(12):eabm2225. doi: 10.1126/sciadv.abm2225. Epub 2022 Mar 25.,Akıl C,Sci Adv,2022,25/3/2022,PMC8956254,,10.1126/sciadv.abm2225,FtsZ
36289351,Membrane mediated phase separation of the bacterial nucleoid occlusion protein Noc,"Babl L, Merino-Salomón A, Kanwa N, Schwille P.",Sci Rep. 2022 Oct 26;12(1):17949. doi: 10.1038/s41598-022-22680-5.,Babl L,Sci Rep,2022,26/10/2022,PMC9606368,,10.1038/s41598-022-22680-5,FtsZ
36123441,Bacterial divisome protein FtsA forms curved antiparallel double filaments when binding to FtsN,"Nierhaus T, McLaughlin SH, Bürmann F, Kureisaite-Ciziene D, Maslen SL, Skehel JM, Yu CWH, Freund SMV, Funke LFH, Chin JW, Löwe J.",Nat Microbiol. 2022 Oct;7(10):1686-1701. doi: 10.1038/s41564-022-01206-9. Epub 2022 Sep 19.,Nierhaus T,Nat Microbiol,2022,19/9/2022,PMC7613929,EMS151223,10.1038/s41564-022-01206-9,FtsZ
30994433,"Vibrio albus sp. nov., isolated from marine sediment","Li CM, Wang NN, Zhou LY, Wang XP, Chen GJ, Du ZJ.",Int J Syst Evol Microbiol. 2019 Jul;69(7):1919-1925. doi: 10.1099/ijsem.0.003402. Epub 2019 Apr 17.,Li CM,Int J Syst Evol Microbiol,2019,18/4/2019,,,10.1099/ijsem.0.003402,FtsZ
33477474,Core and Accessory Genome Analysis of Vibrio mimicus,"Guardiola-Avila I, Sánchez-Busó L, Acedo-Félix E, Gomez-Gil B, Zúñiga-Cabrera M, González-Candelas F, Noriega-Orozco L.",Microorganisms. 2021 Jan 18;9(1):191. doi: 10.3390/microorganisms9010191.,Guardiola-Avila I,Microorganisms,2021,22/1/2021,PMC7831076,,10.3390/microorganisms9010191,FtsZ
30934309,Tubulation pattern of membrane vesicles coated with biofilaments,"Kumar G, Ramakrishnan N, Sain A.",Phys Rev E. 2019 Feb;99(2-1):022414. doi: 10.1103/PhysRevE.99.022414.,Kumar G,Phys Rev E,2019,3/4/2019,,,10.1103/PhysRevE.99.022414,FtsZ
30693575,Agrobacterium tumefaciens divisome proteins regulate the transition from polar growth to cell division,"Howell M, Aliashkevich A, Sundararajan K, Daniel JJ, Lariviere PJ, Goley ED, Cava F, Brown PJB.",Mol Microbiol. 2019 Apr;111(4):1074-1092. doi: 10.1111/mmi.14212. Epub 2019 Mar 4.,Howell M,Mol Microbiol,2019,30/1/2019,PMC6482847,NIHMS1008448,10.1111/mmi.14212,FtsZ
36593202,[Effect of exogenous CdS nanoparticle on the growth of Escherichia coli],"Wang J, Yang Y, Cui D, Zhao M.",Sheng Wu Gong Cheng Xue Bao. 2022 Dec 25;38(12):4681-4691. doi: 10.13345/j.cjb.210880.,Wang J,Sheng Wu Gong Cheng Xue Bao,2022,2/1/2023,,,10.13345/j.cjb.210880,FtsZ
32434840,Interactions of PatA with the Divisome during Heterocyst Differentiation in Anabaena,"Valladares A, Velázquez-Suárez C, Herrero A.",mSphere. 2020 May 20;5(3):e00188-20. doi: 10.1128/mSphere.00188-20.,Valladares A,mSphere,2020,22/5/2020,PMC7380572,,10.1128/mSphere.00188-20,FtsZ
34489908,Hyperosmotic Shock Transiently Accelerates Constriction Rate in Escherichia coli,"Sun J, Shi H, Huang KC.",Front Microbiol. 2021 Aug 13;12:718600. doi: 10.3389/fmicb.2021.718600. eCollection 2021.,Sun J,Front Microbiol,2021,7/9/2021,PMC8418109,,10.3389/fmicb.2021.718600,FtsZ
32811832,Geometric principles underlying the proliferation of a model cell system,"Wu LJ, Lee S, Park S, Eland LE, Wipat A, Holden S, Errington J.",Nat Commun. 2020 Aug 18;11(1):4149. doi: 10.1038/s41467-020-17988-7.,Wu LJ,Nat Commun,2020,20/8/2020,PMC7434903,,10.1038/s41467-020-17988-7,FtsZ
34232633,Orthogonal Degron System for Controlled Protein Degradation in Cyanobacteria,"Sakkos JK, Hernandez-Ortiz S, Osteryoung KW, Ducat DC.",ACS Synth Biol. 2021 Jul 16;10(7):1667-1681. doi: 10.1021/acssynbio.1c00035. Epub 2021 Jul 7.,Sakkos JK,ACS Synth Biol,2021,7/7/2021,,,10.1021/acssynbio.1c00035,FtsZ
32839512,"Circadian clock-controlled gene expression in co-cultured, mat-forming cyanobacteria","Hörnlein C, Confurius-Guns V, Grego M, Stal LJ, Bolhuis H.",Sci Rep. 2020 Aug 24;10(1):14095. doi: 10.1038/s41598-020-69294-3.,Hörnlein C,Sci Rep,2020,26/8/2020,PMC7445270,,10.1038/s41598-020-69294-3,FtsZ
32873767,The Nucleoid Occlusion Protein SlmA Binds to Lipid Membranes,"Robles-Ramos MÁ, Margolin W, Sobrinos-Sanguino M, Alfonso C, Rivas G, Monterroso B, Zorrilla S.",mBio. 2020 Sep 1;11(5):e02094-20. doi: 10.1128/mBio.02094-20.,Robles-Ramos MÁ,mBio,2020,3/9/2020,PMC7468209,,10.1128/mBio.02094-20,FtsZ
36840189,Improvements for Tissue-Chopping-Based Immunofluorescence Staining Method of Chloroplast Proteins,"Wang L, Chen Y, Niu D, Tang M, An J, Xue S, Liu X, Gao H.",Plants (Basel). 2023 Feb 13;12(4):841. doi: 10.3390/plants12040841.,Wang L,Plants (Basel),2023,25/2/2023,PMC9963192,,10.3390/plants12040841,FtsZ
33737746,Single-molecule imaging reveals that Z-ring condensation is essential for cell division in Bacillus subtilis,"Squyres GR, Holmes MJ, Barger SR, Pennycook BR, Ryan J, Yan VT, Garner EC.",Nat Microbiol. 2021 May;6(5):553-562. doi: 10.1038/s41564-021-00878-z. Epub 2021 Mar 18.,Squyres GR,Nat Microbiol,2021,19/3/2021,PMC8085161,NIHMS1673288,10.1038/s41564-021-00878-z,FtsZ
33794350,Wolbachia supergroup E found in Hypochthonius rufulus (Acari: Oribatida) in Poland,"Konecka E, Olszanowski Z.",Infect Genet Evol. 2021 Jul;91:104829. doi: 10.1016/j.meegid.2021.104829. Epub 2021 Mar 29.,Konecka E,Infect Genet Evol,2021,1/4/2021,,,10.1016/j.meegid.2021.104829,FtsZ
35370694,Natural Antibacterial and Antivirulence Alkaloids From Macleaya cordata Against Methicillin-Resistant Staphylococcus aureus,"Liu ZH, Wang WM, Zhang Z, Sun L, Wu SC.",Front Pharmacol. 2022 Mar 17;13:813172. doi: 10.3389/fphar.2022.813172. eCollection 2022.,Liu ZH,Front Pharmacol,2022,4/4/2022,PMC8968424,,10.3389/fphar.2022.813172,FtsZ
34103513,The archaeal protein SepF is essential for cell division in Haloferax volcanii,"Nußbaum P, Gerstner M, Dingethal M, Erb C, Albers SV.",Nat Commun. 2021 Jun 8;12(1):3469. doi: 10.1038/s41467-021-23686-9.,Nußbaum P,Nat Commun,2021,9/6/2021,PMC8187382,,10.1038/s41467-021-23686-9,FtsZ
30792100,Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action,"Cai S, Yuan W, Li Y, Huang X, Guo Q, Tang Z, Fang Z, Lin H, Wong WL, Wong KY, Lu YJ, Sun N.",Bioorg Med Chem. 2019 Apr 1;27(7):1274-1282. doi: 10.1016/j.bmc.2019.02.024. Epub 2019 Feb 14.,Cai S,Bioorg Med Chem,2019,23/2/2019,,,10.1016/j.bmc.2019.02.024,FtsZ
35687096,Comprehensive analysis of PNA-based antisense antibiotics targeting various essential genes in uropathogenic Escherichia coli,"Popella L, Jung J, Do PT, Hayward RJ, Barquist L, Vogel J.",Nucleic Acids Res. 2022 Jun 24;50(11):6435-6452. doi: 10.1093/nar/gkac362.,Popella L,Nucleic Acids Res,2022,10/6/2022,PMC9226493,,10.1093/nar/gkac362,FtsZ
36671519,Diversity and Potential Multifunctionality of Archaeal CetZ Tubulin-like Cytoskeletal Proteins,"Brown HJ, Duggin IG.",Biomolecules. 2023 Jan 9;13(1):134. doi: 10.3390/biom13010134.,Brown HJ,Biomolecules,2023,21/1/2023,PMC9856176,,10.3390/biom13010134,FtsZ
33812992,The Arabidopsis thaliana chloroplast division protein FtsZ1 counterbalances FtsZ2 filament stability in vitro,"Porter KJ, Cao L, Chen Y, TerBush AD, Chen C, Erickson HP, Osteryoung KW.",J Biol Chem. 2021 Jan-Jun;296:100627. doi: 10.1016/j.jbc.2021.100627. Epub 2021 Apr 2.,Porter KJ,J Biol Chem,2021,4/4/2021,PMC8142252,,10.1016/j.jbc.2021.100627,FtsZ
35499319,TnFLXopen: Markerless Transposons for Functional Fluorescent Fusion Proteins and Protein Interaction Prediction,"Dempwolff F, Kearns DB.",Microbiol Spectr. 2022 Jun 29;10(3):e0242821. doi: 10.1128/spectrum.02428-21. Epub 2022 May 2.,Dempwolff F,Microbiol Spectr,2022,2/5/2022,PMC9241775,,10.1128/spectrum.02428-21,FtsZ
31104932,Mechanistic Origin of Cell-Size Control and Homeostasis in Bacteria,"Si F, Le Treut G, Sauls JT, Vadia S, Levin PA, Jun S.",Curr Biol. 2019 Jun 3;29(11):1760-1770.e7. doi: 10.1016/j.cub.2019.04.062. Epub 2019 May 16.,Si F,Curr Biol,2019,21/5/2019,PMC6548602,NIHMS1528322,10.1016/j.cub.2019.04.062,FtsZ
30602584,In Vivo Imaging of the Segregation of the 2 Chromosomes and the Cell Division Proteins of Rhodobacter sphaeroides Reveals an Unexpected Role for MipZ,"Dubarry N, Willis CR, Ball G, Lesterlin C, Armitage JP.",mBio. 2019 Jan 2;10(1):e02515-18. doi: 10.1128/mBio.02515-18.,Dubarry N,mBio,2019,4/1/2019,PMC6315104,,10.1128/mBio.02515-18,FtsZ
34045745,Modification of cell wall polysaccharide guides cell division in Streptococcus mutans,"Zamakhaeva S, Chaton CT, Rush JS, Ajay Castro S, Kenner CW, Yarawsky AE, Herr AB, van Sorge NM, Dorfmueller HC, Frolenkov GI, Korotkov KV, Korotkova N.",Nat Chem Biol. 2021 Aug;17(8):878-887. doi: 10.1038/s41589-021-00803-9. Epub 2021 May 27.,Zamakhaeva S,Nat Chem Biol,2021,28/5/2021,PMC8403489,NIHMS1724957,10.1038/s41589-021-00803-9,FtsZ
34018921,Asymmetric localization of the cell division machinery during Bacillus subtilis sporulation,"Khanna K, Lopez-Garrido J, Sugie J, Pogliano K, Villa E.",Elife. 2021 May 21;10:e62204. doi: 10.7554/eLife.62204.,Khanna K,Elife,2021,21/5/2021,PMC8192124,,10.7554/eLife.62204,FtsZ
30013214,Dissipative adaptation in driven self-assembly leading to self-dividing fibrils,"Te Brinke E, Groen J, Herrmann A, Heus HA, Rivas G, Spruijt E, Huck WTS.",Nat Nanotechnol. 2018 Sep;13(9):849-855. doi: 10.1038/s41565-018-0192-1. Epub 2018 Jul 16.,Te Brinke E,Nat Nanotechnol,2018,18/7/2018,,,10.1038/s41565-018-0192-1,FtsZ
35887146,Targeting the Achilles' Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide,"Sionov RV, Banerjee S, Bogomolov S, Smoum R, Mechoulam R, Steinberg D.",Int J Mol Sci. 2022 Jul 14;23(14):7798. doi: 10.3390/ijms23147798.,Sionov RV,Int J Mol Sci,2022,27/7/2022,PMC9319909,,10.3390/ijms23147798,FtsZ
30295028,Light-Induced Printing of Protein Structures on Membranes in Vitro,"Jia H, Kai L, Heymann M, García-Soriano DA, Härtel T, Schwille P.",Nano Lett. 2018 Nov 14;18(11):7133-7140. doi: 10.1021/acs.nanolett.8b03187. Epub 2018 Oct 10.,Jia H,Nano Lett,2018,9/10/2018,,,10.1021/acs.nanolett.8b03187,FtsZ
32656177,"Synthesis and Antimycobacterial Activity of 2,5-Disubstituted and 1,2,5-Trisubstituted Benzimidazoles","Jiménez-Juárez R, Cruz-Chávez W, de Jesús-Ramírez N, Castro-Ramírez GI, Uribe-González I, Martínez-Mejía G, Ruiz-Nicolás R, Aguirre-Alvarado C, Castrejón-Jiménez NS, García-Pérez BE.",Front Chem. 2020 Jun 19;8:433. doi: 10.3389/fchem.2020.00433. eCollection 2020.,Jiménez-Juárez R,Front Chem,2020,14/7/2020,PMC7325987,,10.3389/fchem.2020.00433,FtsZ
36421120,Global Regulator AdpA_1075 Regulates Morphological Differentiation and Ansamitocin Production in Actinosynnema pretiosum subsp. auranticum,"Guo S, Leng T, Sun X, Zheng J, Li R, Chen J, Hu F, Liu F, Hua Q.",Bioengineering (Basel). 2022 Nov 21;9(11):719. doi: 10.3390/bioengineering9110719.,Guo S,Bioengineering (Basel),2022,24/11/2022,PMC9687425,,10.3390/bioengineering9110719,FtsZ
34643449,Greenhead (Tabanus nigrovittatus) Wolbachia and Its Microbiome: A Preliminary Study,"Lefoulon E, Truchon A, Clark T, Long C, Frey D, Slatko BE.",Microbiol Spectr. 2021 Oct 31;9(2):e0051721. doi: 10.1128/Spectrum.00517-21. Epub 2021 Oct 13.,Lefoulon E,Microbiol Spectr,2021,13/10/2021,PMC8515936,,10.1128/Spectrum.00517-21,FtsZ
36106080,Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division,"Chai WC, Whittall JJ, Polyak SW, Foo K, Li X, Dutschke CJ, Ogunniyi AD, Ma S, Sykes MJ, Semple SJ, Venter H.",Front Microbiol. 2022 Aug 29;13:967949. doi: 10.3389/fmicb.2022.967949. eCollection 2022.,Chai WC,Front Microbiol,2022,15/9/2022,PMC9465178,,10.3389/fmicb.2022.967949,FtsZ
31919386,Non-essentiality of canonical cell division genes in the planctomycete Planctopirus limnophila,"Rivas-Marin E, Peeters SH, Claret Fernández L, Jogler C, van Niftrik L, Wiegand S, Devos DP.",Sci Rep. 2020 Jan 9;10(1):66. doi: 10.1038/s41598-019-56978-8.,Rivas-Marin E,Sci Rep,2020,11/1/2020,PMC6952346,,10.1038/s41598-019-56978-8,FtsZ
37090588,Widespread PRC barrel proteins play critical roles in archaeal cell division,"Zhao S, Makarova KS, Zheng W, Liu Y, Zhan L, Wan Q, Gong H, Krupovic M, Lutkenhaus J, Chen X, Koonin EV, Du S.",bioRxiv. 2023 Mar 28:2023.03.28.534520. doi: 10.1101/2023.03.28.534520. Preprint.,Zhao S,bioRxiv,2023,24/4/2023,PMC10120694,,10.1101/2023.03.28.534520,FtsZ
31074603,Shape and Size Control of Artificial Cells for Bottom-Up Biology,"Fanalista F, Birnie A, Maan R, Burla F, Charles K, Pawlik G, Deshpande S, Koenderink GH, Dogterom M, Dekker C.",ACS Nano. 2019 May 28;13(5):5439-5450. doi: 10.1021/acsnano.9b00220. Epub 2019 May 16.,Fanalista F,ACS Nano,2019,11/5/2019,PMC6543616,,10.1021/acsnano.9b00220,FtsZ
35575547,A Silent Operon of Photorhabdus luminescens Encodes a Prodrug Mimic of GTP,"Shahsavari N, Wang B, Imai Y, Mori M, Son S, Liang L, Böhringer N, Manuse S, Gates MF, Morrissette M, Corsetti R, Espinoza JL, Dupont CL, Laub MT, Lewis K.",mBio. 2022 Jun 28;13(3):e0070022. doi: 10.1128/mbio.00700-22. Epub 2022 May 16.,Shahsavari N,mBio,2022,16/5/2022,PMC9239236,,10.1128/mbio.00700-22,FtsZ
35297088,Structure-based virtual screening and biological evaluation of novel inhibitors of mycobacterium Z-ring formation,"Alexey R, Dariya S, Liudmyla I, Lilia V, Valeriy M, Dmytro L, Oleksandr B, Svitlana S, Sergii O, Elijah B, Mariia S, Yaroslav B, Pavel K.",J Cell Biochem. 2022 May;123(5):852-862. doi: 10.1002/jcb.30232. Epub 2022 Mar 16.,Alexey R,J Cell Biochem,2022,17/3/2022,,,10.1002/jcb.30232,FtsZ
31238181,"Antibacterial activity of 3,3'-dihydroxycurcumin (DHC) is associated with membrane perturbation","Polaquini CR, Morão LG, Nazaré AC, Torrezan GS, Dilarri G, Cavalca LB, Campos DL, Silva IC, Pereira JA, Scheffers DJ, Duque C, Pavan FR, Ferreira H, Regasini LO.",Bioorg Chem. 2019 Sep;90:103031. doi: 10.1016/j.bioorg.2019.103031. Epub 2019 Jun 7.,Polaquini CR,Bioorg Chem,2019,26/6/2019,,,10.1016/j.bioorg.2019.103031,FtsZ
32781386,A microgravity responsive synthetic genetic device in Escherichia coli,"Mukhopadhyay S, Bagh S.",Biosens Bioelectron. 2020 Nov 1;167:112462. doi: 10.1016/j.bios.2020.112462. Epub 2020 Aug 1.,Mukhopadhyay S,Biosens Bioelectron,2020,12/8/2020,,,10.1016/j.bios.2020.112462,FtsZ
30869785,Evidence for the natural occurrence of Wolbachia in Aedes aegypti mosquitoes,"Balaji S, Jayachandran S, Prabagaran SR.",FEMS Microbiol Lett. 2019 Mar 1;366(6):fnz055. doi: 10.1093/femsle/fnz055.,Balaji S,FEMS Microbiol Lett,2019,15/3/2019,,,10.1093/femsle/fnz055,FtsZ
35173244,Antibacterial action and target mechanisms of zinc oxide nanoparticles against bacterial pathogens,"Mendes CR, Dilarri G, Forsan CF, Sapata VMR, Lopes PRM, de Moraes PB, Montagnolli RN, Ferreira H, Bidoia ED.",Sci Rep. 2022 Feb 16;12(1):2658. doi: 10.1038/s41598-022-06657-y.,Mendes CR,Sci Rep,2022,17/2/2022,PMC8850488,,10.1038/s41598-022-06657-y,FtsZ
35506695,RefZ and Noc Act Synthetically to Prevent Aberrant Divisions during Bacillus subtilis Sporulation,"Miller AK, Herman JK.",J Bacteriol. 2022 Jun 21;204(6):e0002322. doi: 10.1128/jb.00023-22. Epub 2022 May 4.,Miller AK,J Bacteriol,2022,4/5/2022,PMC9210962,,10.1128/jb.00023-22,FtsZ
30202647,A bioinformatics approach to identifying Wolbachia infections in arthropods,"Pascar J, Chandler CH.",PeerJ. 2018 Sep 3;6:e5486. doi: 10.7717/peerj.5486. eCollection 2018.,Pascar J,PeerJ,2018,12/9/2018,PMC6126470,,10.7717/peerj.5486,FtsZ
34896287,Molecular survey and genetic diversity of Bartonella spp. in domestic cats from Paraguay,"Sepúlveda-García P, Pérez-Macchi S, Gonçalves LR, do Amaral RB, Bittencourt P, André MR, Muller A.",Infect Genet Evol. 2022 Jan;97:105181. doi: 10.1016/j.meegid.2021.105181. Epub 2021 Dec 9.,Sepúlveda-García P,Infect Genet Evol,2022,13/12/2021,,,10.1016/j.meegid.2021.105181,FtsZ
29729679,Bartonella vinsonii subsp. berkhoffii and B. henselae in dogs,"Müller A, Soto F, Sepúlveda M, Bittencourt P, Benevenute JL, Ikeda P, Machado RZ, André MR.",Epidemiol Infect. 2018 Jul;146(9):1202-1204. doi: 10.1017/S0950268818001127. Epub 2018 May 6.,Müller A,Epidemiol Infect,2018,7/5/2018,PMC9134356,,10.1017/S0950268818001127,FtsZ
31182798,RocS drives chromosome segregation and nucleoid protection in Streptococcus pneumoniae,"Mercy C, Ducret A, Slager J, Lavergne JP, Freton C, Nagarajan SN, Garcia PS, Noirot-Gros MF, Dubarry N, Nourikyan J, Veening JW, Grangeasse C.",Nat Microbiol. 2019 Oct;4(10):1661-1670. doi: 10.1038/s41564-019-0472-z. Epub 2019 Jun 10.,Mercy C,Nat Microbiol,2019,12/6/2019,PMC7611331,EMS129546,10.1038/s41564-019-0472-z,FtsZ
35335270,Inhibition of Filamentous Thermosensitive Mutant-Z Protein in Bacillus subtilis by Cyanobacterial Bioactive Compounds,"Gurnani M, Rath P, Chauhan A, Ranjan A, Ghosh A, Lal R, Mukerjee N, Aljarba NH, Alkahtani S, Rajput VD, Sushkova S, Prazdnova EV, Minkina T, Jindal T.",Molecules. 2022 Mar 15;27(6):1907. doi: 10.3390/molecules27061907.,Gurnani M,Molecules,2022,26/3/2022,PMC8948890,,10.3390/molecules27061907,FtsZ
29722581,Antibacterial activity of 3-methylbenzo[d]thiazol-methylquinolinium derivatives and study of their action mechanism,"Sun N, Du RL, Zheng YY, Guo Q, Cai SY, Liu ZH, Fang ZY, Yuan WC, Liu T, Li XM, Lu YJ, Wong KY.",J Enzyme Inhib Med Chem. 2018 Dec;33(1):879-889. doi: 10.1080/14756366.2018.1465055.,Sun N,J Enzyme Inhib Med Chem,2018,4/5/2018,PMC6010097,,10.1080/14756366.2018.1465055,FtsZ
30832265,Regeneration of Escherichia coli Giant Protoplasts to Their Original Form,"Tabata KV, Sogo T, Moriizumi Y, Noji H.",Life (Basel). 2019 Mar 1;9(1):24. doi: 10.3390/life9010024.,Tabata KV,Life (Basel),2019,6/3/2019,PMC6463199,,10.3390/life9010024,FtsZ
34253066,HetF Protein Is a New Divisome Component in a Filamentous and Developmental Cyanobacterium,"Xing WY, Liu J, Wang ZQ, Zhang JY, Zeng X, Yang Y, Zhang CC.",mBio. 2021 Aug 31;12(4):e0138221. doi: 10.1128/mBio.01382-21. Epub 2021 Jul 13.,Xing WY,mBio,2021,13/7/2021,PMC8406250,,10.1128/mBio.01382-21,FtsZ
33561747,"The study of 9,10-dihydroacridine derivatives as a new and effective molecular scaffold for antibacterial agent development","Chen CC, Zhang YQ, Zhong DX, Huang XH, Zhang YH, Jiang WH, Li M, Chen Q, Wong WL, Lu YJ.",Biochem Biophys Res Commun. 2021 Mar 26;546:40-45. doi: 10.1016/j.bbrc.2021.01.096. Epub 2021 Feb 6.,Chen CC,Biochem Biophys Res Commun,2021,9/2/2021,,,10.1016/j.bbrc.2021.01.096,FtsZ
33077634,Bacteriophage SP01 Gene Product 56 Inhibits Bacillus subtilis Cell Division by Interacting with FtsL and Disrupting Pbp2B and FtsW Recruitment,"Bhambhani A, Iadicicco I, Lee J, Ahmed S, Belfatto M, Held D, Marconi A, Parks A, Stewart CR, Margolin W, Levin PA, Haeusser DP.",J Bacteriol. 2020 Dec 18;203(2):e00463-20. doi: 10.1128/JB.00463-20. Print 2020 Dec 18.,Bhambhani A,J Bacteriol,2020,20/10/2020,PMC7950406,,10.1128/JB.00463-20,FtsZ
34019789,Chemical-genetic interrogation of RNA polymerase mutants reveals structure-function relationships and physiological tradeoffs,"Shiver AL, Osadnik H, Peters JM, Mooney RA, Wu PI, Henry KK, Braberg H, Krogan NJ, Hu JC, Landick R, Huang KC, Gross CA.",Mol Cell. 2021 May 20;81(10):2201-2215.e9. doi: 10.1016/j.molcel.2021.04.027.,Shiver AL,Mol Cell,2021,21/5/2021,PMC8484514,NIHMS1715604,10.1016/j.molcel.2021.04.027,FtsZ
35515309,Antibacterial activity and mechanism of action of a thiophenyl substituted pyrimidine derivative,"Fang Z, Li Y, Zheng Y, Li X, Lu YJ, Yan SC, Wong WL, Chan KF, Wong KY, Sun N.",RSC Adv. 2019 Apr 5;9(19):10739-10744. doi: 10.1039/c9ra01001g. eCollection 2019 Apr 3.,Fang Z,RSC Adv,2019,6/5/2022,PMC9062536,,10.1039/c9ra01001g,FtsZ
37167075,"Vibrio eleionomae sp. nov., isolated from shrimp (Penaeus vannamei) pond water","Enciso-Ibarra J, Roque A, Bolán-Mejia C, Enciso-Ibarra K, González-Castillo A, Gomez-Gil B.",Int J Syst Evol Microbiol. 2023 May;73(5). doi: 10.1099/ijsem.0.005866.,Enciso-Ibarra J,Int J Syst Evol Microbiol,2023,11/5/2023,,,10.1099/ijsem.0.005866,FtsZ
31166018,Cryo-EM structure of the MinCD copolymeric filament from Pseudomonas aeruginosa at 3.1 Å resolution,"Szewczak-Harris A, Wagstaff J, Löwe J.",FEBS Lett. 2019 Aug;593(15):1915-1926. doi: 10.1002/1873-3468.13471. Epub 2019 Jun 14.,Szewczak-Harris A,FEBS Lett,2019,6/6/2019,PMC6771821,,10.1002/1873-3468.13471,FtsZ
35032606,Attenuation of Enterococcus faecalis biofilm formation by Rhodethrin: A combinatorial study with an antibiotic,"Tatta ER, Kumavath R.",Microb Pathog. 2022 Feb;163:105401. doi: 10.1016/j.micpath.2022.105401. Epub 2022 Jan 13.,Tatta ER,Microb Pathog,2022,15/1/2022,,,10.1016/j.micpath.2022.105401,FtsZ
32783950,Limits and Constraints on Mechanisms of Cell-Cycle Regulation Imposed by Cell Size-Homeostasis Measurements,"Willis L, Jönsson H, Huang KC.",Cell Rep. 2020 Aug 11;32(6):107992. doi: 10.1016/j.celrep.2020.107992.,Willis L,Cell Rep,2020,14/8/2020,,,10.1016/j.celrep.2020.107992,FtsZ
34069707,Molecular Detection of Bartonella quintana among Long-Tailed Macaques (Macaca fascicularis) in Thailand,"Sricharern W, Kaewchot S, Saengsawang P, Kaewmongkol S, Inpankaew T.",Pathogens. 2021 May 19;10(5):629. doi: 10.3390/pathogens10050629.,Sricharern W,Pathogens,2021,2/6/2021,PMC8160695,,10.3390/pathogens10050629,FtsZ
31045565,Novel T9 loop conformation of filamenting temperature-sensitive mutant Z from Mycobacterium tuberculosis,"Lazo EO, Jakoncic J, RoyChowdhury S, Awasthi D, Ojima I.",Acta Crystallogr F Struct Biol Commun. 2019 May 1;75(Pt 5):359-367. doi: 10.1107/S2053230X19004618. Epub 2019 Apr 24.,Lazo EO,Acta Crystallogr F Struct Biol Commun,2019,3/5/2019,PMC6497106,,10.1107/S2053230X19004618,FtsZ
33734087,"PomX, a ParA/MinD ATPase activating protein, is a triple regulator of cell division in Myxococcus xanthus","Schumacher D, Harms A, Bergeler S, Frey E, Søgaard-Andersen L.",Elife. 2021 Mar 18;10:e66160. doi: 10.7554/eLife.66160.,Schumacher D,Elife,2021,18/3/2021,PMC7993993,,10.7554/eLife.66160,FtsZ
31982966,"Photobacterium lucens sp. nov., Isolated from a Cultured Shrimp Penaeus vannamei","Enciso-Ibarra J, González-Castillo A, Soto-Rodriguez SA, Enciso-Ibarra K, Bolán-Mejia C, Gomez-Gil B.",Curr Microbiol. 2020 Jun;77(6):1111-1116. doi: 10.1007/s00284-020-01893-9. Epub 2020 Jan 25.,Enciso-Ibarra J,Curr Microbiol,2020,27/1/2020,,,10.1007/s00284-020-01893-9,FtsZ
35094518,Biomineralized Cascade Enzyme-Encapsulated ZIF-8 Nanoparticles Combined with Antisense Oligonucleotides for Drug-Resistant Bacteria Treatment,"Zhang Y, Lai L, Liu Y, Chen B, Yao J, Zheng P, Pan Q, Zhu W.",ACS Appl Mater Interfaces. 2022 Feb 9;14(5):6453-6464. doi: 10.1021/acsami.1c23808. Epub 2022 Jan 30.,Zhang Y,ACS Appl Mater Interfaces,2022,31/1/2022,,,10.1021/acsami.1c23808,FtsZ
30610286,Morphology engineering for enhanced production of medium-chain-length polyhydroxyalkanoates in Pseudomonas mendocina NK-01,"Zhao F, Gong T, Liu X, Fan X, Huang R, Ma T, Wang S, Gao W, Yang C.",Appl Microbiol Biotechnol. 2019 Feb;103(4):1713-1724. doi: 10.1007/s00253-018-9546-8. Epub 2019 Jan 4.,Zhao F,Appl Microbiol Biotechnol,2019,6/1/2019,,,10.1007/s00253-018-9546-8,FtsZ
34695291,"Bats and their ectoparasites (Nycteribiidae and Spinturnicidae) carry diverse novel Bartonella genotypes, China","Han HJ, Li ZM, Li X, Liu JX, Peng QM, Wang R, Gu XL, Jiang Y, Zhou CM, Li D, Xiao X, Yu XJ.",Transbound Emerg Dis. 2022 Jul;69(4):e845-e858. doi: 10.1111/tbed.14357. Epub 2021 Nov 2.,Han HJ,Transbound Emerg Dis,2022,25/10/2021,PMC9543326,,10.1111/tbed.14357,FtsZ
31331697,Consequences of dosing and timing on the antibacterial effects of ADEP antibiotics,"Mayer C, Sass P, Brötz-Oesterhelt H.",Int J Med Microbiol. 2019 Nov;309(7):151329. doi: 10.1016/j.ijmm.2019.151329. Epub 2019 Jul 14.,Mayer C,Int J Med Microbiol,2019,24/7/2019,,,10.1016/j.ijmm.2019.151329,FtsZ
32096689,Phytophthora capsici PcFtsZ2 Is Required for Asexual Development and Plant Infection,"Li J, Ai C, Yang C, Jiang W, Sheng H, Morris PF, Zhang X.",Mol Plant Microbe Interact. 2020 May;33(5):727-741. doi: 10.1094/MPMI-01-20-0002-R. Epub 2020 Apr 2.,Li J,Mol Plant Microbe Interact,2020,26/2/2020,,,10.1094/MPMI-01-20-0002-R,FtsZ
32365468,The In Vitro Non-Tetramerizing ZapA(I83E) Mutant Is Unable to Recruit ZapB to the Division Plane In Vivo in Escherichia coli,"Meiresonne NY, den Blaauwen T.",Int J Mol Sci. 2020 Apr 29;21(9):3130. doi: 10.3390/ijms21093130.,Meiresonne NY,Int J Mol Sci,2020,6/5/2020,PMC7246612,,10.3390/ijms21093130,FtsZ
34218658,Dysregulation of ClpP by Small-Molecule Activators Used Against Xanthomonas oryzae pv. oryzae Infections,"Yang T, Zhang T, Zhou X, Wang P, Gan J, Song B, Yang S, Yang CG.",J Agric Food Chem. 2021 Jul 14;69(27):7545-7553. doi: 10.1021/acs.jafc.1c01470. Epub 2021 Jul 3.,Yang T,J Agric Food Chem,2021,5/7/2021,,,10.1021/acs.jafc.1c01470,FtsZ
30890709,Simulations suggest a constrictive force is required for Gram-negative bacterial cell division,"Nguyen LT, Oikonomou CM, Ding HJ, Kaplan M, Yao Q, Chang YW, Beeby M, Jensen GJ.",Nat Commun. 2019 Mar 19;10(1):1259. doi: 10.1038/s41467-019-09264-0.,Nguyen LT,Nat Commun,2019,21/3/2019,PMC6425016,,10.1038/s41467-019-09264-0,FtsZ
32579605,ZapE/Afg1 interacts with Oxa1 and its depletion causes a multifaceted phenotype,"Pyrih J, Rašková V, Škodová-Sveráková I, Pánek T, Lukeš J.",PLoS One. 2020 Jun 24;15(6):e0234918. doi: 10.1371/journal.pone.0234918. eCollection 2020.,Pyrih J,PLoS One,2020,25/6/2020,PMC7314023,,10.1371/journal.pone.0234918,FtsZ
30367002,Work Patterns of MamXY Proteins during Magnetosome Formation in Magnetospirillum gryphiswaldense MSR-1,"Wang Q, Wu S, Li X, Zhang T, Yang J, Wang X, Li F, Li Y, Peng Y, Li J.",Appl Environ Microbiol. 2019 Jan 9;85(2):e02394-18. doi: 10.1128/AEM.02394-18. Print 2019 Jan 15.,Wang Q,Appl Environ Microbiol,2019,28/10/2018,PMC6328765,,10.1128/AEM.02394-18,FtsZ
33249680,Protein-protein interaction network and potential drug target candidates of Streptococcus suis,"Tan MF, Zou G, Wei Y, Liu WQ, Li HQ, Hu Q, Zhang LS, Zhou R.",J Appl Microbiol. 2021 Aug;131(2):658-670. doi: 10.1111/jam.14950. Epub 2021 Mar 9.,Tan MF,J Appl Microbiol,2021,29/11/2020,,,10.1111/jam.14950,FtsZ
34776361,Enrichment of membrane curvature-sensing proteins from Escherichia coli using spherical supported lipid bilayers,"Tanaka M, Ueno Y, Miyake T, Sakuma T, Okochi M.",J Biosci Bioeng. 2022 Feb;133(2):98-104. doi: 10.1016/j.jbiosc.2021.10.003. Epub 2021 Nov 11.,Tanaka M,J Biosci Bioeng,2022,15/11/2021,,,10.1016/j.jbiosc.2021.10.003,FtsZ
30742332,Division-site localization of RodZ is required for efficient Z ring formation in Escherichia coli,"Yoshii Y, Niki H, Shiomi D.",Mol Microbiol. 2019 May;111(5):1229-1244. doi: 10.1111/mmi.14217. Epub 2019 Mar 18.,Yoshii Y,Mol Microbiol,2019,12/2/2019,,,10.1111/mmi.14217,FtsZ
35248159,"Phylogenetic relationship between the endosymbiont ""Candidatus Riesia pediculicola"" and its human louse host","Hammoud A, Louni M, Missé D, Cortaredona S, Fenollar F, Mediannikov O.",Parasit Vectors. 2022 Mar 5;15(1):73. doi: 10.1186/s13071-022-05203-z.,Hammoud A,Parasit Vectors,2022,6/3/2022,PMC8898481,,10.1186/s13071-022-05203-z,FtsZ
36180460,FtsN maintains active septal cell wall synthesis by forming a processive complex with the septum-specific peptidoglycan synthases in E. coli,"Lyu Z, Yahashiri A, Yang X, McCausland JW, Kaus GM, McQuillen R, Weiss DS, Xiao J.",Nat Commun. 2022 Sep 30;13(1):5751. doi: 10.1038/s41467-022-33404-8.,Lyu Z,Nat Commun,2022,30/9/2022,PMC9525312,,10.1038/s41467-022-33404-8,FtsZ
30929206,Natural Genetic Transformation: A Direct Route to Easy Insertion of Chimeric Genes into the Pneumococcal Chromosome,"Mortier-Barrière I, Campo N, Bergé MA, Prudhomme M, Polard P.",Methods Mol Biol. 2019;1968:63-78. doi: 10.1007/978-1-4939-9199-0_6.,Mortier-Barrière I,Methods Mol Biol,2019,1/4/2019,,,10.1007/978-1-4939-9199-0_6,FtsZ
30258191,The MinDE system is a generic spatial cue for membrane protein distribution in vitro,"Ramm B, Glock P, Mücksch J, Blumhardt P, García-Soriano DA, Heymann M, Schwille P.",Nat Commun. 2018 Sep 26;9(1):3942. doi: 10.1038/s41467-018-06310-1.,Ramm B,Nat Commun,2018,28/9/2018,PMC6158289,,10.1038/s41467-018-06310-1,FtsZ
34031039,DivIVA Regulates Its Expression and the Orientation of New Septum Growth in Deinococcus radiodurans,"Chaudhary R, Kota S, Misra HS.",J Bacteriol. 2021 Jul 8;203(15):e0016321. doi: 10.1128/JB.00163-21. Epub 2021 Jul 8.,Chaudhary R,J Bacteriol,2021,25/5/2021,PMC8407354,,10.1128/JB.00163-21,FtsZ
33229266,The cytotoxicity of endogenous CdS and Cd(2+) ions during CdS NPs biosynthesis,"Cui D, Wang J, Wang H, Yang Y, Zhao M.",J Hazard Mater. 2021 May 5;409:124485. doi: 10.1016/j.jhazmat.2020.124485. Epub 2020 Nov 7.,Cui D,J Hazard Mater,2021,24/11/2020,,,10.1016/j.jhazmat.2020.124485,FtsZ
36199205,Enzyme 1 of the phosphoenolpyruvate:sugar phosphotransferase system is involved in resistance to MreB disruption in wild-type and ∆envC cells,"Sloan R, Surber J, Roy EJ, Hartig E, Morgenstein RM.",Mol Microbiol. 2022 Nov;118(5):588-600. doi: 10.1111/mmi.14988. Epub 2022 Oct 17.,Sloan R,Mol Microbiol,2022,6/10/2022,PMC9671846,NIHMS1841619,10.1111/mmi.14988,FtsZ
31175681,How FtsEX localizes to the Z ring and interacts with FtsA to regulate cell division,"Du S, Henke W, Pichoff S, Lutkenhaus J.",Mol Microbiol. 2019 Sep;112(3):881-895. doi: 10.1111/mmi.14324. Epub 2019 Jun 20.,Du S,Mol Microbiol,2019,9/6/2019,PMC6831102,NIHMS1034720,10.1111/mmi.14324,FtsZ
35647874,GpsB Coordinates Cell Division and Cell Surface Decoration by Wall Teichoic Acids in Staphylococcus aureus,"Hammond LR, Sacco MD, Khan SJ, Spanoudis C, Hough-Neidig A, Chen Y, Eswara PJ.",Microbiol Spectr. 2022 Jun 29;10(3):e0141322. doi: 10.1128/spectrum.01413-22. Epub 2022 Jun 1.,Hammond LR,Microbiol Spectr,2022,1/6/2022,PMC9241681,,10.1128/spectrum.01413-22,FtsZ
30088771,Inhibiting Methicillin-Resistant Staphylococcus aureus by Tetrahedral DNA Nanostructure-Enabled Antisense Peptide Nucleic Acid Delivery,"Zhang Y, Ma W, Zhu Y, Shi S, Li Q, Mao C, Zhao D, Zhan Y, Shi J, Li W, Wang L, Fan C, Lin Y.",Nano Lett. 2018 Sep 12;18(9):5652-5659. doi: 10.1021/acs.nanolett.8b02166. Epub 2018 Aug 13.,Zhang Y,Nano Lett,2018,9/8/2018,,,10.1021/acs.nanolett.8b02166,FtsZ
35563376,"The SCO2102 Protein Harbouring a DnaA II Protein-Interaction Domain Is Essential for the SCO2103 Methylenetetrahydrofolate Reductase Positioning at Streptomyces Sporulating Hyphae, Enhancing DNA Replication during Sporulation","Fernández-García G, González-Quiñónez N, Rioseras B, Alonso-Fernández S, Fernández J, Lombó F, Manteca Á.",Int J Mol Sci. 2022 Apr 30;23(9):4984. doi: 10.3390/ijms23094984.,Fernández-García G,Int J Mol Sci,2022,14/5/2022,PMC9099993,,10.3390/ijms23094984,FtsZ
31311880,A SpoIID Homolog Cleaves Glycan Strands at the Chlamydial Division Septum,"Jacquier N, Yadav AK, Pillonel T, Viollier PH, Cava F, Greub G.",mBio. 2019 Jul 16;10(4):e01128-19. doi: 10.1128/mBio.01128-19.,Jacquier N,mBio,2019,18/7/2019,PMC6635528,,10.1128/mBio.01128-19,FtsZ
31779160,"Interactions Screenings Unearth Potential New Divisome Components in the Chlamydia-Related Bacterium, Waddlia chondrophila","Bayramova F, Jacquier N, Greub G.",Microorganisms. 2019 Nov 26;7(12):617. doi: 10.3390/microorganisms7120617.,Bayramova F,Microorganisms,2019,30/11/2019,PMC6956297,,10.3390/microorganisms7120617,FtsZ
31024470,Deciphering the Role of a SLOG Superfamily Protein YpsA in Gram-Positive Bacteria,"Brzozowski RS, Huber M, Burroughs AM, Graham G, Walker M, Alva SS, Aravind L, Eswara PJ.",Front Microbiol. 2019 Apr 5;10:623. doi: 10.3389/fmicb.2019.00623. eCollection 2019.,Brzozowski RS,Front Microbiol,2019,27/4/2019,PMC6459960,,10.3389/fmicb.2019.00623,FtsZ
31598014,"Mycopyranone: a 8,8'-binaphthopyranone with potent anti-MRSA activity from the fungus Phialemoniopsis sp","Rivera-Chávez J, Caesar L, Garcia-Salazar JJ, Raja HA, Cech NB, Pearce CJ, Oberlies NH.",Tetrahedron Lett. 2019 Feb 21;60(8):594-597. doi: 10.1016/j.tetlet.2019.01.029. Epub 2019 Jan 17.,Rivera-Chávez J,Tetrahedron Lett,2019,11/10/2019,PMC6785197,NIHMS1519702,10.1016/j.tetlet.2019.01.029,FtsZ
32867174,Viriditoxin Stabilizes Microtubule Polymers in SK-OV-3 Cells and Exhibits Antimitotic and Antimetastatic Potential,"Su M, Zhao C, Li D, Cao J, Ju Z, Kim E, Jung YS, Jung JH.",Mar Drugs. 2020 Aug 27;18(9):445. doi: 10.3390/md18090445.,Su M,Mar Drugs,2020,2/9/2020,PMC7551567,,10.3390/md18090445,FtsZ
29967164,Disruption of divisome assembly rescued by FtsN-FtsA interaction in Escherichia coli,"Pichoff S, Du S, Lutkenhaus J.",Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6855-E6862. doi: 10.1073/pnas.1806450115. Epub 2018 Jul 2.,Pichoff S,Proc Natl Acad Sci U S A,2018,4/7/2018,PMC6055203,,10.1073/pnas.1806450115,FtsZ
31242975,Application of the CRISPRi system to repress sepF expression in Mycobacterium smegmatis,"Xiao J, Jia H, Pan L, Li Z, Lv L, Du B, Zhang L, Du F, Huang Y, Cao T, Sun Q, Wei R, Xing A, Zhang Z.",Infect Genet Evol. 2019 Aug;72:183-190. doi: 10.1016/j.meegid.2018.06.033. Epub 2018 Jul 6.,Xiao J,Infect Genet Evol,2019,28/6/2019,,,10.1016/j.meegid.2018.06.033,FtsZ
33050236,Investigating the Modes of Action of the Antimicrobial Chalcones BC1 and T9A,"Morão LG, Lorenzoni ASG, Chakraborty P, Ayusso GM, Cavalca LB, Santos MB, Marques BC, Dilarri G, Zamuner C, Regasini LO, Ferreira H, Scheffers DJ.",Molecules. 2020 Oct 9;25(20):4596. doi: 10.3390/molecules25204596.,Morão LG,Molecules,2020,14/10/2020,PMC7587203,,10.3390/molecules25204596,FtsZ
34311369,Quantification of pathogens and antibiotic resistance genes in backyard and commercial composts,"Mao Y, Akdeniz N, Nguyen TH.",Sci Total Environ. 2021 Nov 25;797:149197. doi: 10.1016/j.scitotenv.2021.149197. Epub 2021 Jul 21.,Mao Y,Sci Total Environ,2021,26/7/2021,,,10.1016/j.scitotenv.2021.149197,FtsZ
33400639,Influence of core divisome proteins on cell division in Streptomyces venezuelae ATCC 10712,"Cantlay S, Sen BC, Flärdh K, McCormick JR.",Microbiology (Reading). 2021 Feb;167(2):001015. doi: 10.1099/mic.0.001015.,Cantlay S,Microbiology (Reading),2021,5/1/2021,PMC8131025,,10.1099/mic.0.001015,FtsZ
36622232,Construction and Characterization of Functional FtsA Sandwich Fusions for Studies of FtsA Localization and Dynamics during Escherichia coli Cell Division,"Cameron TA, Margolin W.",J Bacteriol. 2023 Jan 26;205(1):e0037322. doi: 10.1128/jb.00373-22. Epub 2023 Jan 9.,Cameron TA,J Bacteriol,2023,9/1/2023,PMC9879108,,10.1128/jb.00373-22,FtsZ
36778425,Eukaryotic-like gephyrin and cognate membrane receptor coordinate corynebacterial cell division and polar elongation,"Martinez M, Petit J, Leyva A, Sogues A, Megrian D, Rodriguez A, Gaday Q, Ben Assaya M, Portela M, Haouz A, Ducret A, Grangeasse C, Alzari PM, Dur N R, Wehenkel A.",bioRxiv. 2023 Feb 1:2023.02.01.526586. doi: 10.1101/2023.02.01.526586. Preprint.,Martinez M,bioRxiv,2023,13/2/2023,PMC9915583,,10.1101/2023.02.01.526586,FtsZ
31811888,Antisense peptide nucleic acids againstftsZ andefaA genes inhibit growth and biofilm formation of Enterococcusfaecalis,"Narenji H, Teymournejad O, Rezaee MA, Taghizadeh S, Mehramuz B, Aghazadeh M, Asgharzadeh M, Madhi M, Gholizadeh P, Ganbarov K, Yousefi M, Pakravan A, Dal T, Ahmadi R, Samadi Kafil H.",Microb Pathog. 2020 Feb;139:103907. doi: 10.1016/j.micpath.2019.103907. Epub 2019 Dec 5.,Narenji H,Microb Pathog,2020,8/12/2019,,,10.1016/j.micpath.2019.103907,FtsZ
32640578,Synthesis and Evaluation of the Antibacterial Activities of 13-Substituted Berberine Derivatives,"Olleik H, Yacoub T, Hoffer L, Gnansounou SM, Benhaiem-Henry K, Nicoletti C, Mekhalfi M, Pique V, Perrier J, Hijazi A, Baydoun E, Raymond J, Piccerelle P, Maresca M, Robin M.",Antibiotics (Basel). 2020 Jul 6;9(7):381. doi: 10.3390/antibiotics9070381.,Olleik H,Antibiotics (Basel),2020,10/7/2020,PMC7400437,,10.3390/antibiotics9070381,FtsZ
31287946,"EzrA, a cell shape regulator contributing to biofilm formation and competitiveness in Streptococcus mutans","Xiang Z, Li Z, Ren Z, Zeng J, Peng X, Li Y, Li J.",Mol Oral Microbiol. 2019 Oct;34(5):194-208. doi: 10.1111/omi.12264. Epub 2019 Jul 22.,Xiang Z,Mol Oral Microbiol,2019,10/7/2019,,,10.1111/omi.12264,FtsZ
31422235,Pdh is involved in the cell division and Normal septation of Streptococcus suis,"Wang Y, Wang Y, Li J, Gong S, Sun L, Grenier D, Li Y.",Microbiol Res. 2019 Nov;228:126304. doi: 10.1016/j.micres.2019.126304. Epub 2019 Aug 2.,Wang Y,Microbiol Res,2019,19/8/2019,,,10.1016/j.micres.2019.126304,FtsZ
33452021,The Ethanologenic Bacterium Zymomonas mobilis Divides Asymmetrically and Exhibits Heterogeneity in DNA Content,"Fuchino K, Chan H, Hwang LC, Bruheim P.",Appl Environ Microbiol. 2021 Feb 26;87(6):e02441-20. doi: 10.1128/AEM.02441-20. Print 2021 Feb 26.,Fuchino K,Appl Environ Microbiol,2021,16/1/2021,PMC8105015,,10.1128/AEM.02441-20,FtsZ
31786246,Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy,"Hotterbeekx A, Raimon S, Abd-Elfarag G, Carter JY, Sebit W, Suliman A, Siewe Fodjo JN, De Witte P, Logora MY, Colebunders R, Kumar-Singh S.",Int J Infect Dis. 2020 Feb;91:119-123. doi: 10.1016/j.ijid.2019.11.029. Epub 2019 Nov 29.,Hotterbeekx A,Int J Infect Dis,2020,2/12/2019,PMC6996151,,10.1016/j.ijid.2019.11.029,FtsZ
32590060,Function analysis of RNase E in the filamentous cyanobacterium Anabaena sp. PCC 7120,"Yan H, Cheng Y, Wang L, Chen W.",Res Microbiol. 2020 Jul-Sep;171(5-6):194-202. doi: 10.1016/j.resmic.2020.06.001. Epub 2020 Jun 23.,Yan H,Res Microbiol,2020,27/6/2020,,,10.1016/j.resmic.2020.06.001,FtsZ
32890990,2-Aryl benzazole derived new class of anti-tubercular compounds: Endowed to eradicate mycobacterium tuberculosis in replicating and non-replicating forms,"Velappan AB, Datta D, Ma R, Rana S, Ghosh KS, Hari N, Franzblau SG, Debnath J.",Bioorg Chem. 2020 Oct;103:104170. doi: 10.1016/j.bioorg.2020.104170. Epub 2020 Aug 27.,Velappan AB,Bioorg Chem,2020,5/9/2020,,,10.1016/j.bioorg.2020.104170,FtsZ
32817092,Overproduction of a Dominant Mutant of the Conserved Era GTPase Inhibits Cell Division in Escherichia coli,"Zhou X, Peters HK 3rd, Li X, Costantino N, Kumari V, Shi G, Tu C, Cameron TA, Haeusser DP, Vega DE, Ji X, Margolin W, Court DL.",J Bacteriol. 2020 Oct 8;202(21):e00342-20. doi: 10.1128/JB.00342-20. Print 2020 Oct 8.,Zhou X,J Bacteriol,2020,21/8/2020,PMC7549363,,10.1128/JB.00342-20,FtsZ
31893220,Enzymatic Labeling of Bacterial Proteins for Super-resolution Imaging in Live Cells,"Ho SH, Tirrell DA.",ACS Cent Sci. 2019 Dec 26;5(12):1911-1919. doi: 10.1021/acscentsci.9b00617. Epub 2019 Nov 21.,Ho SH,ACS Cent Sci,2019,2/1/2020,PMC6935894,,10.1021/acscentsci.9b00617,FtsZ
35943250,MraZ Transcriptionally Controls the Critical Level of FtsL Required for Focusing Z-Rings and Kickstarting Septation in Bacillus subtilis,"White ML, Hough-Neidig A, Khan SJ, Eswara PJ.",J Bacteriol. 2022 Sep 20;204(9):e0024322. doi: 10.1128/jb.00243-22. Epub 2022 Aug 9.,White ML,J Bacteriol,2022,9/8/2022,PMC9487581,,10.1128/jb.00243-22,FtsZ
30848888,A Chemical Inhibitor of Cell Growth Reduces Cell Size in Bacillus subtilis,"McAuley S, Vadia S, Jani C, Huynh A, Yang Z, Levin PA, Nodwell JR.",ACS Chem Biol. 2019 Apr 19;14(4):688-695. doi: 10.1021/acschembio.8b01066. Epub 2019 Mar 18.,McAuley S,ACS Chem Biol,2019,9/3/2019,PMC6474795,NIHMS1017955,10.1021/acschembio.8b01066,FtsZ
35463830,Comparative Proteomic Analysis of Membrane Vesicles from Clinical C. acnes Isolates with Differential Antibiotic Resistance,"Jiang M, Fan X, Jiang Z, Chen H, Liu Y, Yu T, Huang Q, Ma Y.",Clin Cosmet Investig Dermatol. 2022 Apr 17;15:703-712. doi: 10.2147/CCID.S363537. eCollection 2022.,Jiang M,Clin Cosmet Investig Dermatol,2022,25/4/2022,PMC9022742,,10.2147/CCID.S363537,FtsZ
30042487,Cytological analysis and structural quantification of FtsZ1-2 and FtsZ2-1 network characteristics in Physcomitrella patens,"Özdemir B, Asgharzadeh P, Birkhold AI, Mueller SJ, Röhrle O, Reski R.",Sci Rep. 2018 Jul 24;8(1):11165. doi: 10.1038/s41598-018-29284-y.,Özdemir B,Sci Rep,2018,26/7/2018,PMC6057934,,10.1038/s41598-018-29284-y,FtsZ
32039534,A novel septal protein of multicellular heterocystous cyanobacteria is associated with the divisome,"Springstein BL, Arévalo S, Helbig AO, Herrero A, Stucken K, Flores E, Dagan T.",Mol Microbiol. 2020 Jun;113(6):1140-1154. doi: 10.1111/mmi.14483. Epub 2020 Feb 24.,Springstein BL,Mol Microbiol,2020,11/2/2020,,,10.1111/mmi.14483,FtsZ
33082450,Artificial modulation of cell width significantly affects the division time of Escherichia coli,"Liang B, Quan B, Li J, Loton C, Bredeche MF, Lindner AB, Xu L.",Sci Rep. 2020 Oct 20;10(1):17847. doi: 10.1038/s41598-020-74778-3.,Liang B,Sci Rep,2020,21/10/2020,PMC7576201,,10.1038/s41598-020-74778-3,FtsZ
32162470,Multi-locus sequencing reveals a novel Bartonella in mammals from the Superorder Xenarthra,"Calchi AC, Vultão JG, Alves MH, Yogui DR, Desbiez ALJ, Amaral RB, Santi M, Teixeira MMG, Werther K, Machado RZ, André MR.",Transbound Emerg Dis. 2020 Mar 11. doi: 10.1111/tbed.13545. Online ahead of print.,Calchi AC,Transbound Emerg Dis,2020,13/3/2020,,,10.1111/tbed.13545,FtsZ
34181483,The Division Defect of a Bacillus subtilis minD noc Double Mutant Can Be Suppressed by Spx-Dependent and Spx-Independent Mechanisms,"Yu Y, Dempwolff F, Oshiro RT, Gueiros-Filho FJ, Jacobson SC, Kearns DB.",J Bacteriol. 2021 Aug 20;203(18):e0024921. doi: 10.1128/JB.00249-21. Epub 2021 Aug 20.,Yu Y,J Bacteriol,2021,28/6/2021,PMC8378480,,10.1128/JB.00249-21,FtsZ
31113895,Robust Stoichiometry of FliW-CsrA Governs Flagellin Homeostasis and Cytoplasmic Organization in Bacillus subtilis,"Oshiro RT, Rajendren S, Hundley HA, Kearns DB.",mBio. 2019 May 21;10(3):e00533-19. doi: 10.1128/mBio.00533-19.,Oshiro RT,mBio,2019,23/5/2019,PMC6529632,,10.1128/mBio.00533-19,FtsZ
29745002,Helicobacter pylori shows asymmetric and polar cell divisome assembly associated with DNA replisome,"Kamran M, Dubey P, Verma V, Dasgupta S, Dhar SK.",FEBS J. 2018 Jul;285(13):2531-2547. doi: 10.1111/febs.14499. Epub 2018 Jun 1.,Kamran M,FEBS J,2018,11/5/2018,,,10.1111/febs.14499,FtsZ
29779502,Multi-locus phylogenetics of the Midichloria endosymbionts reveals variable specificity of association with ticks,"Buysse M, Duron O.",Parasitology. 2018 Dec;145(14):1969-1978. doi: 10.1017/S0031182018000793. Epub 2018 May 21.,Buysse M,Parasitology,2018,22/5/2018,,,10.1017/S0031182018000793,FtsZ
33002406,Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli,"Xu Y, Cui P, Zhang Y, Zhang W.",Discov Med. 2020 Mar-Apr;29(157):103-112.,Xu Y,Discov Med,2020,1/10/2020,,,,FtsZ
35497125,Antibacterial activity evaluation and mode of action study of novel thiazole-quinolinium derivatives,"Li Y, Sun N, Ser HL, Long W, Li Y, Chen C, Zheng B, Huang X, Liu Z, Lu YJ.",RSC Adv. 2020 Apr 16;10(25):15000-15014. doi: 10.1039/d0ra00691b. eCollection 2020 Apr 8.,Li Y,RSC Adv,2020,2/5/2022,PMC9052103,,10.1039/d0ra00691b,FtsZ
32041796,Critical Role for the Extended N Terminus of Chlamydial MreB in Directing Its Membrane Association and Potential Interaction with Divisome Proteins,"Lee J, Cox JV, Ouellette SP.",J Bacteriol. 2020 Apr 9;202(9):e00034-20. doi: 10.1128/JB.00034-20. Print 2020 Apr 9.,Lee J,J Bacteriol,2020,12/2/2020,PMC7148133,,10.1128/JB.00034-20,FtsZ
32699122,Interdependent YpsA- and YfhS-Mediated Cell Division and Cell Size Phenotypes in Bacillus subtilis,"Brzozowski RS, Tomlinson BR, Sacco MD, Chen JJ, Ali AN, Chen Y, Shaw LN, Eswara PJ.",mSphere. 2020 Jul 22;5(4):e00655-20. doi: 10.1128/mSphere.00655-20.,Brzozowski RS,mSphere,2020,24/7/2020,PMC7376506,,10.1128/mSphere.00655-20,FtsZ
33951287,"Redox-sensitive transcriptional regulator SoxR directly controls antibiotic production, development and thiol-oxidative stress response in Streptomyces avermitilis","Wang Q, Lu X, Yang H, Yan H, Wen Y.",Microb Biotechnol. 2022 Feb;15(2):561-576. doi: 10.1111/1751-7915.13813. Epub 2021 May 5.,Wang Q,Microb Biotechnol,2022,5/5/2021,PMC8867992,,10.1111/1751-7915.13813,FtsZ
33895137,"ZapG (YhcB/DUF1043), a novel cell division protein in gamma-proteobacteria linking the Z-ring to septal peptidoglycan synthesis","Mehla J, Liechti G, Morgenstein RM, Caufield JH, Hosseinnia A, Gagarinova A, Phanse S, Goodacre N, Brockett M, Sakhawalkar N, Babu M, Xiao R, Montelione GT, Vorobiev S, den Blaauwen T, Hunt JF, Uetz P.",J Biol Chem. 2021 Jan-Jun;296:100700. doi: 10.1016/j.jbc.2021.100700. Epub 2021 Apr 23.,Mehla J,J Biol Chem,2021,25/4/2021,PMC8163987,,10.1016/j.jbc.2021.100700,FtsZ
30504892,Z-ring membrane anchors associate with cell wall synthases to initiate bacterial cell division,"Pazos M, Peters K, Casanova M, Palacios P, VanNieuwenhze M, Breukink E, Vicente M, Vollmer W.",Nat Commun. 2018 Nov 30;9(1):5090. doi: 10.1038/s41467-018-07559-2.,Pazos M,Nat Commun,2018,4/12/2018,PMC6269477,,10.1038/s41467-018-07559-2,FtsZ
33803189,PBP4 Is Likely Involved in Cell Division of the Longitudinally Dividing Bacterium Candidatus Thiosymbion Oneisti,"Wang J, Alvarez L, Bulgheresi S, Cava F, den Blaauwen T.",Antibiotics (Basel). 2021 Mar 9;10(3):274. doi: 10.3390/antibiotics10030274.,Wang J,Antibiotics (Basel),2021,3/4/2021,PMC7999549,,10.3390/antibiotics10030274,FtsZ
36012385,"Discovery of Epipodophyllotoxin-Derived B(2) as Promising XooFtsZ Inhibitor for Controlling Bacterial Cell Division: Structure-Based Virtual Screening, Synthesis, and SAR Study","Song YL, Liu SS, Yang J, Xie J, Zhou X, Wu ZB, Liu LW, Wang PY, Yang S.",Int J Mol Sci. 2022 Aug 14;23(16):9119. doi: 10.3390/ijms23169119.,Song YL,Int J Mol Sci,2022,26/8/2022,PMC9408963,,10.3390/ijms23169119,FtsZ
32045111,An expanded CRISPRi toolbox for tunable control of gene expression in Pseudomonas putida,"Batianis C, Kozaeva E, Damalas SG, Martín-Pascual M, Volke DC, Nikel PI, Martins Dos Santos VAP.",Microb Biotechnol. 2020 Mar;13(2):368-385. doi: 10.1111/1751-7915.13533. Epub 2020 Feb 11.,Batianis C,Microb Biotechnol,2020,12/2/2020,PMC7017828,,10.1111/1751-7915.13533,FtsZ
30206170,Structural Analysis of the Interaction between the Bacterial Cell Division Proteins FtsQ and FtsB,"Kureisaite-Ciziene D, Varadajan A, McLaughlin SH, Glas M, Montón Silva A, Luirink R, Mueller C, den Blaauwen T, Grossmann TN, Luirink J, Löwe J.",mBio. 2018 Sep 11;9(5):e01346-18. doi: 10.1128/mBio.01346-18.,Kureisaite-Ciziene D,mBio,2018,13/9/2018,PMC6134095,,10.1128/mBio.01346-18,FtsZ
33318506,Isolation of a member of the candidate phylum 'Atribacteria' reveals a unique cell membrane structure,"Katayama T, Nobu MK, Kusada H, Meng XY, Hosogi N, Uematsu K, Yoshioka H, Kamagata Y, Tamaki H.",Nat Commun. 2020 Dec 14;11(1):6381. doi: 10.1038/s41467-020-20149-5.,Katayama T,Nat Commun,2020,15/12/2020,PMC7736352,,10.1038/s41467-020-20149-5,FtsZ
37022498,Application of nanotags and nanobodies for live cell single-molecule imaging of the Z-ring in Escherichia coli,"Westlund E, Bergenstråle A, Pokhrel A, Chan H, Skoglund U, Daley DO, Söderström B.",Curr Genet. 2023 Jun;69(2-3):153-163. doi: 10.1007/s00294-023-01266-2. Epub 2023 Apr 6.,Westlund E,Curr Genet,2023,6/4/2023,PMC10163087,,10.1007/s00294-023-01266-2,FtsZ
32345642,Novel Divisome-Associated Protein Spatially Coupling the Z-Ring with the Chromosomal Replication Terminus in Caulobacter crescentus,"Ozaki S, Jenal U, Katayama T.",mBio. 2020 Apr 28;11(2):e00487-20. doi: 10.1128/mBio.00487-20.,Ozaki S,mBio,2020,30/4/2020,PMC7188993,,10.1128/mBio.00487-20,FtsZ
30204770,Filamentation and restoration of normal growth in Escherichia coli using a combined CRISPRi sgRNA/antisense RNA approach,"Mückl A, Schwarz-Schilling M, Fischer K, Simmel FC.",PLoS One. 2018 Sep 11;13(9):e0198058. doi: 10.1371/journal.pone.0198058. eCollection 2018.,Mückl A,PLoS One,2018,12/9/2018,PMC6133276,,10.1371/journal.pone.0198058,FtsZ
36372839,Evaluation of candidate reference genes stability for gene expression analysis by reverse transcription qPCR in Clostridium perfringens,"Williams ML, Ghanem M.",Sci Rep. 2022 Nov 13;12(1):19434. doi: 10.1038/s41598-022-23804-7.,Williams ML,Sci Rep,2022,13/11/2022,PMC9659559,,10.1038/s41598-022-23804-7,FtsZ
34829983,The Escherichia coli Outer Membrane β-Barrel Assembly Machinery (BAM) Crosstalks with the Divisome,"Consoli E, Luirink J, den Blaauwen T.",Int J Mol Sci. 2021 Nov 9;22(22):12101. doi: 10.3390/ijms222212101.,Consoli E,Int J Mol Sci,2021,27/11/2021,PMC8620860,,10.3390/ijms222212101,FtsZ
35044567,"Sulfuriroseicoccus oceanibius gen. nov., sp. nov., a representative of the phylum Verrucomicrobia with a special cytoplasmic membrane","Feng X, Liang QY, Zou QH, Ye MQ, Du ZJ.",Antonie Van Leeuwenhoek. 2022 Feb;115(2):337-352. doi: 10.1007/s10482-021-01689-2. Epub 2022 Jan 19.,Feng X,Antonie Van Leeuwenhoek,2022,19/1/2022,,,10.1007/s10482-021-01689-2,FtsZ
33526615,TusA Is a Versatile Protein That Links Translation Efficiency to Cell Division in Escherichia coli,"Yildiz T, Leimkühler S.",J Bacteriol. 2021 Mar 8;203(7):e00659-20. doi: 10.1128/JB.00659-20. Print 2021 Mar 8.,Yildiz T,J Bacteriol,2021,2/2/2021,PMC8088512,,10.1128/JB.00659-20,FtsZ
33525829,Archaeal cell biology: diverse functions of tubulin-like cytoskeletal proteins at the cell envelope,"Liao Y, Ithurbide S, de Silva RT, Erdmann S, Duggin IG.",Emerg Top Life Sci. 2018 Dec 14;2(4):547-559. doi: 10.1042/ETLS20180026.,Liao Y,Emerg Top Life Sci,2018,2/2/2021,,,10.1042/ETLS20180026,FtsZ
36778977,Infestation of Rice by Gall Midge Influences Density and Diversity of Pseudomonas and Wolbachia in the Host Plant Microbiome,"Sinha DK, Gupta A, Padmakumari AP, Bentur JS, Nair S.",Curr Genomics. 2022 Jun 10;23(2):126-136. doi: 10.2174/1389202923666220401101604.,Sinha DK,Curr Genomics,2022,13/2/2023,PMC9878839,,10.2174/1389202923666220401101604,FtsZ
32300955,Behavior of filamentous temperature-sensitive Z2 (FtsZ2) in the male gametophyte during sexual reproduction processes of flowering plants,"Ohashi Y, Mori T, Igawa T.",Protoplasma. 2020 Jul;257(4):1201-1210. doi: 10.1007/s00709-020-01503-2. Epub 2020 Apr 3.,Ohashi Y,Protoplasma,2020,18/4/2020,,,10.1007/s00709-020-01503-2,FtsZ
37215002,Metabolic flux regulates growth transitions and antibiotic tolerance in uropathogenic Escherichia coli,"Morrison JJ, Banas DA, Madden EK, DiBiasio EC, Rowley DC, Cohen PS, Camberg JL.",bioRxiv. 2023 May 10:2023.05.09.540013. doi: 10.1101/2023.05.09.540013. Preprint.,Morrison JJ,bioRxiv,2023,22/5/2023,PMC10197701,,10.1101/2023.05.09.540013,FtsZ
33359126,The Escherichia coli QseB/QseC signaling is required for correct timing of replication initiation and cell motility,"Wu D, Baigalmaa L, Yao Y, Li G, Su M, Fan L, Morigen.",Gene. 2021 Mar 20;773:145374. doi: 10.1016/j.gene.2020.145374. Epub 2020 Dec 23.,Wu D,Gene,2021,28/12/2020,,,10.1016/j.gene.2020.145374,FtsZ
33595656,Continuous flow synthesis and antimicrobial evaluation of NHC* silver carboxylate derivatives of SBC3 in vitro and in vivo,"O'Beirne C, Piatek ME, Fossen J, Müller-Bunz H, Andes DR, Kavanagh K, Patil SA, Baumann M, Tacke M.",Metallomics. 2021 Feb 17;13(2):mfaa011. doi: 10.1093/mtomcs/mfaa011.,O'Beirne C,Metallomics,2021,17/2/2021,,,10.1093/mtomcs/mfaa011,FtsZ
31488573,Allelic Variation in the Chloroplast Division Gene FtsZ2-2 Leads to Natural Variation in Chloroplast Size,"Kadirjan-Kalbach DK, Turmo A, Wang J, Smith BC, Chen C, Porter KJ, Childs KL, DellaPenna D, Osteryoung KW.",Plant Physiol. 2019 Nov;181(3):1059-1074. doi: 10.1104/pp.19.00841. Epub 2019 Sep 5.,Kadirjan-Kalbach DK,Plant Physiol,2019,7/9/2019,PMC6836828,,10.1104/pp.19.00841,FtsZ
34653531,The phylogenetic distribution of the cell division system would not imply a cellular LUCA but a progenotic LUCA,Di Giulio M.,Biosystems. 2021 Dec;210:104563. doi: 10.1016/j.biosystems.2021.104563. Epub 2021 Oct 13.,Di Giulio M,Biosystems,2021,15/10/2021,,,10.1016/j.biosystems.2021.104563,FtsZ
31250110,Reference genes for real-time RT-PCR expression studies in an Antarctic Pseudomonas exposed to different temperature conditions,"García-Laviña CX, Castro-Sowinski S, Ramón A.",Extremophiles. 2019 Sep;23(5):625-633. doi: 10.1007/s00792-019-01109-4. Epub 2019 Jun 27.,García-Laviña CX,Extremophiles,2019,29/6/2019,,,10.1007/s00792-019-01109-4,FtsZ
35495694,How Do MinC-D Copolymers Act on Z-Ring Localization Regulation? A New Model of Bacillus subtilis Min System,"Wang N, Zhang T, Du S, Zhou Y, Chen Y.",Front Microbiol. 2022 Apr 15;13:841171. doi: 10.3389/fmicb.2022.841171. eCollection 2022.,Wang N,Front Microbiol,2022,2/5/2022,PMC9051478,,10.3389/fmicb.2022.841171,FtsZ
31332059,Upregulation of PBP1B and LpoB in cysB Mutants Confers Mecillinam (Amdinocillin) Resistance in Escherichia coli,"Thulin E, Andersson DI.",Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00612-19. doi: 10.1128/AAC.00612-19. Print 2019 Oct.,Thulin E,Antimicrob Agents Chemother,2019,24/7/2019,PMC6761508,,10.1128/AAC.00612-19,FtsZ
35765559,Validation of reference genes for the normalization of RT-qPCR gene expression in Bacillus siamensis 1021 grown in different culture media,"Nuwong W, Kittiwongwattana C.",Iran J Microbiol. 2022 Apr;14(2):194-202. doi: 10.18502/ijm.v14i2.9188.,Nuwong W,Iran J Microbiol,2022,29/6/2022,PMC9168254,,10.18502/ijm.v14i2.9188,FtsZ
30914397,Wolbachia of phylogenetic supergroup E identified in oribatid mite Gustavia microcephala (Acari: Oribatida),"Konecka E, Olszanowski Z, Koczura R.",Mol Phylogenet Evol. 2019 Jun;135:230-235. doi: 10.1016/j.ympev.2019.03.019. Epub 2019 Mar 23.,Konecka E,Mol Phylogenet Evol,2019,28/3/2019,,,10.1016/j.ympev.2019.03.019,FtsZ
35621928,Lulworthinone: In Vitro Mode of Action Investigation of an Antibacterial Dimeric Naphthopyrone Isolated from a Marine Fungus,"Juskewitz E, Mishchenko E, Dubey VK, Jenssen M, Jakubec M, Rainsford P, Isaksson J, Andersen JH, Ericson JU.",Mar Drugs. 2022 Apr 21;20(5):277. doi: 10.3390/md20050277.,Juskewitz E,Mar Drugs,2022,27/5/2022,PMC9147123,,10.3390/md20050277,FtsZ
32514868,Antibacterial mechanism of rhodomyrtone involves the disruption of nucleoid segregation checkpoint in Streptococcus suis,"Traithan A, Tongtawe P, Thanongsaksrikul J, Voravuthikunchai S, Srimanote P.",AMB Express. 2020 Jun 8;10(1):110. doi: 10.1186/s13568-020-01047-x.,Traithan A,AMB Express,2020,10/6/2020,PMC7280372,,10.1186/s13568-020-01047-x,FtsZ
33922200,"Molecular Simplification of Natural Products: Synthesis, Antibacterial Activity, and Molecular Docking Studies of Berberine Open Models","Milani G, Cavalluzzi MM, Solidoro R, Salvagno L, Quintieri L, Di Somma A, Rosato A, Corbo F, Franchini C, Duilio A, Caputo L, Habtemariam S, Lentini G.",Biomedicines. 2021 Apr 22;9(5):452. doi: 10.3390/biomedicines9050452.,Milani G,Biomedicines,2021,30/4/2021,PMC8146520,,10.3390/biomedicines9050452,FtsZ
36959324,An Arg/Ala-rich helix in the N-terminal region of M. tuberculosis FtsQ is a potential membrane anchor of the Z-ring,"Smrt ST, Escobar CA, Dey S, Cross TA, Zhou HX.",Commun Biol. 2023 Mar 23;6(1):311. doi: 10.1038/s42003-023-04686-5.,Smrt ST,Commun Biol,2023,24/3/2023,PMC10036325,,10.1038/s42003-023-04686-5,FtsZ
31187734,"Isolation, identification, and histopathological analysis of Vibrio tubiashii from lined seahorse Hippocampus erectus","Shao P, Yong P, Wang X, Xie S, Fan Y, Zang L, Cui L, Sun J.",Dis Aquat Organ. 2019 Mar 28;133(3):195-205. doi: 10.3354/dao03350.,Shao P,Dis Aquat Organ,2019,13/6/2019,,,10.3354/dao03350,FtsZ
31109649,"Antibacterial evaluation and mode of action study of BIMQ, a novel bacterial cell division inhibitor","Sun N, Li M, Cai S, Li Y, Chen C, Zheng Y, Li X, Fang Z, Lv H, Lu YJ.",Biochem Biophys Res Commun. 2019 Jul 5;514(4):1224-1230. doi: 10.1016/j.bbrc.2019.05.086. Epub 2019 May 17.,Sun N,Biochem Biophys Res Commun,2019,22/5/2019,,,10.1016/j.bbrc.2019.05.086,FtsZ
32566778,The development of species-specific antisense peptide nucleic acid method for the treatment and detection of viable Salmonella,"Adebowale OO, Goh S, Good L.",Heliyon. 2020 Jun 10;6(6):e04110. doi: 10.1016/j.heliyon.2020.e04110. eCollection 2020 Jun.,Adebowale OO,Heliyon,2020,23/6/2020,PMC7298406,,10.1016/j.heliyon.2020.e04110,FtsZ
33807152,Genome-Wide Analysis of Tubulin Gene Family in Cassava and Expression of Family Member FtsZ2-1 during Various Stress,"Li S, Cao P, Wang C, Guo J, Zang Y, Wu K, Ran F, Liu L, Wang D, Min Y.",Plants (Basel). 2021 Mar 31;10(4):668. doi: 10.3390/plants10040668.,Li S,Plants (Basel),2021,3/4/2021,PMC8065747,,10.3390/plants10040668,FtsZ
35132948,"Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents","Yalcin-Ozkat G, Ersan RH, Ulger M, Ulger ST, Burmaoglu S, Yildiz I, Algul O.",J Biomol Struct Dyn. 2023 Apr;41(7):2667-2686. doi: 10.1080/07391102.2022.2036241. Epub 2022 Feb 8.,Yalcin-Ozkat G,J Biomol Struct Dyn,2023,8/2/2022,,,10.1080/07391102.2022.2036241,FtsZ
37060070,"Characterizing the Wolbachia infection in field-collected Culicidae mosquitoes from Hainan Province, China","Li Y, Sun Y, Zou J, Zhong D, Liu R, Zhu C, Li W, Zhou Y, Cui L, Zhou G, Lu G, Li T.",Parasit Vectors. 2023 Apr 14;16(1):128. doi: 10.1186/s13071-023-05719-y.,Li Y,Parasit Vectors,2023,14/4/2023,PMC10103416,,10.1186/s13071-023-05719-y,FtsZ
32380314,Isolation and genetic properties of Bartonella in eastern bent-wing bats (Miniopterus fuliginosus) in Japan,"Nabeshima K, Sato S, Kabeya H, Kato C, Suzuki K, Maruyama S.",Infect Genet Evol. 2020 Sep;83:104354. doi: 10.1016/j.meegid.2020.104354. Epub 2020 May 5.,Nabeshima K,Infect Genet Evol,2020,8/5/2020,PMC7198413,,10.1016/j.meegid.2020.104354,FtsZ
36300930,"FtsK, a DNA Motor Protein, Coordinates the Genome Segregation and Early Cell Division Processes in Deinococcus radiodurans","Mishra S, Misra HS, Kota S.",mBio. 2022 Dec 20;13(6):e0174222. doi: 10.1128/mbio.01742-22. Epub 2022 Oct 27.,Mishra S,mBio,2022,27/10/2022,PMC9764985,,10.1128/mbio.01742-22,FtsZ
29769312,The chloroplast division protein ARC6 acts to inhibit disassembly of GDP-bound FtsZ2,"Sung MW, Shaik R, TerBush AD, Osteryoung KW, Vitha S, Holzenburg A.",J Biol Chem. 2018 Jul 6;293(27):10692-10706. doi: 10.1074/jbc.RA117.000999. Epub 2018 May 16.,Sung MW,J Biol Chem,2018,18/5/2018,PMC6036205,,10.1074/jbc.RA117.000999,FtsZ
31131713,Phosphoproteomic and proteomic profiling of serine/threonine protein kinase PkaE of Streptomyces coelicolor A3(2) and its role in secondary metabolism and morphogenesis,"Hirakata T, Urabe H, Sugita T.",Biosci Biotechnol Biochem. 2019 Oct;83(10):1843-1850. doi: 10.1080/09168451.2019.1618698. Epub 2019 May 25.,Hirakata T,Biosci Biotechnol Biochem,2019,28/5/2019,,,10.1080/09168451.2019.1618698,FtsZ
34585574,DNA Nanodevice as a Co-delivery Vehicle of Antisense Oligonucleotide and Silver Ions for Selective Inhibition of Bacteria Growth,"Long Q, Jia B, Shi Y, Wang Q, Yu H, Li Z.",ACS Appl Mater Interfaces. 2021 Oct 13;13(40):47987-47995. doi: 10.1021/acsami.1c15585. Epub 2021 Sep 29.,Long Q,ACS Appl Mater Interfaces,2021,29/9/2021,,,10.1021/acsami.1c15585,FtsZ
35529647,Cytotoxic and antimicrobial indole alkaloids from an endophytic fungus Chaetomium sp. SYP-F7950 of Panax notoginseng,"Peng F, Hou SY, Zhang TY, Wu YY, Zhang MY, Yan XM, Xia MY, Zhang YX.",RSC Adv. 2019 Sep 12;9(49):28754-28763. doi: 10.1039/c9ra04747f. eCollection 2019 Sep 9.,Peng F,RSC Adv,2019,9/5/2022,PMC9071232,,10.1039/c9ra04747f,FtsZ
31419361,A gradient-forming MipZ protein mediating the control of cell division in the magnetotactic bacterium Magnetospirillum gryphiswaldense,"Toro-Nahuelpan M, Corrales-Guerrero L, Zwiener T, Osorio-Valeriano M, Müller FD, Plitzko JM, Bramkamp M, Thanbichler M, Schüler D.",Mol Microbiol. 2019 Nov;112(5):1423-1439. doi: 10.1111/mmi.14369. Epub 2019 Sep 24.,Toro-Nahuelpan M,Mol Microbiol,2019,17/8/2019,,,10.1111/mmi.14369,FtsZ
31512605,MtFtsX a predicted membrane domain of ABC transporter complex MtFtsEX of Mycobacterium tuberculosis interacts with the cell division protein MtFtsZ,"Mir MA, Srinivasan R, Ajitkumar P.",Int J Mycobacteriol. 2019 Jul-Sep;8(3):281-286. doi: 10.4103/ijmy.ijmy_98_19.,Mir MA,Int J Mycobacteriol,2019,13/9/2019,,,10.4103/ijmy.ijmy_98_19,FtsZ
32748754,"Identification of Antimycobacterial Agent Using In Silico Virtual Screening, ADME Prediction, Docking, and Molecular Dynamics Simulations Approach","Tripathy S, Sahu SK, Azam MA, Jupudi S, Gupta VK, Sharma S.",Curr Comput Aided Drug Des. 2021;17(6):806-816. doi: 10.2174/1573409916999200730182308.,Tripathy S,Curr Comput Aided Drug Des,2021,5/8/2020,,,10.2174/1573409916999200730182308,FtsZ
37040122,Investigation on the Anticancer and Antibacterial Mechanism of Thiazoline/Imidazoline Derived Palladium(II) Complexes,"Mahanty S, Sudharsan M, Suresh D, Rathinasamy K.",Chem Biodivers. 2023 May;20(5):e202201043. doi: 10.1002/cbdv.202201043. Epub 2023 Apr 25.,Mahanty S,Chem Biodivers,2023,11/4/2023,,,10.1002/cbdv.202201043,FtsZ
33269494,Organization of peptidoglycan synthesis in nodes and separate rings at different stages of cell division of Streptococcus pneumoniae,"Perez AJ, Boersma MJ, Bruce KE, Lamanna MM, Shaw SL, Tsui HT, Taguchi A, Carlson EE, VanNieuwenhze MS, Winkler ME.",Mol Microbiol. 2021 Jun;115(6):1152-1169. doi: 10.1111/mmi.14659. Epub 2020 Dec 21.,Perez AJ,Mol Microbiol,2021,3/12/2020,PMC8575487,NIHMS1658290,10.1111/mmi.14659,FtsZ
33101614,A NanoFE simulation-based surrogate machine learning model to predict mechanical functionality of protein networks from live confocal imaging,"Asgharzadeh P, Birkhold AI, Trivedi Z, Özdemir B, Reski R, Röhrle O.",Comput Struct Biotechnol J. 2020 Sep 24;18:2774-2788. doi: 10.1016/j.csbj.2020.09.024. eCollection 2020.,Asgharzadeh P,Comput Struct Biotechnol J,2020,26/10/2020,PMC7559262,,10.1016/j.csbj.2020.09.024,FtsZ
29882274,Multilocus sequence analysis of Vibrionaceae isolated from farmed amberjack and the development of a multiplex PCR assay for the detection of pathogenic species,"Nishiki I, Minami T, Murakami A, Hoai TD, Fujiwara A.",J Fish Dis. 2018 Jun 7. doi: 10.1111/jfd.12823. Online ahead of print.,Nishiki I,J Fish Dis,2018,9/6/2018,,,10.1111/jfd.12823,FtsZ
30414406,Cooperative DNA Binding of the Plasmid Partitioning Protein TubR from the Bacillus cereus pXO1 Plasmid,"Hayashi I, Oda T, Sato M, Fuchigami S.",J Mol Biol. 2018 Dec 7;430(24):5015-5028. doi: 10.1016/j.jmb.2018.11.001. Epub 2018 Nov 8.,Hayashi I,J Mol Biol,2018,11/11/2018,,,10.1016/j.jmb.2018.11.001,FtsZ
33922245,"Molecular Detection of Bartonella spp. and Hematological Evaluation in Domestic Cats and Dogs from Bangkok, Thailand","Saengsawang P, Kaewmongkol G, Inpankaew T.",Pathogens. 2021 Apr 22;10(5):503. doi: 10.3390/pathogens10050503.,Saengsawang P,Pathogens,2021,30/4/2021,PMC8146774,,10.3390/pathogens10050503,FtsZ
31828448,"Corynebacterium glutamicum whiA plays roles in cell division, cell envelope formation, and general cell physiology","Lee JH, Jeong H, Kim Y, Lee HS.",Antonie Van Leeuwenhoek. 2020 May;113(5):629-641. doi: 10.1007/s10482-019-01370-9. Epub 2019 Dec 11.,Lee JH,Antonie Van Leeuwenhoek,2020,13/12/2019,,,10.1007/s10482-019-01370-9,FtsZ
34040598,"How Teichoic Acids Could Support a Periplasm in Gram-Positive Bacteria, and Let Cell Division Cheat Turgor Pressure",Erickson HP.,Front Microbiol. 2021 May 10;12:664704. doi: 10.3389/fmicb.2021.664704. eCollection 2021.,Erickson HP,Front Microbiol,2021,27/5/2021,PMC8141598,,10.3389/fmicb.2021.664704,FtsZ
31989175,A single-component light sensor system allows highly tunable and direct activation of gene expression in bacterial cells,"Li X, Zhang C, Xu X, Miao J, Yao J, Liu R, Zhao Y, Chen X, Yang Y.",Nucleic Acids Res. 2020 Apr 6;48(6):e33. doi: 10.1093/nar/gkaa044.,Li X,Nucleic Acids Res,2020,29/1/2020,PMC7102963,,10.1093/nar/gkaa044,FtsZ
33773234,Gene expression analysis for selection and validation of suitable housekeeping gene(s) in cadmium exposed pigeonpea plants inoculated with arbuscular mycorrhizae,"Bisht A, Bhalla S, Kumar A, Kaur J, Garg N.",Plant Physiol Biochem. 2021 May;162:592-602. doi: 10.1016/j.plaphy.2021.03.024. Epub 2021 Mar 15.,Bisht A,Plant Physiol Biochem,2021,27/3/2021,,,10.1016/j.plaphy.2021.03.024,FtsZ
33495624,A two-track model for the spatiotemporal coordination of bacterial septal cell wall synthesis revealed by single-molecule imaging of FtsW,"Yang X, McQuillen R, Lyu Z, Phillips-Mason P, De La Cruz A, McCausland JW, Liang H, DeMeester KE, Santiago CC, Grimes CL, de Boer P, Xiao J.",Nat Microbiol. 2021 May;6(5):584-593. doi: 10.1038/s41564-020-00853-0. Epub 2021 Jan 25.,Yang X,Nat Microbiol,2021,26/1/2021,PMC8085133,NIHMS1655208,10.1038/s41564-020-00853-0,FtsZ
30745377,A Xylose-Inducible Expression System and a CRISPR Interference Plasmid for Targeted Knockdown of Gene Expression in Clostridioides difficile,"Müh U, Pannullo AG, Weiss DS, Ellermeier CD.",J Bacteriol. 2019 Jun 21;201(14):e00711-18. doi: 10.1128/JB.00711-18. Print 2019 Jul 15.,Müh U,J Bacteriol,2019,13/2/2019,PMC6597395,,10.1128/JB.00711-18,FtsZ
29313064,Genetic Diversity of Bartonella spp. in Wild Mammals and Ectoparasites in Brazilian Pantanal,"de Sousa KCM, do Amaral RB, Herrera HM, Santos FM, Macedo GC, de Andrade Pinto PCE, Barros-Battesti DM, Machado RZ, André MR.",Microb Ecol. 2018 Aug;76(2):544-554. doi: 10.1007/s00248-017-1138-0. Epub 2018 Jan 8.,de Sousa KCM,Microb Ecol,2018,10/1/2018,,,10.1007/s00248-017-1138-0,FtsZ
37162334,Binary or Nonbinary Fission? Reproductive Mode of a Predatory Bacterium Depends on Prey Size,"Pląskowska K, Makowski Ł, Strzałka A, Zakrzewska-Czerwińska J.",mBio. 2023 May 10:e0077223. doi: 10.1128/mbio.00772-23. Online ahead of print.,Pląskowska K,mBio,2023,10/5/2023,,,10.1128/mbio.00772-23,FtsZ
29985348,Fluorescence Live-cell Imaging of the Complete Vegetative Cell Cycle of the Slow-growing Social Bacterium Myxococcus xanthus,"Schumacher D, Søgaard-Andersen L.",J Vis Exp. 2018 Jun 20;(136):57860. doi: 10.3791/57860.,Schumacher D,J Vis Exp,2018,10/7/2018,PMC6101962,,10.3791/57860,FtsZ
32709907,The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance,"Ahmed MN, Abdelsamad A, Wassermann T, Porse A, Becker J, Sommer MOA, Høiby N, Ciofu O.",NPJ Biofilms Microbiomes. 2020 Jul 24;6(1):28. doi: 10.1038/s41522-020-00138-8.,Ahmed MN,NPJ Biofilms Microbiomes,2020,26/7/2020,PMC7381665,,10.1038/s41522-020-00138-8,FtsZ
31139822,Identification of novel genes that promote persister formation by repressing transcription and cell division in Pseudomonas aeruginosa,"Long Y, Fu W, Li S, Ren H, Li M, Liu C, Zhang B, Xia Y, Fan Z, Xu C, Liu J, Jin Y, Bai F, Cheng Z, Liu X, Jin S, Wu W.",J Antimicrob Chemother. 2019 Sep 1;74(9):2575-2587. doi: 10.1093/jac/dkz214.,Long Y,J Antimicrob Chemother,2019,30/5/2019,,,10.1093/jac/dkz214,FtsZ
34880885,Residue 49 of AtMinD1 Plays a Key Role in the Guidance of Chloroplast Division by Regulating the ARC6-AtMinD1 Interaction,"Zhang Y, Zhang X, Cui H, Ma X, Hu G, Wei J, He Y, Hu Y.",Front Plant Sci. 2021 Nov 22;12:752790. doi: 10.3389/fpls.2021.752790. eCollection 2021.,Zhang Y,Front Plant Sci,2021,9/12/2021,PMC8646090,,10.3389/fpls.2021.752790,FtsZ
33004977,Validation of stable reference genes in Staphylococcus aureus to study gene expression under photodynamic treatment: a case study of SEB virulence factor analysis,"Ogonowska P, Nakonieczna J.",Sci Rep. 2020 Oct 1;10(1):16354. doi: 10.1038/s41598-020-73409-1.,Ogonowska P,Sci Rep,2020,2/10/2020,PMC7530716,,10.1038/s41598-020-73409-1,FtsZ
37191556,The Unique N-Terminal Domain of Chlamydial Bactofilin Mediates Its Membrane Localization and Ring-Forming Properties,"Lee J, Cox JV, Ouellette SP.",J Bacteriol. 2023 May 16:e0009223. doi: 10.1128/jb.00092-23. Online ahead of print.,Lee J,J Bacteriol,2023,16/5/2023,,,10.1128/jb.00092-23,FtsZ
33227996,Intra- and Inter-Host Assessment of Bartonella Diversity with Focus on Non-Hematophagous Bats and Associated Ectoparasites from Brazil,"Ikeda P, Marinho Torres J, Perles L, Lourenço EC, Herrera HM, de Oliveira CE, Zacarias Machado R, André MR.",Microorganisms. 2020 Nov 19;8(11):1822. doi: 10.3390/microorganisms8111822.,Ikeda P,Microorganisms,2020,24/11/2020,PMC7699196,,10.3390/microorganisms8111822,FtsZ
29885061,A cell length-dependent transition in MinD-dynamics promotes a switch in division-site placement and preservation of proliferating elongated Vibrio parahaemolyticus swarmer cells,"Muraleedharan S, Freitas C, Mann P, Glatter T, Ringgaard S.",Mol Microbiol. 2018 Aug;109(3):365-384. doi: 10.1111/mmi.13996.,Muraleedharan S,Mol Microbiol,2018,10/6/2018,,,10.1111/mmi.13996,FtsZ
31133994,Isolation and Pathogenic Characterization of Vibrio bivalvicida Associated With a Massive Larval Mortality Event in a Commercial Hatchery of Scallop Argopecten purpuratus in Chile,"Rojas R, Miranda CD, Romero J, Barja JL, Dubert J.",Front Microbiol. 2019 May 10;10:855. doi: 10.3389/fmicb.2019.00855. eCollection 2019.,Rojas R,Front Microbiol,2019,29/5/2019,PMC6524457,,10.3389/fmicb.2019.00855,FtsZ
31619523,Prosthetic Valve Endocarditis with Bartonella washoensis in a Human European Patient and Its Detection in Red Squirrels (Sciurus vulgaris),"von Loewenich FD, Seckert C, Dauber E, Kik MJL, de Vries A, Sprong H, Buschmann K, Aardema ML, Brandstetter M.",J Clin Microbiol. 2019 Dec 23;58(1):e01404-19. doi: 10.1128/JCM.01404-19. Print 2019 Dec 23.,von Loewenich FD,J Clin Microbiol,2019,18/10/2019,PMC6935924,,10.1128/JCM.01404-19,FtsZ
33947758,The Chaperonin GroESL Facilitates Caulobacter crescentus Cell Division by Supporting the Functions of the Z-Ring Regulators FtsA and FzlA,"Schroeder K, Heinrich K, Neuwirth I, Jonas K.",mBio. 2021 May 4;12(3):e03564-20. doi: 10.1128/mBio.03564-20.,Schroeder K,mBio,2021,5/5/2021,PMC8262945,,10.1128/mBio.03564-20,FtsZ
30668658,Wolbachia (Alphaproteobacteria: Rickettsiales) Infections in Isolated Aphid Populations from Oceanic Islands of the Azores Archipelago: Revisiting the Supergroups M and N,"Moreira M, Aguiar AMF, Bourtzis K, Latorre A, Khadem M.",Environ Entomol. 2019 Apr 3;48(2):326-334. doi: 10.1093/ee/nvy189.,Moreira M,Environ Entomol,2019,23/1/2019,,,10.1093/ee/nvy189,FtsZ
31518377,"The ClpX chaperone controls autolytic splitting of Staphylococcus aureus daughter cells, but is bypassed by β-lactam antibiotics or inhibitors of WTA biosynthesis","Jensen C, Bæk KT, Gallay C, Thalsø-Madsen I, Xu L, Jousselin A, Ruiz Torrubia F, Paulander W, Pereira AR, Veening JW, Pinho MG, Frees D.",PLoS Pathog. 2019 Sep 13;15(9):e1008044. doi: 10.1371/journal.ppat.1008044. eCollection 2019 Sep.,Jensen C,PLoS Pathog,2019,14/9/2019,PMC6760813,,10.1371/journal.ppat.1008044,FtsZ
32649185,Synthesis and Docking Study of N-(Cinnamoyl)-N'-(substituted)acryloyl Hydrazide Derivatives Containing Pyridinium Moieties as a Novel Class of Filamentous Temperature-Sensitive Protein Z Inhibitors against the Intractable Xanthomonas oryzae pv. oryzae Infections in Rice,"Zhou X, Feng YM, Qi PY, Shao WB, Wu ZB, Liu LW, Wang Y, Ma HD, Wang PY, Li Z, Yang S.",J Agric Food Chem. 2020 Aug 5;68(31):8132-8142. doi: 10.1021/acs.jafc.0c01565. Epub 2020 Jul 22.,Zhou X,J Agric Food Chem,2020,11/7/2020,,,10.1021/acs.jafc.0c01565,FtsZ
30842445,Prevention of EloR/KhpA heterodimerization by introduction of site-specific amino acid substitutions renders the essential elongasome protein PBP2b redundant in Streptococcus pneumoniae,"Winther AR, Kjos M, Stamsås GA, Håvarstein LS, Straume D.",Sci Rep. 2019 Mar 6;9(1):3681. doi: 10.1038/s41598-018-38386-6.,Winther AR,Sci Rep,2019,8/3/2019,PMC6403258,,10.1038/s41598-018-38386-6,FtsZ
36774691,"Biogenic synthesis, molecular docking, biomedical and environmental applications of multifunctional CuO nanoparticles mediated Phragmites australis","Kocabas BB, Attar A, Yuka SA, Yapaoz MA.",Bioorg Chem. 2023 Apr;133:106414. doi: 10.1016/j.bioorg.2023.106414. Epub 2023 Feb 9.,Kocabas BB,Bioorg Chem,2023,12/2/2023,,,10.1016/j.bioorg.2023.106414,FtsZ
34276634,Identification of a Genetically Linked but Functionally Independent Two-Component System Important for Cell Division of the Rice Pathogen Burkholderia glumae,"Marunga J, Goo E, Kang Y, Hwang I.",Front Microbiol. 2021 Jul 1;12:700333. doi: 10.3389/fmicb.2021.700333. eCollection 2021.,Marunga J,Front Microbiol,2021,19/7/2021,PMC8281045,,10.3389/fmicb.2021.700333,FtsZ
37250038,Nucleotide-dependent activities of FtsA regulate the early establishment of a functional divisome during the Escherichia coli cell cycle,"Morrison JJ, Ferreira CN, Siler EM, Nelson K, Trebino CE, Piraino B, Camberg JL.",Front Microbiol. 2023 May 12;14:1171376. doi: 10.3389/fmicb.2023.1171376. eCollection 2023.,Morrison JJ,Front Microbiol,2023,30/5/2023,PMC10213515,,10.3389/fmicb.2023.1171376,FtsZ
30792700,"Escherichia coli CrfC Protein, a Nucleoid Partition Factor, Localizes to Nucleoid Poles via the Activities of Specific Nucleoid-Associated Proteins","Taniguchi S, Kasho K, Ozaki S, Katayama T.",Front Microbiol. 2019 Feb 7;10:72. doi: 10.3389/fmicb.2019.00072. eCollection 2019.,Taniguchi S,Front Microbiol,2019,23/2/2019,PMC6374313,,10.3389/fmicb.2019.00072,FtsZ
37014250,"FtsE, the Nucleotide Binding Domain of the ABC Transporter Homolog FtsEX, Regulates Septal PG Synthesis in E. coli","Mallik S, Dodia H, Ghosh A, Srinivasan R, Good L, Raghav SK, Beuria TK.",Microbiol Spectr. 2023 Apr 4:e0286322. doi: 10.1128/spectrum.02863-22. Online ahead of print.,Mallik S,Microbiol Spectr,2023,4/4/2023,,,10.1128/spectrum.02863-22,FtsZ
37266021,Enabling deep-space experimentations on cyanobacteria by monitoring cell division resumption in dried Chroococcidiopsis sp. 029 with accumulated DNA damage,"Fagliarone C, Mosca C, Di Stefano G, Leuko S, Moeller R, Rabbow E, Rettberg P, Billi D.",Front Microbiol. 2023 May 17;14:1150224. doi: 10.3389/fmicb.2023.1150224. eCollection 2023.,Fagliarone C,Front Microbiol,2023,2/6/2023,PMC10229888,,10.3389/fmicb.2023.1150224,FtsZ
36683448,Reconstitution and expression of mcy gene cluster in the model cyanobacterium Synechococcus 7942 reveals a role of MC-LR in cell division,"Zheng Y, Xue C, Chen H, Jia A, Zhao L, Zhang J, Zhang L, Wang Q.",New Phytol. 2023 May;238(3):1101-1114. doi: 10.1111/nph.18766. Epub 2023 Feb 14.,Zheng Y,New Phytol,2023,23/1/2023,,,10.1111/nph.18766,FtsZ
30290265,"Role of cell division protein divIVA in Enterococcus faecalis pathogenesis, biofilm and drug resistance: A future perspective by in silico approaches","Sharma D, Khan AU.",Microb Pathog. 2018 Dec;125:361-365. doi: 10.1016/j.micpath.2018.10.001. Epub 2018 Oct 2.,Sharma D,Microb Pathog,2018,6/10/2018,,,10.1016/j.micpath.2018.10.001,FtsZ
36836896,Pan-Genomics of Escherichia albertii for Antibiotic Resistance Profiling in Different Genome Fractions and Natural Product Mediated Intervention: In Silico Approach,"Jalal K, Khan K, Hayat A, Alnasser SM, Meshal A, Basharat Z.",Life (Basel). 2023 Feb 15;13(2):541. doi: 10.3390/life13020541.,Jalal K,Life (Basel),2023,25/2/2023,PMC9962377,,10.3390/life13020541,FtsZ
37209207,Efficient and precise control of gene expression in Geobacter sulfurreducens through new genetic elements and tools for pollutant conversion,"Liu JQ, Min D, He RL, Cheng ZH, Wu J, Liu DF.",Biotechnol Bioeng. 2023 May 20. doi: 10.1002/bit.28433. Online ahead of print.,Liu JQ,Biotechnol Bioeng,2023,20/5/2023,,,10.1002/bit.28433,FtsZ
36726573,Bacillus subtilis forms twisted cells with cell wall integrity defects upon removal of the molecular chaperones DnaK and trigger factor,"Matavacas J, Hallgren J, von Wachenfeldt C.",Front Microbiol. 2023 Jan 16;13:988768. doi: 10.3389/fmicb.2022.988768. eCollection 2022.,Matavacas J,Front Microbiol,2023,2/2/2023,PMC9886141,,10.3389/fmicb.2022.988768,FtsZ
30526497,Adaptation mechanism and tolerance of Rhodopseudomonas palustris PSB-S under pyrazosulfuron-ethyl stress,"Luo XW, Zhang DY, Zhu TH, Zhou XG, Peng J, Zhang SB, Liu Y.",BMC Microbiol. 2018 Dec 7;18(1):207. doi: 10.1186/s12866-018-1361-y.,Luo XW,BMC Microbiol,2018,12/12/2018,PMC6286529,,10.1186/s12866-018-1361-y,FtsZ
34977598,Super-resolution confocal cryo-CLEM with cryo-FIB milling for in situ imaging of Deinococcus radiodurans,"Sexton DL, Burgold S, Schertel A, Tocheva EI.",Curr Res Struct Biol. 2021 Dec 13;4:1-9. doi: 10.1016/j.crstbi.2021.12.001. eCollection 2022.,Sexton DL,Curr Res Struct Biol,2021,3/1/2022,PMC8688812,,10.1016/j.crstbi.2021.12.001,FtsZ
32406895,Reversible membrane deformations by straight DNA origami filaments,"Franquelim HG, Dietz H, Schwille P.",Soft Matter. 2021 Jan 22;17(2):276-287. doi: 10.1039/d0sm00150c.,Franquelim HG,Soft Matter,2021,15/5/2020,,,10.1039/d0sm00150c,FtsZ
30930874,Physiological and Microscopic Characterization of Cyclic-di-GMP-Mediated Autoaggregation in Erwinia amylovora,"Kharadi RR, Sundin GW.",Front Microbiol. 2019 Mar 12;10:468. doi: 10.3389/fmicb.2019.00468. eCollection 2019.,Kharadi RR,Front Microbiol,2019,2/4/2019,PMC6423407,,10.3389/fmicb.2019.00468,FtsZ
29885047,"In long bacterial cells, the Min system can act off-center","MacCready JS, Vecchiarelli AG.",Mol Microbiol. 2018 Aug;109(3):268-272. doi: 10.1111/mmi.13995.,MacCready JS,Mol Microbiol,2018,10/6/2018,,,10.1111/mmi.13995,FtsZ
31664808,Carbohydrate-Coated Gold-Silver Nanoparticles for Efficient Elimination of Multidrug Resistant Bacteria and in Vivo Wound Healing,"Kumar S, Majhi RK, Singh A, Mishra M, Tiwari A, Chawla S, Guha P, Satpati B, Mohapatra H, Goswami L, Goswami C.",ACS Appl Mater Interfaces. 2019 Nov 20;11(46):42998-43017. doi: 10.1021/acsami.9b17086. Epub 2019 Nov 11.,Kumar S,ACS Appl Mater Interfaces,2019,31/10/2019,,,10.1021/acsami.9b17086,FtsZ
37162900,Identification of FacZ as a division site placement factor in Staphylococcus aureus,"Bartlett TM, Sisley TA, Mychack A, Walker S, Baker RW, Rudner DZ, Bernhardt TG.",bioRxiv. 2023 Apr 24:2023.04.24.538170. doi: 10.1101/2023.04.24.538170. Preprint.,Bartlett TM,bioRxiv,2023,10/5/2023,PMC10168275,,10.1101/2023.04.24.538170,FtsZ
32779779,A new method for protein characterization and classification using geometrical features for 3D face analysis: An example of tubulin structures,"Di Grazia L, Aminpour M, Vezzetti E, Rezania V, Marcolin F, Tuszynski JA.",Proteins. 2020 Aug 11:e25993. doi: 10.1002/prot.25993. Online ahead of print.,Di Grazia L,Proteins,2020,12/8/2020,,,10.1002/prot.25993,FtsZ
32424210,Regulation of peptidoglycan synthesis and remodelling,"Egan AJF, Errington J, Vollmer W.",Nat Rev Microbiol. 2020 Aug;18(8):446-460. doi: 10.1038/s41579-020-0366-3. Epub 2020 May 18.,Egan AJF,Nat Rev Microbiol,2020,20/5/2020,,,10.1038/s41579-020-0366-3,FtsZ
30543779,Septins Recognize and Entrap Dividing Bacterial Cells for Delivery to Lysosomes,"Krokowski S, Lobato-Márquez D, Chastanet A, Pereira PM, Angelis D, Galea D, Larrouy-Maumus G, Henriques R, Spiliotis ET, Carballido-López R, Mostowy S.",Cell Host Microbe. 2018 Dec 12;24(6):866-874.e4. doi: 10.1016/j.chom.2018.11.005.,Krokowski S,Cell Host Microbe,2018,14/12/2018,PMC6299245,,10.1016/j.chom.2018.11.005,FtsZ
36947615,Inhibition of peptidoglycan synthesis is sufficient for total arrest of staphylococcal cell division,"Puls JS, Brajtenbach D, Schneider T, Kubitscheck U, Grein F.",Sci Adv. 2023 Mar 22;9(12):eade9023. doi: 10.1126/sciadv.ade9023. Epub 2023 Mar 22.,Puls JS,Sci Adv,2023,22/3/2023,PMC10032595,,10.1126/sciadv.ade9023,FtsZ
36731197,Molecular identification and differential proteomics of drug resistant Salmonella Typhi,"Safi AUR, Bendixen E, Rahman H, Khattak B, Wu W, Ullah W, Khan N, Ali F, Yasin N, Qasim M.",Diagn Microbiol Infect Dis. 2023 Apr;105(4):115883. doi: 10.1016/j.diagmicrobio.2022.115883. Epub 2022 Dec 21.,Safi AUR,Diagn Microbiol Infect Dis,2023,2/2/2023,,,10.1016/j.diagmicrobio.2022.115883,FtsZ
36504836,"Genetic diversity of Bartonella infection in residential and field rodents in Hebei, China","Jian R, Ren Q, Xue J, Xie GC, Wang J, Chen GQ, Du L, Guo WP.",Front Microbiol. 2022 Nov 25;13:1039665. doi: 10.3389/fmicb.2022.1039665. eCollection 2022.,Jian R,Front Microbiol,2022,12/12/2022,PMC9732461,,10.3389/fmicb.2022.1039665,FtsZ
33949407,Chiral self-sorting of active semiflexible filaments with intrinsic curvature,"Moore JM, Glaser MA, Betterton MD.",Soft Matter. 2021 May 5;17(17):4559-4565. doi: 10.1039/d0sm01163k.,Moore JM,Soft Matter,2021,5/5/2021,,,10.1039/d0sm01163k,FtsZ
32538147,Multiple ways to kill bacteria via inhibiting novel cell wall or membrane targets,"Naclerio GA, Sintim HO.",Future Med Chem. 2020 Jul;12(13):1253-1279. doi: 10.4155/fmc-2020-0046. Epub 2020 Jun 15.,Naclerio GA,Future Med Chem,2020,16/6/2020,,,10.4155/fmc-2020-0046,FtsZ
31166174,Regulation of Cell Division in Streptococci: Comparing with the Model Rods,"Xiang Z, Li Z, Zeng J, Li Y, Li J.",Curr Issues Mol Biol. 2019;32:259-326. doi: 10.21775/cimb.032.259. Epub 2019 Jun 5.,Xiang Z,Curr Issues Mol Biol,2019,6/6/2019,,,10.21775/cimb.032.259,FtsZ
31152469,"The ParB homologs, Spo0J and Noc, together prevent premature midcell Z ring assembly when the early stages of replication are blocked in Bacillus subtilis","Hajduk IV, Mann R, Rodrigues CDA, Harry EJ.",Mol Microbiol. 2019 Sep;112(3):766-784. doi: 10.1111/mmi.14319. Epub 2019 Jun 11.,Hajduk IV,Mol Microbiol,2019,2/6/2019,PMC6852036,,10.1111/mmi.14319,FtsZ
34043824,Integrative proteomics and metabolomics approach to elucidate the antimicrobial effect of simvastatin on Escherichia coli,"Kocak E, Nemutlu E, Kır S, Sagıroglu M, Özkul C.",Biomed Chromatogr. 2021 Oct;35(10):e5180. doi: 10.1002/bmc.5180. Epub 2021 Jun 13.,Kocak E,Biomed Chromatogr,2021,27/5/2021,,,10.1002/bmc.5180,FtsZ
31986172,Selection and validation of reference genes for gene expression studies in Pseudomonas brassicacearum GS20 using real-time quantitative reverse transcription PCR,"Bai B, Ren J, Bai F, Hao L.",PLoS One. 2020 Jan 27;15(1):e0227927. doi: 10.1371/journal.pone.0227927. eCollection 2020.,Bai B,PLoS One,2020,28/1/2020,PMC6984700,,10.1371/journal.pone.0227927,FtsZ
36873852,Next-generation membrane-active glycopeptide antibiotics that also inhibit bacterial cell division,"Sarkar P, De K, Modi M, Dhanda G, Priyadarshini R, Bandow JE, Haldar J.",Chem Sci. 2023 Jan 6;14(9):2386-2398. doi: 10.1039/d2sc05600c. eCollection 2023 Mar 1.,Sarkar P,Chem Sci,2023,6/3/2023,PMC9977398,,10.1039/d2sc05600c,FtsZ
33329433,Antagonistic Mechanism of Metabolites Produced by Lactobacillus casei on Lysis of Enterohemorrhagic Escherichia coli,"Aditya A, Peng M, Young A, Biswas D.",Front Microbiol. 2020 Nov 23;11:574422. doi: 10.3389/fmicb.2020.574422. eCollection 2020.,Aditya A,Front Microbiol,2020,17/12/2020,PMC7719638,,10.3389/fmicb.2020.574422,FtsZ
32712725,Morphology engineering: a new strategy to construct microbial cell factories,"Huo K, Zhao F, Zhang F, Liu R, Yang C.",World J Microbiol Biotechnol. 2020 Jul 26;36(9):127. doi: 10.1007/s11274-020-02903-5.,Huo K,World J Microbiol Biotechnol,2020,27/7/2020,,,10.1007/s11274-020-02903-5,FtsZ
31280333,"Vibrio chemaguriensis sp. nov., from Sundarbans, Bay of Bengal","Ghosh A, Bhadury P.",Curr Microbiol. 2019 Oct;76(10):1118-1127. doi: 10.1007/s00284-019-01731-7. Epub 2019 Jul 6.,Ghosh A,Curr Microbiol,2019,8/7/2019,,,10.1007/s00284-019-01731-7,FtsZ
35037113,The Planctomycetia: an overview of the currently largest class within the phylum Planctomycetes,"Vitorino IR, Lage OM.",Antonie Van Leeuwenhoek. 2022 Feb;115(2):169-201. doi: 10.1007/s10482-021-01699-0. Epub 2022 Jan 17.,Vitorino IR,Antonie Van Leeuwenhoek,2022,17/1/2022,,,10.1007/s10482-021-01699-0,FtsZ
34864906,Bacterial Endosymbionts of Bactericera maculipennis and Three Mitochondrial Haplotypes of B. cockerelli (Hemiptera: Psylloidea: Triozidae),"Cooper WR, Horton DR, Swisher-Grimm K, Krey K, Wildung MR.",Environ Entomol. 2022 Feb 16;51(1):94-107. doi: 10.1093/ee/nvab133.,Cooper WR,Environ Entomol,2022,5/12/2021,,,10.1093/ee/nvab133,FtsZ
33088653,Characterization of multidrug resistance in Vibrio species isolated from marine invertebrates from Andaman Sea,"Kumari P, Poddar A, Das SK.",3 Biotech. 2020 Oct;10(10):456. doi: 10.1007/s13205-020-02445-5. Epub 2020 Sep 30.,Kumari P,3 Biotech,2020,22/10/2020,PMC7525928,,10.1007/s13205-020-02445-5,FtsZ
32724139,Penicillin-binding proteins regulate multiple steps in the polarized cell division process of Chlamydia,"Cox JV, Abdelrahman YM, Ouellette SP.",Sci Rep. 2020 Jul 28;10(1):12588. doi: 10.1038/s41598-020-69397-x.,Cox JV,Sci Rep,2020,30/7/2020,PMC7387471,,10.1038/s41598-020-69397-x,FtsZ
31064824,Morphological Plasticity in a Sulfur-Oxidizing Marine Bacterium from the SUP05 Clade Enhances Dark Carbon Fixation,"Shah V, Zhao X, Lundeen RA, Ingalls AE, Nicastro D, Morris RM.",mBio. 2019 May 7;10(3):e00216-19. doi: 10.1128/mBio.00216-19.,Shah V,mBio,2019,9/5/2019,PMC6509183,,10.1128/mBio.00216-19,FtsZ
37041994,Association of multilocus sequencing types and antimicrobial resistance profiles of methicillin-resistant Mammaliicoccus sciuri in animals in Southern Thailand,"Boonchuay K, Sontigun N, Wongtawan T, Fungwithaya P.",Vet World. 2023 Feb;16(2):291-295. doi: 10.14202/vetworld.2023.291-295. Epub 2023 Feb 15.,Boonchuay K,Vet World,2023,12/4/2023,PMC10082716,,10.14202/vetworld.2023.291-295,FtsZ
36365035,"Molecular Detection and Phylogenetic Analyses of Diverse Bartonella Species in Bat Ectoparasites Collected from Yunnan Province, China","Kuang G, Zhang J, Yang W, Pan H, Han X, Yang L, Wang J, Yang T, Song Z, Feng Y, Liang G.",Pathogens. 2022 Nov 1;11(11):1283. doi: 10.3390/pathogens11111283.,Kuang G,Pathogens,2022,11/11/2022,PMC9699461,,10.3390/pathogens11111283,FtsZ
36143472,"The Role of MreB, MreC and MreD in the Morphology of the Diazotrophic Filament of Anabaena sp. PCC 7120","Velázquez-Suárez C, Luque I, Herrero A.",Life (Basel). 2022 Sep 15;12(9):1437. doi: 10.3390/life12091437.,Velázquez-Suárez C,Life (Basel),2022,23/9/2022,PMC9503725,,10.3390/life12091437,FtsZ
35055035,"Narrow Genetic Diversity of Wolbachia Symbionts in Acrididae Grasshopper Hosts (Insecta, Orthoptera)","Ilinsky Y, Demenkova M, Bykov R, Bugrov A.",Int J Mol Sci. 2022 Jan 13;23(2):853. doi: 10.3390/ijms23020853.,Ilinsky Y,Int J Mol Sci,2022,21/1/2022,PMC8775660,,10.3390/ijms23020853,FtsZ
32373093,Microbiome and Functional Analysis of a Traditional Food Process: Isolation of a Novel Species (Vibrio hibernica) With Industrial Potential,"Woods DF, Kozak IM, O'Gara F.",Front Microbiol. 2020 Apr 9;11:647. doi: 10.3389/fmicb.2020.00647. eCollection 2020.,Woods DF,Front Microbiol,2020,7/5/2020,PMC7179675,,10.3389/fmicb.2020.00647,FtsZ
32109355,"CRISPRi System as an Efficient, Simple Platform for Rapid Identification of Genes Involved in Pollutant Transformation by Aeromonas hydrophila","Wu J, Cheng ZH, Min D, Cheng L, He RL, Liu DF, Li WW.",Environ Sci Technol. 2020 Mar 17;54(6):3306-3315. doi: 10.1021/acs.est.9b07191. Epub 2020 Mar 5.,Wu J,Environ Sci Technol,2020,29/2/2020,,,10.1021/acs.est.9b07191,FtsZ
30145374,Synthesis and antibacterial evaluation of 13-substituted cycloberberine derivatives as a novel class of anti-MRSA agents,"Fan TY, Wang YX, Tang S, Hu XX, Zen QX, Pang J, Yang YS, You XF, Song DQ.",Eur J Med Chem. 2018 Sep 5;157:877-886. doi: 10.1016/j.ejmech.2018.08.050. Epub 2018 Aug 18.,Fan TY,Eur J Med Chem,2018,27/8/2018,,,10.1016/j.ejmech.2018.08.050,FtsZ
29778634,Genetic characterization of Anaplasma marginale strains from Tunisia using single and multiple gene typing reveals novel variants with an extensive genetic diversity,"Ben Said M, Ben Asker A, Belkahia H, Ghribi R, Selmi R, Messadi L.",Ticks Tick Borne Dis. 2018 Jul;9(5):1275-1285. doi: 10.1016/j.ttbdis.2018.05.008. Epub 2018 May 12.,Ben Said M,Ticks Tick Borne Dis,2018,21/5/2018,,,10.1016/j.ttbdis.2018.05.008,FtsZ
36858742,Elucidating the mechanism of antimicrobial resistance in Mycobacterium tuberculosis using gene interaction networks,"G K, Vasudevan K, Dey H, Kausar T, Udhaya Kumar S, Thirumal Kumar D, Zayed H, George Priya Doss C.",Adv Protein Chem Struct Biol. 2023;134:53-74. doi: 10.1016/bs.apcsb.2022.11.017. Epub 2022 Dec 22.,G K,Adv Protein Chem Struct Biol,2023,1/3/2023,,,10.1016/bs.apcsb.2022.11.017,FtsZ
35336065,Detection of Potential Zoonotic Bartonella Species in African Giant Rats (Cricetomys gambianus) and Fleas from an Urban Area in Senegal,"Demoncheaux JP, Medkour H, Louni M, Laugier L, Pasqualini C, Fenollar F, Davoust B, Mediannikov O.",Microorganisms. 2022 Feb 22;10(3):489. doi: 10.3390/microorganisms10030489.,Demoncheaux JP,Microorganisms,2022,26/3/2022,PMC8953472,,10.3390/microorganisms10030489,FtsZ
32777455,First report on Bartonella henselae in dromedary camels (Camelus dromedarius),"Selmi R, Ben Said M, Ben Yahia H, Abdelaali H, Boulouis HJ, Messadi L.",Infect Genet Evol. 2020 Nov;85:104496. doi: 10.1016/j.meegid.2020.104496. Epub 2020 Aug 7.,Selmi R,Infect Genet Evol,2020,11/8/2020,,,10.1016/j.meegid.2020.104496,FtsZ
31111929,Regulation by FurC in Anabaena Links the Oxidative Stress Response to Photosynthetic Metabolism,"Sevilla E, Sarasa-Buisan C, González A, Cases R, Kufryk G, Peleato ML, Fillat MF.",Plant Cell Physiol. 2019 Aug 1;60(8):1778-1789. doi: 10.1093/pcp/pcz094.,Sevilla E,Plant Cell Physiol,2019,22/5/2019,,,10.1093/pcp/pcz094,FtsZ
30959879,Survey of Toxin⁻Antitoxin Systems in Erwinia amylovora Reveals Insights into Diversity and Functional Specificity,"Shidore T, Zeng Q, Triplett LR.",Toxins (Basel). 2019 Apr 6;11(4):206. doi: 10.3390/toxins11040206.,Shidore T,Toxins (Basel),2019,10/4/2019,PMC6521040,,10.3390/toxins11040206,FtsZ
30676080,A Comprehensive Multilocus Sequence Typing Scheme for Identification and Genotyping of Staphylococcus Strains,"Song M, Li Q, He Y, Lan L, Feng Z, Fan Y, Liu H, Qin F, Chen D, Yang M.",Foodborne Pathog Dis. 2019 May;16(5):331-338. doi: 10.1089/fpd.2018.2565. Epub 2019 Jan 24.,Song M,Foodborne Pathog Dis,2019,25/1/2019,,,10.1089/fpd.2018.2565,FtsZ
30316784,"Rewired Downregulation of DNA Gyrase Impacts Cell Division, Expression of Topology Modulators, and Transcription in Mycobacterium smegmatis","Guha S, Udupa S, Ahmed W, Nagaraja V.",J Mol Biol. 2018 Dec 7;430(24):4986-5001. doi: 10.1016/j.jmb.2018.10.001. Epub 2018 Oct 11.,Guha S,J Mol Biol,2018,15/10/2018,,,10.1016/j.jmb.2018.10.001,FtsZ
29286204,Genetic variation and potential coinfection of Wolbachia among widespread Asian citrus psyllid (Diaphorina citri Kuwayama) populations,"Chu CC, Hoffmann M, Braswell WE, Pelz-Stelinski KS.",Insect Sci. 2019 Aug;26(4):671-682. doi: 10.1111/1744-7917.12566. Epub 2018 Feb 13.,Chu CC,Insect Sci,2019,30/12/2017,PMC7379232,,10.1111/1744-7917.12566,FtsZ
31784208,"Halomonas borealis sp. nov. and Halomonas niordiana sp. nov., two new species isolated from seawater","Diéguez AL, Balboa S, Romalde JL.",Syst Appl Microbiol. 2020 Jan;43(1):126040. doi: 10.1016/j.syapm.2019.126040. Epub 2019 Nov 17.,Diéguez AL,Syst Appl Microbiol,2020,1/12/2019,,,10.1016/j.syapm.2019.126040,FtsZ
35579491,Dendrimersome Synthetic Cells Harbor Cell Division Machinery of Bacteria,"Wagner AM, Eto H, Joseph A, Kohyama S, Haraszti T, Zamora RA, Vorobii M, Giannotti MI, Schwille P, Rodriguez-Emmenegger C.",Adv Mater. 2022 Jul;34(28):e2202364. doi: 10.1002/adma.202202364. Epub 2022 Jun 6.,Wagner AM,Adv Mater,2022,17/5/2022,,,10.1002/adma.202202364,FtsZ
34453005,FtsA acts through FtsW to promote cell wall synthesis during cell division in Escherichia coli,"Park KT, Pichoff S, Du S, Lutkenhaus J.",Proc Natl Acad Sci U S A. 2021 Aug 31;118(35):e2107210118. doi: 10.1073/pnas.2107210118.,Park KT,Proc Natl Acad Sci U S A,2021,28/8/2021,PMC8536321,,10.1073/pnas.2107210118,FtsZ
33784496,Genetic requirements for cell division in a genomically minimal cell,"Pelletier JF, Sun L, Wise KS, Assad-Garcia N, Karas BJ, Deerinck TJ, Ellisman MH, Mershin A, Gershenfeld N, Chuang RY, Glass JI, Strychalski EA.",Cell. 2021 Apr 29;184(9):2430-2440.e16. doi: 10.1016/j.cell.2021.03.008. Epub 2021 Mar 29.,Pelletier JF,Cell,2021,30/3/2021,,,10.1016/j.cell.2021.03.008,FtsZ
33436999,"Diversity unearthed by the estimated molecular phylogeny and ecologically quantitative characteristics of uncultured Ehrlichia bacteria in Haemaphysalis ticks, Japan","Su H, Onoda E, Tai H, Fujita H, Sakabe S, Azuma K, Akachi S, Oishi S, Abe F, Ando S, Ohashi N.",Sci Rep. 2021 Jan 12;11(1):687. doi: 10.1038/s41598-020-80690-7.,Su H,Sci Rep,2021,13/1/2021,PMC7804854,,10.1038/s41598-020-80690-7,FtsZ
32416080,AimB Is a Small Protein Regulator of Cell Size and MreB Assembly,"Werner JN, Shi H, Hsin J, Huang KC, Gitai Z, Klein EA.",Biophys J. 2020 Aug 4;119(3):593-604. doi: 10.1016/j.bpj.2020.04.029. Epub 2020 May 4.,Werner JN,Biophys J,2020,17/5/2020,PMC7399478,,10.1016/j.bpj.2020.04.029,FtsZ
30903818,QSAR-based investigation on antibiotics facilitating emergence and dissemination of antibiotic resistance genes: A case study of sulfonamides against mutation and conjugative transfer in Escherichia coli,"Sun H, Chen R, Jiang W, Chen X, Lin Z.",Environ Res. 2019 Jun;173:87-96. doi: 10.1016/j.envres.2019.03.020. Epub 2019 Mar 8.,Sun H,Environ Res,2019,24/3/2019,,,10.1016/j.envres.2019.03.020,FtsZ
34928180,What Is Motion? Recent Advances in the Study of Molecular Movement Patterns of the Peptidoglycan Synthesis Machines,"Lamanna MM, Maurelli AT.",J Bacteriol. 2022 Apr 19;204(4):e0059821. doi: 10.1128/JB.00598-21. Epub 2021 Dec 20.,Lamanna MM,J Bacteriol,2022,20/12/2021,PMC9017339,,10.1128/JB.00598-21,FtsZ
33454013,The C-terminal region of the plasmid partitioning protein TubY is a tetramer that can bind membranes and DNA,Hayashi I.,J Biol Chem. 2020 Dec 18;295(51):17770-17780. doi: 10.1074/jbc.RA120.014705.,Hayashi I,J Biol Chem,2020,17/1/2021,PMC7762940,,10.1074/jbc.RA120.014705,FtsZ
32066776,Chemically labeled toxins or bioactive peptides show a heterogeneous intracellular distribution and low spatial overlap with autofluorescence in bloom-forming cyanobacteria,"Kurmayer R, Entfellner E, Weisse T, Offterdinger M, Rentmeister A, Deng L.",Sci Rep. 2020 Feb 17;10(1):2781. doi: 10.1038/s41598-020-59381-w.,Kurmayer R,Sci Rep,2020,19/2/2020,PMC7026079,,10.1038/s41598-020-59381-w,FtsZ
31829914,"Frankia soli sp. nov., an actinobacterium isolated from soil beneath Ceanothus jepsonii","Gtari M, Ghodhbane-Gtari F, Nouioui I.",Int J Syst Evol Microbiol. 2020 Feb;70(2):1203-1209. doi: 10.1099/ijsem.0.003899.,Gtari M,Int J Syst Evol Microbiol,2020,13/12/2019,,,10.1099/ijsem.0.003899,FtsZ
31290194,SosA inhibits cell division in Staphylococcus aureus in response to DNA damage,"Bojer MS, Wacnik K, Kjelgaard P, Gallay C, Bottomley AL, Cohn MT, Lindahl G, Frees D, Veening JW, Foster SJ, Ingmer H.",Mol Microbiol. 2019 Oct;112(4):1116-1130. doi: 10.1111/mmi.14350. Epub 2019 Aug 16.,Bojer MS,Mol Microbiol,2019,11/7/2019,PMC6851548,,10.1111/mmi.14350,FtsZ
29804705,"Photobacterium malacitanum sp. nov., and Photobacterium andalusiense sp. nov., two new bacteria isolated from diseased farmed fish in Southern Spain","Labella AM, Castro MD, Manchado M, Lucena T, Arahal DR, Borrego JJ.",Syst Appl Microbiol. 2018 Sep;41(5):444-451. doi: 10.1016/j.syapm.2018.04.005. Epub 2018 May 24.,Labella AM,Syst Appl Microbiol,2018,29/5/2018,,,10.1016/j.syapm.2018.04.005,FtsZ
35030199,Cytoplasmic incompatibility in the semivoltine longicorn beetle Acalolepta fraudatrix (Coleoptera: Cerambycidae) double infected with Wolbachia,"Aikawa T, Maehara N, Ichihara Y, Masuya H, Nakamura K, Anbutsu H.",PLoS One. 2022 Jan 14;17(1):e0261928. doi: 10.1371/journal.pone.0261928. eCollection 2022.,Aikawa T,PLoS One,2022,14/1/2022,PMC8759696,,10.1371/journal.pone.0261928,FtsZ
34835442,YgfY Contributes to Stress Tolerance in Shewanella oneidensis Neither as an Antitoxin Nor as a Flavinylation Factor of Succinate Dehydrogenase,"Zhang MX, Zheng KL, Tang AG, Hu XX, Guo XX, Wu C, Cheng YY.",Microorganisms. 2021 Nov 9;9(11):2316. doi: 10.3390/microorganisms9112316.,Zhang MX,Microorganisms,2021,27/11/2021,PMC8621075,,10.3390/microorganisms9112316,FtsZ
34293284,Armeniaspirols inhibit the AAA+ proteases ClpXP and ClpYQ leading to cell division arrest in Gram-positive bacteria,"Labana P, Dornan MH, Lafrenière M, Czarny TL, Brown ED, Pezacki JP, Boddy CN.",Cell Chem Biol. 2021 Dec 16;28(12):1703-1715.e11. doi: 10.1016/j.chembiol.2021.07.001. Epub 2021 Jul 21.,Labana P,Cell Chem Biol,2021,22/7/2021,,,10.1016/j.chembiol.2021.07.001,FtsZ
33753466,"Bacillus anthracis chain length, a virulence determinant, is regulated by membrane localized serine/threonine protein kinase PrkC","Dhasmana N, Kumar N, Gangwal A, Keshavam CC, Singh LK, Sangwan N, Nashier P, Biswas S, Pomerantsev AP, Leppla SH, Singh Y, Gupta M.",J Bacteriol. 2021 Jun 1;203(11):e00582-20. doi: 10.1128/JB.00582-20. Epub 2021 Mar 22.,Dhasmana N,J Bacteriol,2021,23/3/2021,PMC8117516,,10.1128/JB.00582-20,FtsZ
32153547,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide,"Jenei S, Tiricz H, Szolomájer J, Tímár E, Klement É, Al Bouni MA, Lima RM, Kata D, Harmati M, Buzás K, Földesi I, Tóth GK, Endre G, Kondorosi É.",Front Microbiol. 2020 Feb 21;11:270. doi: 10.3389/fmicb.2020.00270. eCollection 2020.,Jenei S,Front Microbiol,2020,11/3/2020,PMC7047876,,10.3389/fmicb.2020.00270,FtsZ
36515540,Magnesium Modulates Bacillus subtilis Cell Division Frequency,"Guo T, Herman JK.",J Bacteriol. 2023 Jan 26;205(1):e0037522. doi: 10.1128/jb.00375-22. Epub 2022 Dec 14.,Guo T,J Bacteriol,2023,14/12/2022,PMC9879117,,10.1128/jb.00375-22,FtsZ
35115684,Cell density-dependent antibiotic tolerance to inhibition of the elongation machinery requires fully functional PBP1B,"Grinnell A, Sloan R, Morgenstein RM.",Commun Biol. 2022 Feb 3;5(1):107. doi: 10.1038/s42003-022-03056-x.,Grinnell A,Commun Biol,2022,4/2/2022,PMC8813938,,10.1038/s42003-022-03056-x,FtsZ
32013778,Prevalence of Bartonella spp. Infection in Patients with Sickle Cell Disease,"Soares TCB, Isaias GAB, Almeida AR, Drummond MR, da Silva MN, Lania BG, Vieira-Damiani G, Saad STO, Ericson ME, Gupta K, Velho PENF.",Vector Borne Zoonotic Dis. 2020 Jul;20(7):509-512. doi: 10.1089/vbz.2019.2545. Epub 2020 Feb 3.,Soares TCB,Vector Borne Zoonotic Dis,2020,5/2/2020,PMC7336878,,10.1089/vbz.2019.2545,FtsZ
30773849,"Antibacterial activity of synthetic 1,3-bis(aryloxy)propan-2-amines against Gram-positive bacteria","Serafim MSM, Lavorato SN, Kronenberger T, Sousa YV, Oliveira GP, Dos Santos SG, Kroon EG, Maltarollo VG, Alves RJ, Mota BEF.",Microbiologyopen. 2019 Nov;8(11):e814. doi: 10.1002/mbo3.814. Epub 2019 Feb 17.,Serafim MSM,Microbiologyopen,2019,19/2/2019,PMC6855212,,10.1002/mbo3.814,FtsZ
30624116,"Shifting the Balance: Heat Stress Challenges the Symbiotic Interactions of the Asian Citrus Psyllid, Diaphorina citri (Hemiptera, Liviidae)","Dossi FCA, da Silva EP, Cônsoli FL.",Biol Bull. 2018 Dec;235(3):195-203. doi: 10.1086/699755. Epub 2018 Oct 1.,Dossi FCA,Biol Bull,2018,10/1/2019,,,10.1086/699755,FtsZ
29686141,"YtfB, an OapA Domain-Containing Protein, Is a New Cell Division Protein in Escherichia coli","Jorgenson MA, Young KD.",J Bacteriol. 2018 Jun 11;200(13):e00046-18. doi: 10.1128/JB.00046-18. Print 2018 Jul 1.,Jorgenson MA,J Bacteriol,2018,25/4/2018,PMC5996693,,10.1128/JB.00046-18,FtsZ
36806683,Interaction of the bacterial division regulator MinE with lipid bicelles studied by NMR spectroscopy,"Cai M, Tugarinov V, Chaitanya Chiliveri S, Huang Y, Schwieters CD, Mizuuchi K, Clore GM.",J Biol Chem. 2023 Apr;299(4):103037. doi: 10.1016/j.jbc.2023.103037. Epub 2023 Feb 17.,Cai M,J Biol Chem,2023,22/2/2023,PMC10031476,,10.1016/j.jbc.2023.103037,FtsZ
34253062,CdrS Is a Global Transcriptional Regulator Influencing Cell Division in Haloferax volcanii,"Liao Y, Vogel V, Hauber S, Bartel J, Alkhnbashi OS, Maaß S, Schwarz TS, Backofen R, Becher D, Duggin IG, Marchfelder A.",mBio. 2021 Aug 31;12(4):e0141621. doi: 10.1128/mBio.01416-21. Epub 2021 Jul 13.,Liao Y,mBio,2021,13/7/2021,PMC8406309,,10.1128/mBio.01416-21,FtsZ
33168082,"Wolbachia in mosquitoes from the Central Valley of California, USA","Torres R, Hernandez E, Flores V, Ramirez JL, Joyce AL.",Parasit Vectors. 2020 Nov 10;13(1):558. doi: 10.1186/s13071-020-04429-z.,Torres R,Parasit Vectors,2020,10/11/2020,PMC7653878,,10.1186/s13071-020-04429-z,FtsZ
32904298,Investigation of Bartonella spp. in brazilian mammals with emphasis on rodents and bats from the Atlantic Forest,"Gonçalves-Oliveira J, Rozental T, Guterres A, Teixeira BR, Andrade-Silva BE, Costa-Neto SFD, Furtado MC, Moratelli R, D'Andrea PS, Lemos ERS.",Int J Parasitol Parasites Wildl. 2020 Jul 15;13:80-89. doi: 10.1016/j.ijppaw.2020.07.004. eCollection 2020 Dec.,Gonçalves-Oliveira J,Int J Parasitol Parasites Wildl,2020,9/9/2020,PMC7452516,,10.1016/j.ijppaw.2020.07.004,FtsZ
35583339,High Abundance of Transcription Regulators Compacts the Nucleoid in Escherichia coli,"Yilmaz C, Schnetz K.",J Bacteriol. 2022 Jun 21;204(6):e0002622. doi: 10.1128/jb.00026-22. Epub 2022 May 18.,Yilmaz C,J Bacteriol,2022,18/5/2022,PMC9210969,,10.1128/jb.00026-22,FtsZ
31993609,Bimetallic gold-silver nanoparticles mediate bacterial killing by disrupting the actin cytoskeleton MreB,"Jena P, Bhattacharya M, Bhattacharjee G, Satpati B, Mukherjee P, Senapati D, Srinivasan R.",Nanoscale. 2020 Feb 14;12(6):3731-3749. doi: 10.1039/c9nr10700b. Epub 2020 Jan 29.,Jena P,Nanoscale,2020,30/1/2020,,,10.1039/c9nr10700b,FtsZ
31085632,GROWTH POLE RING protein forms a 200-nm-diameter ring structure essential for polar growth and rod shape in Agrobacterium tumefaciens,"Zupan JR, Grangeon R, Robalino-Espinosa JS, Garnica N, Zambryski P.",Proc Natl Acad Sci U S A. 2019 May 28;116(22):10962-10967. doi: 10.1073/pnas.1905900116. Epub 2019 May 13.,Zupan JR,Proc Natl Acad Sci U S A,2019,16/5/2019,PMC6561148,,10.1073/pnas.1905900116,FtsZ
37047147,Anti-Bacterial and Anti-Biofilm Activities of Anandamide against the Cariogenic Streptococcus mutans,"Wolfson G, Sionov RV, Smoum R, Korem M, Polacheck I, Steinberg D.",Int J Mol Sci. 2023 Mar 24;24(7):6177. doi: 10.3390/ijms24076177.,Wolfson G,Int J Mol Sci,2023,13/4/2023,PMC10094667,,10.3390/ijms24076177,FtsZ
34474805,"Detection of zoonotic Bartonella species in ticks and fleas parasitizing free-ranging cats and dogs residing in temples of Bangkok, Thailand","Saengsawang P, Kaewmongkol G, Phoosangwalthong P, Chimnoi W, Inpankaew T.",Vet Parasitol Reg Stud Reports. 2021 Jul;25:100612. doi: 10.1016/j.vprsr.2021.100612. Epub 2021 Jul 25.,Saengsawang P,Vet Parasitol Reg Stud Reports,2021,3/9/2021,,,10.1016/j.vprsr.2021.100612,FtsZ
34190606,Improved Dynamic Range of a Rhamnose-Inducible Promoter for Gene Expression in Burkholderia spp,"Hogan AM, Jeffers KR, Palacios A, Cardona ST.",Appl Environ Microbiol. 2021 Aug 26;87(18):e0064721. doi: 10.1128/AEM.00647-21. Epub 2021 Aug 26.,Hogan AM,Appl Environ Microbiol,2021,30/6/2021,PMC8388826,,10.1128/AEM.00647-21,FtsZ
33722843,"A newly identified prophage-encoded gene, ymfM, causes SOS-inducible filamentation in Escherichia coli","Ansari S, Walsh JC, Bottomley AL, Duggin IG, Burke C, Harry EJ.",J Bacteriol. 2021 Jun 1;203(11):e00646-20. doi: 10.1128/JB.00646-20. Epub 2021 Mar 15.,Ansari S,J Bacteriol,2021,16/3/2021,PMC8117526,,10.1128/JB.00646-20,FtsZ
32681185,Proteomic profiling of developing wheat heads under water-stress,"Islam S, Wang P, Vincent D, Khan JM, Juhasz A, Diepeveen D, Lipscombe RJ, Ma W, Appels R.",Funct Integr Genomics. 2020 Sep;20(5):695-710. doi: 10.1007/s10142-020-00746-9. Epub 2020 Jul 17.,Islam S,Funct Integr Genomics,2020,19/7/2020,,,10.1007/s10142-020-00746-9,FtsZ
30700498,Minimal in vitro systems shed light on cell polarity,"Vendel KJA, Tschirpke S, Shamsi F, Dogterom M, Laan L.",J Cell Sci. 2019 Jan 30;132(4):jcs217554. doi: 10.1242/jcs.217554.,Vendel KJA,J Cell Sci,2019,1/2/2019,,,10.1242/jcs.217554,FtsZ
37262044,Comparison of molecular methods for Bartonella henselae detection in blood donors,"Drummond MR, Dos Santos LS, de Almeida AR, Lins KA, Barjas-Castro ML, Diniz PPVP, Velho PENF.",PLoS Negl Trop Dis. 2023 Jun 1;17(6):e0011336. doi: 10.1371/journal.pntd.0011336. eCollection 2023 Jun.,Drummond MR,PLoS Negl Trop Dis,2023,1/6/2023,PMC10234562,,10.1371/journal.pntd.0011336,FtsZ
36557738,"Investigation of the Antibacterial, Anti-Biofilm, and Antioxidative Effect of Piper betle Leaf Extract against Bacillus gaemokensis MW067143 Isolated from Dental Caries, an In Vitro-In Silico Approach","Jalil V, Khan M, Haider SZ, Shamim S.",Microorganisms. 2022 Dec 15;10(12):2485. doi: 10.3390/microorganisms10122485.,Jalil V,Microorganisms,2022,23/12/2022,PMC9788100,,10.3390/microorganisms10122485,FtsZ
33864545,"Vibrio nitrifigilis sp. nov., a marine nitrogen-fixing bacterium isolated from the lagoon sediment of an islet inside an atoll","Huang WS, Wang LT, Chen JS, Chen YT, Wei ST, Chiang YR, Wang PL, Lee TH, Lin ST, Huang L, Shieh WY.",Antonie Van Leeuwenhoek. 2021 Jul;114(7):933-945. doi: 10.1007/s10482-021-01567-x. Epub 2021 Apr 17.,Huang WS,Antonie Van Leeuwenhoek,2021,17/4/2021,,,10.1007/s10482-021-01567-x,FtsZ
31548275,Regulation of Cell Division in Bacteria by Monitoring Genome Integrity and DNA Replication Status,"Burby PE, Simmons LA.",J Bacteriol. 2020 Jan 2;202(2):e00408-19. doi: 10.1128/JB.00408-19. Print 2020 Jan 2.,Burby PE,J Bacteriol,2020,25/9/2019,PMC6941525,,10.1128/JB.00408-19,FtsZ
30030730,"Frankia torreyi sp. nov., the first actinobacterium of the genus Frankia Brunchorst 1886, 174(AL) isolated in axenic culture","Nouioui I, Ghodhbane-Gtari F, Jando M, Tisa LS, Klenk HP, Gtari M.",Antonie Van Leeuwenhoek. 2019 Jan;112(1):57-65. doi: 10.1007/s10482-018-1131-8. Epub 2018 Jul 20.,Nouioui I,Antonie Van Leeuwenhoek,2019,22/7/2018,,,10.1007/s10482-018-1131-8,FtsZ
36636928,Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study,"Zheng BX, Yu J, Long W, Chan KH, Leung AS, Wong WL.",Chem Commun (Camb). 2023 Feb 2;59(11):1415-1433. doi: 10.1039/d2cc05945b.,Zheng BX,Chem Commun (Camb),2023,13/1/2023,,,10.1039/d2cc05945b,FtsZ
35884202,Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling,"Boussamba-Digombou KJ, Sandasi M, Kamatou GP, van Vuuren S, Sawicki R, Fakhar Z, Viljoen AM.",Antibiotics (Basel). 2022 Jul 14;11(7):948. doi: 10.3390/antibiotics11070948.,Boussamba-Digombou KJ,Antibiotics (Basel),2022,27/7/2022,PMC9311982,,10.3390/antibiotics11070948,FtsZ
32529355,"Molecular characterization of Cardinium, Rickettsia, Spiroplasma and Wolbachia in mite species from citrus orchards","Pina T, Sabater-Muñoz B, Cabedo-López M, Cruz-Miralles J, Jaques JA, Hurtado-Ruiz MA.",Exp Appl Acarol. 2020 Jul;81(3):335-355. doi: 10.1007/s10493-020-00508-z. Epub 2020 Jun 11.,Pina T,Exp Appl Acarol,2020,13/6/2020,,,10.1007/s10493-020-00508-z,FtsZ
31013389,Small alarmones (p)ppGpp regulate virulence associated traits and pathogenesis of Salmonella enterica serovar Typhi,"Dasgupta S, Das S, Biswas A, Bhadra RK, Das S.",Cell Microbiol. 2019 Aug;21(8):e13034. doi: 10.1111/cmi.13034. Epub 2019 May 9.,Dasgupta S,Cell Microbiol,2019,24/4/2019,,,10.1111/cmi.13034,FtsZ
37098535,Screening of natural Wolbachia infection in mosquitoes (Diptera: Culicidae) from the Cape Verde islands,"da Moura AJF, Valadas V, Da Veiga Leal S, Montalvo Sabino E, Sousa CA, Pinto J.",Parasit Vectors. 2023 Apr 25;16(1):142. doi: 10.1186/s13071-023-05745-w.,da Moura AJF,Parasit Vectors,2023,25/4/2023,PMC10131387,,10.1186/s13071-023-05745-w,FtsZ
33462399,"Genetic diversity of Bartonella species in small mammals in the Qaidam Basin, western China","Rao H, Li S, Lu L, Wang R, Song X, Sun K, Shi Y, Li D, Yu J.",Sci Rep. 2021 Jan 18;11(1):1735. doi: 10.1038/s41598-021-81508-w.,Rao H,Sci Rep,2021,19/1/2021,PMC7814127,,10.1038/s41598-021-81508-w,FtsZ
31527115,Cryptic-Prophage-Encoded Small Protein DicB Protects Escherichia coli from Phage Infection by Inhibiting Inner Membrane Receptor Proteins,"Ragunathan PT, Vanderpool CK.",J Bacteriol. 2019 Nov 5;201(23):e00475-19. doi: 10.1128/JB.00475-19. Print 2019 Dec 1.,Ragunathan PT,J Bacteriol,2019,19/9/2019,PMC6832061,,10.1128/JB.00475-19,FtsZ
30505805,"Survival, Virulent Characteristics, and Transcriptomic Analyses of the Pathogenic Vibrio anguillarum Under Starvation Stress","Gao X, Pi D, Chen N, Li X, Liu X, Yang H, Wei W, Zhang X.",Front Cell Infect Microbiol. 2018 Nov 16;8:389. doi: 10.3389/fcimb.2018.00389. eCollection 2018.,Gao X,Front Cell Infect Microbiol,2018,4/12/2018,PMC6250815,,10.3389/fcimb.2018.00389,FtsZ
32985137,Molecular survey of Bartonella spp. and haemoplasmas in American minks (Neovison vison),"Sepúlveda-García P, Raffo E, Medina-Vogel G, Muñoz F, Muñoz P, Alabí A, Navarrete-Talloni MJ, Gonçalves LR, Califre de Mello VV, Machado RZ, André MR, Bittencourt P, Müller A.",Transbound Emerg Dis. 2021 Jul;68(4):2094-2110. doi: 10.1111/tbed.13857. Epub 2020 Oct 16.,Sepúlveda-García P,Transbound Emerg Dis,2021,28/9/2020,,,10.1111/tbed.13857,FtsZ
31505765,First Report of Microcystis Strains Producing MC-FR and -WR Toxins in Japan,"Ikehara T, Kuniyoshi K, Yamaguchi H, Tanabe Y, Sano T, Yoshimoto M, Oshiro N, Nakashima S, Yasumoto-Hirose M.",Toxins (Basel). 2019 Sep 9;11(9):521. doi: 10.3390/toxins11090521.,Ikehara T,Toxins (Basel),2019,12/9/2019,PMC6784158,,10.3390/toxins11090521,FtsZ
29653822,"Robust Frankia phylogeny, species delineation and intraspecies diversity based on Multi-Locus Sequence Analysis (MLSA) and Single-Locus Strain Typing (SLST) adapted to a large sample size","Pozzi AC, Bautista-Guerrero HH, Abby SS, Herrera-Belaroussi A, Abrouk D, Normand P, Menu F, Fernandez MP.",Syst Appl Microbiol. 2018 Jul;41(4):311-323. doi: 10.1016/j.syapm.2018.03.002. Epub 2018 Mar 29.,Pozzi AC,Syst Appl Microbiol,2018,15/4/2018,,,10.1016/j.syapm.2018.03.002,FtsZ
33582485,Diversity of methicillin-resistant coagulase-negative Staphylococcus spp. and methicillin-resistant Mammaliicoccus spp. isolated from ruminants and New World camelids,"Schauer B, Szostak MP, Ehricht R, Monecke S, Feßler AT, Schwarz S, Spergser J, Krametter-Frötscher R, Loncaric I.",Vet Microbiol. 2021 Mar;254:109005. doi: 10.1016/j.vetmic.2021.109005. Epub 2021 Feb 4.,Schauer B,Vet Microbiol,2021,14/2/2021,,,10.1016/j.vetmic.2021.109005,FtsZ
34650158,E. coli aggregation and impaired cell division after terahertz irradiation,"Peltek S, Meshcheryakova I, Kiseleva E, Oshchepkov D, Rozanov A, Serdyukov D, Demidov E, Vasiliev G, Vinokurov N, Bryanskaya A, Bannikova S, Popik V, Goryachkovskaya T.",Sci Rep. 2021 Oct 14;11(1):20464. doi: 10.1038/s41598-021-99665-3.,Peltek S,Sci Rep,2021,15/10/2021,PMC8516962,,10.1038/s41598-021-99665-3,FtsZ
29784711,Quantitative Proteome and Phosphoproteome Analyses of Streptomyces coelicolor Reveal Proteins and Phosphoproteins Modulating Differentiation and Secondary Metabolism,"Rioseras B, Shliaha PV, Gorshkov V, Yagüe P, López-García MT, Gonzalez-Quiñonez N, Kovalchuk S, Rogowska-Wrzesinska A, Jensen ON, Manteca A.",Mol Cell Proteomics. 2018 Aug;17(8):1591-1611. doi: 10.1074/mcp.RA117.000515. Epub 2018 May 21.,Rioseras B,Mol Cell Proteomics,2018,23/5/2018,PMC6072539,EMS78969,10.1074/mcp.RA117.000515,FtsZ
33601139,Antibacterial activity of a new monocarbonyl analog of curcumin MAC 4 is associated with divisome disruption,"Polaquini CR, Marques BC, Ayusso GM, Morão LG, Sardi JCO, Campos DL, Silva IC, Cavalca LB, Scheffers DJ, Rosalen PL, Pavan FR, Ferreira H, Regasini LO.",Bioorg Chem. 2021 Apr;109:104668. doi: 10.1016/j.bioorg.2021.104668. Epub 2021 Jan 27.,Polaquini CR,Bioorg Chem,2021,18/2/2021,,,10.1016/j.bioorg.2021.104668,FtsZ
31870290,Wolbachia infection in Argentinean populations of Anastrepha fraterculus sp1: preliminary evidence of sex ratio distortion by one of two strains,"Conte CA, Segura DF, Milla FH, Augustinos A, Cladera JL, Bourtzis K, Lanzavecchia SB.",BMC Microbiol. 2019 Dec 24;19(Suppl 1):289. doi: 10.1186/s12866-019-1652-y.,Conte CA,BMC Microbiol,2019,25/12/2019,PMC6929328,,10.1186/s12866-019-1652-y,FtsZ
30323039,Pathway-Directed Screen for Inhibitors of the Bacterial Cell Elongation Machinery,"Buss JA, Baidin V, Welsh MA, Flores-Kim J, Cho H, Wood BM, Uehara T, Walker S, Kahne D, Bernhardt TG.",Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01530-18. doi: 10.1128/AAC.01530-18. Print 2019 Jan.,Buss JA,Antimicrob Agents Chemother,2018,17/10/2018,PMC6325226,,10.1128/AAC.01530-18,FtsZ
32571427,"Development of a multiplex qPCR-based approach for the diagnosis of Dirofilaria immitis, D. repens and Acanthocheilonema reconditum","Laidoudi Y, Davoust B, Varloud M, Niang EHA, Fenollar F, Mediannikov O.",Parasit Vectors. 2020 Jun 22;13(1):319. doi: 10.1186/s13071-020-04185-0.,Laidoudi Y,Parasit Vectors,2020,24/6/2020,PMC7309989,,10.1186/s13071-020-04185-0,FtsZ
31076434,A Strongly Fluorescing Anaerobic Reporter and Protein-Tagging System for Clostridium Organisms Based on the Fluorescence-Activating and Absorption-Shifting Tag Protein (FAST),"Streett HE, Kalis KM, Papoutsakis ET.",Appl Environ Microbiol. 2019 Jul 1;85(14):e00622-19. doi: 10.1128/AEM.00622-19. Print 2019 Jul 15.,Streett HE,Appl Environ Microbiol,2019,12/5/2019,PMC6606882,,10.1128/AEM.00622-19,FtsZ
33604234,Computational insight into the protective mechanism of Allium iranicum Wendelbo. Alliaceae in a mouse model of Staphylococcosis: focus on dietary phytocannabinoid trans-caryophyllene,"Mohammed LJ, Chehri K, Karimi I, Karimi N.",In Silico Pharmacol. 2021 Feb 7;9(1):17. doi: 10.1007/s40203-021-00078-x. eCollection 2021.,Mohammed LJ,In Silico Pharmacol,2021,19/2/2021,PMC7867674,,10.1007/s40203-021-00078-x,FtsZ
33482884,Lipoptena fortisetosa as a vector of Bartonella bacteria in Japanese sika deer (Cervus nippon),"Sato S, Kabeya H, Ishiguro S, Shibasaki Y, Maruyama S.",Parasit Vectors. 2021 Jan 22;14(1):73. doi: 10.1186/s13071-021-04585-w.,Sato S,Parasit Vectors,2021,23/1/2021,PMC7821476,,10.1186/s13071-021-04585-w,FtsZ
36731116,Properties of Configurationally Stable Atropoenantiomers in Macrocyclic Natural Products and the Chrysophaentin Family,"Bewley CA, Sulikowski GA, Yang ZJ, Bifulco G, Cho HM, Fullenkamp CR.",Acc Chem Res. 2023 Feb 21;56(4):414-424. doi: 10.1021/acs.accounts.2c00648. Epub 2023 Feb 2.,Bewley CA,Acc Chem Res,2023,2/2/2023,,,10.1021/acs.accounts.2c00648,FtsZ
35758678,Development and Application of Two Inducible Expression Systems for Streptococcus suis,"Zhang L, Zou W, Ni M, Hu Q, Zhao L, Liao X, Huang Q, Zhou R.",Microbiol Spectr. 2022 Aug 31;10(4):e0036322. doi: 10.1128/spectrum.00363-22. Epub 2022 Jun 27.,Zhang L,Microbiol Spectr,2022,27/6/2022,PMC9430170,,10.1128/spectrum.00363-22,FtsZ
30683747,A Novel AdpA Homologue Negatively Regulates Morphological Differentiation in Streptomyces xiamenensis 318,"Bu XL, Weng JY, He BB, Xu MJ, Xu J.",Appl Environ Microbiol. 2019 Mar 22;85(7):e03107-18. doi: 10.1128/AEM.03107-18. Print 2019 Apr 1.,Bu XL,Appl Environ Microbiol,2019,27/1/2019,PMC6585501,,10.1128/AEM.03107-18,FtsZ
37052704,Mutation of CsARC6 affects fruit color and increases fruit nutrition in cucumber,"Sun W, Li X, Huang H, Wei J, Zeng F, Huang Y, Sun Q, Miao W, Tian Y, Li Y, Gao L, Li X, Gao H.",Theor Appl Genet. 2023 Apr 13;136(5):111. doi: 10.1007/s00122-023-04337-7.,Sun W,Theor Appl Genet,2023,13/4/2023,,,10.1007/s00122-023-04337-7,FtsZ
33205554,Two novel heteropolymer-forming proteins maintain the multicellular shape of the cyanobacterium Anabaena sp. PCC 7120,"Springstein BL, Nürnberg DJ, Woehle C, Weissenbach J, Theune ML, Helbig AO, Maldener I, Dagan T, Stucken K.",FEBS J. 2021 May;288(10):3197-3216. doi: 10.1111/febs.15630. Epub 2020 Dec 10.,Springstein BL,FEBS J,2021,18/11/2020,,,10.1111/febs.15630,FtsZ
32915258,Morphological plasticity of hyperelongated cells caused by overexpression of translation elongation factor P in Synechococcus elongatus PCC7942,"Ngoennet S, Sirisattha S, Honda M, Hibino T, Kageyama H, Waditee-Sirisattha R.",Appl Microbiol Biotechnol. 2020 Oct;104(20):8801-8812. doi: 10.1007/s00253-020-10874-8. Epub 2020 Sep 11.,Ngoennet S,Appl Microbiol Biotechnol,2020,11/9/2020,,,10.1007/s00253-020-10874-8,FtsZ
31362350,"Molecular Analysis of Canine Filaria and Its Wolbachia Endosymbionts in Domestic Dogs Collected from Two Animal University Hospitals in Bangkok Metropolitan Region, Thailand","Satjawongvanit H, Phumee A, Tiawsirisup S, Sungpradit S, Brownell N, Siriyasatien P, Preativatanyou K.",Pathogens. 2019 Jul 29;8(3):114. doi: 10.3390/pathogens8030114.,Satjawongvanit H,Pathogens,2019,1/8/2019,PMC6789508,,10.3390/pathogens8030114,FtsZ
30871775,"Subunit interactions as mediated by ""non-interface"" residues in living cells for multiple homo-oligomeric proteins","Fu X, Wang Y, Song X, Shi X, Shao H, Liu Y, Zhang M, Chang Z.",Biochem Biophys Res Commun. 2019 Apr 23;512(1):100-105. doi: 10.1016/j.bbrc.2019.03.004. Epub 2019 Mar 11.,Fu X,Biochem Biophys Res Commun,2019,16/3/2019,,,10.1016/j.bbrc.2019.03.004,FtsZ
32028994,"Description, molecular characteristics and Wolbachia endosymbionts of Onchocerca borneensis Uni, Mat Udin & Takaoka n. sp. (Nematoda: Filarioidea) from the Bornean bearded pig Sus barbatus Müller (Cetartiodactyla: Suidae) of Sarawak, Malaysia","Uni S, Mat Udin AS, Agatsuma T, Junker K, Saijuntha W, Bunchom N, Fukuda M, Martin C, Lefoulon E, Labat A, Khan FAA, Low VL, Cheah PL, Lim YA, Ramli R, Belabut DM, Zainuri NA, Matsubayashi M, Omar H, Bhassu S, Uga S, Hashim R, Takaoka H, Azirun MS.",Parasit Vectors. 2020 Feb 6;13(1):50. doi: 10.1186/s13071-020-3907-8.,Uni S,Parasit Vectors,2020,8/2/2020,PMC7006428,,10.1186/s13071-020-3907-8,FtsZ
32312423,Protein-protein complexes as targets for drug discovery against infectious diseases,"Akhter Y, Hussain R.",Adv Protein Chem Struct Biol. 2020;121:237-251. doi: 10.1016/bs.apcsb.2019.11.012. Epub 2019 Dec 18.,Akhter Y,Adv Protein Chem Struct Biol,2020,22/4/2020,,,10.1016/bs.apcsb.2019.11.012,FtsZ
32241960,"Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer","Liao VWY, Kumari A, Narlawar R, Vignarajan S, Hibbs DE, Panda D, Groundwater PW.",Mol Pharmacol. 2020 Jun;97(6):409-422. doi: 10.1124/mol.119.118539. Epub 2020 Apr 2.,Liao VWY,Mol Pharmacol,2020,4/4/2020,,,10.1124/mol.119.118539,FtsZ
36522324,A secreted effector with a dual role as a toxin and as a transcriptional factor,"Wang D, Zhu L, Zhen X, Yang D, Li C, Chen Y, Wang H, Qu Y, Liu X, Yin Y, Gu H, Xu L, Wan C, Wang Y, Ouyang S, Shen X.",Nat Commun. 2022 Dec 16;13(1):7779. doi: 10.1038/s41467-022-35522-9.,Wang D,Nat Commun,2022,15/12/2022,PMC9755527,,10.1038/s41467-022-35522-9,FtsZ
30301234,Design of Antibacterial Agents: Alkyl Dihydroxybenzoates against Xanthomonas citri subsp. citri,"Nazaré AC, Polaquini CR, Cavalca LB, Anselmo DB, Saiki MFC, Monteiro DA, Zielinska A, Rahal P, Gomes E, Scheffers DJ, Ferreira H, Regasini LO.",Int J Mol Sci. 2018 Oct 6;19(10):3050. doi: 10.3390/ijms19103050.,Nazaré AC,Int J Mol Sci,2018,11/10/2018,PMC6213047,,10.3390/ijms19103050,FtsZ
34152602,"Characterization of a novel shrimp pathogen, Vibrio brasiliensis, isolated from Pacific white shrimp, Penaeus vannamei","Li G, Xie G, Wang H, Wan X, Li X, Shi C, Wang Z, Gong M, Li T, Wang P, Zhang Q, Huang J.",J Fish Dis. 2021 Oct;44(10):1543-1552. doi: 10.1111/jfd.13475. Epub 2021 Jun 21.,Li G,J Fish Dis,2021,21/6/2021,,,10.1111/jfd.13475,FtsZ
31937373,Identification and molecular characterization of Wolbachia strains in natural populations of Aedes albopictus in China,"Hu Y, Xi Z, Liu X, Wang J, Guo Y, Ren D, Wu H, Wang X, Chen B, Liu Q.",Parasit Vectors. 2020 Jan 14;13(1):28. doi: 10.1186/s13071-020-3899-4.,Hu Y,Parasit Vectors,2020,16/1/2020,PMC6961339,,10.1186/s13071-020-3899-4,FtsZ
